TW202313931A - Electron barrier material, organic semiconductor element and compound - Google Patents

Electron barrier material, organic semiconductor element and compound Download PDF

Info

Publication number
TW202313931A
TW202313931A TW111123192A TW111123192A TW202313931A TW 202313931 A TW202313931 A TW 202313931A TW 111123192 A TW111123192 A TW 111123192A TW 111123192 A TW111123192 A TW 111123192A TW 202313931 A TW202313931 A TW 202313931A
Authority
TW
Taiwan
Prior art keywords
general formula
group
substituted
atom
present
Prior art date
Application number
TW111123192A
Other languages
Chinese (zh)
Inventor
小澤寛晃
森尾桃子
後藤亜衣子
森本京
黃松慧
趙龍周
柏﨑貴弘
Original Assignee
日商九州有機光材股份有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/JP2022/023781 external-priority patent/WO2022270354A1/en
Application filed by 日商九州有機光材股份有限公司 filed Critical 日商九州有機光材股份有限公司
Publication of TW202313931A publication Critical patent/TW202313931A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56Ring systems containing three or more rings
    • C07D209/80[b, c]- or [b, d]-condensed
    • C07D209/82Carbazoles; Hydrogenated carbazoles
    • C07D209/86Carbazoles; Hydrogenated carbazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the ring system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • C07D491/044Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
    • C07D491/048Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being five-membered
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D519/00Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/02Boron compounds
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K11/00Luminescent, e.g. electroluminescent, chemiluminescent materials
    • C09K11/06Luminescent, e.g. electroluminescent, chemiluminescent materials containing organic luminescent materials
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02EREDUCTION OF GREENHOUSE GAS [GHG] EMISSIONS, RELATED TO ENERGY GENERATION, TRANSMISSION OR DISTRIBUTION
    • Y02E10/00Energy generation through renewable energy sources
    • Y02E10/50Photovoltaic [PV] energy
    • Y02E10/549Organic PV cells

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

This compound represented by a general formula is useful as an electron barrier material. R1 through R5 are a deuterium atom, a substituent other than a cyano group; n1, n3, n5 are 0-4; n2 is 0-3; n4 is 0-2; X is O or S; and Ar is a monocyclic arylene group or a monocyclic heteroarylene group.

Description

電子障壁材料、有機半導體元件及化合物Electron barrier materials, organic semiconductor elements and compounds

本發明係有關一種作為電子障壁材料有用的化合物及使用了該化合物之有機半導體元件。The present invention relates to a compound useful as an electron barrier material and an organic semiconductor device using the compound.

在積極地進行提高有機電致發光元件(有機EL元件)等有機半導體元件的性能之研究。例如,為了改善有機電致發光元件的元件壽命和驅動電壓,期望改善電子傳輸材料、空穴傳輸材料、電子障壁材料、空穴障壁材料等與電荷傳輸相關之材料的功能,因此還進行對該等材料的開發或改良。 例如,電子障壁材料為如下材料:設置於發光層與空穴傳輸層之間以阻止存在於發光層中之電子從發光層脫落至空穴傳輸層,並且承擔來自空穴傳輸層的空穴傳輸至發光層之功能之電子障壁層的材料。只要使用優異之電子障壁材料,則提高發光層中的電子和空穴的再鍵結機率,最終延長元件壽命。以往,作為電子障壁材料提出有各種化合物,例如在專利文獻1中,提出有具有下述結構之化合物。 We are actively conducting research to improve the performance of organic semiconductor devices such as organic electroluminescent devices (organic EL devices). For example, in order to improve the device life and driving voltage of organic electroluminescent elements, it is desired to improve the functions of materials related to charge transport such as electron transport materials, hole transport materials, electron barrier materials, and hole barrier materials. Development or improvement of other materials. For example, the electron barrier material is a material that is provided between the light-emitting layer and the hole transport layer to prevent electrons present in the light-emitting layer from dropping from the light-emitting layer to the hole transport layer, and undertakes hole transport from the hole transport layer The material of the electron barrier layer to the function of the light-emitting layer. As long as an excellent electron barrier material is used, the recombination probability of electrons and holes in the light-emitting layer will be increased, and the lifetime of the device will be prolonged. Conventionally, various compounds have been proposed as electron barrier materials. For example, Patent Document 1 proposes a compound having the following structure.

[化學式1]

Figure 02_image004
[chemical formula 1]
Figure 02_image004

[專利文獻1]WO2010/140482[Patent Document 1] WO2010/140482

然而,將上述化合物用作電子障壁材料之有機電致發光元件在元件壽命方面存在改善的餘地。因此,本發明人等以提供在用於有機電致發光元件時能夠延長元件壽命之電子障壁材料為課題進行了苦心探討。However, there is room for improvement in the lifetime of an organic electroluminescent device using the above compound as an electron barrier material. Therefore, the inventors of the present invention have earnestly studied to provide an electron barrier material capable of prolonging the device life when used in an organic electroluminescence device.

進行了苦心探討之結果,本發明人等發現了具有特定結構之化合物作為優異之電子障壁材料而發揮作用。本發明為依據該種見解而提出者,具體而言,具有以下結構。 [1]一種電子障壁材料,其係包含下述通式(1)所表示之化合物。 [化學式2]

Figure 02_image006
[式中,R 1~R 5分別獨立地表示氘原子或不包含氰基的取代基。R 1~R 5不與其他R 1~R 5或Ar鍵結而形成環狀結構,但是相鄰之R 3彼此可以相互鍵結而形成苯并氟骨架或苯并噻吩并骨架。n1、n3、n5分別獨立地表示0~4中的任一個整數,n2表示0~3中的任一個整數,n4表示0~2中的任一個整數。X表示氧原子或硫原子。Ar表示單環伸芳基或單環雜伸芳基,前述單環伸芳基及前述單環雜伸芳基可以經氘原子或不包含氰基的取代基取代。] [2]如[1]所述之電子障壁材料,其中,前述化合物具有下述通式(2A)所表示之結構。 [化學式3]
Figure 02_image008
[式中,R 1~R 6分別獨立地表示氘原子或不包含氰基的取代基。R 1~R 6不與其他R 1~R 6鍵結而形成環狀結構,但是相鄰之R 3彼此可以相互鍵結而形成苯并氟骨架或苯并噻吩并骨架。n1、n3、n5分別獨立地表示0~4中的任一個整數,n2、n6分別獨立地表示0~3中的任一個整數,n4表示0~2中的任一個整數。X表示氧原子或硫原子。] [3]如[1]所述之電子障壁材料,其中,前述化合物具有下述通式(2B)所表示之結構。 [化學式4]
Figure 02_image010
[式中,R 1~R 6分別獨立地表示氘原子或不包含氰基的取代基。R 1~R 6不與其他R 1~R 6鍵結而形成環狀結構,但是相鄰之R 3彼此可以相互鍵結而形成苯并氟骨架或苯并噻吩并骨架。n1、n3、n5分別獨立地表示0~4中的任一個整數,n2、n6分別獨立地表示0~3中的任一個整數,n4表示0~2中的任一個整數。X表示氧原子或硫原子。] [4]如[1]所述之電子障壁材料,其中,前述化合物具有下述通式(3)所表示之結構。 [化學式5]
Figure 02_image012
[式中,R 1~R 6分別獨立地表示氘原子或不包含氰基的取代基。R 1~R 6不與其他R 1~R 6鍵結而形成環狀結構,但是相鄰之R 3彼此可以相互鍵結而形成苯并氟骨架或苯并噻吩并骨架。n1、n3、n5分別獨立地表示0~4中的任一個整數,n2、n6分別獨立地表示0~3中的任一個整數,n4表示0~2中的任一個整數。其中,n1+n3+n4+n5為1以上。R 1及R 3~R 5中的一個或兩個表示可以被氘化的烷基或可以經氘原子取代的苯基。X表示氧原子或硫原子。] [5]如[2]至[4]之任一項所述之電子障壁材料,其中,n1、n2、n6為0。 [6]如[1]至[5]之任一項所述之電子障壁材料,其中,n3~n5分別獨立地為0或1。 [7]如[1]所述之電子障壁材料,其係具有下述中的任一個結構。 [化學式6]
Figure 02_image014
[8]如[1]至[7]之任一項所述之電子障壁材料,其係用於與下述通式(G)所表示之化合物組合使用。 通式(G) [化學式7]
Figure 02_image016
[在通式(G)中,X 1及X 2中的一者為氮原子,另一者為硼原子。R 1~R 26、A 1、A 2分別獨立地表示氫原子、氘原子或取代基。R 1和R 2、R 2和R 3、R 3和R 4、R 4和R 5、R 5和R 6、R 6和R 7、R 7和R 8、R 8和R 9、R 9和R 10、R 10和R 11、R 11和R 12、R 13和R 14、R 14和R 15、R 15和R 16、R 16和R 17、R 17和R 18、R 18和R 19、R 19和R 20、R 20和R 21、R 21和R 22、R 22和R 23、R 23和R 24、R 24和R 25、R 25和R 26可以彼此鍵結而形成環狀結構。其中,在X 1為氮原子時,R 17和R 18彼此鍵結而形成單鍵以形成吡咯環,在X 2為氮原子時,R 21和R 22彼此鍵結而形成單鍵以形成吡咯環。] 在本發明的一態樣中,在X 1為氮原子,R 7和R 8及R 21和R 22經由氮原子鍵結而形成6員環,R 17和R 18彼此鍵結而形成單鍵時,R 1~R 6中的至少一個為經取代或未經取代的芳基或者R 1和R 2、R 2和R 3、R 3和R 4、R 4和R 5、R 5和R 6中的任一個彼此鍵結而形成芳香環或雜芳環。在本發明的一態樣中,在X 1為硼原子,X 2為氮原子,R 7和R 8、R 17和R 18彼此鍵結而形成包含硼原子之環狀結構之情況下,該環狀結構為5~7員環,在為6員環之情況下,R 7和R 8、R 17和R 18彼此鍵結而形成-B(R 32)-、-CO-、-CS-或-N(R 27)-。R 27表示氫原子、氘原子或取代基。 [9]一種有機半導體元件,其係包含[1]至[7]之任一項所述之電子障壁材料。 [10]如[9]所述之有機半導體元件,其中,前述有機半導體元件為有機電致發光元件,該有機電致發光元件具有陽極、陰極及在前述陽極與前述陰極之間包括包含前述電子障壁材料之電子障壁層和發光層之至少兩層有機層。 [11]如[10]所述之有機半導體元件,其中,前述發光層包含主體材料和延遲螢光材料。 [12]如[10]所述之有機半導體元件,其中,前述發光層包含主體材料、延遲螢光材料及螢光發光材料,來自元件的發光中來自前述螢光發光材料的發光量最大。 [13]如[10]至[12]之任一項所述之有機半導體元件,其中,前述發光層與前述電子障壁層相鄰。 [14]如[10]至[13]之任一項所述之有機半導體元件,其中,前述發光層包含前述通式(G)所表示之化合物。 [15]如[10]至[14]之任一項所述之有機半導體元件,其中,前述發光層包含下述通式(4)所表示之化合物。 [化學式8]
Figure 02_image018
[在通式(4)中,R 21~R 23中的一個表示氰基或下述通式(5)所表示之基團,R 21~R 23的其餘兩個和R 24及R 25中的至少一個表示下述通式(6)所表示之基團,R 21~R 25的其餘部分表示氫原子或取代基(其中,在此所述之取代基不是氰基、下述通式(5)所表示之基團、下述通式(6)所表示之基團)。] [化學式9]
Figure 02_image020
[在通式(5)中,L 1表示單鍵或2價的連接基,R 31及R 32分別獨立地表示氫原子或取代基,*表示鍵結位置。] [化學式10]
Figure 02_image022
[在通式(6)中,L 2表示單鍵或2價的連接基,R 33及R 34分別獨立地表示氫原子或取代基,*表示鍵結位置。] [16]一種化合物,其係由前述通式(3)表示,其中,在n3+n4+n5為0時,R 1不是未經取代的苯基。 [發明效果] As a result of painstaking studies, the present inventors discovered that a compound having a specific structure functions as an excellent electron barrier material. This invention was made based on this knowledge, Specifically, it has the following structures. [1] An electron barrier material comprising a compound represented by the following general formula (1). [chemical formula 2]
Figure 02_image006
[wherein, R 1 to R 5 each independently represent a deuterium atom or a substituent not containing a cyano group. R 1 to R 5 are not bonded to other R 1 to R 5 or Ar to form a ring structure, but adjacent R 3 may bond to each other to form a benzofluoro skeleton or a benzothieno skeleton. n1, n3, and n5 each independently represent any integer of 0-4, n2 represents any integer of 0-3, and n4 represents any integer of 0-2. X represents an oxygen atom or a sulfur atom. Ar represents a monocyclic arylylene group or a monocyclic heteroarylylene group, and the aforementioned monocyclic arylylene group and the aforementioned monocyclic heteroarylylene group may be substituted by a deuterium atom or a substituent not containing a cyano group. ] [2] The electron barrier material according to [1], wherein the compound has a structure represented by the following general formula (2A). [chemical formula 3]
Figure 02_image008
[wherein, R 1 to R 6 each independently represent a deuterium atom or a substituent not containing a cyano group. R 1 to R 6 are not bonded to other R 1 to R 6 to form a ring structure, but adjacent R 3 may bond to each other to form a benzofluoro skeleton or a benzothieno skeleton. n1, n3, and n5 each independently represent any integer of 0-4, n2 and n6 each independently represent any integer of 0-3, and n4 represents any integer of 0-2. X represents an oxygen atom or a sulfur atom. ] [3] The electron barrier material according to [1], wherein the compound has a structure represented by the following general formula (2B). [chemical formula 4]
Figure 02_image010
[wherein, R 1 to R 6 each independently represent a deuterium atom or a substituent not containing a cyano group. R 1 to R 6 are not bonded to other R 1 to R 6 to form a ring structure, but adjacent R 3 may bond to each other to form a benzofluoro skeleton or a benzothieno skeleton. n1, n3, and n5 each independently represent any integer of 0-4, n2 and n6 each independently represent any integer of 0-3, and n4 represents any integer of 0-2. X represents an oxygen atom or a sulfur atom. ] [4] The electron barrier material according to [1], wherein the compound has a structure represented by the following general formula (3). [chemical formula 5]
Figure 02_image012
[wherein, R 1 to R 6 each independently represent a deuterium atom or a substituent not containing a cyano group. R 1 to R 6 are not bonded to other R 1 to R 6 to form a ring structure, but adjacent R 3 may bond to each other to form a benzofluoro skeleton or a benzothieno skeleton. n1, n3, and n5 each independently represent any integer of 0-4, n2 and n6 each independently represent any integer of 0-3, and n4 represents any integer of 0-2. However, n1+n3+n4+n5 is 1 or more. One or both of R 1 and R 3 to R 5 represent an alkyl group which may be deuterated or a phenyl group which may be substituted with a deuterium atom. X represents an oxygen atom or a sulfur atom. [5] The electron barrier material according to any one of [2] to [4], wherein n1, n2, and n6 are 0. [6] The electron barrier material according to any one of [1] to [5], wherein n3 to n5 are each independently 0 or 1. [7] The electron barrier material according to [1], which has any one of the following structures. [chemical formula 6]
Figure 02_image014
[8] The electron barrier material according to any one of [1] to [7], which is used in combination with a compound represented by the following general formula (G). General formula (G) [Chemical formula 7]
Figure 02_image016
[In the general formula (G), one of X 1 and X 2 is a nitrogen atom, and the other is a boron atom. R 1 to R 26 , A 1 and A 2 each independently represent a hydrogen atom, a deuterium atom or a substituent. R 1 and R 2 , R 2 and R 3 , R 3 and R 4 , R 4 and R 5 , R 5 and R 6 , R 6 and R 7 , R 7 and R 8 , R 8 and R 9 , R 9 and R 10 , R 10 and R 11 , R 11 and R 12 , R 13 and R 14 , R 14 and R 15 , R 15 and R 16 , R 16 and R 17 , R 17 and R 18 , R 18 and R 19 , R 19 and R 20 , R 20 and R 21 , R 21 and R 22 , R 22 and R 23 , R 23 and R 24 , R 24 and R 25 , R 25 and R 26 may be bonded to each other to form a ring shape structure. Wherein, when X 1 is a nitrogen atom, R 17 and R 18 are bonded to each other to form a single bond to form a pyrrole ring, and when X 2 is a nitrogen atom, R 21 and R 22 are bonded to each other to form a single bond to form a pyrrole ring ring. ] In one aspect of the present invention, X 1 is a nitrogen atom, R 7 and R 8 and R 21 and R 22 are bonded via nitrogen atoms to form a 6-membered ring, R 17 and R 18 are bonded to each other to form a single When a bond is used, at least one of R 1 to R 6 is a substituted or unsubstituted aryl group or R 1 and R 2 , R 2 and R 3 , R 3 and R 4 , R 4 and R 5 , R 5 and Any one of R 6 is bonded to each other to form an aromatic ring or a heteroaromatic ring. In one aspect of the present invention, when X 1 is a boron atom, X 2 is a nitrogen atom, and R 7 and R 8 , R 17 and R 18 are bonded to each other to form a ring structure containing a boron atom, the The ring structure is a 5-7-membered ring. In the case of a 6-membered ring, R 7 and R 8 , R 17 and R 18 are bonded to each other to form -B(R 32 )-, -CO-, -CS- or -N(R 27 )-. R 27 represents a hydrogen atom, a deuterium atom or a substituent. [9] An organic semiconductor device comprising the electron barrier material described in any one of [1] to [7]. [10] The organic semiconductor element as described in [9], wherein the organic semiconductor element is an organic electroluminescence element, and the organic electroluminescence element has an anode, a cathode, and an electrode containing the electrons between the anode and the cathode. The electron barrier layer of the barrier material and at least two organic layers of the light emitting layer. [11] The organic semiconductor device according to [10], wherein the light emitting layer includes a host material and a delayed fluorescent material. [12] The organic semiconductor device according to [10], wherein the light-emitting layer includes a host material, a delayed fluorescent material, and a fluorescent light-emitting material, and the amount of light emitted from the fluorescent light-emitting material is the largest among the light emitted from the device. [13] The organic semiconductor device according to any one of [10] to [12], wherein the light emitting layer is adjacent to the electron barrier layer. [14] The organic semiconductor device according to any one of [10] to [13], wherein the light-emitting layer contains the compound represented by the general formula (G). [15] The organic semiconductor device according to any one of [10] to [14], wherein the light-emitting layer contains a compound represented by the following general formula (4). [chemical formula 8]
Figure 02_image018
[In general formula (4), one of R 21 to R 23 represents a cyano group or a group represented by the following general formula (5), and the remaining two of R 21 to R 23 and R 24 and R 25 At least one of R 21 to R 25 represents a group represented by the following general formula (6), and the rest of R 21 to R 25 represent a hydrogen atom or a substituent (wherein, the substituent described here is not a cyano group, the following general formula ( 5) the group represented by, the group represented by the following general formula (6)). ] [chemical formula 9]
Figure 02_image020
[In general formula (5), L 1 represents a single bond or a divalent linking group, R 31 and R 32 each independently represent a hydrogen atom or a substituent, and * represents a bonding position. ] [chemical formula 10]
Figure 02_image022
[In general formula (6), L 2 represents a single bond or a divalent linking group, R 33 and R 34 each independently represent a hydrogen atom or a substituent, and * represents a bonding position. ] [16] A compound represented by the aforementioned general formula (3), wherein, when n3+n4+n5 is 0, R 1 is not an unsubstituted phenyl group. [Invention effect]

通式(1)所表示之化合物作為電子障壁材料有用,能夠有效地用於有機半導體元件中。例如,藉由將本發明的化合物用於有機電致發光元件的電子障壁層中,能夠延長元件壽命。The compound represented by the general formula (1) is useful as an electron barrier material and can be effectively used in an organic semiconductor device. For example, by using the compound of the present invention in an electron barrier layer of an organic electroluminescent device, the device life can be extended.

在以下中,對本發明的內容進行詳細說明。以下所記載之構成要件的說明有時依據本發明的代表性實施態樣或具體例而進行的,但是本發明並不限定於該種實施態樣或具體例。再者,在本發明中,使用“~”所表示之數值範圍表示包含“~”的前後中所記載之數值作為下限值及上限值之範圍。又,在本發明中,“由~組成”表示僅由“由~組成”的前面所記載者組成,並且不包含除此以外者。又,存在於本發明中所使用之化合物的分子內之氫原子的一部分或全部能夠取代為氘原子( 2H、氘D)。在本說明書的化學結構式中,氫原子表示為H或者省略其表示。例如,在省略表示與苯環的環骨架構成碳原子鍵結之原子時,設為在省略表示之部位H與環骨架構成碳原子鍵結者。在本說明書中,“取代基”這一術語表示除了氫原子及氘原子以外的原子或原子團。另一方面,“經取代或未經取代的”“可以經取代的”這一表現表示氫原子可以經氘原子或取代基取代。又,本發明中之“透明”是指可見光的透射率為50%以上,較佳為80%以上,更佳為90%以上,進一步較佳為99%以上。關於可見光的透射率,能夠藉由紫外-可見光分光光度計進行測定。 In the following, the contents of the present invention will be described in detail. The description of the constituent requirements described below may be based on representative embodiments or specific examples of the present invention, but the present invention is not limited to such embodiment or specific examples. In addition, in this invention, the numerical range represented by "-" means the range which includes the numerical value described before and after "-" as a lower limit and an upper limit. In addition, in the present invention, "consisting of -" means consisting of only those described above "consisting of -" and does not include other things. Also, some or all of the hydrogen atoms present in the molecule of the compound used in the present invention can be substituted with deuterium atoms ( 2 H, deuterium D). In the chemical structural formulas in this specification, a hydrogen atom is represented by H or omitted. For example, when an atom that is bonded to a carbon atom of the ring skeleton of a benzene ring is omitted, it is assumed that the H at the omitted site is bonded to a carbon atom of the ring skeleton. In this specification, the term "substituent" means an atom or an atom group other than a hydrogen atom and a deuterium atom. On the other hand, the expression "substituted or unsubstituted" and "may be substituted" means that a hydrogen atom may be substituted with a deuterium atom or a substituent. Also, "transparent" in the present invention means that the transmittance of visible light is 50% or more, preferably 80% or more, more preferably 90% or more, still more preferably 99% or more. The transmittance of visible light can be measured with an ultraviolet-visible spectrophotometer.

(通式(1)所表示之化合物) 在本發明中,使用下述通式(1)所表示之化合物。 [化學式11]

Figure 02_image024
(Compound Represented by General Formula (1)) In the present invention, a compound represented by the following general formula (1) is used. [chemical formula 11]
Figure 02_image024

在通式(1)中,R 1~R 5分別獨立地表示氘原子或不包含氰基的取代基。 在本發明的一態樣中,R 1~R 5的取代基分別獨立地為哈米特的σp值在-0.3~0.3的範圍內之取代基。在本發明的較佳的一態樣中,R 1~R 5的取代基分別獨立地為哈米特的σp值在-0.2~0.2的範圍內之取代基。在本發明的較佳的一態樣中,R 1~R 5的取代基分別獨立地為哈米特的σp值在-0.1~0.1的範圍內之取代基。在本發明的一態樣中,R 1~R 5的取代基分別獨立地為哈米特的σp值在大於0且0.3以下的範圍內之取代基。在本發明的一態樣中,R 1~R 5的取代基分別獨立地為哈米特的σp值在-0.3以上且小於0的範圍內之取代基。 其中,“哈米特的σp值”為由L.P.哈米特提出者,並且為將取代基對對位取代苯衍生物的反應速率或平衡造成之影響定量化者。具體而言,為在對位取代苯衍生物中之取代基與反應速率常數或平衡常數之間成立之下述式: log(k/k 0)=ρσp 或 log(K/K 0)=ρσp 中之取代基特有的常數(σp)。在上式中,k 0表示不具有取代基的苯衍生物的速率常數,k表示經取代基取代之苯衍生物的速率常數,K 0表示不具有取代基的苯衍生物的平衡常數,K表示經取代基取代之苯衍生物的平衡常數,ρ表示藉由反應的種類和條件來確定之反應常數。關於與本發明中之“哈米特的σp值”相關之說明和各取代基的數值,能夠參照與Hansch,C.et.al.,Chem.Rev.,91,165-195(1991)的σp值相關之記載。存在哈米特的σp值為負的基團顯示供電子性(供體性)且哈米特的σp值為正的基團顯示吸電子性(受體性)之傾向。 在本發明的一態樣中,R 1~R 5分別獨立地為不具有孤電子對的取代基。在本發明的一態樣中,R 1~R 5分別獨立地為不具有π電子的取代基。 In the general formula (1), R 1 to R 5 each independently represent a deuterium atom or a substituent not containing a cyano group. In one aspect of the present invention, the substituents of R 1 to R 5 are each independently a substituent whose Hammett's σp value is in the range of -0.3 to 0.3. In a preferred aspect of the present invention, the substituents of R 1 to R 5 are each independently a substituent whose Hammett's σp value is in the range of -0.2 to 0.2. In a preferred aspect of the present invention, the substituents of R 1 to R 5 are independently substituents with a Hammett's σp value in the range of -0.1 to 0.1. In one aspect of the present invention, the substituents of R 1 to R 5 are each independently a substituent with a Hammett's σp value in the range of greater than 0 and less than 0.3. In one aspect of the present invention, the substituents of R 1 to R 5 are each independently a substituent whose Hammett's σp value is in the range of -0.3 or more and less than 0. Among them, "Hammett's σp value" is proposed by LP Hammett, and is a quantification of the effect of substituents on the reaction rate or equilibrium of the para-substituted benzene derivative. Specifically, it is the following formula established between the substituents in the p-substituted benzene derivatives and the reaction rate constant or equilibrium constant: log(k/k 0 )=ρσp or log(K/K 0 )=ρσp A constant (σp) specific to the substituent in . In the above formula, k 0 represents the rate constant of benzene derivatives without substituents, k represents the rate constant of benzene derivatives substituted by substituents, K 0 represents the equilibrium constant of benzene derivatives without substituents, K represents an equilibrium constant of a benzene derivative substituted by a substituent, and ρ represents a reaction constant determined by the type and conditions of the reaction. For the description of "Hammett's σp value" in the present invention and the numerical value of each substituent, refer to the σp value of Hansch, C.et.al., Chem.Rev., 91, 165-195 (1991) related records. There is a tendency that a group having a negative Hammett's σp value exhibits electron donating property (donating property) and a group having a positive Hammett's σp value exhibits electron withdrawing property (accepting property). In one aspect of the present invention, R 1 to R 5 are each independently a substituent having no lone electron pair. In one aspect of the present invention, R 1 to R 5 are each independently a substituent without π electrons.

在本發明的一態樣中,R 1~R 5分別獨立地為選自包括烷基及芳基(例如,碳數6~30)之群組中的一個基團或兩個以上組合而獲得之基團。 In one aspect of the present invention, R 1 to R 5 are each independently a group selected from the group consisting of an alkyl group and an aryl group (for example, having 6 to 30 carbon atoms) or a combination of two or more group.

在本發明的一態樣中,R 1~R 5分別獨立地為可以經碳數6~20的芳基取代的碳數1~30的烷基。在本發明的一態樣中,R 1~R 5分別獨立地為可以經碳數1~30的烷基取代的碳數6~20的芳基。在本發明的一態樣中,R 1~R 5分別獨立地為碳數1~30的未經取代的烷基。在本發明的一態樣中,R 1~R 5分別獨立地為碳數6~20的未經取代的芳基。 In one aspect of the present invention, R 1 to R 5 are each independently an alkyl group with 1 to 30 carbons that may be substituted with an aryl group with 6 to 20 carbons. In one aspect of the present invention, R 1 to R 5 are each independently an aryl group with 6 to 20 carbons that may be substituted with an alkyl group with 1 to 30 carbons. In one aspect of the present invention, R 1 to R 5 are each independently an unsubstituted alkyl group having 1 to 30 carbons. In one aspect of the present invention, R 1 to R 5 are each independently an unsubstituted aryl group having 6 to 20 carbon atoms.

R 1~R 5不與其他R 1~R 5或Ar鍵結而形成環狀結構,但是相鄰之R 3彼此可以相互鍵結而形成苯并氟骨架或苯并噻吩并骨架。因此,通式(1)中的左側的二苯并呋喃(3環結構)不進一步與環縮環而成為4環以上的結構。又,通式(1)中的右側的苯并氟咔唑(5環結構)、苯并噻吩并咔唑(5環結構)、雙苯并氟咔唑(7環結構)、雙苯并噻吩并咔唑(7環結構)等不進一步與環縮環。再者,通式(1)的右側的結構為5環結構為較佳。亦即,在本發明的較佳的一態樣中,R 3彼此不相互鍵結而形成環狀結構。 R 1 to R 5 are not bonded to other R 1 to R 5 or Ar to form a ring structure, but adjacent R 3 may bond to each other to form a benzofluoro skeleton or a benzothieno skeleton. Therefore, the dibenzofuran (three-ring structure) on the left side in the general formula (1) becomes a structure of four or more rings without further ring-condensation. Also, benzofluorocarbazole (5-ring structure), benzothienocarbazole (5-ring structure), bisbenzofluorocarbazole (7-ring structure), and bisbenzothiophene on the right side of the general formula (1) And carbazole (7-ring structure), etc. will not be further condensed with the ring. Furthermore, it is preferable that the structure on the right side of the general formula (1) is a 5-ring structure. That is, in a preferred aspect of the present invention, R 3 are not bonded to each other to form a ring structure.

在通式(1)中,n1、n3、n5分別獨立地表示0~4中的任一個整數,n2表示0~3中的任一個整數,n4表示0~2中的任一個整數。在本發明的一態樣中,n1~n5分別獨立地為0~2中的任一個整數。在本發明的一態樣中,n1為0。在本發明的一態樣中,n2為0。在本發明的一態樣中,n3為0或1。在本發明的一態樣中,n4為0或1。在本發明的一態樣中,n5為0或1。在本發明的較佳的一態樣中,n3+n4+n5為1以上。在本發明的較佳的一態樣中,n3+n4+n5為1。在本發明的較佳的一態樣中,n3+n4+n5為2。在本發明的較佳的一態樣中,n1、n2、n4、n5為0,n3為1。在本發明的較佳的一態樣中,n1~n3、n5為0,n4為1。在本發明的較佳的一態樣中,n1~n4為0,n5為1。在本發明的較佳的一態樣中,n1、n2、n4為0,n3和n5為1。在本發明的較佳的一態樣中,n1、n2、n5為0,n3和n4為1。In general formula (1), n1, n3, and n5 each independently represent any integer of 0-4, n2 represents any integer of 0-3, and n4 represents any integer of 0-2. In one aspect of the present invention, n1-n5 are each independently any integer of 0-2. In an aspect of the present invention, n1 is 0. In an aspect of the present invention, n2 is 0. In an aspect of the present invention, n3 is 0 or 1. In an aspect of the present invention, n4 is 0 or 1. In an aspect of the present invention, n5 is 0 or 1. In a preferred aspect of the present invention, n3+n4+n5 is 1 or more. In a preferred aspect of the present invention, n3+n4+n5 is 1. In a preferred aspect of the present invention, n3+n4+n5 is 2. In a preferred aspect of the present invention, n1, n2, n4, n5 are 0, and n3 is 1. In a preferred aspect of the present invention, n1-n3 and n5 are 0, and n4 is 1. In a preferred aspect of the present invention, n1-n4 are 0, and n5 is 1. In a preferred aspect of the present invention, n1, n2, n4 are 0, and n3 and n5 are 1. In a preferred aspect of the present invention, n1, n2, n5 are 0, and n3 and n4 are 1.

在通式(1)中,X表示氧原子或硫原子。在本發明的一態樣中,X為硫原子。在本發明的較佳的一態樣中,X為氧原子。 在通式(1)中,單鍵從與X的右側鍵結之苯環的鄰位沿左下方向延伸。該單鍵可以與通式(1)的位於Ar的右側之咔唑結構的1~4位中的任一位鍵結。又,X亦可以與通式(1)的位於Ar的右側之咔唑結構的1~4位中的任一位鍵結。其中,單鍵和X分別與構成咔唑結構的骨架之相鄰之碳原子鍵結。因此,在單鍵在2位鍵結時,X在1位或3位鍵結。在單鍵在3位鍵結時,X在2位或4位鍵結。在單鍵在1位鍵結時,X在2位鍵結。在單鍵在4位鍵結時,X在3位鍵結。在通式(1)中,X記載於比單鍵更靠上方的位置上,但是通式(1)亦包含單鍵位於比X更靠下方之下述通式(1’)的結構。 [化學式12]

Figure 02_image026
In the general formula (1), X represents an oxygen atom or a sulfur atom. In one aspect of the present invention, X is a sulfur atom. In a preferred aspect of the present invention, X is an oxygen atom. In the general formula (1), the single bond extends in the lower left direction from the ortho position of the benzene ring bonded to the right side of X. This single bond may be bonded to any one of the 1-4 positions of the carbazole structure located on the right side of Ar in the general formula (1). In addition, X may be bonded to any one of the 1-4 positions of the carbazole structure located on the right side of Ar in the general formula (1). Wherein, the single bond and X are respectively bonded to adjacent carbon atoms of the skeleton constituting the carbazole structure. Therefore, when a single bond is bonded at 2-position, X is bonded at 1-position or 3-position. When a single bond is bonded at the 3rd position, X is bonded at the 2nd or 4th position. When a single bond is bonded at 1 position, X is bonded at 2 positions. When a single bond is bonded at 4-position, X is bonded at 3-position. In the general formula (1), X is described above the single bond, but the general formula (1) also includes the structure of the following general formula (1′) in which the single bond is located below the X. [chemical formula 12]
Figure 02_image026

作為與通式(1)的Ar鍵結之苯并氟咔唑-9-基,能夠採用經取代或未經取代的苯并氟[2,3-a]咔唑-9-基。又,亦能夠採用經取代或未經取代的苯并氟[3,2-a]咔唑-9-基。又,亦能夠採用經取代或未經取代的苯并氟[2,3-b]咔唑-9-基。又,亦能夠採用經取代或未經取代的苯并氟[3,2-b]咔唑-9-基。又,亦能夠採用經取代或未經取代的苯并氟[2,3-c]咔唑-9-基。又,亦能夠採用經取代或未經取代的苯并氟[3,2-c]咔唑-9-基。 作為與通式(1)的Ar鍵結之苯并噻吩并咔唑-9-基,能夠採用經取代或未經取代的苯并噻吩并[2,3-a]咔唑-9-基。又,亦能夠採用經取代或未經取代的苯并噻吩并[3,2-a]咔唑-9-基。又,亦能夠採用經取代或未經取代的苯并噻吩并[2,3-b]咔唑-9-基。又,亦能夠採用經取代或未經取代的苯并噻吩并[3,2-b]咔唑-9-基。又,亦能夠採用經取代或未經取代的苯并噻吩并[2,3-c]咔唑-9-基。又,亦能夠採用經取代或未經取代的苯并噻吩并[3,2-c]咔唑-9-基。 作為與通式(1)的Ar鍵結之雙苯并氟咔唑-9-基,能夠採用經取代或未經取代的雙苯并氟[2,3-a:2’,3’-f]咔唑-9-基。又,亦能夠採用經取代或未經取代的雙苯并氟[3,2-a:3’,2’-f]咔唑-9-基。又,亦能夠採用經取代或未經取代的雙苯并氟[2,3-b:2’,3’-e]咔唑-9-基。又,亦能夠採用經取代或未經取代的雙苯并氟[3,2-b:3’,2’-e]咔唑-9-基。又,亦能夠採用經取代或未經取代的雙苯并氟[2,3-c:2’,3’-d]咔唑-9-基。又,亦能夠採用經取代或未經取代的雙苯并氟[3,2-c:3’,2’-d]咔唑-9-基。 作為與通式(1)的Ar鍵結之雙苯并噻吩并咔唑-9-基,能夠採用經取代或未經取代的雙苯并噻吩并[2,3-a:2’,3’-f]咔唑-9-基。又,亦能夠採用經取代或未經取代的雙苯并噻吩并[3,2-a:3’,2’-f]咔唑-9-基。又,亦能夠採用經取代或未經取代的雙苯并噻吩并[2,3-b:2’,3’-e]咔唑-9-基。又,亦能夠採用經取代或未經取代的雙苯并噻吩并[3,2-b:3’,2’-e]咔唑-9-基。又,亦能夠採用經取代或未經取代的雙苯并噻吩并[2,3-c:2’,3’-d]咔唑-9-基。又,亦能夠採用經取代或未經取代的雙苯并噻吩并[3,2-c:3’,2’-d]咔唑-9-基。 As the benzofluorocarbazol-9-yl group bonded to Ar of the general formula (1), substituted or unsubstituted benzofluoro[2,3-a]carbazol-9-yl groups can be used. Also, a substituted or unsubstituted benzofluoro[3,2-a]carbazol-9-yl group can also be used. In addition, substituted or unsubstituted benzofluoro[2,3-b]carbazol-9-yl groups can also be used. In addition, substituted or unsubstituted benzofluoro[3,2-b]carbazol-9-yl groups can also be used. In addition, substituted or unsubstituted benzofluoro[2,3-c]carbazol-9-yl groups can also be used. In addition, substituted or unsubstituted benzofluoro[3,2-c]carbazol-9-yl groups can also be used. As the benzothienocarbazol-9-yl group bonded to Ar of the general formula (1), a substituted or unsubstituted benzothieno[2,3-a]carbazol-9-yl group can be used. In addition, a substituted or unsubstituted benzothieno[3,2-a]carbazol-9-yl group can also be used. In addition, a substituted or unsubstituted benzothieno[2,3-b]carbazol-9-yl group can also be used. In addition, a substituted or unsubstituted benzothieno[3,2-b]carbazol-9-yl group can also be used. In addition, a substituted or unsubstituted benzothieno[2,3-c]carbazol-9-yl group can also be used. In addition, a substituted or unsubstituted benzothieno[3,2-c]carbazol-9-yl group can also be used. As the bisbenzofluorocarbazol-9-yl group bonded to Ar of the general formula (1), substituted or unsubstituted bisbenzofluoro[2,3-a:2',3'-f ]carbazol-9-yl. Also, a substituted or unsubstituted bisbenzofluoro[3,2-a:3',2'-f]carbazol-9-yl group can also be used. Also, a substituted or unsubstituted bisbenzofluoro[2,3-b:2',3'-e]carbazol-9-yl group can also be used. Also, substituted or unsubstituted bisbenzofluoro[3,2-b:3',2'-e]carbazol-9-yl can also be used. Also, a substituted or unsubstituted bisbenzofluoro[2,3-c:2',3'-d]carbazol-9-yl group can also be used. Also, substituted or unsubstituted bisbenzofluoro[3,2-c:3',2'-d]carbazol-9-yl can also be used. As the bisbenzothienocarbazol-9-yl group bonded to Ar of the general formula (1), substituted or unsubstituted bisbenzothieno[2,3-a:2',3' -f]carbazol-9-yl. In addition, a substituted or unsubstituted bisbenzothieno[3,2-a:3',2'-f]carbazol-9-yl group can also be used. In addition, a substituted or unsubstituted bisbenzothieno[2,3-b:2',3'-e]carbazol-9-yl group can also be used. In addition, a substituted or unsubstituted bisbenzothieno[3,2-b:3',2'-e]carbazol-9-yl group can also be used. In addition, a substituted or unsubstituted bisbenzothieno[2,3-c:2',3'-d]carbazol-9-yl group can also be used. In addition, a substituted or unsubstituted bisbenzothieno[3,2-c:3',2'-d]carbazol-9-yl group can also be used.

將與通式(1)的Ar鍵結之經取代或未經取代的苯并氟咔唑-9-基和經取代或未經取代的苯并噻吩并咔唑-9-基的具體例例示於以下。其中,在本發明中能夠採用之結構不被該等具體例做限定性地解釋。在本發明中,*表示鍵結位置。Ph表示未經取代的苯基。又,在本發明中,甲基不表述為CH 3而如D7的左下方省略CH 3表述。 [化學式13]

Figure 02_image028
Figure 02_image030
Specific examples of substituted or unsubstituted benzofluorocarbazol-9-yl and substituted or unsubstituted benzothienocarbazol-9-yl bonded to Ar of the general formula (1) are illustrated in the following. However, the structures that can be adopted in the present invention are not limitedly interpreted by these specific examples. In the present invention, * represents a bonding position. Ph represents unsubstituted phenyl. Also, in the present invention, the methyl group is not expressed as CH 3 and the expression of CH 3 is omitted as in the lower left of D7. [chemical formula 13]
Figure 02_image028
Figure 02_image030

將上述D1~D64的所有氫原子取代為氘原子者以D1(D)~D64(D)的形式例示於此。又,將僅將與上述D7~D18、D37~D48的烷基鍵結之氫原子取代為氘原子者以D7(R)~D18(R)、D37(R)~D48(R)的形式例示於此。進而,將僅將與上述D19~D30、D49~D60的苯基鍵結之氫原子取代為氘原子者以D19(Ph)~D30(Ph)、D49(Ph)~D60(Ph)的形式例示於此。在本發明的較佳的一態樣中,與通式(1)的Ar鍵結之經取代或未經取代的苯并氟咔唑-9-基和經取代或未經取代的苯并噻吩并咔唑-9-基從D1~D60、D1(D)~D60(D)、D7(R)~D18(R)、D37(R)~D48(R)、D19(Ph)~D30(Ph)、D49(Ph)~D60(Ph)進行選擇,更佳為從D1~D30、D1(D)~D30(D)、D7(R)~D18(R)、D19(Ph)~D30(Ph)進行選擇。在本發明的較佳的一態樣中,從D7~D30、D37~D60、D7(D)~D30(D)、D37(D)~D60(D)、D7(R)~D18(R)、D37(R)~D48(R)、D19(Ph)~D30(Ph)、D49(Ph)~D60(Ph)進行選擇,更佳為從D19~D30、D49~D60、D19(D)~D30(D)、D49(D)~D60(D)、D19(Ph)~D30(Ph)、D49(Ph)~D60(Ph)進行選擇,進一步較佳為從D19~D30、D19(D)~D30(D)、D19(Ph)~D30(Ph)進行選擇。Those in which all the hydrogen atoms in D1 to D64 are replaced with deuterium atoms are exemplified here as D1(D) to D64(D). In addition, those in which only the hydrogen atoms bonded to the alkyl groups of D7-D18 and D37-D48 above are replaced with deuterium atoms are exemplified in the form of D7(R)-D18(R), D37(R)-D48(R) here. Furthermore, those in which only the hydrogen atoms bonded to the phenyl groups of D19 to D30 and D49 to D60 are replaced with deuterium atoms are exemplified in the form of D19 (Ph) to D30 (Ph), D49 (Ph) to D60 (Ph) here. In a preferred aspect of the present invention, the substituted or unsubstituted benzofluorocarbazol-9-yl and substituted or unsubstituted benzothiophene bonded to Ar of the general formula (1) And carbazol-9-yl from D1 ~ D60, D1 (D) ~ D60 (D), D7 (R) ~ D18 (R), D37 (R) ~ D48 (R), D19 (Ph) ~ D30 (Ph ), D49(Ph)~D60(Ph), more preferably from D1~D30, D1(D)~D30(D), D7(R)~D18(R), D19(Ph)~D30(Ph ) to select. In a preferred aspect of the present invention, from D7 to D30, D37 to D60, D7 (D) to D30 (D), D37 (D) to D60 (D), D7 (R) to D18 (R) , D37(R)~D48(R), D19(Ph)~D30(Ph), D49(Ph)~D60(Ph), more preferably from D19~D30, D49~D60, D19(D)~ D30(D), D49(D)~D60(D), D19(Ph)~D30(Ph), D49(Ph)~D60(Ph) for selection, more preferably from D19~D30, D19(D) ~D30(D), D19(Ph)~D30(Ph) to select.

在通式(1)中,Ar表示單環伸芳基或單環雜伸芳基。在此所述之單環伸芳基表示沒有縮環的伸苯基。又,單環雜伸芳基表示為沒有縮環的單一環狀結構的芳香環基且包含雜原子作為環骨架構成原子之基團。單環雜伸芳基的環骨架構成原子數量為5~7個為較佳,5或6個為更佳,例如能夠採用6個者。作為構成單環雜伸芳基的環骨架之雜原子,可以例示出氮原子、氧原子及硫原子,氮原子為較佳。作為構成單環雜伸芳基之環,可以舉出吡啶環、嗒𠯤環、嘧啶環、吡𠯤環、三𠯤環。 在通式(1)的右側表述之咔唑在構成Ar之單環的1位鍵結時,在通式(1)的左側表述之二苯并呋喃可以在構成Ar之單環中的任一個位置鍵結。較佳為二苯并呋喃在構成Ar之單環的3位或4位鍵結之情況。特佳為二苯并呋喃在構成Ar之單環的3位鍵結之情況(例如,Ar為經取代或未經取代的1,3-伸苯基之情況),並且比二苯并呋喃在2位或4位鍵結之情況更優異。 In the general formula (1), Ar represents a monocyclic arylylene group or a monocyclic heteroarylylene group. The monocyclic arylylene group mentioned here means a phenylene group without ring shrinkage. Also, the monocyclic heteroarylylene group means an aromatic ring group having a single ring structure without ring condensation and containing a heteroatom as a ring skeleton constituting atom. The number of atoms constituting the ring skeleton of the monocyclic heteroarylylene group is preferably 5 to 7, more preferably 5 or 6, for example, 6 atoms can be used. Examples of the heteroatom constituting the ring skeleton of the monocyclic heteroarylenyl group include nitrogen atom, oxygen atom and sulfur atom, and nitrogen atom is preferred. Examples of the ring constituting the monocyclic heteroarylenyl group include a pyridine ring, a pyridine ring, a pyrimidine ring, a pyridine ring and a tripyridine ring. When the carbazole expressed on the right side of the general formula (1) is bonded at the 1-position of the single ring constituting Ar, the dibenzofuran expressed on the left side of the general formula (1) can be in any of the single rings constituting Ar. positional bond. Preferably, dibenzofuran is bonded to the 3-position or 4-position of the monocyclic ring constituting Ar. Especially preferred is the case where dibenzofuran is bonded at the 3-position of the monocyclic ring constituting Ar (for example, the case where Ar is a substituted or unsubstituted 1,3-phenylene group), and is more effective than dibenzofuran in the The case of 2-position or 4-position bonding is more excellent.

Ar能夠採用之單環伸芳基及單環雜伸芳基可以分別經氘原子或不包含氰基的取代基取代。在本發明的較佳的一態樣中,選擇哈米特的σp值在-0.3~0.3的範圍內之取代基作為取代基。關於哈米特的σp值在-0.3~0.3的範圍內之取代基的說明和較佳範圍等,能夠參照R 1~R 5的對應之說明。在本發明的一態樣中,選擇不具有孤電子對的基團作為取代基。在本發明的一態樣中,選擇不具有π電子的基團作為取代基。在本發明的較佳的一態樣中,選擇選自包括烷基(例如,碳數1~40)及芳基(例如,碳數6~30)之群組中的一個基團或兩個以上組合而獲得之基團作為取代基。在本發明的較佳的一態樣中,選擇碳數1~30的烷基作為取代基。關於烷基的說明和較佳範圍,能夠參照R 1~R 5的對應之說明。 在本發明的較佳的一態樣中,Ar為可以經1~4個碳數1~20的烷基取代的伸苯基或可以經1~3個碳數1~20的烷基取代的單環雜伸芳基。在本發明的較佳的一態樣中,Ar為未經取代的伸苯基或未經取代的單環雜伸芳基。 The monocyclic arylylene and monocyclic heteroarylylene that Ar can adopt may be substituted with a deuterium atom or a substituent not containing a cyano group, respectively. In a preferred aspect of the present invention, a substituent whose Hammett's σp value is in the range of -0.3 to 0.3 is selected as the substituent. For the description and preferable range of the substituent whose Hammett's σp value is in the range of -0.3 to 0.3, the corresponding description of R 1 to R 5 can be referred to. In one aspect of the present invention, a group without a lone electron pair is selected as a substituent. In one aspect of the present invention, a group without π electrons is selected as a substituent. In a preferred aspect of the present invention, one or two groups selected from the group consisting of alkyl (for example, carbon number 1-40) and aryl group (for example, carbon number 6-30) are selected Groups obtained by combining the above are used as substituents. In a preferred aspect of the present invention, an alkyl group having 1 to 30 carbons is selected as the substituent. Regarding the description and preferable range of the alkyl group, the corresponding descriptions of R 1 to R 5 can be referred to. In a preferred aspect of the present invention, Ar is a phenylene group that may be substituted by 1 to 4 alkyl groups with 1 to 20 carbons or may be substituted by 1 to 3 alkyl groups with 1 to 20 carbons. Monocyclic heteroaryl. In a preferred aspect of the present invention, Ar is an unsubstituted phenylene group or an unsubstituted monocyclic heteroarylylene group.

將通式(1)的Ar的具體例例示於以下,但是在本發明中能夠採用之結構不被該等具體例做限定性地解釋。t-Bu表示三級丁基,Ph表示未經取代的苯基。 [化學式14]

Figure 02_image032
Specific examples of Ar in the general formula (1) are shown below, but the structures that can be employed in the present invention are not limitedly interpreted by these specific examples. t-Bu represents a tertiary butyl group, and Ph represents an unsubstituted phenyl group. [chemical formula 14]
Figure 02_image032

將上述Ar1~Ar15的所有氫原子取代為氘原子者以Ar1(D)~Ar15(D)的形式例示於此。又,將僅將與上述Ar2~Ar9的烷基鍵結之氫原子取代為氘原子者以Ar2(R)~Ar9(R)的形式例示於此。進而,將僅將與上述Ar10的苯基鍵結之氫原子取代為氘原子者以Ar10(Ph)的形式例示於此。在本發明的較佳的一態樣中,通式(1)的Ar從Ar1~Ar9、Ar1(D)~Ar9(D)、Ar2(R)~Ar9(R)進行選擇,更佳為從Ar1~Ar9進行選擇。在本發明的較佳的一態樣中,通式(1)的Ar為Ar1或Ar1(D),更佳為Ar1。Those in which all the hydrogen atoms of Ar1 to Ar15 are replaced with deuterium atoms are exemplified here as Ar1(D) to Ar15(D). Also, those in which only hydrogen atoms bonded to the alkyl groups of Ar2 to Ar9 are substituted with deuterium atoms are exemplified here as Ar2 (R) to Ar9 (R). Furthermore, what replaced only the hydrogen atom bonded to the phenyl group of Ar10 with a deuterium atom is shown here as Ar10 (Ph). In a preferred aspect of the present invention, Ar of the general formula (1) is selected from Ar1~Ar9, Ar1(D)~Ar9(D), Ar2(R)~Ar9(R), more preferably from Ar1 to Ar9 are selected. In a preferred aspect of the present invention, Ar in the general formula (1) is Ar1 or Ar1(D), more preferably Ar1.

在通式(1)的左側表述之二苯并呋喃可以在1~4位中的任一位中與Ar鍵結。在本發明的較佳的一態樣中,二苯并呋喃在2位與Ar鍵結。在本發明的一態樣中,二苯并呋喃在1位與Ar鍵結。在本發明的一態樣中,二苯并呋喃在3位與Ar鍵結。在本發明的一態樣中,二苯并呋喃在4位與Ar鍵結。再者,二苯并呋喃的1~4位如下。 [化學式15]

Figure 02_image034
The dibenzofuran represented on the left side of the general formula (1) may be bonded to Ar at any one of the 1-4 positions. In a preferred aspect of the present invention, dibenzofuran is bonded to Ar at the 2-position. In one aspect of the present invention, dibenzofuran is bonded to Ar at the 1-position. In one aspect of the present invention, dibenzofuran is bonded to Ar at the 3-position. In one aspect of the present invention, dibenzofuran is bonded to Ar at the 4-position. In addition, the 1-4 positions of dibenzofuran are as follows. [chemical formula 15]
Figure 02_image034

將與通式(1)的Ar鍵結之二苯并呋喃基的具體例例示於以下,但是在本發明中能夠採用之結構不被該等具體例做限定性地解釋。 [化學式16]

Figure 02_image036
Specific examples of the dibenzofuran group bonded to Ar of the general formula (1) are shown below, but the structures that can be employed in the present invention are not limitedly interpreted by these specific examples. [chemical formula 16]
Figure 02_image036

將上述B1~B12的所有氫原子取代為氘原子者以B1(D)~B12(D)的形式例示於此。又,將僅將與上述B2、B5、B8、B11的烷基鍵結之氫原子取代為氘原子者以B2(R)、B5(R)、B8(R)、B11(R)的形式例示於此。進而,將僅將與上述B3、B6、B9、B12的苯基鍵結之氫原子取代為氘原子者以B3(Ph)、B6(Ph)、B9(Ph)、B12(Ph)的形式例示於此。在本發明的較佳的一態樣中,與通式(1)的Ar鍵結之二苯并呋喃基從B1~B3、B1(D)~B3(D)、B2(R)、B3(Ph)進行選擇,更佳為從B1~B3進行選擇。在本發明的一態樣中,與通式(1)的Ar鍵結之二苯并呋喃基從B1、B4、B7、B10、B1(D)、B4(D)、B7(D)、B10(D)進行選擇,更佳為從B1、B4、B7、B10進行選擇。Those in which all the hydrogen atoms of B1 to B12 are replaced with deuterium atoms are exemplified here as B1(D) to B12(D). In addition, those in which only the hydrogen atoms bonded to the alkyl groups of B2, B5, B8, and B11 above are replaced with deuterium atoms are exemplified in the form of B2 (R), B5 (R), B8 (R), and B11 (R). here. Furthermore, those in which only the hydrogen atoms bonded to the phenyl groups of B3, B6, B9, and B12 are substituted with deuterium atoms are exemplified in the form of B3 (Ph), B6 (Ph), B9 (Ph), and B12 (Ph) here. In a preferred aspect of the present invention, the dibenzofuran group bonded to Ar of the general formula (1) is from B1 to B3, B1 (D) to B3 (D), B2 (R), B3 ( Ph), more preferably from B1 to B3. In one aspect of the present invention, the dibenzofuran group bonded to Ar of the general formula (1) is from B1, B4, B7, B10, B1(D), B4(D), B7(D), B10 (D) Select, more preferably select from B1, B4, B7, B10.

本發明中之“烷基”可以為直鏈狀、支鏈狀、環狀中的任一個。又,可以混合存在直鏈部分、環狀部分及支鏈部分中的兩種以上。烷基的碳數例如能夠設為1以上、2以上、4以上。又,碳數能夠設為30以下、20以下、10以下、6以下、4以下。作為烷基的具體例,可以舉出甲基、乙基、正丙基、異丙基、正丁基、異丁基、三級丁基、正戊基、異戊基、正己基、環戊基、環己基、環庚基。在本發明的一態樣中,烷基的碳數為1~4。在本發明的一態樣中,烷基為甲基。在本發明的一態樣中,烷基為異丙基。在本發明的一態樣中,烷基為三級丁基。在通式(1)所表示之分子內存在複數個烷基時,該等烷基可以彼此相同,亦可以不同。在本發明的一態樣中,通式(1)所表示之分子內的烷基均為相同。通式(1)所表示之分子內的烷基的數量能夠設為零個以上、一個以上、兩個以上、四個以上、八個以上。通式(1)所表示之分子內的烷基的數量可以設為20個以下、10個以下、5個以下、3個以下。通式(1)所表示之分子內的烷基的數量可以為零個。再者,在此所述之烷基的數量亦包含取代為苯基之烷基的數量。 本發明中之“可以經烷基取代的苯基”表示存在於苯基中之五個氫原子中的至少一個可以經烷基取代。在本發明的一態樣中,苯基經0~3個烷基取代。例如,經0~2個烷基取代。在本發明的一態樣中,苯基未經烷基取代。取代為苯基之烷基的碳數為1~6為較佳,1~4為更佳。例如,可以舉出4-甲基苯基、3-甲基苯基、3,5-二甲基苯基、2,4,6-三甲基苯基、2,3,4,5,6-七甲基苯基、4-異丙基苯基、3-異丙基苯基、3,5-二異丙基苯基、4-三級丁基苯基、3-三級丁基苯基、3,5-二三級丁基苯基。又,亦能夠例示出該等具體例中的烷基取代基中存在之氫原子全部取代為氘原子之基團。進而,亦能夠例示出該等具體例中存在之所有氫原子取代為氘原子之基團。 本發明中之“可以被氘化的烷基”表示烷基的氫原子中的至少一個可以取代為氘原子。烷基的氫原子均可以取代為氘原子。例如,可以被氘化的甲基包含CH 3、CDH 2、CD 2H、CD 3。“可以被氘化的烷基”為完全不被氘化的烷基或所有氫原子取代為氘原子之烷基為較佳。在本發明的一態樣中,作為“可以被氘化的烷基”,選擇完全不被氘化的烷基。在本發明的一態樣中,作為“可以被氘化的烷基”,選擇所有氫原子取代為氘原子之烷基。 The "alkyl" in the present invention may be any of linear, branched and cyclic. In addition, two or more types of linear moieties, cyclic moieties, and branched moieties may be present in admixture. The carbon number of the alkyl group can be, for example, 1 or more, 2 or more, or 4 or more. In addition, the carbon number can be 30 or less, 20 or less, 10 or less, 6 or less, and 4 or less. Specific examples of the alkyl group include methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, tertiary butyl, n-pentyl, isopentyl, n-hexyl, cyclopentyl, base, cyclohexyl, cycloheptyl. In one aspect of the present invention, the carbon number of the alkyl group is 1-4. In one aspect of the invention, the alkyl group is methyl. In one aspect of the invention, the alkyl group is isopropyl. In one aspect of the invention, the alkyl group is tertiary butyl. When a plurality of alkyl groups exist in the molecule represented by the general formula (1), these alkyl groups may be the same as or different from each other. In one aspect of the present invention, the alkyl groups in the molecules represented by the general formula (1) are all the same. The number of alkyl groups in the molecule represented by the general formula (1) can be zero or more, one or more, two or more, four or more, and eight or more. The number of alkyl groups in the molecule represented by general formula (1) may be 20 or less, 10 or less, 5 or less, or 3 or less. The number of alkyl groups in the molecule represented by general formula (1) may be zero. Furthermore, the number of alkyl groups mentioned here also includes the number of alkyl groups substituted with phenyl groups. The "phenyl group which may be substituted with an alkyl group" in the present invention means that at least one of the five hydrogen atoms present in the phenyl group may be substituted with an alkyl group. In one aspect of the present invention, the phenyl group is substituted with 0-3 alkyl groups. For example, substituted with 0 to 2 alkyl groups. In one aspect of the invention, the phenyl groups are not substituted with alkyl groups. The carbon number of the alkyl group substituted with phenyl is preferably 1-6, more preferably 1-4. For example, 4-methylphenyl, 3-methylphenyl, 3,5-dimethylphenyl, 2,4,6-trimethylphenyl, 2,3,4,5,6 -Heptamethylphenyl, 4-isopropylphenyl, 3-isopropylphenyl, 3,5-diisopropylphenyl, 4-tertiary butylphenyl, 3-tertiary butylphenyl group, 3,5-two tertiary butylphenyl. In addition, a group in which all hydrogen atoms present in the alkyl substituent in these specific examples are substituted with deuterium atoms can also be exemplified. Furthermore, a group in which all hydrogen atoms present in these specific examples are substituted with deuterium atoms can also be exemplified. The "alkyl group that may be deuterated" in the present invention means that at least one of the hydrogen atoms of the alkyl group may be replaced by a deuterium atom. All hydrogen atoms of the alkyl group may be substituted with deuterium atoms. For example, methyl groups that can be deuterated include CH3 , CDH2 , CD2H , CD3 . The "alkyl group that may be deuterated" is preferably an alkyl group that is not deuterated at all or an alkyl group in which all hydrogen atoms are replaced with deuterium atoms. In one aspect of the present invention, as the "alkyl group that may be deuterated", an alkyl group that is not deuterated at all is selected. In one aspect of the present invention, as the "alkyl group that may be deuterated", an alkyl group in which all hydrogen atoms are replaced with deuterium atoms is selected.

在通式(1)中,不存在氰基。在本發明的較佳的一態樣中,通式(1)僅由碳原子、氫原子、氮原子、氧原子及硫原子組成。在本發明的較佳的一態樣中,通式(1)僅由碳原子、氫原子、氮原子及氧原子組成。通式(1)所表示之化合物的分子量為499以上,700以下為較佳,600以下為更佳,例如可以為550以下,亦可以為530以下。In the general formula (1), no cyano group is present. In a preferred aspect of the present invention, the general formula (1) consists only of carbon atoms, hydrogen atoms, nitrogen atoms, oxygen atoms and sulfur atoms. In a preferred aspect of the present invention, the general formula (1) consists only of carbon atoms, hydrogen atoms, nitrogen atoms and oxygen atoms. The molecular weight of the compound represented by general formula (1) is 499 or more, Preferably it is 700 or less, More preferably, it is 600 or less, For example, it may be 550 or less, and may be 530 or less.

作為通式(1)所表示之化合物,可以較佳地例示出下述通式(2A)所表示之化合物。 [化學式17]

Figure 02_image038
As a compound represented by General formula (1), the compound represented by following General formula (2A) can be illustrated preferably. [chemical formula 17]
Figure 02_image038

作為通式(1)所表示之化合物,可以較佳地例示出下述通式(2B)所表示之化合物。 [化學式18]

Figure 02_image040
As a compound represented by General formula (1), the compound represented by following General formula (2B) can be illustrated preferably. [chemical formula 18]
Figure 02_image040

關於通式(2A)及通式(2B)中之R 1~R 5、n1~n5、X的定義和說明,能夠參照通式(1)的對應之定義和說明。 關於通式(2A)及通式(2B)中之R 6的定義和說明,能夠參照通式(1)的R 1~R 5的定義和說明。通式(2A)及通式(2B)中之n6為0~3中的任一個整數。n6能夠在0~2的範圍內進行選擇或者設為0或1,0亦較佳。通式(2A)及通式(2B)中之n1~n6能夠分別獨立地在0~2的範圍內進行選擇或者設為0或1。又,n1~n6均可以為0。 在通式(2A)及通式(2B)所表示之結構中,特佳為在通式(2A)及通式(2B)中(R 6n6鍵結之伸苯基為1,3-伸苯基(甲基伸苯基)之結構。 For the definitions and descriptions of R 1 to R 5 , n1 to n5, and X in the general formula (2A) and the general formula (2B), reference can be made to the corresponding definitions and descriptions of the general formula (1). For the definition and description of R 6 in the general formula (2A) and the general formula (2B), reference can be made to the definition and description of R 1 to R 5 in the general formula (1). n6 in general formula (2A) and general formula (2B) is any integer among 0-3. n6 can be selected from the range of 0 to 2 or set to 0 or 1, and 0 is also preferable. n1-n6 in general formula (2A) and general formula (2B) can each independently be selected within the range of 0-2, or can be set to 0 or 1. Also, all of n1 to n6 may be 0. In the structures represented by the general formula (2A) and the general formula (2B), it is particularly preferred that the (R 6 ) n6 -bonded phenylene group in the general formula (2A) and the general formula (2B) is 1,3- The structure of phenylene (methyl phenylene).

作為通式(1)所表示之化合物,可以特佳地例示出下述通式(3)所表示之化合物。 [化學式19]

Figure 02_image042
As a compound represented by General formula (1), the compound represented by following General formula (3) can be illustrated particularly preferably. [chemical formula 19]
Figure 02_image042

在通式(3)中,R 1~R 6分別獨立地表示氘原子或不包含氰基的取代基。R 1~R 6不與其他R 1~R 6鍵結而形成環狀結構,但是相鄰之R 3彼此可以相互鍵結而形成苯并氟骨架或苯并噻吩并骨架。n1、n3、n5分別獨立地表示0~4中的任一個整數,n2、n6分別獨立地表示0~3中的任一個整數,n4表示0~2中的任一個整數。其中,n1+n3+n4+n5為1以上。R 1及R 3~R 5中的一個或兩個表示可以被氘化的烷基或可以經氘原子取代的苯基。X表示氧原子或硫原子。 關於通式(3)的R 1~R 6、n1~n6的定義和說明,能夠參照通式(2A)及通式(2B)的R 1~R 6、n1~n6的定義和說明,僅在通式(3)中,n1+n3+n4+n5為1以上,R 1及R 3~R 5中的一個或兩個表示可以被氘化的烷基或可以經氘原子取代的苯基(以下中,“苯基A”稱為)之點不同。在通式(3)中,R 1及R 3~R 5中的三個以上不是苯基A。在本發明的一態樣中,僅一個R 1為苯基A。在本發明的一態樣中,僅一個R 3為苯基A。在本發明的一態樣中,僅一個R 4為苯基A。在本發明的一態樣中,僅一個R 5為苯基A。在本發明的一態樣中,僅一個R 3和一個R 4為苯基A。在本發明的一態樣中,僅一個R 3和一個R 5為苯基A。在本發明的一態樣中,僅一個R 4和一個R 5為苯基A。在本發明中,僅兩個R 3、僅兩個R 4或僅兩個R 5可以為苯基A。再者,在n3+n4+n5為0時,R 1不是未經取代的苯基為較佳。 在本發明的一態樣中,R 3~R 5中的至少一個為苯基A,n3+n4+n5為1以上。在從構成咔唑的環骨架之氮原子的鍵結位置觀察時,R 3~R 5的苯基A中的至少一個在間位(咔唑環的2位)鍵結。在本發明的較佳的一態樣中,在從構成咔唑的環骨架之氮原子的鍵結位置觀察時,R 3~R 5的苯基A中的至少一個在對位(咔唑環的3位)鍵結。在本發明的一態樣中,在從構成咔唑的環骨架之氮原子的鍵結位置觀察時,R 3~R 5的苯基A僅在間位(咔唑環的2位)鍵結。在本發明的較佳的一態樣中,在從構成咔唑的環骨架之氮原子的鍵結位置觀察時,R 3~R 5的苯基A僅在對位(咔唑環的3位)鍵結。在本發明的一態樣中,在從構成苯并氟結構的環骨架之氧原子或構成苯并噻吩并結構的環骨架之硫原子的鍵結位置觀察時,R 3~R 5的苯基A僅在對位鍵結。在本發明的較佳的一態樣中,在從構成咔唑的環骨架之氮原子的鍵結位置觀察時,R 3~R 5的苯基A在對位鍵結一個,在從構成苯并氟結構的環骨架之氧原子或構成苯并噻吩并結構的環骨架之硫原子的鍵結位置觀察時,R 3~R 5的苯基A在對位鍵結一個。 在本發明的一態樣中,苯基A為可以經可以被氘化的烷基取代的苯基。在本發明的較佳的一態樣中,苯基A為可以經氘原子取代的苯基。在本發明的特佳的一態樣中,苯基A為未經取代的苯基。 通式(3)中之n3+n4+n5為1~10中的任一個整數,1~8中的任一個整數為較佳,1~6中的任一個整數為更佳,1~4中的任一個整數為進一步較佳。在本發明的較佳的一態樣中,n3+n4+n5為1。在本發明的較佳的一態樣中,n3+n4+n5為2。 In the general formula (3), R 1 to R 6 each independently represent a deuterium atom or a substituent not containing a cyano group. R 1 to R 6 are not bonded to other R 1 to R 6 to form a ring structure, but adjacent R 3 may bond to each other to form a benzofluoro skeleton or a benzothieno skeleton. n1, n3, and n5 each independently represent any integer of 0-4, n2 and n6 each independently represent any integer of 0-3, and n4 represents any integer of 0-2. However, n1+n3+n4+n5 is 1 or more. One or both of R 1 and R 3 to R 5 represent an alkyl group which may be deuterated or a phenyl group which may be substituted with a deuterium atom. X represents an oxygen atom or a sulfur atom. Regarding the definitions and descriptions of R 1 to R 6 and n1 to n6 in general formula (3), you can refer to the definitions and descriptions of R 1 to R 6 and n1 to n6 in general formula (2A) and general formula (2B). In the general formula (3), n1+n3+n4+n5 is 1 or more, and one or two of R 1 and R 3 to R 5 represent an alkyl group that may be deuterated or a phenyl group that may be substituted by a deuterium atom (hereinafter referred to as "phenyl A") is different. In the general formula (3), three or more of R 1 and R 3 to R 5 are not phenyl A. In one aspect of the invention, only one R 1 is phenyl A. In one aspect of the invention, only one R3 is phenyl A. In one aspect of the invention, only one R4 is phenyl A. In one aspect of the invention, only one R 5 is phenyl A. In one aspect of the invention, only one R3 and one R4 is phenyl A. In one aspect of the invention, only one R3 and one R5 is phenyl A. In one aspect of the invention, only one R4 and one R5 is phenyl A. In the present invention, only two R 3 , only two R 4 or only two R 5 may be phenyl A. Furthermore, when n3+n4+n5 is 0, it is preferable that R1 is not an unsubstituted phenyl group. In one aspect of the present invention, at least one of R 3 to R 5 is phenyl A, and n3+n4+n5 is 1 or more. At least one of the phenyl groups A of R 3 to R 5 is bonded at the meta position (2-position of the carbazole ring) when viewed from the bonding position of the nitrogen atom constituting the ring skeleton of the carbazole. In a preferred aspect of the present invention, when viewed from the bonding position of the nitrogen atom constituting the ring skeleton of carbazole, at least one of the phenyl groups A of R 3 to R 5 is in the para position (carbazole ring 3 bits) bonded. In one aspect of the present invention, when viewed from the bonding position of the nitrogen atom constituting the ring skeleton of carbazole, the phenyl groups A of R 3 to R 5 are bonded only at the meta position (2-position of the carbazole ring). . In a preferred aspect of the present invention, when viewed from the bonding position of the nitrogen atom constituting the ring skeleton of carbazole, the phenyl A of R 3 to R 5 is only in the para position (the 3 position of the carbazole ring ) bond. In one aspect of the present invention, when viewed from the bonding position of the oxygen atom constituting the ring skeleton of the benzofluorine structure or the sulfur atom constituting the ring skeleton of the benzothieno structure, the phenyl groups of R 3 to R 5 A bonds only in the para position. In a preferred aspect of the present invention, when viewed from the bonding position of the nitrogen atom constituting the ring skeleton of carbazole, one of the phenyl groups A of R 3 to R 5 is bonded at the para position, When observing the bonding position of the oxygen atom of the ring skeleton of the fluorine structure or the sulfur atom constituting the ring skeleton of the benzothieno structure, one of the phenyl groups A of R 3 to R 5 is bonded at the para position. In one aspect of the present invention, the phenyl group A is a phenyl group that may be substituted with an alkyl group that may be deuterated. In a preferred aspect of the present invention, the phenyl group A is a phenyl group that may be substituted with a deuterium atom. In a particularly preferred aspect of the present invention, phenyl A is unsubstituted phenyl. n3+n4+n5 in general formula (3) is any integer from 1 to 10, preferably any integer from 1 to 8, more preferably any integer from 1 to 6, and any integer from 1 to 4 Any integer of is further preferred. In a preferred aspect of the present invention, n3+n4+n5 is 1. In a preferred aspect of the present invention, n3+n4+n5 is 2.

例如,在意圖藉由蒸鍍法將包含通式(1)所表示之化合物之有機層形成為膜而使用之情況下,通式(1)所表示之化合物的分子量為1500以下為較佳,1200以下為更佳,1000以下為進一步較佳,900以下為更進一步較佳。分子量的下限值為通式(1)所表示之化合物組的最小化合物的分子量。 通式(1)所表示之化合物與分子量無關地可以藉由塗佈法進行成膜。只要使用塗佈法,則即使為分子量相對大的化合物亦能夠進行成膜。通式(1)所表示之化合物具有容易溶解於有機溶劑中等優點。因此,通式(1)所表示之化合物容易適用塗佈法且容易純化以提高純度。 For example, when the organic layer containing the compound represented by the general formula (1) is intended to be used as a film by vapor deposition, the molecular weight of the compound represented by the general formula (1) is preferably 1500 or less. 1200 or less is more preferable, 1000 or less is still more preferable, and 900 or less is still more preferable. The lower limit of the molecular weight is the molecular weight of the smallest compound of the compound group represented by the general formula (1). The compound represented by the general formula (1) can be formed into a film by a coating method regardless of the molecular weight. As long as the coating method is used, even a compound with a relatively large molecular weight can be formed into a film. The compound represented by the general formula (1) has the advantage of being easily soluble in organic solvents. Therefore, the compound represented by the general formula (1) is easy to apply the coating method and is easy to purify to increase the purity.

通式(1)所表示之化合物不包含金屬原子或硼原子為較佳。例如,作為通式(1)所表示之化合物,能夠選擇由選自包括碳原子、氫原子、氘原子、氮原子、氧原子及硫原子之群組中的原子組成之化合物。例如,作為通式(1)所表示之化合物,能夠選擇由選自包括碳原子、氫原子、氘原子、氮原子及氧原子之群組中的原子組成之化合物。例如,作為通式(1)所表示之化合物,能夠選擇由選自包括碳原子、氫原子、氮原子及氧原子之群組中的原子組成之化合物。The compound represented by the general formula (1) preferably does not contain metal atoms or boron atoms. For example, as the compound represented by the general formula (1), a compound composed of atoms selected from the group consisting of carbon atoms, hydrogen atoms, deuterium atoms, nitrogen atoms, oxygen atoms, and sulfur atoms can be selected. For example, as the compound represented by the general formula (1), a compound composed of atoms selected from the group consisting of carbon atoms, hydrogen atoms, deuterium atoms, nitrogen atoms, and oxygen atoms can be selected. For example, as the compound represented by the general formula (1), a compound composed of atoms selected from the group consisting of carbon atoms, hydrogen atoms, nitrogen atoms, and oxygen atoms can be selected.

在以下,舉出通式(1)所表示之化合物的具體例,但是在本發明中能夠使用之化合物不被該等具體例做限定性地解釋。再者,P6~P14中之D表示氘原子。 [化學式20]

Figure 02_image044
Figure 02_image046
Figure 02_image048
Figure 02_image050
Figure 02_image052
Figure 02_image054
Specific examples of the compound represented by the general formula (1) are given below, but compounds usable in the present invention are not limitedly interpreted by these specific examples. Furthermore, D in P6 to P14 represents a deuterium atom. [chemical formula 20]
Figure 02_image044
Figure 02_image046
Figure 02_image048
Figure 02_image050
Figure 02_image052
Figure 02_image054

作為通式(1)所表示之化合物,亦能夠採用下述化合物。 [化學式21]

Figure 02_image056
As the compound represented by the general formula (1), the following compounds can also be used. [chemical formula 21]
Figure 02_image056

作為通式(1)所表示之化合物,亦能夠採用下述化合物。 [化學式22]

Figure 02_image058
As the compound represented by the general formula (1), the following compounds can also be used. [chemical formula 22]
Figure 02_image058

作為通式(1)所表示之化合物,亦能夠採用下述化合物。 [化學式23]

Figure 02_image060
As the compound represented by the general formula (1), the following compounds can also be used. [chemical formula 23]
Figure 02_image060

作為通式(1)所表示之化合物,亦能夠採用下述化合物。 [化學式24]

Figure 02_image062
As the compound represented by the general formula (1), the following compounds can also be used. [chemical formula 24]
Figure 02_image062

作為通式(1)所表示之化合物,亦能夠採用下述化合物。 [化學式25]

Figure 02_image064
As the compound represented by the general formula (1), the following compounds can also be used. [chemical formula 25]
Figure 02_image064

作為通式(1)所表示之化合物,亦能夠採用下述化合物。 [化學式26]

Figure 02_image066
As the compound represented by the general formula (1), the following compounds can also be used. [chemical formula 26]
Figure 02_image066

作為通式(1)所表示之化合物,亦能夠採用下述化合物。 [化學式27]

Figure 02_image068
As the compound represented by the general formula (1), the following compounds can also be used. [chemical formula 27]
Figure 02_image068

[化學式28]

Figure 02_image070
[chemical formula 28]
Figure 02_image070

將化合物1a~47n的所有氫原子取代為氘原子者以化合物1a(D)~化合物47n(D)的形式例示於此。將僅將與化合物1a~21d的苯基鍵結之氫原子取代為氘原子者以化合物1a(Ph)~化合物21d(Ph)的形式例示於此。 在本發明中,作為比化合物22、23更佳的化合物,可以舉出化合物1a~21d。在本發明的一態樣中,從化合物na(n為1~21的整數,在此所述之化合物na表示由化合物1a、2a、3a・・・21a組成之組)進行選擇。在本發明的較佳的一態樣中,從化合物nb(n表示1~21的整數)進行選擇。在本發明的一態樣中,從化合物nc(n表示1~21的整數)進行選擇。在本發明的一態樣中,從化合物nd(n表示1~21的整數)進行選擇。在本發明的一態樣中,從化合物1a~5d進行選擇。在本發明的一態樣中,從化合物7a~9d進行選擇。在本發明的一態樣中,從化合物10a~12d進行選擇。在本發明的一態樣中,從化合物13a~15d進行選擇。在本發明的一態樣中,從化合物16a~18d進行選擇。在本發明的一態樣中,從化合物19a~21d進行選擇。 又,在本發明中,作為比化合物23更佳的化合物,可以舉出化合物24a~47n,作為進一步較佳的化合物,可以舉出化合物24a~27n。在本發明的一態樣中,從化合物24a~24n進行選擇。在本發明的一態樣中,從化合物25a~25n進行選擇。在本發明的一態樣中,從化合物26a~26n進行選擇。在本發明的一態樣中,從化合物27a~27n進行選擇。在本發明的一態樣中,從化合物24a、25a、26a、27a、24f、25f、26f、27f進行選擇。 Compounds 1a to 47n in which all the hydrogen atoms are replaced by deuterium atoms are exemplified here as compounds 1a(D) to 47n(D). Compounds 1a (Ph) to 21d (Ph) in which only hydrogen atoms bonded to the phenyl groups of Compounds 1a to 21d are substituted with deuterium atoms are exemplified here. In the present invention, compounds 1a to 21d are examples of compounds more preferable than compounds 22 and 23. In one aspect of the present invention, it is selected from the compound na (n is an integer of 1 to 21, and the compound na described here represents the group consisting of compounds 1a, 2a, 3a···21a). In a preferred aspect of the present invention, it is selected from compound nb (n represents an integer of 1-21). In one aspect of the present invention, it is selected from compound nc (n represents an integer of 1 to 21). In one aspect of the present invention, it is selected from compound nd (n represents an integer of 1-21). In one aspect of the present invention, compounds 1a to 5d are selected. In one aspect of the present invention, compounds 7a to 9d are selected. In one aspect of the present invention, compounds 10a to 12d are selected. In one aspect of the present invention, compounds 13a to 15d are selected. In one aspect of the present invention, compounds 16a-18d are selected. In one aspect of the present invention, compounds 19a-21d are selected. Moreover, in the present invention, compounds 24a to 47n are mentioned as compounds more preferable than compound 23, and compounds 24a to 27n are mentioned as further preferable compounds. In one aspect of the present invention, compounds 24a-24n are selected. In one aspect of the present invention, compounds 25a-25n are selected. In one aspect of the present invention, compounds 26a-26n are selected. In one aspect of the present invention, compounds 27a-27n are selected. In one aspect of the invention, compounds 24a, 25a, 26a, 27a, 24f, 25f, 26f, 27f are selected.

在本發明的較佳的一態樣中,通式(1)所表示之化合物從下述化合物組進行選擇。 [化學式29]

Figure 02_image072
Figure 02_image074
Figure 02_image076
In a preferred aspect of the present invention, the compound represented by the general formula (1) is selected from the following compound groups. [chemical formula 29]
Figure 02_image072
Figure 02_image074
Figure 02_image076

在本說明書中,關於作為電子障壁材料或主體材料有用的化合物,還揭示下述通式(A)所表示之化合物。 [化學式30]

Figure 02_image078
In this specification, the compound represented by the following general formula (A) is also disclosed about the compound useful as an electron barrier material or a host material. [chemical formula 30]
Figure 02_image078

在通式(A)中,X 1表示氧原子或硫原子。X 2表示氧原子、硫原子、N(R 7)或C(R 8)(R 9)。R 1~R 6分別獨立地表示選自包括氘原子、烷基及芳基之群組中的一個原子或基團或者兩個以上組合而獲得之基團。至少一個R 1為可以經選自包括氘原子、烷基及芳基之群組中的一個原子或基團或者兩個以上組合而獲得之基團取代的芳基。R 1~R 6不與其他R 1~R 6鍵結而形成環狀結構,但是相鄰之R 3彼此可以相互鍵結而形成苯并氟骨架或苯并噻吩并骨架。n1表示1~4的整數,n3、n5、n6分別獨立地表示0~4中的任一個整數,n2表示0~3中的任一個整數,n4表示0~2中的任一個整數。再者,在通式(A)中,(R 5n5鍵結之苯環和(R 4n4鍵結之苯環藉由單鍵和經由X 2之連接基這兩個鍵連接,但是該等兩個鍵的左右的位置關係亦可以相反。亦即,在上述通式(A)中,在左側示出單鍵且在右側示出經由X 2之連接基,但是在右側示出單鍵且在左側示出經由X 2之連接基之結構亦包含於通式(A)中。 In the general formula (A), X 1 represents an oxygen atom or a sulfur atom. X 2 represents an oxygen atom, a sulfur atom, N(R 7 ) or C(R 8 )(R 9 ). R 1 to R 6 each independently represent one atom or group selected from the group including a deuterium atom, an alkyl group and an aryl group, or a group obtained by combining two or more. At least one R 1 is an aryl group which may be substituted with one atom or group selected from the group consisting of a deuterium atom, an alkyl group, and an aryl group, or a group obtained by combining two or more. R 1 to R 6 are not bonded to other R 1 to R 6 to form a ring structure, but adjacent R 3 may bond to each other to form a benzofluoro skeleton or a benzothieno skeleton. n1 represents an integer of 1-4, n3, n5, and n6 each independently represent any integer of 0-4, n2 represents any integer of 0-3, and n4 represents any integer of 0-2. Furthermore, in the general formula (A), the (R 5 ) n5 -bonded benzene ring and the (R 4 ) n4 -bonded benzene ring are linked by a single bond and a linker via X 2 , but The left and right positional relationship of these two keys can also be reversed. That is, in the above general formula (A), a single bond is shown on the left side and a linking group via X2 is shown on the right side, but a single bond is shown on the right side and a linking group via X2 is shown on the left side It is also included in the general formula (A).

在本發明的較佳的一態樣中,X 1和X 2相同。在本發明的一態樣中,X 1和X 2不同。在本發明的較佳的一態樣中,X 1和X 2均為氧原子。在本發明的一態樣中,X 1和X 2均為硫原子。在本發明的一態樣中,X 1為氧原子,X 2為硫原子。在本發明的一態樣中,X 1為硫原子,X 2為氧原子。在本發明的一態樣中,X 1為氧原子,X 2為N(R 7)。在本發明的一態樣中,X 1為氧原子,X 2為C(R 8)(R 9)。在本發明的較佳的一態樣中,X 1為氧原子。在本發明的較佳的一態樣中,X 2為氧原子或硫原子,更佳為氧原子。 In a preferred aspect of the present invention, X1 and X2 are the same. In one aspect of the invention, X1 and X2 are different. In a preferred aspect of the present invention, both X1 and X2 are oxygen atoms. In one aspect of the present invention, both X1 and X2 are sulfur atoms. In one aspect of the present invention, X 1 is an oxygen atom, and X 2 is a sulfur atom. In one aspect of the present invention, X 1 is a sulfur atom, and X 2 is an oxygen atom. In one aspect of the present invention, X 1 is an oxygen atom, and X 2 is N(R 7 ). In one aspect of the present invention, X 1 is an oxygen atom, and X 2 is C(R 8 )(R 9 ). In a preferred aspect of the present invention, X 1 is an oxygen atom. In a preferred aspect of the present invention, X 2 is an oxygen atom or a sulfur atom, more preferably an oxygen atom.

R 1~R 6分別獨立地為選自包括氘原子、烷基及芳基之群組中的一個原子或基團或者兩個以上組合而獲得之基團,較佳為氘原子、可以經氘原子取代的烷基或者可以經選自包括氘原子、烷基及芳基之群組中的一個原子或基團或者兩個以上組合而獲得之基團取代的芳基。在本發明的較佳的一態樣中,R 1~R 6分別獨立地為氘原子或者可以經選自包括氘原子及芳基之群組中的一個原子或基團或者兩個以上組合而獲得之基團取代的芳基。通式(1)的說明中之烷基的碳數能夠在通常1~40、較佳為1~15、更佳為1~6、例如1~3的範圍內進行選擇。芳基的碳數能夠在通常6~30、較佳為6~18、更佳為6~14、例如6~10的範圍內進行選擇。在本發明的一態樣中,R 3彼此相互鍵結而形成苯并氟骨架。在本發明的一態樣中,R 3彼此相互鍵結而形成苯并噻吩并骨架。苯并氟骨架或苯并噻吩并骨架可以經選自包括氘原子、烷基及芳基之群組中的一個原子或基團或者兩個以上組合而獲得之基團取代。在本發明的一態樣中,R 3彼此不相互鍵結而形成環狀結構。 R 1 to R 6 are each independently an atom or group selected from the group consisting of a deuterium atom, an alkyl group and an aryl group, or a group obtained by combining two or more, preferably a deuterium atom, which can be deuterium An atom-substituted alkyl group or an aryl group which may be substituted with one atom or group selected from the group consisting of a deuterium atom, an alkyl group, and an aryl group, or a group obtained by combining two or more. In a preferred aspect of the present invention, R 1 to R 6 are each independently a deuterium atom, or can be formed by an atom or group selected from the group including a deuterium atom and an aryl group, or a combination of two or more The obtained radical substituted aryl. The carbon number of the alkyl group in the description of general formula (1) can be selected within the range of 1-40 normally, Preferably it is 1-15, More preferably, it is 1-6, For example, 1-3. The carbon number of an aryl group can be selected within the range of 6-30 normally, Preferably it is 6-18, More preferably, it is 6-14, For example, 6-10. In one aspect of the present invention, R 3 are bonded to each other to form a benzofluorine skeleton. In one aspect of the present invention, R 3 are bonded to each other to form a benzothieno skeleton. The benzofluorine skeleton or the benzothieno skeleton may be substituted with one atom or group selected from the group including a deuterium atom, an alkyl group, and an aryl group, or a group obtained by combining two or more. In one aspect of the present invention, R 3 are not bonded to each other to form a ring structure.

至少一個R 1為可以經選自包括氘原子、烷基及芳基之群組中的一個原子或基團或者兩個以上組合而獲得之基團取代的芳基,更佳為可以經選自包括氘原子、烷基及芳基之群組中的一個原子或基團或者兩個以上組合而獲得之基團取代的苯基,進一步較佳為可以經選自包括氘原子及苯基之群組中的一個原子或基團或者兩個以上組合而獲得之基團取代的苯基。在本發明的一態樣中,該種R 1為未經取代的芳基或所有氫原子經氘原子取代之芳基,較佳為未經取代的苯基或所有氫原子經氘原子取代之苯基。在本發明的較佳的一態樣中,僅一個R 1為可以經選自包括氘原子、烷基及芳基之群組中的一個原子或基團或者兩個以上組合而獲得之基團取代的芳基。在本發明的一態樣中,兩個R 1為可以經選自包括氘原子、烷基及芳基之群組中的一個原子或基團或者兩個以上組合而獲得之基團取代的芳基。作為至少一個R 1能夠採用之基團的具體例,可以舉出上述P1~P14。其中,在本發明中能夠採用之R 1不被該等具體例做限定性地解釋。 再者,在通式(A)中,在從右側與(R 5n5鍵結之苯環鍵結之基團[通式(A)的右方的5環基]為苯并氟[3,2-a]咔唑基時,R 1不是未經取代的苯基。 At least one R 1 is an aryl group that may be substituted by an atom or group selected from the group including a deuterium atom, an alkyl group, and an aryl group, or a group obtained by combining two or more, and more preferably may be substituted by a group selected from A phenyl group substituted by one atom or group in the group including a deuterium atom, an alkyl group and an aryl group, or a group obtained by combining two or more groups, further preferably, it can be selected from the group including a deuterium atom and a phenyl group A phenyl group substituted by one atom or group in the group or a combination of two or more groups. In one aspect of the present invention, the R is an unsubstituted aryl group or an aryl group in which all hydrogen atoms are substituted by deuterium atoms, preferably an unsubstituted phenyl group or an aryl group in which all hydrogen atoms are substituted by deuterium atoms phenyl. In a preferred aspect of the present invention, only one R is a group that can be obtained through one atom or group selected from the group including deuterium atom, alkyl group and aryl group, or a combination of two or more Substituted aryl. In one aspect of the present invention, two R 1 are aryl that may be substituted by one atom or group selected from the group consisting of deuterium atom, alkyl and aryl, or a group obtained by combining two or more base. Specific examples of the group that can be used as at least one R 1 include the aforementioned P1 to P14. Among them, R 1 that can be used in the present invention is not limitedly interpreted by these specific examples. Furthermore, in the general formula (A), the group [ the 5- ring group on the right side of the general formula (A)] that is bonded to the benzene ring bonded to (R 5 ) n5 from the right side is benzofluoro[3 ,2-a] carbazolyl, R 1 is not unsubstituted phenyl.

在通式(A)所表示之化合物中,例如可以較佳地採用下述通式(A1)所表示之化合物。 [化學式31]

Figure 02_image080
Among the compounds represented by the general formula (A), for example, a compound represented by the following general formula (A1) can be preferably used. [chemical formula 31]
Figure 02_image080

關於通式(A1)中之X 1、X 2、R 1~R 6、n1~n6的定義和說明,能夠參照上述通式(A)的對應之記載。 For the definition and description of X 1 , X 2 , R 1 to R 6 , and n1 to n6 in the general formula (A1), reference can be made to the corresponding description of the above general formula (A).

[有機半導體元件] 通式(1)所表示之化合物能夠較佳地適用於有機半導體元件中。例如,能夠製作使用了通式(1)所表示之化合物之CMOS(互補型金屬氧化膜半導體)等。在本揭示的某一實施形態中,能夠使用通式(1)所表示之化合物來製作有機電致發光元件或固體攝像元件(例如,CMOS圖像感測器)等有機發光元件。其中,本發明的通式(1)所表示之化合物能夠用於有機電致發光元件(有機EL元件)等有機發光元件中。尤其,本發明的通式(1)所表示之化合物能夠有效地用作有機發光元件的電子障壁材料。尤其,藉由將本發明的通式(1)所表示之化合物用於電子障壁層中,能夠延長元件壽命。 [Organic semiconductor device] The compound represented by the general formula (1) can be suitably used in organic semiconductor devices. For example, CMOS (Complementary Metal Oxide Semiconductor) etc. using the compound represented by the general formula (1) can be produced. In a certain embodiment of the present disclosure, organic light-emitting devices such as organic electroluminescent devices and solid-state imaging devices (for example, CMOS image sensors) can be produced using the compound represented by the general formula (1). Among them, the compound represented by the general formula (1) of the present invention can be used in organic light-emitting devices such as organic electroluminescent devices (organic EL devices). In particular, the compound represented by the general formula (1) of the present invention can be effectively used as an electron barrier material of an organic light-emitting device. In particular, the device life can be extended by using the compound represented by the general formula (1) of the present invention for the electron barrier layer.

有機電致發光元件至少具有陽極、陰極及陽極與陰極之間形成有機層之結構。有機層為至少包括發光層者,並且為除了發光層以外還具有一層以上的有機層(尤其,電子障壁層)者為較佳。作為構成有機電致發光元件之有機層,可以舉出空穴傳輸層、空穴注入層、電子障壁層、空穴障壁層、電子注入層、電子傳輸層、激子障壁層、發光層用基底層等。空穴傳輸層可以為具有空穴注入功能之空穴注入傳輸層,電子傳輸層可以為具有電子注入功能之電子注入傳輸層。 在以下中,對有機電致發光元件的各構件及各層進行說明。再者,基板和發光層的說明亦對應於有機光致發光元件的基板和發光層。 The organic electroluminescent element has at least an anode, a cathode, and a structure in which an organic layer is formed between the anode and the cathode. The organic layer includes at least a light-emitting layer, and preferably has one or more organic layers (especially electron barrier layers) in addition to the light-emitting layer. Examples of the organic layer constituting the organic electroluminescent element include a hole transport layer, a hole injection layer, an electron barrier layer, a hole barrier layer, an electron injection layer, an electron transport layer, an exciton barrier layer, and a substrate for a light emitting layer. layers etc. The hole transport layer can be a hole injection transport layer with a hole injection function, and the electron transport layer can be an electron injection transport layer with an electron injection function. In the following, each member and each layer of the organic electroluminescence element will be described. Furthermore, the description of the substrate and the light-emitting layer also corresponds to the substrate and the light-emitting layer of the organic photoluminescence element.

(電子障壁層) 在本發明的較佳的一態樣中,通式(1)所表示之化合物用於有機電致發光元件的電子障壁層中。電子障壁層可以僅包含通式(1)所表示之化合物,亦可以包含除了通式(1)所表示之化合物以外的化合物。電子障壁層中之通式(1)所表示之化合物的濃度為50重量%以上為較佳,90重量%以上為更佳,例如可以設為99重量%以上,亦可以設為99.9重量%以上。電子障壁層的厚度為1nm以上為較佳,3nm以上為更佳,例如能夠設為5nm以上或者例如設為10nm以上。電子障壁層的厚度小於30nm為較佳,小於20nm為更佳,例如能夠設為15nm以下。電子障壁層的厚度小於發光層的厚度為較佳。電子障壁層的厚度為發光層的厚度的1/2以下為較佳,1/3以下為更佳,例如能夠設為1/4以下。又,1/20以上為較佳,例如能夠設為1/10以上或者例如設為1/6以上。 包含通式(1)所表示之化合物之電子障壁層設置於發光層與陽極之間為較佳。在本發明的一態樣中,發光層與電子障壁層以直接接觸的方式積層。 在本發明的一態樣中,包括從陽極側依序積層包含通式(1)所表示之化合物之電子障壁層、基底層、發光層之積層結構。電子障壁層與基底層以直接接觸的方式積層,基底層與發光層以直接接觸的方式積層,但是電子障壁層與發光層不接觸。 (Electron barrier layer) In a preferred aspect of the present invention, the compound represented by the general formula (1) is used in the electron barrier layer of the organic electroluminescent device. The electron barrier layer may contain only the compound represented by General formula (1), or may contain a compound other than the compound represented by General formula (1). The concentration of the compound represented by the general formula (1) in the electron barrier layer is preferably 50% by weight or more, more preferably 90% by weight or more, for example, 99% by weight or more, or 99.9% by weight or more . The thickness of the electron barrier layer is preferably 1 nm or more, more preferably 3 nm or more, and can be, for example, 5 nm or more or, for example, 10 nm or more. The thickness of the electron barrier layer is preferably less than 30 nm, more preferably less than 20 nm, and can be, for example, 15 nm or less. The thickness of the electron barrier layer is preferably smaller than that of the light emitting layer. The thickness of the electron barrier layer is preferably 1/2 or less of the thickness of the light emitting layer, more preferably 1/3 or less, for example, can be set to 1/4 or less. Moreover, 1/20 or more is preferable, For example, it can be 1/10 or more or, for example, 1/6 or more. It is preferable that the electron barrier layer containing the compound represented by general formula (1) is provided between a light emitting layer and an anode. In one aspect of the present invention, the light emitting layer and the electron barrier layer are laminated in direct contact. One aspect of the present invention includes a laminated structure in which an electron barrier layer containing a compound represented by general formula (1), a base layer, and a light emitting layer are sequentially laminated from the anode side. The electron barrier layer and the base layer are laminated in direct contact, and the base layer and the light-emitting layer are laminated in direct contact, but the electron barrier layer and the light-emitting layer are not in contact.

(基底層) 基底層為以提高發光層的取向性等目的而形成者,並且為包含空穴傳輸性的材料之層。在本發明的一態樣中,基底層包含具有與發光層中所包含之化合物共同的部分結構之化合物。在此所述之共同的部分結構表示由除了氫原子和氘原子以外的原子12個以上組成之部分結構共同,由除了氫原子和氘原子以外的原子16個以上組成之部分結構共同為較佳,例如由除了氫原子和氘原子以外的原子20個以上組成之部分結構可以共同。在本發明的一態樣中,基底層包含與發光層中所包含之化合物相同的化合物。在本發明的一態樣中,基底層僅包含與發光層中所包含之化合物相同的化合物。在本發明的一態樣中,基底層包含與發光層中所包含之主體材料相同的化合物。基底層的厚度為1nm以上為較佳,3nm以上為更佳,例如能夠設為5nm以上。相鄰層的厚度小於30nm為較佳,小於20nm為更佳,例如能夠設為10nm以下或者設為7nm以下。基底層的厚度小於發光層的厚度為較佳。基底層的厚度為發光層的厚度的1/2以下為較佳,1/3以下為更佳,例如能夠設為1/4以下。又,1/20以上為較佳,例如能夠設為1/10以上。基底層的厚度小於電子障壁層的厚度為較佳。基底層的厚度例如能夠設為電子障壁層的厚度的3/4以下、例如設為2/3以下或者例如設為1/2以下。又,1/20以上為較佳,例如能夠設為1/10以上或者例如設為1/4以上。 (basal layer) The base layer is formed for the purpose of improving the orientation of the light-emitting layer, etc., and is a layer containing a hole-transporting material. In one aspect of the present invention, the base layer contains a compound having a common partial structure with the compound contained in the light emitting layer. The common partial structure mentioned here means that the partial structure composed of 12 or more atoms other than hydrogen atom and deuterium atom is common, and the partial structure composed of 16 or more atoms other than hydrogen atom and deuterium atom is preferably common , for example, a partial structure composed of 20 or more atoms other than hydrogen atoms and deuterium atoms may be common. In one aspect of the present invention, the base layer contains the same compound as that contained in the light emitting layer. In one aspect of the present invention, the base layer only contains the same compounds as those contained in the light-emitting layer. In one aspect of the present invention, the base layer contains the same compound as the host material contained in the light emitting layer. The thickness of the base layer is preferably at least 1 nm, more preferably at least 3 nm, and can be, for example, at least 5 nm. The thickness of the adjacent layer is preferably less than 30 nm, more preferably less than 20 nm, and can be set to, for example, 10 nm or less or 7 nm or less. The thickness of the base layer is preferably smaller than that of the light emitting layer. The thickness of the base layer is preferably 1/2 or less of the thickness of the light emitting layer, more preferably 1/3 or less, for example, can be set to 1/4 or less. Moreover, 1/20 or more is preferable, For example, it can be set as 1/10 or more. The thickness of the base layer is preferably smaller than that of the electron barrier layer. The thickness of the base layer can be, for example, 3/4 or less, for example, 2/3 or less, or, for example, 1/2 or less of the thickness of the electron barrier layer. Moreover, 1/20 or more is preferable, For example, it can be set as 1/10 or more or, for example, 1/4 or more.

(發光層) 發光層為藉由分別從陽極及陰極注入之空穴及電子再鍵結而生成激子之後發光之層。發光層至少包含發光材料。 為了使有機電致發光元件顯現出高發光效率,將發光材料的單重態激子及三重態激子限制在發光材料中是重要的。因此,在發光層中除了發光材料以外還使用主體材料為較佳。作為主體材料,能夠使用激發單重態能量具有高於本發明的發光材料的值之有機化合物,使用激發單重態能量和激發三重態能量均具有高於發光材料的值之有機化合物為較佳。藉由使用主體材料,能夠將發光材料中所生成之單重態激子及三重態激子限制在發光材料的分子中,並且能夠充分發揮該發光效率。然而,還有即使無法充分限制單重態激子及三重態激子,亦能夠獲得高發光效率的情況,因此只要為能夠實現高發光效率之主體材料,則能夠無特別限制地用於本發明中。在本發明的有機電致發光元件中,來自元件的發光量最大的是來自發光層中所包含之發光材料的發光。該發光包含螢光發光,亦可以包含延遲螢光。其中,亦可以發光的一部分或局部存在來自主體材料的發光。 在使用主體材料之情況下,發光層中之發光材料的濃度為0.1重量%以上為較佳,1重量%以上為更佳,並且50重量%以下為較佳,20重量%以下為更佳,10重量%以下為進一步較佳。 (luminous layer) The light-emitting layer is a layer that emits light after generating excitons by rebonding holes and electrons injected from the anode and the cathode, respectively. The light emitting layer contains at least a light emitting material. In order for an organic electroluminescent device to exhibit high luminous efficiency, it is important to confine the singlet excitons and triplet excitons of the luminescent material to the luminescent material. Therefore, it is preferable to use a host material in addition to the light-emitting material in the light-emitting layer. As a host material, an organic compound having a higher value of excited singlet energy than the light-emitting material of the present invention can be used, and it is preferable to use an organic compound with higher values of excited singlet energy and excited triplet energy than the light-emitting material. By using a host material, the singlet excitons and triplet excitons generated in the light emitting material can be confined to the molecules of the light emitting material, and the light emitting efficiency can be fully exhibited. However, there are cases where high luminous efficiency can be obtained even if singlet excitons and triplet excitons cannot be sufficiently restricted, so as long as it is a host material that can realize high luminous efficiency, it can be used in the present invention without particular limitation. . In the organic electroluminescent device of the present invention, the largest amount of light emitted from the device is the light emitted from the light-emitting material contained in the light-emitting layer. The luminescence includes fluorescent luminescence, and may also include delayed fluorescence. However, part or part of the emitted light may be emitted from the host material. In the case of using a host material, the concentration of the luminescent material in the luminescent layer is preferably 0.1% by weight or more, more preferably 1% by weight or more, and preferably 50% by weight or less, more preferably 20% by weight or less, It is further preferably 10% by weight or less.

在發光層中,可以使用輔助摻雜劑。此時,發光層由主體材料、輔助摻雜劑及發光材料構成。其中,使用最低激發單重態能階高於輔助摻雜劑者作為主體材料,並且使用最低激發單重態能階低於輔助摻雜劑者作為發光材料。在本發明中,使用延遲螢光材料作為輔助摻雜劑為特佳。延遲螢光為如下螢光:在成為激發狀態之化合物中,在產生從激發三重態向激發單重態的逆系間跨越之後,從該激發單重態返回至基態時輻射之螢光,並且為比來自從基態直接過渡之激發單重態的螢光(即時螢光)更延遲觀測到之螢光。在本發明中,對於包含對象化合物之薄膜,在300K下測定發光的瞬態衰減曲線時,在除了發光壽命短的發光成分(即時螢光)以外還觀測到發光壽命長的發光成分(延遲螢光)之情況下,將該對象化合物設為延遲螢光材料。延遲螢光材料為藉由吸收熱能而能夠產生逆系間跨越之熱活性型延遲螢光材料為較佳。關於為熱活性型延遲螢光材料,能夠藉由測定發光的瞬態衰減曲線所求出之發光壽命依據測定溫度而變長之情況來確認。藉由將延遲螢光材料用作輔助摻雜劑,在輔助摻雜劑中,藉由從基態直接過渡而生成之激發單重態的能量及基於逆系間跨越之激發單重態能量效率良好地轉移至發光材料,從而能夠有效地輔助發光材料的發光。 在由主體材料、輔助摻雜劑及發光材料構成發光層之情況下,發光層中之輔助摻雜劑的濃度小於主體材料的含量為較佳。具體而言,在將主體材料的含量、輔助摻雜劑的含量及發光材料的含量的合計重量設為100重量%時,主體材料的含量為15重量%以上、99.9重量%以下為較佳,輔助摻雜劑的含量為5.0重量%以上、50重量%以下為較佳,發光材料的含量為0.5重量%以上、5.0重量%以下為較佳。 在本發明的一態樣中,發光層不包含無機化合物。又,在本發明的一態樣中,發光層不包含金屬原子。在本發明的一態樣中,在300K下,從發光層未觀測到磷光。 In the light emitting layer, an auxiliary dopant can be used. In this case, the light-emitting layer is composed of a host material, an auxiliary dopant, and a light-emitting material. Wherein, the lowest excited singlet energy level is higher than the auxiliary dopant as the host material, and the lowest excited singlet energy level is lower than the auxiliary dopant as the light emitting material. In the present invention, it is particularly preferred to use a delayed fluorescent material as the auxiliary dopant. Delayed fluorescence is fluorescence that is emitted when the excited singlet state returns to the ground state after an inverse intersystem transition from the excited triplet state to the excited singlet state occurs in a compound that has become an excited state, and is the ratio Fluorescence from the excited singlet state that transitions directly from the ground state (instant fluorescence) is more delayed than the observed fluorescence. In the present invention, when measuring the transient decay curve of luminescence at 300K for a thin film containing the target compound, a luminescence component with a long luminescence lifetime (delayed fluorescence) was observed in addition to a luminescence component with a short luminescence lifetime (instant fluorescence). In the case of light), the target compound is set as a retarded fluorescent material. The delayed fluorescent material is preferably a thermally active delayed fluorescent material capable of generating inverse intersystem crossing by absorbing thermal energy. It can be confirmed that it is a thermally active delayed fluorescent material by the fact that the luminescence lifetime obtained by measuring the transient attenuation curve of luminescence becomes longer depending on the measurement temperature. By using a delayed fluorescent material as an auxiliary dopant, in the auxiliary dopant, the energy of the excited singlet state generated by direct transition from the ground state and the energy of the excited singlet state based on the inverse inter-system crossing are efficiently transferred to the luminescent material, thereby effectively assisting the luminescence of the luminescent material. When the light-emitting layer is composed of a host material, an auxiliary dopant, and a light-emitting material, the concentration of the auxiliary dopant in the light-emitting layer is preferably smaller than that of the host material. Specifically, when the total weight of the content of the host material, the content of the auxiliary dopant, and the content of the luminescent material is taken as 100% by weight, the content of the host material is preferably 15% by weight or more and 99.9% by weight or less. The content of the auxiliary dopant is preferably not less than 5.0% by weight and not more than 50% by weight, and the content of the luminescent material is preferably not less than 0.5% by weight and not more than 5.0% by weight. In one aspect of the present invention, the light-emitting layer does not contain inorganic compounds. Also, in one aspect of the present invention, the light-emitting layer does not contain metal atoms. In one aspect of the invention, at 300K, no phosphorescence was observed from the light-emitting layer.

用於發光層中之主體材料具有空穴傳輸能力和電子傳輸能力,進而防止發光的長波長化,而且具有高的玻璃轉移溫度之有機化合物為較佳。在本發明的一態樣中,作為主體材料,可以較佳地選擇包含咔唑結構之化合物。在本發明的較佳的一態樣中,作為主體材料,能夠選擇包含選自包括咔唑結構、二苯并呋喃結構及二苯并噻吩結構之群組中的兩個以上的結構(例如包含兩個結構)之化合物或具有三個結構之化合物。在本發明的較佳的一態樣中,作為主體材料,能夠選擇包含1,3-伸苯基結構之化合物。在本發明的較佳的一態樣中,作為主體材料,能夠選擇包含聯伸苯基結構之化合物。在本發明的較佳的一態樣中,作為主體材料,能夠選擇包含在分子內之苯環為5~8個之化合物,例如可以選擇五個之化合物、選擇6個之化合物或者選擇7個之化合物。 在以下,舉出能夠用作主體材料的較佳化合物,但是在本發明中能夠採用之主體材料不被以下具體例做限定性地解釋。 [化學式32]

Figure 02_image082
Figure 02_image084
Figure 02_image086
The host material used in the light-emitting layer has hole-transporting ability and electron-transporting ability to prevent long-wavelength emission, and an organic compound with a high glass transition temperature is preferable. In one aspect of the present invention, as the host material, a compound containing a carbazole structure can be preferably selected. In a preferred aspect of the present invention, as a host material, two or more structures selected from the group consisting of a carbazole structure, a dibenzofuran structure and a dibenzothiophene structure (for example, including two structures) or compounds with three structures. In a preferred aspect of the present invention, a compound containing a 1,3-phenylene structure can be selected as the host material. In a preferred aspect of the present invention, a compound containing a biphenylene structure can be selected as the host material. In a preferred aspect of the present invention, as the host material, a compound containing 5 to 8 benzene rings in the molecule can be selected, for example, five compounds, six compounds, or seven compounds can be selected. compound. In the following, preferred compounds that can be used as host materials are listed, but the host materials that can be used in the present invention are not limitedly interpreted by the following specific examples. [chemical formula 32]
Figure 02_image082
Figure 02_image084
Figure 02_image086

在發光層中,能夠使用延遲螢光材料作為發光材料或輔助摻雜劑。又,作為發光材料和輔助摻雜劑,能夠使用分別不同之延遲螢光材料。在藉由螢光壽命測定系統(Hamamatsu Photonics K.K.製條紋照相系統等)測定發光壽命時,從延遲螢光材料中通常觀測到發光壽命為100ns(奈秒)以上的螢光。延遲螢光材料的最低激發單重態能量與77K的最低激發三重態能量之差ΔE ST為0.3eV以下為較佳,0.25eV以下為更佳,0.2eV以下為更佳,0.15eV以下為更佳,0.1eV以下為進一步較佳,0.07eV以下為更進一步較佳,0.05eV以下為又進一步較佳,0.03eV以下為再進一步較佳,0.01eV以下為特佳。若ΔE ST小,則藉由吸收熱能而容易從激發單重態逆系間跨越至激發三重態,因此作為熱活化型延遲螢光材料而發揮作用。熱活化型延遲螢光材料能夠吸收裝置所發出之熱而相對容易地從激發三重態逆系間跨越至激發單重態,將該激發三重態能量效率良好地貢獻於發光。 In the light emitting layer, a delayed fluorescent material can be used as a light emitting material or an auxiliary dopant. In addition, different retarded fluorescent materials can be used as the light emitting material and the auxiliary dopant. When the luminescence lifetime is measured with a fluorescence lifetime measurement system (Hamamatsu Photonics KK's streak camera system, etc.), fluorescence with a luminescence lifetime of 100 ns (nanosecond) or more is usually observed from delayed fluorescent materials. The difference ΔE ST between the lowest excited singlet energy of the delayed fluorescent material and the lowest excited triplet energy of 77K is preferably 0.3eV or less, more preferably 0.25eV or less, more preferably 0.2eV or less, and more preferably 0.15eV or less 0.1 eV or less is still more preferable, 0.07 eV or less is still more preferable, 0.05 eV or less is still more preferable, 0.03 eV or less is still more preferable, 0.01 eV or less is especially preferable. When ΔE ST is small, the inverse intersystem transition from the excited singlet state to the excited triplet state is easily performed by absorbing thermal energy, and thus functions as a heat-activated delayed fluorescent material. The thermally activated delayed fluorescent material can absorb the heat emitted by the device and relatively easily transition from the excited triplet state to the excited singlet state, and the excited triplet state energy can be efficiently contributed to light emission.

本發明中之化合物的最低激發單重態能量(E S1)和最低激發三重態能量(E T1)為藉由下述步驟而求出之值。ΔE ST為藉由計算E S1-E T1而求出之值。 (1)最低激發單重態能量(E S1) 製備測定對象化合物的薄膜或甲苯溶液(濃度10 -5mol/L)作為試樣。在常溫(300K)下測定該試樣的螢光光譜。在螢光光譜中,將縱軸設為發光,將橫軸設為波長。相對於該發光光譜的短波側的上升繪製切線,並求出該切線與橫軸的交點的波長值λedge[nm]。將藉由以下所示之換算式將該波長值換算成能量值而獲得之值設為E S1。 換算式:E S1[eV]=1239.85/λedge 關於後述實施例中之發光光譜的測定,使用LED光源(Thorlabs, Inc.製、M300L4)作為激發光源,並藉由檢測器(Hamamatsu Photonics K.K.製、PMA-12多頻道光譜儀 C10027-01)來進行。 (2)最低激發三重態能量(E T1) 藉由液態氮將與在最低激發單重態能量(E S1)的測定中所使用者相同的試樣冷卻至77[K],將激發光(300nm)照射到磷光測定用試樣上,並使用檢測器來測定磷光。將照射激發光之後100毫秒以後的發光設為磷光光譜。相對於該磷光光譜的短波長側的上升繪製切線,並求出該切線與橫軸的交點的波長值λedge[nm]。將藉由以下所示之換算式將該波長值換算成能量值而獲得之值設為E T1。 換算式:E T1[eV]=1239.85/λedge 相對於磷光光譜的短波長側的上升之切線以如下方式繪製。當在光譜曲線上從磷光光譜的短波長側移動至光譜的極大值中的、最短波長側的極大值時,考慮朝向長波長側在曲線上的各點上之切線。該切線隨著曲線上升(亦即,隨著縱軸增加)而斜率增加。將在該斜率的值取極大值之點上繪製之切線設為相對於該磷光光譜的短波長側的上升之切線。 再者,具有光譜的最大峰值強度的10%以下的峰值強度之極大點不包含於上述最短波長側的極大值中而最接近最短波長側的極大值,將在斜率的值取極大值之點上繪製之切線設為相對於該磷光光譜的短波長側的上升之切線。 The lowest excited singlet energy (E S1 ) and the lowest excited triplet energy (E T1 ) of the compounds in the present invention are values obtained by the following procedure. ΔE ST is a value obtained by calculating E S1 -E T1 . (1) Minimum excited singlet energy ( ES1 ) Prepare a thin film or toluene solution (concentration: 10 -5 mol/L) of the compound to be measured as a sample. The fluorescence spectrum of this sample was measured at normal temperature (300K). In the fluorescence spectrum, the vertical axis represents luminescence, and the horizontal axis represents wavelength. A tangent line is drawn with respect to the rising of the short-wave side of the emission spectrum, and the wavelength value λedge [nm] of the intersection point of the tangent line and the horizontal axis is obtained. Let the value obtained by converting this wavelength value into an energy value by the conversion formula shown below be E S1 . Conversion formula: E S1 [eV]=1239.85/λedge Regarding the measurement of the emission spectrum in the examples described later, an LED light source (manufactured by Thorlabs, Inc., M300L4) was used as the excitation light source, and a detector (manufactured by Hamamatsu Photonics KK, PMA-12 multi-channel spectrometer C10027-01) to carry out. (2) Minimum excited triplet energy (E T1 ) Cool the same sample as used in the measurement of the lowest excited singlet energy (E S1 ) to 77 [K] with liquid nitrogen, and emit excitation light (300nm ) is irradiated onto the sample for phosphorescence measurement, and the phosphorescence is measured using a detector. The luminescence after 100 milliseconds after irradiation with excitation light was defined as the phosphorescence spectrum. A tangent line is drawn with respect to the rising of the short-wavelength side of the phosphorescence spectrum, and the wavelength value λedge [nm] of the intersection point of the tangent line and the horizontal axis is obtained. Let the value obtained by converting this wavelength value into an energy value by the conversion formula shown below be E T1 . Conversion formula: E T1 [eV]=1239.85/λedge The tangent line to the rise on the short-wavelength side of the phosphorescence spectrum is drawn as follows. When moving from the short-wavelength side of the phosphorescence spectrum to the maximum value on the shortest wavelength side among the maximum values of the spectrum on the spectral curve, a tangent line at each point on the curve toward the long-wavelength side is considered. The tangent line increases in slope as the curve rises (ie, as the vertical axis increases). A tangent line drawn at a point where the value of the slope takes a maximum value is defined as a tangent line with respect to the rise of the short-wavelength side of the phosphorescence spectrum. Furthermore, the maximum point of the peak intensity having 10% or less of the maximum peak intensity of the spectrum is not included in the above-mentioned maximum value on the shortest wavelength side, and the maximum value on the shortest wavelength side is the point where the value of the slope takes the maximum value. The tangent line drawn above is set as a tangent line with respect to the rise of the short-wavelength side of the phosphorescence spectrum.

延遲螢光材料不包含金屬原子為較佳。例如,作為延遲螢光材料,能夠選擇由選自包括碳原子、氫原子、氘原子、氮原子、氧原子及硫原子之群組中的原子組成之化合物。例如,作為延遲螢光材料,可以選擇由碳原子、氫原子及氮原子組成之化合物。 作為典型的延遲螢光材料,可以舉出具有苯環與1~2個受體基團和至少一個供體基團鍵結而成之結構之化合物。作為受體基團,可以較佳地例示出氰基、包含三𠯤環等包含氮原子作為環骨架構成原子之雜芳基環之基團。作為供體基團,例如可以較佳地例示出經取代或未經取代的咔唑-9-基。例如,可以例示出三個以上的經取代或未經取代的咔唑-9-基與前述苯環鍵結之化合物或者經取代或未經取代的苯并呋喃環、經取代或未經取代的苯并噻吩環、經取代或未經取代的吲哚環、經取代或未經取代的茚環、經取代或未經取代的矽烷茚環的各5員環部分與構成咔唑-9-基之兩個苯環中的至少一者縮合之化合物等。 Preferably, the delayed fluorescent material does not contain metal atoms. For example, as the delayed fluorescent material, a compound composed of atoms selected from the group consisting of carbon atoms, hydrogen atoms, deuterium atoms, nitrogen atoms, oxygen atoms, and sulfur atoms can be selected. For example, as a delayed fluorescent material, a compound composed of carbon atoms, hydrogen atoms, and nitrogen atoms can be selected. Typical delayed fluorescent materials include compounds having a structure in which a benzene ring is bonded to 1 to 2 acceptor groups and at least one donor group. As the acceptor group, preferably, a cyano group, a group including a heteroaryl ring including a nitrogen atom as an atom constituting a ring skeleton such as a trioxane ring can be exemplified. As the donor group, for example, a substituted or unsubstituted carbazol-9-yl group can be preferably exemplified. For example, a compound in which three or more substituted or unsubstituted carbazol-9-yl groups are bonded to the aforementioned benzene ring, a substituted or unsubstituted benzofuran ring, a substituted or unsubstituted Each 5-membered ring part of a benzothiophene ring, a substituted or unsubstituted indole ring, a substituted or unsubstituted indene ring, a substituted or unsubstituted silane indene ring and a carbazol-9-yl Compounds in which at least one of the two benzene rings is condensed, etc.

在本發明的較佳的一態樣中,使用下述通式(4)所表示之化合物作為延遲螢光材料。 [化學式33]

Figure 02_image088
在通式(4)中,R 21~R 23中的一個表示氰基或下述通式(5)所表示之基團,R 21~R 23的其餘兩個和R 24及R 25中的至少一個表示下述通式(6)所表示之基團,R 21~R 25的其餘部分表示氫原子或取代基(其中,在此所述之取代基不是氰基、下述通式(5)所表示之基團、下述通式(6)所表示之基團)。 [化學式34]
Figure 02_image090
在通式(5)中,L 1表示單鍵或2價的連接基,R 31及R 32分別獨立地表示氫原子或取代基,*表示鍵結位置。 [化學式35]
Figure 02_image092
在通式(6)中,L 2表示單鍵或2價的連接基,R 33及R 34分別獨立地表示氫原子或取代基,*表示鍵結位置。 In a preferred aspect of the present invention, a compound represented by the following general formula (4) is used as a delayed fluorescent material. [chemical formula 33]
Figure 02_image088
In general formula (4), one of R 21 to R 23 represents a cyano group or a group represented by the following general formula (5), the other two of R 21 to R 23 and R 24 and R 25 At least one represents the group represented by the following general formula (6), and the rest of R 21 to R 25 represent hydrogen atoms or substituents (wherein the substituents mentioned here are not cyano groups, the following general formula (5 ), a group represented by the following general formula (6)). [chemical formula 34]
Figure 02_image090
In the general formula (5), L 1 represents a single bond or a divalent linking group, R 31 and R 32 each independently represent a hydrogen atom or a substituent, and * represents a bonding position. [chemical formula 35]
Figure 02_image092
In the general formula (6), L 2 represents a single bond or a divalent linking group, R 33 and R 34 each independently represent a hydrogen atom or a substituent, and * represents a bonding position.

在本發明的較佳的一態樣中,R 22為氰基。在本發明的較佳的一態樣中,R 22為通式(5)所表示之基團。在本發明的一態樣中,R 21為氰基或通式(5)所表示之基團。在本發明的一態樣中,R 23為氰基或通式(5)所表示之基團。在本發明的一態樣中,R 21~R 23中的一個為氰基。在本發明的一態樣中,R 21~R 23中的一個為通式(5)所表示之基團。 In a preferred aspect of the present invention, R 22 is cyano. In a preferred aspect of the present invention, R 22 is a group represented by general formula (5). In one aspect of the present invention, R 21 is a cyano group or a group represented by general formula (5). In one aspect of the present invention, R 23 is a cyano group or a group represented by general formula (5). In one aspect of the present invention, one of R 21 to R 23 is cyano. In one aspect of the present invention, one of R 21 to R 23 is a group represented by general formula (5).

在本發明的較佳的一態樣中,通式(5)中之L 1為單鍵。在本發明的一態樣中,L 1為2價的連接基,較佳為經取代或未經取代的伸芳基或者經取代或未經取代的雜伸芳基,更佳為經取代或未經取代的伸芳基,進一步較佳為經取代或未經取代的1,4-伸苯基(作為取代基,例如碳數1~3的烷基)。 在本發明的一態樣中,通式(5)中之R 31及R 32分別獨立地為選自包括烷基(例如,碳數1~40)、芳基(例如,碳數6~30)、雜芳基(例如環骨架構成原子數5~30)、烯基(例如,碳數1~40)及炔基(例如,碳數1~40)之群組中的一個基團或兩個以上組合而獲得之基團(在以下中,將該等基團稱為“取代基組A的基團”)。在本發明的較佳的一態樣中,R 31及R 32分別獨立地為經取代或未經取代的芳基(例如,碳數6~30),作為芳基的取代基,可以舉出取代基組A的基團。在本發明的較佳的一態樣中,R 31及R 32相同。 In a preferred aspect of the present invention, L 1 in the general formula (5) is a single bond. In one aspect of the present invention, L is a divalent linking group, preferably a substituted or unsubstituted aryl or a substituted or unsubstituted heteroaryl, more preferably a substituted or The unsubstituted arylylene group is more preferably a substituted or unsubstituted 1,4-phenylene group (as a substituent, for example, an alkyl group having 1 to 3 carbon atoms). In one aspect of the present invention, R 31 and R 32 in the general formula (5) are each independently selected from the group consisting of alkyl (for example, with 1 to 40 carbons), aryl (for example, with 6 to 30 carbons) ), heteroaryl (for example, ring skeleton with 5-30 atoms), alkenyl (for example, carbon number 1-40) and alkynyl (for example, carbon number 1-40) group or two Groups obtained by combining the above groups (hereinafter, these groups are referred to as "groups of substituent group A"). In a preferred aspect of the present invention, R 31 and R 32 are independently substituted or unsubstituted aryl groups (for example, with 6 to 30 carbon atoms), and as substituents for aryl groups, there are A radical of substituent group A. In a preferred aspect of the present invention, R 31 and R 32 are the same.

在本發明的較佳的一態樣中,通式(6)中之L 2為單鍵。在本發明的一態樣中,L 2為2價的連接基,較佳為經取代或未經取代的伸芳基或者經取代或未經取代的雜伸芳基,更佳為經取代或未經取代的伸芳基,進一步較佳為經取代或未經取代的1,4-伸苯基(作為取代基,例如碳數1~3的烷基)。 在本發明的一態樣中,通式(6)中之R 33及R 34分別獨立地表示經取代或未經取代的烷基(例如,碳數1~40)、經取代或未經取代的烯基(例如,碳數1~40)、經取代或未經取代的芳基(例如,碳數6~30)或者經取代或未經取代的雜芳基(例如,碳數5~30)。作為在此所述之烷基、烯基、芳基、雜芳基的取代基,可以舉出選自包括羥基、鹵素原子(例如,氟原子、氯原子、溴原子、碘原子)、烷基(例如,碳數1~40)、烷氧基(例如,碳數1~40)、烷硫基(例如,碳數1~40)、芳基(例如,碳數6~30)、芳氧基(例如,碳數6~30)、芳硫基(例如,碳數6~30)、雜芳基(例如,環骨架構成原子數5~30)、雜芳氧基(例如,環骨架構成原子數5~30)、雜芳硫基(例如,環骨架構成原子數5~30)、醯基(例如,碳數1~40)、烯基(例如,碳數1~40)、炔基(例如,碳數1~40)、烷氧羰基(例如,碳數1~40)、芳氧羰基(例如,碳數1~40)、雜芳氧羰基(例如,碳數1~40)、甲矽烷基(例如,碳數1~40的三烷基甲矽烷基)、硝基及氰基之群組中的一個基團或兩個以上組合而獲得之基團(在以下中,將該等基團稱為“取代基組B的基團”)。 R 33和R 34可以彼此經由單鍵或連接基鍵結而形成環狀結構。尤其,在R 33和R 34為芳基之情況下,彼此經由單鍵或連接基鍵結而形成環狀結構為較佳。作為在此所述之連接基,可以舉出-O-、-S-、-N(R 35)-、-C(R 36)(R 37)-、-C(=O)-,-O-、-S-、-N(R 35)-、-C(R 36)(R 37)-為較佳,-O-、-S-、-N(R 35)-為更佳。R 35~R 37分別獨立地表示氫原子或取代基。作為取代基,能夠選擇上述取代基組A的基團或者選擇下述取代基組B的基團,較佳為選自包括碳數1~10的烷基及碳數6~14的芳基之群組中的一個基團或兩個以上組合而獲得之基團。 In a preferred aspect of the present invention, L 2 in the general formula (6) is a single bond. In one aspect of the present invention, L is a divalent linking group, preferably a substituted or unsubstituted arylylene or a substituted or unsubstituted heteroarylylene, more preferably a substituted or The unsubstituted arylylene group is more preferably a substituted or unsubstituted 1,4-phenylene group (as a substituent, for example, an alkyl group having 1 to 3 carbon atoms). In one aspect of the present invention, R 33 and R 34 in general formula (6) independently represent substituted or unsubstituted alkyl (for example, carbon number 1-40), substituted or unsubstituted Alkenyl (for example, 1 to 40 carbons), substituted or unsubstituted aryl (for example, 6 to 30 carbons) or substituted or unsubstituted heteroaryl (for example, 5 to 30 carbons ). Examples of substituents for the alkyl, alkenyl, aryl, and heteroaryl groups described here include hydroxyl, halogen atoms (for example, fluorine, chlorine, bromine, and iodine atoms), alkyl (for example, carbon number 1-40), alkoxy group (for example, carbon number 1-40), alkylthio group (for example, carbon number 1-40), aryl group (for example, carbon number 6-30), aryloxy group (for example, carbon number 6-30), arylthio group (for example, carbon number 6-30), heteroaryl group (for example, ring skeleton composition atom number 5-30), heteroaryloxy group (for example, ring skeleton composition 5-30 atoms), heteroarylthio group (for example, 5-30 atoms in the ring skeleton), acyl group (for example, 1-40 carbon atoms), alkenyl group (for example, 1-40 carbon atoms), alkynyl group (for example, carbon number 1-40), alkoxycarbonyl group (for example, carbon number 1-40), aryloxycarbonyl group (for example, carbon number 1-40), heteroaryloxycarbonyl group (for example, carbon number 1-40), A silyl group (for example, a trialkylsilyl group having 1 to 40 carbon atoms), a nitro group, and a cyano group, or a group obtained by combining two or more (hereinafter, the Such groups are referred to as "groups of substituent group B"). R 33 and R 34 may be bonded to each other via a single bond or a linker to form a ring structure. In particular, when R 33 and R 34 are aryl groups, it is preferable to bond each other via a single bond or a linker to form a ring structure. Examples of the linking group described here include -O-, -S-, -N(R 35 )-, -C(R 36 )(R 37 )-, -C(=O)-, -O -, -S-, -N(R 35 )-, -C(R 36 )(R 37 )- are preferred, and -O-, -S-, -N(R 35 )- are more preferred. R 35 to R 37 each independently represent a hydrogen atom or a substituent. As a substituent, the group of the above-mentioned substituent group A or the group of the following substituent group B can be selected, preferably selected from the group consisting of an alkyl group with 1 to 10 carbons and an aryl group with 6 to 14 carbons. A group in a group or a group obtained by combining two or more groups.

通式(6)所表示之基團為下述通式(7)所表示之基團為較佳。 [化學式36]

Figure 02_image094
The group represented by the general formula (6) is preferably a group represented by the following general formula (7). [chemical formula 36]
Figure 02_image094

通式(7)的L 11表示單鍵或2價的連接基。關於L 11的說明和較佳範圍,能夠參照上述L 2的說明和較佳範圍。 通式(7)的R 41~R 48分別獨立地表示氫原子或取代基。R 41和R 42、R 42和R 43、R 43和R 44、R 44和R 45、R 45和R 46、R 46和R 47、R 47和R 48可以彼此鍵結而形成環狀結構。彼此鍵結而形成之環狀結構可以為芳香環,亦可以為脂肪環,並且亦可以為包含雜原子者,環狀結構還可以為2環以上的縮合環。作為在此所述之雜原子,選自包括氮原子、氧原子及硫原子之群組中者為較佳。作為所形成之環狀結構的例,可以舉出苯環、萘環、吡啶環、嗒𠯤環、嘧啶環、吡𠯤環、吡咯環、咪唑環、吡唑環、咪唑啉環、㗁唑環、異㗁唑環、噻唑環、異噻唑環、環己二烯環、環己烯環、環戊二烯環、環庚三烯環、環庚二烯環、環庚烯環、呋喃環、噻吩環、口奈啶環、喹㗁啉環、喹啉環等。例如,可以形成如菲環或聯三伸苯環那樣複數個環縮合而成之環。通式(7)所表示之基團中所包含之環的數量可以在3~5個的範圍內進行選擇,亦可以在5~7個的範圍內進行選擇。 作為R 41~R 48能夠採用之取代基,可以舉出上述取代基組B的基團,較佳為可以經碳數1~10的未經取代的烷基或碳數1~10的未經取代的烷基取代的碳數6~10的芳基。在本發明的較佳的一態樣中,R 41~R 48為氫原子或碳數1~10的未經取代的烷基。在本發明的較佳的一態樣中,R 41~R 48為氫原子或碳數6~10的未經取代的芳基。在本發明的較佳的一態樣中,R 41~R 48均為氫原子。 在通式(7)中,*表示鍵結位置。 L 11 in the general formula (7) represents a single bond or a divalent linking group. For the description and preferred range of L11 , the description and preferred range of L2 above can be referred to. R 41 to R 48 in the general formula (7) each independently represent a hydrogen atom or a substituent. R 41 and R 42 , R 42 and R 43 , R 43 and R 44 , R 44 and R 45 , R 45 and R 46 , R 46 and R 47 , R 47 and R 48 may be bonded to each other to form a ring structure . The cyclic structure formed by bonding with each other may be an aromatic ring or an aliphatic ring, and may include heteroatoms, and the cyclic structure may be a condensed ring of two or more rings. As the hetero atom mentioned here, one selected from the group consisting of nitrogen atom, oxygen atom and sulfur atom is preferable. Examples of the formed ring structure include a benzene ring, a naphthalene ring, a pyridine ring, a pyrimidine ring, a pyrimidine ring, a pyrrole ring, a pyrrole ring, an imidazole ring, a pyrazole ring, an imidazoline ring, and a pyrazole ring. , isoxazole ring, thiazole ring, isothiazole ring, cyclohexadiene ring, cyclohexene ring, cyclopentadiene ring, cycloheptatriene ring, cycloheptadiene ring, cycloheptene ring, furan ring, Thiophene ring, naridine ring, quinoline ring, quinoline ring, etc. For example, a ring formed by condensing a plurality of rings such as a phenanthrene ring or a biterphenylene ring can be formed. The number of rings included in the group represented by the general formula (7) may be selected within a range of 3 to 5, or may be selected within a range of 5 to 7. The substituents that can be used for R 41 to R 48 include the above substituent group B, preferably an unsubstituted alkyl group having 1 to 10 carbons or an unsubstituted alkyl group having 1 to 10 carbons. An aryl group having 6 to 10 carbon atoms substituted by a substituted alkyl group. In a preferred aspect of the present invention, R 41 -R 48 are hydrogen atoms or unsubstituted alkyl groups with 1-10 carbons. In a preferred aspect of the present invention, R 41 -R 48 are hydrogen atoms or unsubstituted aryl groups with 6-10 carbons. In a preferred aspect of the present invention, R 41 to R 48 are all hydrogen atoms. In the general formula (7), * represents a bonding position.

在本發明的較佳的一態樣中,使用氮雜苯衍生物作為延遲螢光材料。在本發明的較佳的一態樣中,氮雜苯衍生物具有苯環的環骨架構成碳原子中的三個取代為氮原子之氮雜苯結構。例如,可以較佳地選擇具有1,3,5-三𠯤結構之氮雜苯衍生物。在本發明的較佳的一態樣中,氮雜苯衍生物具有苯環的環骨架構成碳原子中的兩個取代為氮原子之氮雜苯結構。例如,可以舉出具有嗒𠯤結構、嘧啶結構、吡𠯤結構之氮雜苯衍生物,可以較佳地選擇具有嘧啶結構之氮雜苯衍生物。在本發明的一態樣中,氮雜苯衍生物具有苯環的環骨架構成碳原子中的一個取代為氮原子之吡啶結構。In a preferred aspect of the present invention, azabenzene derivatives are used as delayed fluorescent materials. In a preferred aspect of the present invention, the azabenzene derivative has an azabenzene structure in which three of the carbon atoms are substituted with nitrogen atoms in the ring skeleton of the benzene ring. For example, azabenzene derivatives having a 1,3,5-trismazonium structure can be preferably selected. In a preferred aspect of the present invention, the azabenzene derivative has a ring skeleton of a benzene ring to form an azabenzene structure in which two of the carbon atoms are substituted with nitrogen atoms. For example, azabenzene derivatives having a pyrimidine structure, a pyrimidine structure, and a pyrimidine structure can be mentioned, and azabenzene derivatives having a pyrimidine structure can be preferably selected. In one aspect of the present invention, the azabenzene derivative has a pyridine structure in which one of the carbon atoms is substituted with a nitrogen atom in the ring skeleton of the benzene ring.

在本發明的較佳的一態樣中,使用下述通式(8)所表示之化合物作為延遲螢光材料。 [化學式37]

Figure 02_image096
在通式(8)中,Y 1、Y 2及Y 3表示至少一個為氮原子且其餘部分為次甲基。在本發明的一態樣中,Y 1為氮原子且Y 2及Y 3為次甲基。較佳為,Y 1及Y 2為氮原子且Y 3為次甲基。更佳為,Y 1~Y 3均為氮原子。 在通式(8)中,Z 1~Z 3分別獨立地表示氫原子或取代基,但是至少一個為供體基團的取代基。供體基團的取代基表示哈米特的σp值為負的基團。較佳為,Z 1~Z 3中的至少一個為包含二芳基胺基結構(與氮原子鍵結之兩個芳基可以彼此鍵結)之基團,更佳為上述通式(6)所表示之基團,例如為上述通式(7)所表示之基團。在本發明的一態樣中,Z 1~Z 3中的僅一個為通式(6)或(7)所表示之基團。在本發明的一態樣中,Z 1~Z 3中的僅兩個分別獨立地為通式(6)或(7)所表示之基團。在本發明的一態樣中,Z 1~Z 3均分別獨立地為通式(6)或(7)所表示之基團。關於通式(6)及通式(7)的詳細內容和較佳範圍,能夠參照上述對應之記載。不是通式(6)及通式(7)所表示之基團的其餘的Z 1~Z 3為經取代或未經取代的芳基(例如,碳數6~40、較佳為6~20)為較佳,作為在此所述之芳基的取代基,可以例示出選自包括芳基(例如,碳數6~20、較佳為6~14)及烷基(例如,碳數1~20、較佳為1~6)之群組中的一個基團或兩個以上組合而獲得之基團。在本發明的一態樣中,通式(8)不包含氰基。 In a preferred aspect of the present invention, a compound represented by the following general formula (8) is used as a delayed fluorescent material. [chemical formula 37]
Figure 02_image096
In the general formula (8), Y 1 , Y 2 and Y 3 represent that at least one is a nitrogen atom and the rest are methine groups. In one aspect of the invention, Y 1 is a nitrogen atom and Y 2 and Y 3 are methine. Preferably, Y 1 and Y 2 are nitrogen atoms and Y 3 is a methine group. More preferably, Y 1 to Y 3 are all nitrogen atoms. In the general formula (8), Z 1 to Z 3 each independently represent a hydrogen atom or a substituent, but at least one is a substituent of a donor group. The substituent of the donor group represents a group having a negative Hammett's σp value. Preferably, at least one of Z 1 to Z 3 is a group containing a diarylamine structure (two aryl groups bonded to nitrogen atoms can be bonded to each other), more preferably the above general formula (6) The group represented is, for example, a group represented by the above general formula (7). In one aspect of the present invention, only one of Z 1 to Z 3 is a group represented by general formula (6) or (7). In one aspect of the present invention, only two of Z 1 to Z 3 are independently groups represented by general formula (6) or (7). In one aspect of the present invention, Z 1 to Z 3 are each independently a group represented by general formula (6) or (7). For details and preferred ranges of the general formula (6) and the general formula (7), reference can be made to the corresponding description above. The remaining Z 1 to Z 3 other than the groups represented by general formula (6) and general formula (7) are substituted or unsubstituted aryl groups (for example, carbon number 6-40, preferably 6-20 ) is preferred. As the substituent for the aryl group described here, examples include aryl (for example, carbon number 6 to 20, preferably 6 to 14) and alkyl (for example, carbon number 1 ~20, preferably 1~6) one group or a combination of two or more groups. In one aspect of the present invention, the general formula (8) does not contain a cyano group.

在本發明的較佳的一態樣中,使用下述通式(9)所表示之化合物作為延遲螢光材料。 [化學式38]

Figure 02_image098
在通式(9)中,Ar 1形成可以取代為下述A 1及D 1的環狀結構,並且表示苯環、萘環、蒽環或菲環。Ar 2、Ar 3可以分別形成環狀結構,在形成環狀結構之情況下,表示苯環、萘環、吡啶環或經氰基取代之苯環。m1表示0~2中的任一個整數,m2表示0~1中的任一個整數。A 1表示氰基、苯基、嘧啶基、三唑基或苯甲腈基。D 1表示經取代或未經取代的5H-吲哚并[3,2,1-de]啡𠯤-5-基或者不包含萘結構的經取代或未經取代的雜環縮合咔唑基,在通式(9)中存在複數個D 1之情況下,它們可以相同,亦可以不同。又,D 1的取代基可以彼此鍵結而形成環狀結構。 In a preferred aspect of the present invention, a compound represented by the following general formula (9) is used as a delayed fluorescent material. [chemical formula 38]
Figure 02_image098
In the general formula (9), Ar 1 forms a ring structure which may be substituted with the following A 1 and D 1 , and represents a benzene ring, a naphthalene ring, an anthracene ring, or a phenanthrene ring. Ar 2 and Ar 3 may each form a ring structure, and when they form a ring structure, they represent a benzene ring, a naphthalene ring, a pyridine ring, or a cyano-substituted benzene ring. m1 represents any integer of 0-2, and m2 represents any integer of 0-1. A 1 represents a cyano group, a phenyl group, a pyrimidinyl group, a triazolyl group or a benzonitrile group. D 1 represents a substituted or unsubstituted 5H-indolo[3,2,1-de]indole-5-yl or a substituted or unsubstituted heterocyclic condensed carbazolyl group that does not contain a naphthalene structure, When a plurality of D 1 exist in the general formula (9), they may be the same or different. In addition, the substituents of D1 may be bonded to each other to form a ring structure.

作為進一步較佳的延遲螢光材料,亦可以舉出以下通式(E1)所表示之化合物。 [化學式39]

Figure 02_image100
As further preferable delayed fluorescent materials, compounds represented by the following general formula (E1) can also be mentioned. [chemical formula 39]
Figure 02_image100

在通式(E1)中,R 1、R 3~R 16分別獨立地表示氫原子、氘原子或取代基。R 2表示受體基團或者R 1和R 2彼此鍵結而形成受體基團或者R 2和R 3彼此鍵結而形成受體基團。R 3和R 4、R 4和R 5、R 5和R 6、R 6和R 7、R 7和R 8、R 9和R 10、R 10和R 11、R 11和R 12、R 12和R 13、R 13和R 14、R 14和R 15、R 15和R 16可以彼此鍵結而形成環狀結構。X 1表示O或NR,R表示取代基。X 2~X 4中的X 3及X 4中的至少一者可以為O或NR且其餘部分為O或NR,亦可以不連接。在不連接時,兩端分別獨立地表示氫原子、氘原子或取代基。通式(1)中的C-R 1、C-R 3、C-R 4、C-R 5、C-R 6、C-R 7、C-R 8、C-R 9、C-R 10、C-R 11、C-R 12、C-R 13、C-R 14、C-R 15、C-R 16可以取代為N。 In the general formula (E1), R 1 , R 3 to R 16 each independently represent a hydrogen atom, a deuterium atom or a substituent. R2 represents an acceptor group or R1 and R2 are bonded to each other to form an acceptor group or R2 and R3 are bonded to each other to form an acceptor group. R 3 and R 4 , R 4 and R 5 , R 5 and R 6 , R 6 and R 7 , R 7 and R 8 , R 9 and R 10 , R 10 and R 11 , R 11 and R 12 , R 12 and R 13 , R 13 and R 14 , R 14 and R 15 , R 15 and R 16 may be bonded to each other to form a ring structure. X 1 represents O or NR, and R represents a substituent. At least one of X 3 and X 4 among X 2 to X 4 may be O or NR, and the rest may be O or NR, or may not be connected. When not connected, both ends independently represent a hydrogen atom, a deuterium atom or a substituent. CR 1 , CR 3 , CR 4 , CR 5 , CR 6 , CR 7 , CR 8 , CR 9 , CR 10 , CR 11 , CR 12 , CR 13 , CR 14 , CR 15 , CR in general formula (1) 16 can be replaced by N.

作為進一步較佳的延遲螢光材料,亦可以舉出以下通式(E2)所表示之化合物。 [化學式40]

Figure 02_image102
As further preferable delayed fluorescent materials, compounds represented by the following general formula (E2) can also be mentioned. [chemical formula 40]
Figure 02_image102

在通式(E2)中,R 1及R 2分別獨立地表示經取代或未經取代的烷基、經取代或未經取代的芳基或者經取代或未經取代的雜芳基,R 3~R 16分別獨立地表示氫原子、氘原子或取代基。R 1和R 3、R 3和R 4、R 4和R 5、R 5和R 6、R 6和R 7、R 7和R 8、R 8和R 9、R 9和R 2、R 2和R 10、R 10和R 11、R 11和R 12、R 12和R 13、R 13和R 14、R 14和R 15、R 15和R 16、R 16和R 1可以彼此鍵結而形成環狀結構。通式(1)中的C-R 3、C-R 4、C-R 5、C-R 6、C-R 7、C-R 8、C-R 9、C-R 10、C-R 11、C-R 12、C-R 13、C-R 14、C-R 15、C-R 16可以經N取代。 In the general formula (E2), R 1 and R 2 independently represent substituted or unsubstituted alkyl, substituted or unsubstituted aryl or substituted or unsubstituted heteroaryl, R 3 ~R 16 each independently represent a hydrogen atom, a deuterium atom or a substituent. R 1 and R 3 , R 3 and R 4 , R 4 and R 5 , R 5 and R 6 , R 6 and R 7 , R 7 and R 8 , R 8 and R 9 , R 9 and R 2 , R 2 and R 10 , R 10 and R 11 , R 11 and R 12 , R 12 and R 13 , R 13 and R 14 , R 14 and R 15 , R 15 and R 16 , R 16 and R 1 may be bonded to each other and form a ring structure. CR 3 , CR 4 , CR 5 , CR 6 , CR 7 , CR 8 , CR 9 , CR 10 , CR 11 , CR 12 , CR 13 , CR 14 , CR 15 , CR 16 in general formula ( 1) can be passed through N substituted.

作為進一步較佳的延遲螢光材料,亦可以舉出以下通式(E3)所表示之化合物。 [化學式41]

Figure 02_image104
As further preferable delayed fluorescent materials, compounds represented by the following general formula (E3) can also be mentioned. [chemical formula 41]
Figure 02_image104

在通式(E3)中,Z 1及Z 2分別獨立地表示經取代或未經取代的芳香環或者經取代或未經取代的雜芳環,R 1~R 9分別獨立地表示氫原子、氘原子或取代基。R 1和R 2、R 2和R 3、R 3和R 4、R 4和R 5、R 5和R 6、R 7和R 8、R 8和R 9可以彼此鍵結而形成環狀結構。其中,Z 1、Z 2、R 1和R 2彼此鍵結而形成之環、R 2和R 3彼此鍵結而形成之環、R 4和R 5彼此鍵結而形成之環及R 5和R 6彼此鍵結而形成之環中的至少一個為經取代或未經取代的苯并呋喃的呋喃環、經取代或未經取代的苯并噻吩的噻吩環、經取代或未經取代的吲哚的吡咯環,並且為R 1~R 9中的至少一個為經取代或未經取代的芳基或受體基團或者Z 1和Z 2中的至少一個具有芳基或受體基團作為取代基之環。構成前述苯并呋喃環、前述苯并噻吩環、前述吲哚環之苯環骨架構成碳原子中能夠取代的碳原子可以經氮原子取代。通式(1)中的C-R 1、C-R 2、C-R 3、C-R 4、C-R 5、C-R 6、C-R 7、C-R 8、C-R 9可以取代為N。 In the general formula (E3), Z 1 and Z 2 each independently represent a substituted or unsubstituted aromatic ring or a substituted or unsubstituted heteroaromatic ring, and R 1 to R 9 each independently represent a hydrogen atom, deuterium atom or substituent. R 1 and R 2 , R 2 and R 3 , R 3 and R 4 , R 4 and R 5 , R 5 and R 6 , R 7 and R 8 , R 8 and R 9 may be bonded to each other to form a ring structure . Among them, the ring formed by Z 1 , Z 2 , R 1 and R 2 bonded to each other, the ring formed by R 2 and R 3 bonded to each other, the ring formed by R 4 and R 5 bonded to each other, and the ring formed by R 5 and At least one of the rings formed by bonding R to each other is the furan ring of substituted or unsubstituted benzofuran, the thiophene ring of substituted or unsubstituted benzothiophene, the substituted or unsubstituted indene ring The pyrrole ring of indole, and at least one of R 1 to R 9 is a substituted or unsubstituted aryl or acceptor group or at least one of Z 1 and Z 2 has an aryl or acceptor group as ring of substituents. Of the carbon atoms constituting the benzene ring skeleton of the benzofuran ring, the benzothiophene ring, and the indole ring, substitutable carbon atoms may be substituted with nitrogen atoms. CR 1 , CR 2 , CR 3 , CR 4 , CR 5 , CR 6 , CR 7 , CR 8 , and CR 9 in the general formula (1) may be substituted with N.

作為進一步較佳的延遲螢光材料,亦可以舉出以下通式(E4)所表示之化合物。 [化學式42]

Figure 02_image106
As further preferable delayed fluorescent materials, compounds represented by the following general formula (E4) can also be mentioned. [chemical formula 42]
Figure 02_image106

在通式(E4)中,Z 1表示經取代或未經取代的苯環縮合而成之呋喃環、經取代或未經取代的苯環縮合而成之噻吩環或者經取代或未經取代的苯環縮合而成之N-取代吡咯環,Z 2及Z 3分別獨立地表示經取代或未經取代的芳香環或者經取代或未經取代的雜芳環,R 1表示氫原子、氘原子或取代基,R 2及R 3分別獨立地表示經取代或未經取代的芳基或者經取代或未經取代的雜芳基。Z 1和R 1、R 2和Z 2、Z 2和Z 3、Z 3和R 3可以彼此鍵結而形成環狀結構。其中,R 2和Z 2、Z 2和Z 3、Z 3和R 3中的至少1組彼此鍵結而形成環狀結構。 In the general formula (E4), Z 1 represents a furan ring formed by condensation of substituted or unsubstituted benzene rings, a thiophene ring formed by condensation of substituted or unsubstituted benzene rings, or a substituted or unsubstituted An N-substituted pyrrole ring formed by condensation of benzene rings, Z2 and Z3 independently represent a substituted or unsubstituted aromatic ring or a substituted or unsubstituted heteroaryl ring, R1 represents a hydrogen atom or a deuterium atom Or a substituent, R 2 and R 3 each independently represent a substituted or unsubstituted aryl group or a substituted or unsubstituted heteroaryl group. Z 1 and R 1 , R 2 and Z 2 , Z 2 and Z 3 , and Z 3 and R 3 may be bonded to each other to form a ring structure. Among them, at least one group among R 2 and Z 2 , Z 2 and Z 3 , and Z 3 and R 3 is bonded to each other to form a ring structure.

作為進一步較佳的延遲螢光材料,亦可以舉出以下通式(E5)所表示之化合物。 [化學式43]

Figure 02_image108
As further preferable delayed fluorescent materials, compounds represented by the following general formula (E5) can also be mentioned. [chemical formula 43]
Figure 02_image108

在通式(E5)中,R 1及R 2分別獨立地表示經取代或未經取代的烷基、經取代或未經取代的芳基或者經取代或未經取代的雜芳基,Z 1及Z 2分別獨立地表示經取代或未經取代的芳香環或者經取代或未經取代的雜芳環,R 3~R 9分別獨立地表示氫原子、氘原子或取代基。其中,R 1、R 2、Z 1及Z 2中的至少一個包含經取代或未經取代的苯并呋喃環、經取代或未經取代的苯并噻吩環、經取代或未經取代的吲哚環。R 1和Z 1、Z 1和R 3、R 3和R 4、R 4和R 5、R 5和Z 2、Z 2和R 2、R 2和R 6、R 6和R 7、R 7和R 8、R 8和R 9、R 9和R 1可以彼此鍵結而形成環狀結構。構成前述苯并呋喃環、前述苯并噻吩環、前述吲哚環之苯環骨架構成碳原子中能夠取代的碳原子可以經氮原子取代。通式(1)中的C-R 3、C-R 4、C-R 5、C-R 6、C-R 7、C-R 8、C-R 9可以取代為N。 In the general formula (E5), R 1 and R 2 independently represent substituted or unsubstituted alkyl, substituted or unsubstituted aryl or substituted or unsubstituted heteroaryl, Z 1 and Z 2 each independently represent a substituted or unsubstituted aromatic ring or a substituted or unsubstituted heteroaryl ring, and R 3 to R 9 each independently represent a hydrogen atom, a deuterium atom or a substituent. Wherein, at least one of R 1 , R 2 , Z 1 and Z 2 contains a substituted or unsubstituted benzofuran ring, a substituted or unsubstituted benzothiophene ring, a substituted or unsubstituted indene Indole ring. R 1 and Z 1 , Z 1 and R 3 , R 3 and R 4 , R 4 and R 5 , R 5 and Z 2 , Z 2 and R 2 , R 2 and R 6 , R 6 and R 7 , R 7 and R 8 , R 8 and R 9 , R 9 and R 1 may be bonded to each other to form a ring structure. Of the carbon atoms constituting the benzene ring skeleton of the benzofuran ring, the benzothiophene ring, and the indole ring, substitutable carbon atoms may be substituted with nitrogen atoms. CR 3 , CR 4 , CR 5 , CR 6 , CR 7 , CR 8 , and CR 9 in the general formula (1) may be replaced by N.

作為進一步較佳的延遲螢光材料,亦可以舉出以下通式(E6)所表示之化合物。 [化學式44]

Figure 02_image110
As further preferable delayed fluorescent materials, compounds represented by the following general formula (E6) can also be mentioned. [chemical formula 44]
Figure 02_image110

在通式(E6)中,R 201~R 221分別獨立地表示氫原子、氘原子或取代基,較佳為表示氫原子、氘原子、烷基、芳基或烷基和芳基鍵結而成之基團。R 201和R 202、R 202和R 203、R 203和R 204、R 205和R 206、R 206和R 207、R 207和R 208、R 214和R 215、R 215和R 216、R 216和R 217、R 218和R 219、R 219和R 220、R 220和R 221中的至少1組彼此鍵結而形成苯并氟結構或苯并噻吩并結構。較佳為,R 201和R 202、R 202和R 203、R 203和R 204、R 205和R 206、R 206和R 207、R 207和R 208中的1組或2組與R 214和R 215、R 215和R 216、R 216和R 217、R 218和R 219、R 219和R 220、R 220和R 221中的1組或2組彼此鍵結而形成苯并氟結構或苯并噻吩并結構。進一步較佳為R 203和R 204彼此鍵結而形成苯并氟結構或苯并噻吩并結構,更進一步較佳為R 203和R 204、R 216和R 217彼此鍵結而形成苯并氟結構或苯并噻吩并結構。特佳為,R 203和R 204、R 216和R 217彼此鍵結而形成苯并氟結構或苯并噻吩并結構,R 206和R 219為經取代或未經取代的芳基(較佳為經取代或未經取代的苯基、更佳為未經取代的苯基)。 通式(E6)包含R 201~R 208、R 214~R 221可以分別獨立地為氘原子而不是氫原子( 1H)的結構。亦即,在R 201~R 208、R 214~R 221包含一個原子之情況下,該原子包含限於氘原子之結構。 In the general formula (E6), R 201 to R 221 independently represent a hydrogen atom, a deuterium atom or a substituent, preferably represent a hydrogen atom, a deuterium atom, an alkyl group, an aryl group, or an alkyl and aryl group are bonded together. into the group. R 201 and R 202 , R 202 and R 203 , R 203 and R 204 , R 205 and R 206 , R 206 and R 207 , R 207 and R 208 , R 214 and R 215 , R 215 and R 216 , R 216 and at least one group of R 217 , R 218 and R 219 , R 219 and R 220 , and R 220 and R 221 are bonded to each other to form a benzofluoro structure or a benzothieno structure. Preferably, one or two groups of R 201 and R 202 , R 202 and R 203 , R 203 and R 204 , R 205 and R 206 , R 206 and R 207 , R 207 and R 208 are combined with R 214 and One or two groups of R 215 , R 215 and R 216 , R 216 and R 217 , R 218 and R 219 , R 219 and R 220 , R 220 and R 221 are bonded to each other to form a benzofluorine structure or a benzene And thieno structure. It is further preferred that R 203 and R 204 are bonded to each other to form a benzofluorine structure or a benzothieno structure, and it is further preferred that R 203 and R 204 , R 216 and R 217 are bonded to each other to form a benzofluorine structure Or benzothieno structure. Particularly preferably, R 203 and R 204 , R 216 and R 217 are bonded to each other to form a benzofluorine structure or a benzothieno structure, and R 206 and R 219 are substituted or unsubstituted aryl groups (preferably substituted or unsubstituted phenyl, more preferably unsubstituted phenyl). The general formula (E6) includes structures in which R 201 to R 208 and R 214 to R 221 may each independently be a deuterium atom instead of a hydrogen atom ( 1 H). That is, when R 201 to R 208 and R 214 to R 221 contain one atom, the atom includes a structure limited to a deuterium atom.

進而,能夠將日本專利2021-103698號、日本專利2021-103699號、日本專利2021-103700號、日本專利2021-081332號、日本專利2021-103701號、日本專利2021-151805號、日本專利2021-188860號的各說明書中所記載之通式(1)所表示之化合物用作延遲螢光材料。將該等通式(1)的說明及具體的化合物作為本說明書的一部分而引用於此。Furthermore, Japanese Patent No. 2021-103698, Japanese Patent No. 2021-103699, Japanese Patent No. 2021-103700, Japanese Patent No. 2021-081332, Japanese Patent No. 2021-103701, Japanese Patent No. 2021-151805, Japanese Patent No. 2021- The compound represented by the general formula (1) described in each specification of No. 188860 is used as a delayed fluorescent material. The description of these general formula (1) and a specific compound are taken in here as a part of this specification.

在以下,舉出能夠用作延遲螢光材料之較佳化合物。在以下的示例性化合物的結構式中,t-Bu表示三級丁基(Tertiary butyl group)。 [化學式45]

Figure 02_image112
Figure 02_image114
Figure 02_image116
Figure 02_image118
Figure 02_image120
Figure 02_image122
Figure 02_image124
Figure 02_image126
Figure 02_image128
Figure 02_image130
Figure 02_image132
Preferred compounds that can be used as delayed fluorescent materials are listed below. In the following structural formulas of exemplary compounds, t-Bu represents a tertiary butyl group. [chemical formula 45]
Figure 02_image112
Figure 02_image114
Figure 02_image116
Figure 02_image118
Figure 02_image120
Figure 02_image122
Figure 02_image124
Figure 02_image126
Figure 02_image128
Figure 02_image130
Figure 02_image132

將上述化合物T1~T151的所有氫原子取代為氘原子之化合物以T1(D)~T151(D)的形式例示於此。將在上述化合物T1~T151中存在之經取代或未經取代的咔唑-9-基(還包含將環縮環者)中之所有氫原子取代為氘原子之化合物以T1(d)~T151(d)的形式例示於此。Compounds in which all the hydrogen atoms of the above-mentioned compounds T1 to T151 are substituted with deuterium atoms are exemplified here as T1(D) to T151(D). Compounds in which all hydrogen atoms in the substituted or unsubstituted carbazol-9-yl (including ring-condensed ones) present in the above compounds T1-T151 are replaced with deuterium atoms are T1(d)-T151 The form of (d) is illustrated here.

除了上述以外,亦能夠適當組合使用公知的延遲螢光材料。又,即使為未知的延遲螢光材料,亦能夠使用。 作為延遲螢光材料,可以舉出WO2013/154064號公報的0008~0048段及0095~0133段、WO2013/011954號公報的0007~0047段及0073~0085段、WO2013/011955號公報的0007~0033段及0059~0066段、WO2013/081088號公報的0008~0071段及0118~0133段、日本特開2013-256490號公報的0009~0046段及0093~0134段、日本特開2013-116975號公報的0008~0020段及0038~0040段、WO2013/133359號公報的0007~0032段及0079~0084段、WO2013/161437號公報的0008~0054段及0101~0121段、日本特開2014-9352號公報的0007~0041段及0060~0069段、日本特開2014-9224號公報的0008~0048段及0067~0076段、日本特開2017-119663號公報的0013~0025段、日本特開2017-119664號公報的0013~0026段、日本特開2017-222623號公報的0012~0025段、日本特開2017-226838號公報的0010~0050段、日本特開2018-100411號公報的0012~0043段、WO2018/047853號公報的0016~0044段中所記載之通式中所包含之化合物、尤其為示例性化合物且輻射延遲螢光者。又,亦能夠採用日本特開2013-253121號公報、WO2013/133359號公報、WO2014/034535號公報、WO2014/115743號公報、WO2014/122895號公報、WO2014/126200號公報、WO2014/136758號公報、WO2014/133121號公報、WO2014/136860號公報、WO2014/196585號公報、WO2014/189122號公報、WO2014/168101號公報、WO2015/008580號公報、WO2014/203840號公報、WO2015/002213號公報、WO2015/016200號公報、WO2015/019725號公報、WO2015/072470號公報、WO2015/108049號公報、WO2015/080182號公報、WO2015/072537號公報、WO2015/080183號公報、日本特開2015-129240號公報、WO2015/129714號公報、WO2015/129715號公報、WO2015/133501號公報、WO2015/136880號公報、WO2015/137244號公報、WO2015/137202號公報、WO2015/137136號公報、WO2015/146541號公報、WO2015/159541號公報中所記載之發光材料且輻射延遲螢光者。再者,在該段中所記載之上述公報作為本說明書的一部分而引用於此。 In addition to the above, known retarded fluorescent materials can also be used in appropriate combination. In addition, even unknown delayed fluorescent materials can be used. Examples of delayed fluorescent materials include paragraphs 0008 to 0048 and paragraphs 0095 to 0133 of WO2013/154064, paragraphs 0007 to 0047 and 0073 to 0085 of WO2013/011954, and paragraphs 0007 to 0033 of WO2013/011955. paragraphs and 0059-0066, paragraphs 0008-0071 and 0118-0133 of WO2013/081088, paragraphs 0009-0046 and 0093-0134 of JP-A-2013-256490, JP-A-2013-116975 0008-0020 and 0038-0040 of WO2013/133359, 0007-0032 and 0079-0084 of WO2013/133359, 0008-0054 and 0101-0121 of WO2013/161437, JP-A-2014-9352 Paragraphs 0007-0041 and 0060-0069 of the communique, paragraphs 0008-0048 and 0067-0076 of the Japanese Patent Application Publication No. 2014-9224, paragraphs 0013-0025 of the Japanese Patent Application Publication No. 2017-119663, Japanese Patent Application Publication No. 2017- Paragraphs 0013-0026 of Japanese Patent Application Publication No. 119664, paragraphs 0012-0025 of Japanese Patent Application Publication No. 2017-222623, paragraphs 0010-0050 of Japanese Patent Application Publication No. 2017-226838, paragraphs 0012-0043 of Japanese Patent Application Publication No. 2018-100411 , Compounds included in the general formula described in paragraphs 0016 to 0044 of WO2018/047853, especially exemplary compounds and radiation-delayed fluorescence. In addition, JP-A-2013-253121, WO2013/133359, WO2014/034535, WO2014/115743, WO2014/122895, WO2014/126200, WO2014/136758, WO2014/133121, WO2014/136860, WO2014/196585, WO2014/189122, WO2014/168101, WO2015/008580, WO2014/203840, WO2015/002 Bulletin No. 213, WO2015/ 016200, WO2015/019725, WO2015/072470, WO2015/108049, WO2015/080182, WO2015/072537, WO2015/080183, JP-A-2015-129240 Bulletin, WO2015 /129714 Gazette, WO2015/129715 Gazette, WO2015/133501 Gazette, WO2015/136880 Gazette, WO2015/137244 Gazette, WO2015/137202 Gazette, WO2015/137136 Gazette, WO2015/146541 Gazette 、WO2015/159541 The luminescent material described in the Publication No. 1 and radiated delayed fluorescence. In addition, the above-mentioned gazette described in this paragraph is incorporated here as a part of this specification.

在發光層中,在將延遲螢光材料用作輔助摻雜劑之情況下,將最低激發單重態能量小於輔助摻雜劑的化合物用作發光材料。作為與輔助摻雜劑組合使用之發光材料,例如可以例示出具有硼原子和氮原子的多重共振效果之化合物或包含蒽、芘、苝等縮合芳香族環結構之化合物。又,亦能夠使用迄今為止例示出之延遲螢光材料。 在本發明的較佳的一態樣中,使用下述通式(F1)所表示之化合物作為與輔助摻雜劑組合使用之發光材料。 通式(F1) [化學式46]

Figure 02_image134
In the light-emitting layer, in the case of using a retarded fluorescent material as the auxiliary dopant, a compound having the lowest excited singlet energy smaller than the auxiliary dopant is used as the light-emitting material. Examples of light-emitting materials used in combination with auxiliary dopants include compounds having multiple resonance effects of boron atoms and nitrogen atoms, and compounds containing condensed aromatic ring structures such as anthracene, pyrene, and perylene. In addition, the retarded fluorescent materials exemplified so far can also be used. In a preferred aspect of the present invention, a compound represented by the following general formula (F1) is used as a light-emitting material used in combination with an auxiliary dopant. General formula (F1) [Chemical formula 46]
Figure 02_image134

在上述通式(F1)中,Ar 1~Ar 3分別獨立地為芳環或雜芳環,該等環中之至少一個氫原子可以經取代,並且環可以縮合。在氫原子經取代之情況下,經氘原子、選自包括芳基、雜芳基及烷基之群組中的一個基團或兩個以上組合而獲得之基團取代為較佳。又,在環縮合之情況下,苯環或雜芳香環(例如,呋喃環、噻吩環、吡咯環等)縮合為較佳。R a及R a’分別獨立地表示取代基,較佳為氘原子、選自包括芳基、雜芳基及烷基之群組中的一個基團或兩個以上組合而獲得之基團。R a和Ar 1、Ar 1和Ar 2、Ar 2和R a’、R a’和Ar 3、Ar 3和R a可以彼此鍵結而形成環狀結構。 In the above general formula (F1), Ar 1 to Ar 3 are each independently an aromatic ring or a heteroaromatic ring, at least one hydrogen atom in these rings may be substituted, and the rings may be condensed. When a hydrogen atom is substituted, it is preferably substituted with a deuterium atom, a group selected from the group consisting of aryl, heteroaryl and alkyl, or a combination of two or more. Also, in the case of ring condensation, condensation of a benzene ring or a heteroaromatic ring (for example, furan ring, thiophene ring, pyrrole ring, etc.) is preferable. R a and R a' each independently represent a substituent, preferably a deuterium atom, one group selected from the group consisting of aryl, heteroaryl and alkyl, or a group obtained by combining two or more. R a and Ar 1 , Ar 1 and Ar 2 , Ar 2 and R a′ , R a′ and Ar 3 , and Ar 3 and R a may be bonded to each other to form a ring structure.

通式(F1)所表示之化合物包含至少一個咔唑結構為較佳。例如,構成咔唑結構之一個苯環可以為Ar 1所表示之環,構成咔唑結構之一個苯環可以為Ar 2所表示之環,構成咔唑結構之一個苯環可以為Ar 3所表示之環。又,咔唑基可以與Ar 1~Ar 3中的任一個以上鍵結。例如,經取代或未經取代的咔唑-9-基可以與Ar 3所表示之環鍵結。 The compound represented by general formula (F1) preferably contains at least one carbazole structure. For example, a benzene ring constituting the carbazole structure can be represented by Ar 1 , a benzene ring constituting the carbazole structure can be represented by Ar 2 , and a benzene ring constituting the carbazole structure can be represented by Ar 3 ring. Also, the carbazolyl group may be bonded to any one or more of Ar 1 to Ar 3 . For example, a substituted or unsubstituted carbazol-9-yl group may be bonded to the ring represented by Ar 3 .

蒽、芘、苝等縮合芳香族環結構可以與Ar 1~Ar 3鍵結。又,Ar 1~Ar 3所表示之環可以為構成縮合芳香族環結構之一個環。進而,R a及R a’中的至少一者可以為具有縮合芳香族環結構之基團。 Condensed aromatic ring structures such as anthracene, pyrene, and perylene may be bonded to Ar 1 to Ar 3 . Also, the rings represented by Ar 1 to Ar 3 may be one ring constituting a condensed aromatic ring structure. Furthermore, at least one of R a and R a' may be a group having a condensed aromatic ring structure.

通式(F1)所表示之骨架可以在化合物中存在複數個。例如,可以具有通式(F1)所表示之骨架彼此經由單鍵或連接基彼此鍵結之結構。又,在通式(F1)所表示之骨架中,可以進一步附加顯示藉由硼原子、氮原子、氧原子、硫原子使苯環彼此連接之多重共振效果之結構。A plurality of skeletons represented by the general formula (F1) may exist in the compound. For example, it may have a structure in which the skeletons represented by the general formula (F1) are bonded to each other via a single bond or a linking group. In addition, to the skeleton represented by the general formula (F1), a structure showing a multiple resonance effect in which benzene rings are connected to each other via a boron atom, a nitrogen atom, an oxygen atom, and a sulfur atom may be added.

在本發明的較佳的一態樣中,使用包含BODIPY(4,4-difluoro-4-bora-3a,4a-diaza-s-indacene:4,4-二氟-4-硼-3a,4a-雙氮雜-s-茚)結構之化合物作為與輔助摻雜劑組合使用之發光材料。例如,使用下述通式(F2)所表示之化合物。 通式(F2) [化學式47]

Figure 02_image136
In a preferred aspect of the present invention, the use contains BODIPY (4,4-difluoro-4-bora-3a,4a-diaza-s-indacene: 4,4-difluoro-4-bora-3a,4a - Compounds with the structure of bis-aza-s-indene are used as luminescent materials in combination with auxiliary dopants. For example, a compound represented by the following general formula (F2) is used. General formula (F2) [Chemical formula 47]
Figure 02_image136

在通式(F2)中,R 1~R 7分別獨立地為氫原子、氘原子或取代基。R 1~R 7中的至少一個為下述通式(F3)所表示之基團為較佳。 通式(F3) [化學式48]

Figure 02_image138
在通式(F3)中,R 11~R 15分別獨立地表示氫原子、氘原子或取代基,*表示鍵結位置。 通式(F3)所表示之基團可以為通式(F2)的R 1~R 7中的一個,亦可以為兩個,亦可以為三個。又,可以設為至少四個,例如能夠設為四個或五個。在本發明的較佳的一態樣中,R 1~R 7中的一個為通式(F3)所表示之基團。在本發明的較佳的一態樣中,至少R 1、R 3、R 5、R 7為通式(F3)所表示之基團。在本發明的較佳的一態樣中,僅R 1、R 3、R 4、R 5、R 7為通式(F3)所表示之基團。在本發明的較佳的一態樣中,R 1、R 3、R 4、R 5、R 7為通式(F3)所表示之基團,R 2及R 4為氫原子、氘原子、未經取代的烷基(例如,碳數1~10)或未經取代的芳基(例如,碳數6~14)。在本發明的一態樣中,R 1~R 7均為通式(F3)所表示之基團。 在本發明的較佳的一態樣中,R 1和R 7相同。在本發明的較佳的一態樣中,R 3和R 5相同。在本發明的較佳的一態樣中,R 2和R 6相同。在本發明的較佳的一態樣中,R 1和R 7相同,R 3和R 5相同,進而R 1和R 3彼此不同。在本發明的較佳的一態樣中,R 1、R 3、R 5、R 7相同。在本發明的較佳的一態樣中,R 1和R 4和R 7相同,R 3和R 5不同。在本發明的較佳的一態樣中,R 3和R 4和R 5相同,R 1和R 7不同。在本發明的較佳的一態樣中,R 1、R 3、R 5、R 7均與R 4不同。 In the general formula (F2), R 1 to R 7 are each independently a hydrogen atom, a deuterium atom or a substituent. It is preferable that at least one of R 1 to R 7 is a group represented by the following general formula (F3). General formula (F3) [Chemical formula 48]
Figure 02_image138
In the general formula (F3), R 11 to R 15 each independently represent a hydrogen atom, a deuterium atom or a substituent, and * represents a bonding position. The group represented by the general formula (F3) may be one, two or three of R 1 to R 7 of the general formula (F2). Also, at least four can be used, for example, four or five can be used. In a preferred aspect of the present invention, one of R 1 to R 7 is a group represented by general formula (F3). In a preferred aspect of the present invention, at least R 1 , R 3 , R 5 , and R 7 are groups represented by general formula (F3). In a preferred aspect of the present invention, only R 1 , R 3 , R 4 , R 5 , and R 7 are groups represented by general formula (F3). In a preferred aspect of the present invention, R 1 , R 3 , R 4 , R 5 , and R 7 are groups represented by general formula (F3), R 2 and R 4 are hydrogen atoms, deuterium atoms, Unsubstituted alkyl group (for example, having 1 to 10 carbon atoms) or unsubstituted aryl group (for example, having 6 to 14 carbon atoms). In one aspect of the present invention, R 1 to R 7 are all groups represented by general formula (F3). In a preferred aspect of the present invention, R 1 and R 7 are the same. In a preferred aspect of the present invention, R3 and R5 are the same. In a preferred aspect of the present invention, R 2 and R 6 are the same. In a preferred aspect of the present invention, R 1 and R 7 are the same, R 3 and R 5 are the same, and R 1 and R 3 are different from each other. In a preferred aspect of the present invention, R 1 , R 3 , R 5 , and R 7 are the same. In a preferred aspect of the present invention, R1 , R4 and R7 are the same, and R3 and R5 are different. In a preferred aspect of the present invention, R3 , R4 and R5 are the same, and R1 and R7 are different. In a preferred aspect of the present invention, R 1 , R 3 , R 5 , and R 7 are all different from R 4 .

作為通式(F3)的R 11~R 15能夠採用之取代基,例如能夠從下述取代基組A進行選擇、從下述取代基組B進行選擇、從下述取代基組C進行選擇或者從下述取代基組D進行選擇。在選擇取代胺基作為取代基之情況下,二取代胺基為較佳,作為相對於胺基之兩個取代基,分別獨立地為經取代或未經取代的芳基、經取代或未經取代的雜芳基或者經取代或未經取代的烷基為較佳,經取代或未經取代的芳基(二芳胺基)為特佳。作為二芳胺基中的兩個芳基能夠採用之取代基,例如能夠從下述取代基組A進行選擇、從下述取代基組B進行選擇、從下述取代基組C進行選擇或者從下述取代基組D進行選擇。二芳胺基中的兩個芳基可以經由單鍵或連接基彼此鍵結,關於在此所述之連接基,能夠參照R 33和R 34中之連接基的說明。作為二芳胺基的具體例,例如能夠採用經取代或未經取代的咔唑-9-基。作為經取代或未經取代的咔唑-9-基,例如可以舉出上述通式(9)的L 11為單鍵之基團。 在本發明的較佳的一態樣中,通式(F3)的僅R 13為取代基,R 11、R 12、R 14、R 15為氫原子。在本發明的較佳的一態樣中,通式(F3)的僅R 11為取代基,R 12、R 13、R 14、R 15為氫原子。在本發明的較佳的一態樣中,通式(F3)的僅R 11和R 13為取代基,R 12、R 14、R 15為氫原子。 在通式(F2)的R 1~R 7中,可以包含通式(F3)的R 11~R 15均為氫原子之基團(亦即,苯基)。例如,R 2、R 4、R 6可以為苯基。 The substituents that can be adopted by R 11 to R 15 of the general formula (F3) are, for example, selected from the following substituent group A, selected from the following substituent group B, selected from the following substituent group C, or Choose from substituent group D described below. In the case of choosing a substituted amino group as a substituent, a disubstituted amino group is preferred, as the two substituents relative to the amino group are independently substituted or unsubstituted aryl, substituted or unsubstituted A substituted heteroaryl group or a substituted or unsubstituted alkyl group is preferred, and a substituted or unsubstituted aryl group (diarylamino group) is particularly preferred. As the substituents that can be adopted by the two aryl groups in the diarylamino group, for example, it can be selected from the following substituent group A, from the following substituent group B, from the following substituent group C, or from Substituent group D described below is selected. The two aryl groups in the diarylamine group can be bonded to each other via a single bond or a linking group. For the linking group described here, reference can be made to the description of the linking group in R 33 and R 34 . As a specific example of the diarylamino group, for example, a substituted or unsubstituted carbazol-9-yl group can be used. Examples of the substituted or unsubstituted carbazol-9-yl include groups in which L 11 of the above general formula (9) is a single bond. In a preferred aspect of the present invention, only R 13 of the general formula (F3) is a substituent, and R 11 , R 12 , R 14 , and R 15 are hydrogen atoms. In a preferred aspect of the present invention, only R 11 of the general formula (F3) is a substituent, and R 12 , R 13 , R 14 , and R 15 are hydrogen atoms. In a preferred aspect of the present invention, only R 11 and R 13 of the general formula (F3) are substituents, and R 12 , R 14 , and R 15 are hydrogen atoms. Among R 1 to R 7 of the general formula (F2), a group in which all of R 11 to R 15 of the general formula (F3) are hydrogen atoms (that is, a phenyl group) may be included. For example, R 2 , R 4 , R 6 may be phenyl.

在通式(F2)中,R 8及R 9分別獨立地為氫原子、氘原子、鹵素原子、選自包括烷基(例如,碳數1~40)、烷氧基(例如,碳數1~40)、芳氧基(例如,碳數6~30)及氰基之群組中的一個基團或兩個以上組合而獲得之基團為較佳。在本發明的較佳實施態樣中,R 8和R 9相同。在本發明的較佳實施態樣中,R 8和R 9為鹵素原子,特佳為氟原子。 In the general formula (F2), R 8 and R 9 are each independently a hydrogen atom, a deuterium atom, a halogen atom, selected from the group consisting of alkyl (for example, with 1 to 40 carbons), alkoxy (for example, with 1 carbon -40), aryloxy (eg, carbon number 6-30) and cyano group, one or a combination of two or more is preferred. In a preferred embodiment of the present invention, R 8 and R 9 are the same. In a preferred embodiment of the present invention, R 8 and R 9 are halogen atoms, particularly preferably fluorine atoms.

在本發明的一態樣中,通式(F2)的R 1~R 9中存在之經取代或未經取代的烷氧基、經取代或未經取代的芳氧基、經取代或未經取代的胺基的數量合計為三個以上為較佳,例如能夠採用為三個之化合物,或者能夠採用為四個之化合物。更佳為,通式(F2)的R 1~R 7中存在之經取代或未經取代的烷氧基、經取代或未經取代的芳氧基、經取代或未經取代的胺基的數量合計為三個以上為較佳,例如能夠採用為三個之化合物或者能夠採用為四個之化合物。此時,在R 8和R 9中可以不存在烷氧基、芳氧基、胺基。進一步較佳為,通式(F2)的R 1、R 3、R 4、R 5、R 7中存在之經取代或未經取代的烷氧基、經取代或未經取代的芳氧基、經取代或未經取代的胺基的數量合計為三個以上為較佳,例如能夠採用為三個之化合物或者能夠採用為四個之化合物。此時,在R 2、R 6、R 8、R 9中可以不存在烷氧基、芳氧基、胺基。在本發明的較佳的一態樣中,經取代或未經取代的烷氧基存在三個以上。在本發明的較佳的一態樣中,經取代或未經取代的烷氧基存在四個以上。在本發明的較佳的一態樣中,經取代或未經取代的烷氧基存在一個以上且經取代或未經取代的芳氧基存在兩個以上。在本發明的較佳的一態樣中,經取代或未經取代的烷氧基存在兩個以上且經取代或未經取代的胺基存在一個以上。在本發明的較佳的一態樣中,在R 1、R 4、R 7中分別存在經取代或未經取代的烷氧基或者經取代或未經取代的芳氧基。在本發明的較佳的一態樣中,在R 1、R 4、R 7中分別存在經取代或未經取代的烷氧基。 In one aspect of the present invention, substituted or unsubstituted alkoxy, substituted or unsubstituted aryloxy, substituted or unsubstituted The total number of substituted amino groups is preferably three or more, for example, three or four compounds can be used. More preferably, the substituted or unsubstituted alkoxy group, substituted or unsubstituted aryloxy group, substituted or unsubstituted amino group present in R 1 to R 7 of the general formula (F2) The total number is preferably three or more, for example, three compounds or four compounds can be used. At this time, there may be no alkoxy group, aryloxy group, or amino group in R8 and R9 . Further preferably , the substituted or unsubstituted alkoxy , substituted or unsubstituted aryloxy , The total number of substituted or unsubstituted amino groups is preferably three or more, for example, three compounds or four compounds can be used. In this case, R 2 , R 6 , R 8 , and R 9 may not have an alkoxy group, an aryloxy group, or an amino group. In a preferred aspect of the present invention, there are three or more substituted or unsubstituted alkoxy groups. In a preferred aspect of the present invention, there are four or more substituted or unsubstituted alkoxy groups. In a preferred aspect of the present invention, there is one or more substituted or unsubstituted alkoxy groups and two or more substituted or unsubstituted aryloxy groups. In a preferred aspect of the present invention, there are two or more substituted or unsubstituted alkoxy groups and one or more substituted or unsubstituted amino groups. In a preferred aspect of the present invention, there are substituted or unsubstituted alkoxy groups or substituted or unsubstituted aryloxy groups in R 1 , R 4 , and R 7 , respectively. In a preferred aspect of the present invention, there are substituted or unsubstituted alkoxy groups in R 1 , R 4 , and R 7 respectively.

在本發明的一態樣中,通式(F2)的R 1~R 9中存在之哈米特的σp值小於-0.2的取代基的合計為三個以上。作為哈米特的σp值小於-0.2的取代基,例如可以舉出甲氧基(-0.27)、乙氧基(-0.24)、正丙氧基(-0.25)、異丙氧基(-0.45)、正丁氧基(-0.32)。另一方面,氟原子(0.06)、甲基(-0.17)、乙基(-0.15)、三級丁基(-0.20)、正己基(-0.15)、環己基(-0.15)等不是哈米特的σp值小於-0.2的取代基。 在本發明的一態樣中,能夠採用通式(F2)的R 1~R 9中存在之哈米特的σp值小於-0.2的取代基的數量為三個之化合物,或者能夠採用為四個之化合物。更佳為,通式(F2)的R 1~R 7中存在之哈米特的σp值小於-0.2的取代基的數量為三個以上為較佳,例如能夠採用為三個之化合物,或者能夠採用為四個之化合物。此時,在R 8和R 9中可以不存在哈米特的σp值小於-0.2的取代基。進一步較佳為,通式(F2)的R 1、R 3、R 4、R 5、R 7中存在之哈米特的σp值小於-0.2的取代基的數量為三個以上為較佳,例如能夠採用為三個之化合物,或者能夠採用為四個之化合物。此時,在R 2、R 6、R 8、R 9中可以不存在哈米特的σp值小於-0.2的取代基。在本發明的較佳的一態樣中,在R 1、R 4、R 7中分別存在哈米特的σp值小於-0.2的取代基。 In one aspect of the present invention, the total number of substituents having a Hammett's σp value of less than -0.2 present in R 1 to R 9 of the general formula (F2) is three or more. Examples of substituents whose Hammett's σp value is less than -0.2 include methoxy (-0.27), ethoxy (-0.24), n-propoxy (-0.25), isopropoxy (-0.45 ), n-butoxy (-0.32). On the other hand, fluorine atom (0.06), methyl group (-0.17), ethyl group (-0.15), tertiary butyl group (-0.20), n-hexyl group (-0.15), cyclohexyl group (-0.15), etc. are not Hami Special substituents with σp values less than -0.2. In one aspect of the present invention, a compound having three or four substituents having a Hammett's σp value of less than -0.2 present in R 1 to R 9 of the general formula (F2) can be used. a compound. More preferably, the number of substituents whose Hammett's σp value is less than -0.2 present in R 1 to R 7 of the general formula (F2) is preferably three or more, for example, three compounds can be used, or Four compounds can be employed. At this time, there may be no substituents whose Hammett's σp value is less than -0.2 in R8 and R9 . Further preferably, the number of substituents whose Hammett's σp value is less than -0.2 in R 1 , R 3 , R 4 , R 5 , and R 7 of the general formula (F2) is preferably three or more, For example, three compounds can be used, or four compounds can be used. In this case, R 2 , R 6 , R 8 , and R 9 may not have substituents whose Hammett's σp value is less than -0.2. In a preferred aspect of the present invention, each of R 1 , R 4 , and R 7 has a substituent whose Hammett's σp value is less than -0.2.

在本發明中,作為與輔助摻雜劑組合使用之發光材料,可以選擇包含咔唑結構之化合物。又,作為與輔助摻雜劑組合使用之發光材料,可以選擇咔唑結構、二苯并呋喃結構、二苯并噻吩結構均不包含的化合物。In the present invention, as a light-emitting material used in combination with an auxiliary dopant, a compound containing a carbazole structure can be selected. Also, as a light-emitting material used in combination with an auxiliary dopant, a compound that does not contain any carbazole structure, dibenzofuran structure, or dibenzothiophene structure can be selected.

在以下,舉出能夠用作與輔助摻雜劑組合使用之發光材料的較佳化合物。其中,在本發明中能夠與輔助摻雜劑組合使用之發光材料不被以下具體例做限定性地解釋。在以下的示例性化合物的結構式中,t-Bu表示三級丁基(Tertiary butyl group)。 [化學式49]

Figure 02_image140
Figure 02_image142
In the following, preferred compounds that can be used as a light-emitting material used in combination with an auxiliary dopant are listed. Wherein, the luminescent material that can be used in combination with the auxiliary dopant in the present invention is not limitedly interpreted by the following specific examples. In the following structural formulas of exemplary compounds, t-Bu represents a tertiary butyl group. [chemical formula 49]
Figure 02_image140
Figure 02_image142

作為上述示例性化合物的衍生物,可以舉出至少一個氫原子經氘原子、烷基、芳基、雜芳基、二芳胺基取代之化合物。 又,WO2015/022974號公報的0220~0239段中所記載的化合物亦能夠較佳地用作與輔助摻雜劑組合使用之發光材料。 Derivatives of the above-mentioned exemplary compounds include compounds in which at least one hydrogen atom is replaced by a deuterium atom, an alkyl group, an aryl group, a heteroaryl group, or a diarylamino group. In addition, the compounds described in paragraphs 0220 to 0239 of WO2015/022974 can also be preferably used as a light-emitting material used in combination with an auxiliary dopant.

在本發明的較佳的一態樣中,在發光層中使用下述通式(G)所表示之化合物。通式(G)所表示之化合物用作與輔助摻雜劑組合使用之發光材料為較佳。通式(G)所表示之化合物可以用作輔助摻雜劑。 通式(G) [化學式50]

Figure 02_image016
In a preferred aspect of the present invention, a compound represented by the following general formula (G) is used in the light-emitting layer. The compound represented by the general formula (G) is preferably used as a light-emitting material used in combination with an auxiliary dopant. The compound represented by the general formula (G) can be used as an auxiliary dopant. General formula (G) [Chemical formula 50]
Figure 02_image016

在通式(G)中,X 1及X 2中的一者為氮原子,另一者為硼原子。在本發明的一態樣中,X 1為氮原子,X 2為硼原子。此時,R 17和R 18彼此鍵結而形成單鍵以形成吡咯環。在本發明的另一態樣中,X 1為硼原子,X 2為氮原子。此時,R 21和R 22彼此鍵結而形成單鍵以形成吡咯環。 In the general formula (G), one of X 1 and X 2 is a nitrogen atom, and the other is a boron atom. In one aspect of the present invention, X 1 is a nitrogen atom, and X 2 is a boron atom. At this time, R17 and R18 are bonded to each other to form a single bond to form a pyrrole ring. In another aspect of the present invention, X 1 is a boron atom, and X 2 is a nitrogen atom. At this time, R21 and R22 are bonded to each other to form a single bond to form a pyrrole ring.

在通式(G)中,R 1~R 26、A 1、A 2分別獨立地表示氫原子、氘原子或取代基。 R 1和R 2、R 2和R 3、R 3和R 4、R 4和R 5、R 5和R 6、R 6和R 7、R 7和R 8、R 8和R 9、R 9和R 10、R 10和R 11、R 11和R 12、R 13和R 14、R 14和R 15、R 15和R 16、R 16和R 17、R 17和R 18、R 18和R 19、R 19和R 20、R 20和R 21、R 21和R 22、R 22和R 23、R 23和R 24、R 24和R 25、R 25和R 26可以彼此鍵結而形成環狀結構。 R 7和R 8鍵結而形成之環狀結構包含硼原子和四個碳原子作為環骨架構成原子。在X 1為硼原子時,R 17和R 18鍵結而形成之環狀結構包含硼原子和四個碳原子作為環骨架構成原子。在X 1為氮原子時,環狀結構被限定為吡咯環。在X 2為硼原子時,R 21和R 22鍵結而形成之環狀結構包含硼原子和四個碳原子作為環骨架構成原子。在X 2為氮原子時,環狀結構被限定為吡咯環。在R 7和R 8、R 17和R 18、R 21和R 22彼此鍵結而形成包含硼原子之環狀結構時,該環狀結構為5~7員環為較佳,5或6員環為更佳,6員環為進一步較佳。在R 7和R 8、R 17和R 18、R 21和R 22彼此鍵結時,彼此鍵結而形成單鍵、-O-、-S-、-N(R 27)-、-C(R 28)(R 29)-、-Si(R 30)(R 31)-、-B(R 32)-、-CO-、-CS-為較佳,形成-O-、-S-或-N(R 27)-為更佳,形成-N(R 27)-為進一步較佳。其中,R 27~R 32分別獨立地表示氫原子、氘原子或取代基。作為取代基,可以採用從後述取代基組A~E中的任一個進行選擇之基團,但是經取代或未經取代的烷基、經取代或未經取代的芳基、經取代或未經取代的雜芳基為較佳,R 27為經取代或未經取代的芳基為特佳。在R 27~R 32為取代基時,R 7和R 8彼此鍵結而形成之環中之R 27~R 32可以與R 6及R 9中的至少一者鍵結而進一步形成環狀結構,R 17和R 18彼此鍵結而形成之環中之R 27~R 32可以與R 16及R 19中的至少一者鍵結而進一步形成環狀結構,R 21和R 22彼此鍵結而形成之環中之R 27~R 32可以與R 20及R 23中的至少一者鍵結而進一步形成環狀結構。在本發明的一態樣中,R 7和R 8、R 17和R 18、R 21和R 22中的僅1組彼此鍵結。在本發明的一態樣中,R 7和R 8、R 17和R 18、R 21和R 22中的僅2組彼此鍵結。在本發明的一態樣中,R 7和R 8、R 17和R 18、R 21和R 22均彼此鍵結。 In the general formula (G), R 1 to R 26 , A 1 , and A 2 each independently represent a hydrogen atom, a deuterium atom, or a substituent. R 1 and R 2 , R 2 and R 3 , R 3 and R 4 , R 4 and R 5 , R 5 and R 6 , R 6 and R 7 , R 7 and R 8 , R 8 and R 9 , R 9 and R 10 , R 10 and R 11 , R 11 and R 12 , R 13 and R 14 , R 14 and R 15 , R 15 and R 16 , R 16 and R 17 , R 17 and R 18 , R 18 and R 19 , R 19 and R 20 , R 20 and R 21 , R 21 and R 22 , R 22 and R 23 , R 23 and R 24 , R 24 and R 25 , R 25 and R 26 may be bonded to each other to form a ring shape structure. The ring structure formed by bonding R 7 and R 8 contains a boron atom and four carbon atoms as ring skeleton constituent atoms. When X 1 is a boron atom, the ring structure formed by bonding R 17 and R 18 includes a boron atom and four carbon atoms as ring skeleton constituent atoms. When X 1 is a nitrogen atom, the ring structure is limited to a pyrrole ring. When X 2 is a boron atom, the ring structure formed by bonding R 21 and R 22 includes a boron atom and four carbon atoms as ring skeleton constituent atoms. When X 2 is a nitrogen atom, the ring structure is limited to a pyrrole ring. When R 7 and R 8 , R 17 and R 18 , R 21 and R 22 are bonded to each other to form a ring structure containing boron atoms, the ring structure is preferably a 5-7-membered ring, 5 or 6-membered A ring is more preferred, and a 6-membered ring is further preferred. When R 7 and R 8 , R 17 and R 18 , R 21 and R 22 are bonded to each other, they are bonded to each other to form a single bond, -O-, -S-, -N(R 27 )-, -C( R 28 )(R 29 )-, -Si(R 30 )(R 31 )-, -B(R 32 )-, -CO-, -CS- are preferred, forming -O-, -S- or - N(R 27 )- is more preferred, and -N(R 27 )- is further preferred. Wherein, R 27 to R 32 each independently represent a hydrogen atom, a deuterium atom or a substituent. As a substituent, a group selected from any of the substituent groups A to E described below can be used, but a substituted or unsubstituted alkyl group, a substituted or unsubstituted aryl group, a substituted or unsubstituted Substituted heteroaryl is preferred, and R 27 is particularly preferred as substituted or unsubstituted aryl. When R 27 to R 32 are substituents, R 27 to R 32 in the ring formed by bonding R 7 and R 8 to each other may bond to at least one of R 6 and R 9 to further form a ring structure , R 17 and R 18 are bonded to each other and R 27 to R 32 in the ring formed by bonding to each other may bond to at least one of R 16 and R 19 to further form a ring structure, and R 21 and R 22 are bonded to each other to form a ring structure R 27 to R 32 in the formed ring may be bonded to at least one of R 20 and R 23 to further form a ring structure. In one aspect of the present invention, only one group of R 7 and R 8 , R 17 and R 18 , R 21 and R 22 are bonded to each other. In one aspect of the present invention, only two groups of R 7 and R 8 , R 17 and R 18 , R 21 and R 22 are bonded to each other. In one aspect of the present invention, R 7 and R 8 , R 17 and R 18 , R 21 and R 22 are all bonded to each other.

R 1和R 2、R 2和R 3、R 3和R 4、R 4和R 5、R 5和R 6、R 6和R 7、R 8和R 9、R 9和R 10、R 10和R 11、R 11和R 12、R 13和R 14、R 14和R 15、R 15和R 16、R 16和R 17、R 18和R 19、R 19和R 20、R 20和R 21、R 22和R 23、R 23和R 24、R 24和R 25、R 25和R 26彼此鍵結而形成之環狀結構可以為芳香環,亦可以為脂肪環,並且可以為包含雜原子者,還可以縮合有1環以上的其他環。作為在此所述之雜原子,選自包括氮原子、氧原子及硫原子之群組中者為較佳。作為所形成之環狀結構的例,可以舉出苯環、吡啶環、嗒𠯤環、嘧啶環、吡𠯤環、吡咯環、咪唑環、吡唑環、三唑環、咪唑啉環、呋喃環、噻吩環、㗁唑環、異㗁唑環、噻唑環、異噻唑環、環己二烯環、環己烯環、環戊烯環、環庚三烯環、環庚二烯環、環庚烯環及選自包括該等環之群組中的一個以上的環進一步縮合而成之環。在本發明的較佳的一態樣中,環狀結構為經取代或未經取代的苯環(還可以縮合有環),例如為可以經烷基或芳基取代的苯環。在本發明的較佳的一態樣中,環狀結構為經取代或未經取代的雜芳環,較佳為苯并呋喃的呋喃環、苯并噻吩的噻吩環。R 1和R 2、R 2和R 3、R 3和R 4、R 4和R 5、R 5和R 6、R 6和R 7、R 8和R 9、R 9和R 10、R 10和R 11、R 11和R 12、R 13和R 14、R 14和R 15、R 15和R 16、R 16和R 17、R 18和R 19、R 19和R 20、R 20和R 21、R 22和R 23、R 23和R 24、R 24和R 25、R 25和R 26中彼此鍵結而形成環狀結構之組合的數量可以為0,例如亦可以為1~6中的任一個。例如可以為1~4中的任一個,能夠選擇1、選擇2或者選擇3或4。在本發明的一態樣中,從R 1和R 2、R 2和R 3、R 3和R 4進行選擇之1組彼此鍵結而形成環狀結構。在本發明的一態樣中,R 5和R 6彼此鍵結而形成環狀結構。在本發明的一態樣中,從R 9和R 10、R 10和R 11、R 11和R 12進行選擇之1組彼此鍵結而形成環狀結構。在本發明的一態樣中,R 1和R 2、R 13和R 14均彼此鍵結而形成環狀結構。在本發明的一態樣中,從R 1和R 2、R 2和R 3、R 3和R 4進行選擇之1組彼此鍵結而形成環狀結構,進而R 5和R 6彼此鍵結而形成環狀結構。在本發明的一態樣中,R 5和R 6、R 19和R 20均彼此鍵結而形成環狀結構。 R 1 and R 2 , R 2 and R 3 , R 3 and R 4 , R 4 and R 5 , R 5 and R 6 , R 6 and R 7 , R 8 and R 9 , R 9 and R 10 , R 10 and R 11 , R 11 and R 12 , R 13 and R 14 , R 14 and R 15 , R 15 and R 16 , R 16 and R 17 , R 18 and R 19 , R 19 and R 20 , R 20 and R 21 , R 22 and R 23 , R 23 and R 24 , R 24 and R 25 , R 25 and R 26 are bonded to each other to form a ring structure that may be an aromatic ring or an aliphatic ring, and may contain hetero In the case of atoms, other rings having one or more rings may be condensed. As the hetero atom mentioned here, one selected from the group consisting of nitrogen atom, oxygen atom and sulfur atom is preferable. Examples of the formed ring structure include a benzene ring, a pyridine ring, a pyridine ring, a pyrimidine ring, a pyridine ring, a pyrrole ring, an imidazole ring, a pyrazole ring, a triazole ring, an imidazoline ring, and a furan ring. , Thiophene ring, azole ring, isoxazole ring, thiazole ring, isothiazole ring, cyclohexadiene ring, cyclohexene ring, cyclopentene ring, cycloheptatriene ring, cycloheptadiene ring, cycloheptadiene ring An alkene ring and a ring formed by further condensation of one or more rings selected from the group including these rings. In a preferred aspect of the present invention, the ring structure is a substituted or unsubstituted benzene ring (rings may also be condensed), such as a benzene ring that may be substituted by an alkyl or aryl group. In a preferred aspect of the present invention, the ring structure is a substituted or unsubstituted heteroaromatic ring, preferably a furan ring of benzofuran and a thiophene ring of benzothiophene. R 1 and R 2 , R 2 and R 3 , R 3 and R 4 , R 4 and R 5 , R 5 and R 6 , R 6 and R 7 , R 8 and R 9 , R 9 and R 10 , R 10 and R 11 , R 11 and R 12 , R 13 and R 14 , R 14 and R 15 , R 15 and R 16 , R 16 and R 17 , R 18 and R 19 , R 19 and R 20 , R 20 and R 21 , R 22 and R 23 , R 23 and R 24 , R 24 and R 25 , R 25 and R 26 are bonded to each other to form a ring structure. The number of combinations may be 0, for example, may be 1 to 6 any of . For example, any one of 1 to 4 may be used, and 1, 2, or 3 or 4 may be selected. In one aspect of the present invention, one group selected from R 1 and R 2 , R 2 and R 3 , and R 3 and R 4 are bonded to each other to form a ring structure. In one aspect of the present invention, R 5 and R 6 are bonded to each other to form a ring structure. In one aspect of the present invention, one group selected from R 9 and R 10 , R 10 and R 11 , and R 11 and R 12 are bonded to each other to form a ring structure. In one aspect of the present invention, R 1 and R 2 , R 13 and R 14 are all bonded to each other to form a ring structure. In one aspect of the present invention, a group selected from R 1 and R 2 , R 2 and R 3 , R 3 and R 4 are bonded to each other to form a ring structure, and R 5 and R 6 are bonded to each other to form a ring structure. In one aspect of the present invention, R 5 and R 6 , R 19 and R 20 are all bonded to each other to form a ring structure.

不與相鄰之R n(n=1~26)彼此鍵結的R 1~R 26為氫原子、氘原子或取代基。作為取代基,能夠採用從後述取代基組A~E中的任一個進行選擇之基團。 R 1~R 26能夠採用之較佳的取代基為經取代或未經取代的烷基、經取代或未經取代的芳基、經取代或未經取代的雜芳基,例如取代基可以為經取代或未經取代的芳基,例如取代基亦可以為經取代或未經取代的烷基。在此所述之烷基、芳基、雜芳基的取代基亦能夠採用從取代基組A~E中的任一個進行選擇之基團,但是較佳為選自包括烷基、芳基及雜芳基之群組中的一個以上的基團,更佳為取代基組E的基團,亦可以為未經取代。在本發明的較佳的一態樣中,R 1~R 6中的至少一個為取代基,較佳為取代基組E的基團。例如,R 2~R 6中的至少一個為取代基,較佳為取代基組E的基團。例如,R 5及R 6中的至少一個為取代基,較佳為取代基組E的基團。在本發明的較佳的一態樣中,R 3及R 6中的至少一者為取代基,更佳為兩者為取代基,並且較佳為取代基組E的基團。在本發明的較佳的一態樣中,在X 1為氮原子時,R 15及R 20中的至少一者為取代基,更佳為兩者為取代基,並且較佳為取代基組E的基團。此時,R 17和R 18彼此鍵結而形成單鍵。在本發明的較佳的一態樣中,在X 2為氮原子時,R 19及R 24中的至少一者為取代基,更佳為兩者為取代基,並且較佳為取代基組E的基團。此時,R 21和R 22彼此鍵結而形成單鍵。在本發明的一態樣中,R 8及R 12中的至少一者為取代基,較佳為兩者為取代基。在本發明的一態樣中,R 8、R 10及R 12為取代基。作為R 8~R 12的取代基,未經取代的烷基為較佳。尤其,在R 8及R 12為碳數2以上的烷基(較佳為碳數3以上的烷基、更佳為碳數3~8的烷基、進一步較佳為3或4的烷基)時,在製成膜時取向性變高,因此為較佳。其中,R 8及R 12為取代基(較佳為烷基、更佳為碳數2以上的烷基、進一步較佳為碳數3以上的烷基、更進一步較佳為碳數3~8的烷基、特佳為3或4的烷基)且R 1~R 6中的至少一個為取代基(較佳為取代基組E的基團)之情況為特佳。在X 1為硼原子時,R 13及R 17中的至少一者為取代基,較佳為兩者為取代基。在本發明的一態樣中,在X 1為硼原子時,R 13、R 15及R 17為取代基。在X 1為硼原子時,作為R 13~R 17的取代基,未經取代的烷基為較佳。在X 2為硼原子時,R 22及R 26中的至少一者為取代基,較佳為兩者為取代基。在本發明的一態樣中,在X 2為硼原子時,R 22、R 24及R 26為取代基。在X 2為硼原子時,作為R 22~R 26的取代基,未經取代的烷基為較佳。以下舉出與在通式(G)中表示為B之硼原子或者X 1或X 2所表示之硼原子鍵結之基團的具體例。其中,在本發明中能夠採用之與硼原子鍵結之基團不被以下具體例做限定性地解釋。再者,在本說明書中,甲基省略CH 3的表示。*表示鍵結位置。 [化學式51]

Figure 02_image145
R 1 to R 26 that are not bonded to adjacent R n (n=1 to 26) are hydrogen atoms, deuterium atoms or substituents. As a substituent, a group selected from any one of substituent groups A to E described below can be used. Preferred substituents for R 1 to R 26 are substituted or unsubstituted alkyl, substituted or unsubstituted aryl, substituted or unsubstituted heteroaryl, for example, the substituents can be Substituted or unsubstituted aryl, for example the substituent may also be substituted or unsubstituted alkyl. The substituents of the alkyl, aryl, and heteroaryl groups described here can also be selected from any one of the substituent groups A to E, but are preferably selected from groups including alkyl, aryl, and One or more groups in the group of heteroaryl groups, more preferably groups of substituent group E, may also be unsubstituted. In a preferred aspect of the present invention, at least one of R 1 to R 6 is a substituent, preferably a substituent group E group. For example, at least one of R 2 to R 6 is a substituent, preferably a substituent group E group. For example, at least one of R 5 and R 6 is a substituent, preferably a group of substituent group E. In a preferred aspect of the present invention, at least one of R 3 and R 6 is a substituent, more preferably both are substituents, and are preferably a group of substituent group E. In a preferred aspect of the present invention, when X 1 is a nitrogen atom, at least one of R 15 and R 20 is a substituent, more preferably both are substituents, and preferably a group of substituents E group. At this time, R 17 and R 18 are bonded to each other to form a single bond. In a preferred aspect of the present invention, when X 2 is a nitrogen atom, at least one of R 19 and R 24 is a substituent, more preferably both are substituents, and preferably a group of substituents E group. At this time, R21 and R22 are bonded to each other to form a single bond. In one aspect of the present invention, at least one of R 8 and R 12 is a substituent, preferably both are substituents. In one aspect of the present invention, R 8 , R 10 and R 12 are substituents. As substituents for R 8 to R 12 , unsubstituted alkyl groups are preferred. In particular, R 8 and R 12 are alkyl groups having 2 or more carbon atoms (preferably alkyl groups having 3 or more carbon atoms, more preferably alkyl groups having 3 to 8 carbon atoms, further preferably 3 or 4 alkyl groups ) is preferable since the orientation becomes high when it is formed into a film. Among them, R 8 and R 12 are substituents (preferably an alkyl group, more preferably an alkyl group with 2 or more carbons, more preferably an alkyl group with 3 or more carbons, even more preferably an alkyl group with 3 to 8 carbons An alkyl group, particularly preferably an alkyl group of 3 or 4) and at least one of R 1 to R 6 is a substituent (preferably a group of substituent group E) is particularly preferred. When X1 is a boron atom, at least one of R13 and R17 is a substituent, preferably both are substituents. In one aspect of the present invention, when X 1 is a boron atom, R 13 , R 15 and R 17 are substituents. When X 1 is a boron atom, unsubstituted alkyl groups are preferred as substituents for R 13 to R 17 . When X 2 is a boron atom, at least one of R 22 and R 26 is a substituent, preferably both are substituents. In one aspect of the present invention, when X 2 is a boron atom, R 22 , R 24 and R 26 are substituents. When X 2 is a boron atom, unsubstituted alkyl groups are preferred as substituents for R 22 to R 26 . Specific examples of the group bonded to the boron atom represented by B in the general formula (G) or the boron atom represented by X1 or X2 are given below. Among them, the groups bonded to boron atoms that can be used in the present invention are not limitedly interpreted by the following specific examples. In addition, in this specification, the representation of CH 3 is omitted for the methyl group. * Indicates bond position. [chemical formula 51]
Figure 02_image145

在以下中,舉出通式(G)的R 1~R 26的具體例。作為R 1~R 7、X 1為氮原子時的R 13~R 21、X 2為氮原子時的R 18~R 26,Z1~Z9為較佳,作為R 8~R 12、X 1為氮原子時的R 22~R 26、X 2為氮原子時的R 13~R 17,Z1~Z7為較佳。其中,在本發明中能夠採用之與硼原子鍵結之基團不被以下具體例做限定性地解釋。D表示氘原子。*表示鍵結位置。 [化學式52]

Figure 02_image147
Specific examples of R 1 to R 26 in the general formula (G) are given below. R 1 to R 7 and R 13 to R 21 when X 1 is a nitrogen atom, and R 18 to R 26 when X 2 is a nitrogen atom are preferably Z1 to Z9, and R 8 to R 12 and X 1 are R 22 to R 26 in the case of a nitrogen atom, and R 13 to R 17 in the case of a nitrogen atom when X 2 is a nitrogen atom, Z1 to Z7 are preferred. Among them, the groups bonded to boron atoms that can be used in the present invention are not limitedly interpreted by the following specific examples. D represents a deuterium atom. * Indicates bond position. [chemical formula 52]
Figure 02_image147

A 1及A 2為氫原子、氘原子或取代基。作為取代基,能夠採用從後述取代基組A~E中的任一個進行選擇之基團。 在本發明的較佳的一態樣中,A 1及A 2分別獨立地為氫原子或氘原子。例如,A 1及A 2為氫原子。例如,A 1及A 2為氘原子。 A 1及A 2中的一者可以為取代基。又,A 1及A 2可以分別獨立地為取代基。A 1及A 2能夠採用之較佳的取代基為受體基團。受體基團為哈米特的σp值為正的基團。 A 1及A 2能夠採用之受體基團為哈米特的σp值大於0.2的基團為更佳。作為哈米特的σp值大於0.2的基團,可以舉出氰基、至少經氰基取代之芳基、包含氟原子之基團、包含氮原子作為環骨架構成原子之經取代或未經取代的雜芳基。在此所述之至少經氰基取代之芳基可以經除了氰基以外的取代基(例如,烷基或芳基)取代,但是亦可以為僅經氰基取代之芳基。至少經氰基取代之芳基為至少經氰基取代之苯基為較佳。氰基的取代數為一個或兩個為較佳,例如可以為一個,亦可以為兩個。作為包含氟原子之基團,可以舉出氟原子、氟化烷基、氟原子或至少經氟化烷基取代之芳基。氟化烷基為全氟烷基為較佳,碳數為1~6為較佳,1~3為更佳。又,包含氮原子作為環骨架構成原子之雜芳基可以為單環,亦可以為兩個以上的環縮合而成之縮合環。在為縮合環之情況下,縮合之後的環的數量為2~6個為較佳,例如能夠從2~4個進行選擇或者設為兩個。作為構成雜芳基之環的具體例,可以舉出吡啶環、嘧啶環、吡𠯤環、三𠯤環、喹啉環、異喹啉環、喹唑啉環、喹㗁啉環、除了喹唑啉環和喹㗁啉環以外的口奈啶環。構成雜芳基之環可以經氘原子或取代基取代,作為取代基,例如可以舉出選自包括烷基、芳基及雜芳基之群組中的一個基團或兩個以上組合而形成之基團。作為A 1及A 2能夠採用之受體基團,特佳為氰基。 在本發明的一態樣中,A 1及A 2中的至少一者為受體基團。在本發明的一態樣中,A 1及A 2中的僅一者為受體基團。在本發明的一態樣中,A 1及A 2這兩者為相同的受體基團。在本發明的一態樣中,A 1及A 2為彼此不同之受體基團。在本發明的一態樣中,A 1及A 2為氰基。在本發明的一態樣中,A 1及A 2為鹵素原子,例如為溴原子。 A1 and A2 are a hydrogen atom, a deuterium atom or a substituent. As a substituent, a group selected from any one of substituent groups A to E described below can be used. In a preferred aspect of the present invention, A 1 and A 2 are each independently a hydrogen atom or a deuterium atom. For example, A1 and A2 are hydrogen atoms. For example, A1 and A2 are deuterium atoms. One of A1 and A2 may be a substituent. Also, A1 and A2 may each independently be a substituent. A preferred substituent that A1 and A2 can adopt is an acceptor group. The acceptor group is a group with a positive Hammett's σp value. The acceptable acceptor groups for A 1 and A 2 are more preferably groups whose Hammett's σp value is greater than 0.2. As groups having a Hammett's σp value greater than 0.2, cyano groups, aryl groups substituted by at least cyano groups, groups containing fluorine atoms, substituted or unsubstituted groups containing nitrogen atoms as ring skeleton constituent atoms, The heteroaryl. The at least cyano-substituted aryl group described herein may be substituted with substituents other than cyano (eg, alkyl or aryl), but may also be an aryl group substituted only with cyano. Preferably, the aryl group substituted with at least cyano group is phenyl group substituted with at least cyano group. The number of substitutions of the cyano group is preferably one or two, for example, one or two. Examples of the group containing a fluorine atom include a fluorine atom, a fluorinated alkyl group, a fluorine atom, or an aryl group substituted with at least a fluorinated alkyl group. The fluorinated alkyl group is preferably a perfluoroalkyl group, preferably having 1-6 carbon atoms, more preferably 1-3 carbon atoms. In addition, the heteroaryl group containing a nitrogen atom as a ring skeleton constituting atom may be a single ring or a condensed ring formed by condensing two or more rings. In the case of condensed rings, the number of condensed rings is preferably 2 to 6, for example, can be selected from 2 to 4 or set to two. Specific examples of the ring constituting the heteroaryl group include a pyridine ring, a pyrimidine ring, a pyridine ring, a triazine ring, a quinoline ring, an isoquinoline ring, a quinazoline ring, a quinoline ring, a quinoline ring, and a quinoline ring. Ornadine rings other than line rings and quinoline rings. The ring constituting the heteroaryl group may be substituted with a deuterium atom or a substituent. As the substituent, for example, one group selected from the group consisting of an alkyl group, an aryl group, and a heteroaryl group or a combination of two or more groups may be mentioned. group. As the acceptor group that A1 and A2 can adopt, a cyano group is particularly preferable. In one aspect of the present invention, at least one of A1 and A2 is an acceptor group. In one aspect of the invention, only one of A1 and A2 is an acceptor group. In one aspect of the present invention, both A1 and A2 are the same acceptor group. In one aspect of the invention, A 1 and A 2 are different acceptor groups from each other. In one aspect of the present invention, A 1 and A 2 are cyano groups. In one aspect of the present invention, A 1 and A 2 are halogen atoms, such as bromine atoms.

在以下中,示出在本發明中能夠採用之受體基團的具體例。其中,在本發明中能夠使用之受體基團不被以下具體例做限定性地解釋。在本說明書中,甲基省略CH 3的表示。因此,例如若為A15,則表示包含兩個4-甲基苯基之基團。又,“D”表示氘原子。*表示鍵結位置。 [化學式53]

Figure 02_image149
Figure 02_image151
Specific examples of acceptor groups that can be used in the present invention are shown below. Among them, the acceptor groups that can be used in the present invention are not limitedly interpreted by the following specific examples. In this specification, the representation of CH 3 is omitted for the methyl group. Therefore, for example, A15 represents a group containing two 4-methylphenyl groups. Also, "D" represents a deuterium atom. * Indicates bond position. [chemical formula 53]
Figure 02_image149
Figure 02_image151

再者,在X 1為氮原子,R 7和R 8經由氮原子鍵結而形成6員環,R 21和R 22經由氮原子鍵結而形成6員環,R 17和R 18彼此鍵結而形成單鍵時,R 1~R 6中的至少一個為經取代或未經取代的芳基或者R 1和R 2、R 2和R 3、R 3和R 4、R 4和R 5、R 5和R 6中的任一個彼此鍵結而形成芳香環(可以縮合的經取代或未經取代的苯環)或雜芳環(較佳為可以縮合的經取代或未經取代的苯并呋喃的呋喃環、可以縮合的經取代或未經取代的苯并噻吩的噻吩環)。 又,在X 1為硼原子,X 2為氮原子,R 7和R 8、R 17和R 18彼此鍵結而形成包含硼原子之環狀結構之情況下,該環狀結構為5~7員環,在為6員環之情況下,R 7和R 8、R 17和R 18彼此鍵結而形成-B(R 32)-、-CO-、-CS-或-N(R 27)-。R 27表示氫原子、氘原子或取代基為較佳。 Furthermore, when X1 is a nitrogen atom, R7 and R8 are bonded via a nitrogen atom to form a 6-membered ring, R21 and R22 are bonded via a nitrogen atom to form a 6-membered ring, and R17 and R18 are bonded to each other When forming a single bond, at least one of R 1 to R 6 is a substituted or unsubstituted aryl group or R 1 and R 2 , R 2 and R 3 , R 3 and R 4 , R 4 and R 5 , Any one of R and R is bonded to each other to form an aromatic ring (substituted or unsubstituted benzene ring that can be condensed) or a heteroaromatic ring (preferably substituted or unsubstituted benzo that can be condensed) furan ring of furan, thiophene ring of substituted or unsubstituted benzothiophene which can be condensed). In addition, when X 1 is a boron atom, X 2 is a nitrogen atom, and R 7 and R 8 , R 17 and R 18 are bonded to each other to form a ring structure containing a boron atom, the ring structure is 5 to 7 In the case of a 6-membered ring, R 7 and R 8 , R 17 and R 18 are bonded to each other to form -B(R 32 )-, -CO-, -CS- or -N(R 27 ) -. R 27 preferably represents a hydrogen atom, a deuterium atom or a substituent.

在通式(G)的X 1為氮原子時,本發明的化合物具有下述骨架(1a)。在通式(G)的X 2為氮原子時,本發明的化合物具有下述骨架(1b)。 [化學式54]

Figure 02_image153
When X 1 of the general formula (G) is a nitrogen atom, the compound of the present invention has the following skeleton (1a). When X 2 in the general formula (G) is a nitrogen atom, the compound of the present invention has the following skeleton (1b). [chemical formula 54]
Figure 02_image153

骨架(1a)及(1b)中之各氫原子可以取代為氘原子或取代基。又,可以與相鄰之氫原子一起取代為連接基而形成環狀結構。關於詳細內容,能夠參照通式(G)的對應之R 1~R 26、A 1、A 2的記載。可以例示出在骨架(1a)及(1b)中與硼原子鍵結之苯基均為取代為均三甲苯基(mesityl)、2,6-二異丙基苯基或2,4,6-三異丙基苯基之化合物等。在本發明的一態樣中,骨架(1a)及(1b)中之各氫原子可以不與相鄰之氫原子一起取代為連接基而形成環狀結構。 Each hydrogen atom in the skeleton (1a) and (1b) may be substituted with a deuterium atom or a substituent. In addition, it may be substituted together with adjacent hydrogen atoms as a linking group to form a ring structure. For details, the description of R 1 to R 26 , A 1 , and A 2 corresponding to the general formula (G) can be referred to. It can be exemplified that the phenyl group bonded to the boron atom in the skeleton (1a) and (1b) is all substituted with mesityl, 2,6-diisopropylphenyl or 2,4,6- Triisopropylphenyl compounds, etc. In one aspect of the present invention, each hydrogen atom in the skeleton (1a) and (1b) may not be substituted with adjacent hydrogen atoms as a linking group to form a ring structure.

作為具有骨架(1a)之化合物的較佳的一組,可以例示出下述通式(1a)所表示之化合物。 通式(1a) [化學式55]

Figure 02_image155
As a preferable group of the compound which has skeleton (1a), the compound represented by following general formula (1a) can be illustrated. General formula (1a) [Chemical formula 55]
Figure 02_image155

在通式(1a)中,Ar 1~Ar 4分別獨立地表示經取代或未經取代的芳基、經取代或未經取代的雜芳基或者經取代或未經取代的烷基,例如可以較佳地選擇經取代或未經取代的芳基。R 41及R 42分別獨立地表示經取代或未經取代的烷基,m1及m2分別獨立地表示0~5的整數,n1及n3分別獨立地表示0~4的整數,n2及n4分別獨立地表示0~3的整數。A 1、A 2分別獨立地表示氫原子、氘原子或取代基。n1~n4中的至少一個為1以上,m1及m2分別獨立地為1~5中的任一個整數為較佳。 在本發明的一態樣中,n1~n4分別獨立地表示0~2的整數。在本發明的較佳的一態樣中,n1~n4中的至少一個為1以上,較佳為n1及n2中的至少一個為1以上,n3及n4中的至少一個為1以上。在本發明的一態樣中,n1及n3分別獨立地為1或2,n2及n4為0。在本發明的一態樣中,n2及n4分別獨立地為1或2,n1及n3為0。在本發明的一態樣中,n1~n4分別獨立地為1或2。在本發明的一態樣中,n1和n3相等,n2和n4相等。在本發明的一態樣中,n1和n3為1,n2和n4為0。在本發明的一態樣中,n1和n3為0,n2和n4為1。在本發明的一態樣中,n1~n4均為1。Ar 1~Ar 4的鍵結位置可以為咔唑環的3、6位中的至少一個,亦可以為2、7位中的至少一個,亦可以為1、8位中的至少一個,亦可以為4、5位中的至少一個。Ar 1~Ar 4的鍵結位置可以為咔唑環的3、6位這兩者,亦可以為2、7位這兩者,亦可以為1、8位這兩者,亦可以為4、5位這兩者。例如,可以較佳地選擇3、6位中的至少一個,或者可以進一步較佳地選擇3、6位這兩者。在本發明的較佳的一態樣中,Ar 1~Ar 4均為相同的基團。在本發明的較佳的一態樣中,Ar 1~Ar 4分別獨立地為經取代或未經取代的芳基,更佳為經取代或未經取代的苯基或萘基,進一步較佳為經取代或未經取代的苯基。作為取代基,可以舉出從後述取代基組A~E中的任一個進行選擇之基團,但是未經取代的苯基亦較佳。作為Ar 1~Ar 4的較佳的具體例,可以舉出苯基、鄰聯苯基、間聯苯基、對聯苯基、聯三苯基。 在本發明的一態樣中,m1及m2分別獨立地為0。在本發明的一態樣中,m1及m2分別獨立地為1~5中的任一個整數。在本發明的一態樣中,m1和m2相等。在本發明的一態樣中,R 41及R 42為碳數1~6的烷基,例如能夠從碳數1~3的烷基進行選擇或者選擇甲基。關於烷基的取代位置,可以將與硼原子鍵結之碳原子設為1位,例示出僅2位,僅3位,僅4位,3位和5位、2位和4位、2位和6位、2位和4位和6位等,至少2位為較佳,至少2位和6位為更佳。 關於A 1及A 2的說明和較佳範圍,能夠參照通式(G)的對應之記載。 In the general formula (1a), Ar 1 to Ar 4 independently represent a substituted or unsubstituted aryl group, a substituted or unsubstituted heteroaryl group or a substituted or unsubstituted alkyl group, for example, A substituted or unsubstituted aryl group is preferably selected. R 41 and R 42 independently represent a substituted or unsubstituted alkyl group, m1 and m2 independently represent an integer of 0 to 5, n1 and n3 independently represent an integer of 0 to 4, n2 and n4 independently ground represents an integer of 0 to 3. A 1 and A 2 each independently represent a hydrogen atom, a deuterium atom or a substituent. It is preferable that at least one of n1 to n4 is 1 or more, and m1 and m2 are each independently any integer of 1 to 5. In one aspect of the present invention, n1-n4 each independently represent an integer of 0-2. In a preferred aspect of the present invention, at least one of n1-n4 is 1 or more, preferably at least one of n1 and n2 is 1 or more, and at least one of n3 and n4 is 1 or more. In one aspect of the present invention, n1 and n3 are 1 or 2 independently, and n2 and n4 are 0. In one aspect of the present invention, n2 and n4 are 1 or 2 independently, and n1 and n3 are 0. In one aspect of the present invention, n1-n4 are 1 or 2 each independently. In one aspect of the present invention, n1 and n3 are equal, and n2 and n4 are equal. In an aspect of the present invention, n1 and n3 are 1, and n2 and n4 are 0. In an aspect of the present invention, n1 and n3 are 0, and n2 and n4 are 1. In one aspect of the present invention, n1˜n4 are all 1. The bonding positions of Ar 1 to Ar 4 may be at least one of the 3 and 6 positions of the carbazole ring, or at least one of the 2 and 7 positions, or at least one of the 1 and 8 positions, or It is at least one of 4 and 5 digits. The bonding positions of Ar 1 to Ar 4 may be both the 3 and 6 positions of the carbazole ring, may also be both the 2 and 7 positions, may also be both the 1 and 8 positions, or may be the 4, 8 positions. 5 bits for both. For example, at least one of 3 and 6 bits may be preferably selected, or both 3 and 6 bits may be further preferably selected. In a preferred aspect of the present invention, Ar 1 to Ar 4 are all the same group. In a preferred aspect of the present invention, Ar 1 to Ar 4 are independently substituted or unsubstituted aryl, more preferably substituted or unsubstituted phenyl or naphthyl, further preferably is a substituted or unsubstituted phenyl group. As the substituent, a group selected from any one of substituent groups A to E described below can be mentioned, but an unsubstituted phenyl group is also preferable. Preferable specific examples of Ar 1 to Ar 4 include phenyl, o-biphenyl, m-biphenyl, p-biphenyl, and terphenyl. In one aspect of the present invention, m1 and m2 are each independently 0. In one aspect of the present invention, m1 and m2 are each independently any integer of 1-5. In one aspect of the invention, m1 and m2 are equal. In one aspect of the present invention, R 41 and R 42 are alkyl groups having 1 to 6 carbons, for example, can be selected from alkyl groups having 1 to 3 carbons or methyl groups. As for the substitution position of the alkyl group, the carbon atom bonded to the boron atom can be set as the 1st position, and examples include only the 2nd position, only the 3rd position, only the 4th position, the 3rd and 5th positions, the 2nd and 4th positions, and the 2nd positions. And 6 bits, 2 bits, 4 bits, 6 bits, etc., at least 2 bits are better, and at least 2 bits and 6 bits are more preferable. For descriptions and preferred ranges of A1 and A2 , reference can be made to the corresponding description of the general formula (G).

在以下中,舉出通式(1a)所表示之化合物的具體例。在本發明中能夠使用之通式(1a)的化合物不被下述一組具體例做限定性地解釋。例如,作為較佳的一組,可以舉出包括除了下述第4列中間的化合物和下述第8列中間的化合物以外的其餘化合物之組。 [化學式56]

Figure 02_image157
Figure 02_image159
Figure 02_image161
Figure 02_image163
Figure 02_image165
Figure 02_image167
Figure 02_image169
Specific examples of the compound represented by the general formula (1a) are given below. The compounds of the general formula (1a) that can be used in the present invention are not limitedly interpreted by the following group of specific examples. For example, a group including compounds other than the compound in the middle of the following column 4 and the compound in the middle of the following column 8 can be mentioned as a preferable group. [chemical formula 56]
Figure 02_image157
Figure 02_image159
Figure 02_image161
Figure 02_image163
Figure 02_image165
Figure 02_image167
Figure 02_image169

在以下中,舉出通式(1a)所表示之化合物的另一組具體例。在本發明中能夠使用之通式(1a)的化合物不被下述一組具體例做限定性地解釋。 [化學式57]

Figure 02_image171
Figure 02_image173
Figure 02_image175
Figure 02_image177
Figure 02_image179
Another specific example of the compound represented by the general formula (1a) is given below. The compounds of the general formula (1a) that can be used in the present invention are not limitedly interpreted by the following group of specific examples. [chemical formula 57]
Figure 02_image171
Figure 02_image173
Figure 02_image175
Figure 02_image177
Figure 02_image179

作為具有骨架(1b)之化合物的較佳的一組,可以例示出下述通式(1b)所表示之化合物。 通式(1b) [化學式58]

Figure 02_image181
As a preferable group of compounds having a skeleton (1b), compounds represented by the following general formula (1b) can be exemplified. General formula (1b) [Chemical formula 58]
Figure 02_image181

在通式(1b)中,Ar 5~Ar 8分別獨立地表示經取代或未經取代的芳基、經取代或未經取代的雜芳基或者經取代或未經取代的烷基,例如可以較佳地選擇經取代或未經取代的芳基。R 43及R 44分別獨立地表示經取代或未經取代的烷基。m3及m4分別獨立地表示0~5的整數,n6及n8分別獨立地表示0~3的整數,n5及n7分別獨立地表示0~4的整數。A 1、A 2分別獨立地表示氫原子、氘原子或取代基。關於Ar 5~Ar 8、R 43及R 44、m3及m4、n5~n8、A 1、A 2的詳細內容,能夠參照通式(1a)的Ar 1~Ar 4、R 41及R 42、m1及m2、n1~n4、A 1、A 2的記載。n5~n8中的至少一個為1以上,m3及m4分別獨立地為1~5中的任一個整數為較佳。 In the general formula (1b), Ar 5 to Ar 8 independently represent a substituted or unsubstituted aryl group, a substituted or unsubstituted heteroaryl group or a substituted or unsubstituted alkyl group, for example, A substituted or unsubstituted aryl group is preferably selected. R 43 and R 44 each independently represent a substituted or unsubstituted alkyl group. m3 and m4 each independently represent an integer of 0 to 5, n6 and n8 each independently represent an integer of 0 to 3, and n5 and n7 each independently represent an integer of 0 to 4. A 1 and A 2 each independently represent a hydrogen atom, a deuterium atom or a substituent. For details of Ar 5 to Ar 8 , R 43 and R 44 , m3 and m4, n5 to n8, A 1 , and A 2 , refer to Ar 1 to Ar 4 , R 41 and R 42 , Description of m1 and m2, n1 to n4, A 1 , and A 2 . It is preferable that at least one of n5-n8 is 1 or more, and m3 and m4 are each independently any integer of 1-5.

在以下中,舉出通式(1b)所表示之化合物的具體例。在本發明中能夠使用之通式(1b)的化合物不被下述具體例做限定性地解釋。 [化學式59]

Figure 02_image183
Specific examples of the compound represented by the general formula (1b) are given below. The compounds of the general formula (1b) that can be used in the present invention are not limitedly interpreted by the following specific examples. [chemical formula 59]
Figure 02_image183

在通式(G)的R 7和R 8彼此鍵結而形成N-Ph時,在X 1為氮原子時,本發明的化合物例如具有下述骨架(2a),在X 2為氮原子時,本發明的化合物例如具有下述骨架(2b)。Ph為苯基。 骨架(2a) [化學式60]

Figure 02_image185
When R 7 and R 8 of the general formula (G) are bonded to each other to form N-Ph, when X 1 is a nitrogen atom, the compound of the present invention has, for example, the following skeleton (2a), when X 2 is a nitrogen atom , the compound of the present invention has, for example, the following skeleton (2b). Ph is phenyl. Skeleton (2a) [Chemical Formula 60]
Figure 02_image185

骨架(2a)及(2b)中之各氫原子可以取代為氘原子或取代基。又,可以與相鄰之氫原子一起取代為連接基而形成環狀結構。關於詳細內容,能夠參照通式(G)的對應之R 1~R 26、A 1、A 2的記載。骨架(2a)中所包含之構成咔唑部分結構之苯環中的至少一個氫原子被經取代或未經取代的芳基取代。在本發明的一態樣中,骨架(2a)及(2b)中之各氫原子可以不與相鄰之氫原子一起取代為連接基而形成環狀結構。 Each hydrogen atom in the skeleton (2a) and (2b) may be substituted with a deuterium atom or a substituent. In addition, it may be substituted together with adjacent hydrogen atoms as a linking group to form a ring structure. For details, the description of R 1 to R 26 , A 1 , and A 2 corresponding to the general formula (G) can be referred to. At least one hydrogen atom in the benzene ring constituting the partial structure of carbazole included in the skeleton (2a) is substituted with a substituted or unsubstituted aryl group. In one aspect of the present invention, each hydrogen atom in the skeleton (2a) and (2b) may not be substituted with adjacent hydrogen atoms as a linking group to form a ring structure.

作為具有骨架(2a)之化合物的較佳的一組,可以例示出下述通式(2a)所表示之化合物。 通式(2a) [化學式61]

Figure 02_image187
As a preferable group of compounds having a skeleton (2a), compounds represented by the following general formula (2a) can be exemplified. general formula (2a) [chemical formula 61]
Figure 02_image187

在通式(2a)中,Ar 9~Ar 14分別獨立地表示經取代或未經取代的芳基、經取代或未經取代的雜芳基或者經取代或未經取代的烷基,例如可以較佳地選擇經取代或未經取代的芳基。n9、n11、n12、n14分別獨立地表示0~4的整數,n10及n13分別獨立地表示0~2的整數。其中,n9、n10、n12、n13中的至少一個為1以上。A 1、A 2分別獨立地表示氫原子、氘原子或取代基。 在本發明的一態樣中,n9~n14分別獨立地表示0~2的整數。在本發明的一態樣中,n9~n14中的至少一個為1以上,例如能夠將n9及n12設為1以上或者將n10及n13設為1以上。在本發明的較佳的一態樣中,n9、n10、n12、n13中的至少一個為1以上。在本發明的一態樣中,n9及n12分別獨立地為1或2,n10、n11、n13、n14為0。在本發明的一態樣中,n10及n13分別獨立地為1或2,n9、n11、n12、n14為0。在本發明的一態樣中,n9及n12分別獨立地為1或2,n10及n13分別獨立地為1或2,n11及n14為0。在本發明的一態樣中,n9~n14均為1。Ar 9~Ar 14的鍵結位置能夠設為咔唑環的3、6位或者設為其他位置。在本發明的較佳的一態樣中,Ar 9~Ar 14均為相同的基團。關於Ar 9~Ar 14的較佳的基團,能夠參照Ar 1~Ar 4的對應之記載。關於A 1及A 2的說明和較佳範圍,能夠參照通式(G)的對應之記載。 In the general formula (2a), Ar 9 to Ar 14 independently represent a substituted or unsubstituted aryl group, a substituted or unsubstituted heteroaryl group or a substituted or unsubstituted alkyl group, for example, A substituted or unsubstituted aryl group is preferably selected. n9, n11, n12, and n14 each independently represent an integer of 0-4, and n10 and n13 each independently represent an integer of 0-2. However, at least one of n9, n10, n12, and n13 is 1 or more. A 1 and A 2 each independently represent a hydrogen atom, a deuterium atom or a substituent. In one aspect of the present invention, n9-n14 each independently represent an integer of 0-2. In one aspect of the present invention, at least one of n9 to n14 is 1 or more, for example, n9 and n12 can be 1 or more, or n10 and n13 can be 1 or more. In a preferred aspect of the present invention, at least one of n9, n10, n12, and n13 is 1 or more. In one aspect of the present invention, n9 and n12 are 1 or 2 independently, and n10, n11, n13, and n14 are 0. In one aspect of the present invention, n10 and n13 are 1 or 2 independently, and n9, n11, n12, and n14 are 0. In one aspect of the present invention, n9 and n12 are 1 or 2 independently, n10 and n13 are 1 or 2 independently, and n11 and n14 are 0. In one aspect of the present invention, n9˜n14 are all 1. The bonding positions of Ar 9 to Ar 14 can be set at the 3rd and 6th positions of the carbazole ring or other positions. In a preferred aspect of the present invention, Ar 9 to Ar 14 are all the same group. For preferred groups of Ar 9 to Ar 14 , reference can be made to the corresponding descriptions of Ar 1 to Ar 4 . For descriptions and preferred ranges of A1 and A2 , reference can be made to the corresponding description of the general formula (G).

在以下中,舉出通式(2a)所表示之化合物的具體例。在本發明中能夠使用之通式(2a)的化合物不被下述具體例做限定性地解釋。 [化學式62]

Figure 02_image189
Specific examples of the compound represented by the general formula (2a) are given below. The compounds of the general formula (2a) that can be used in the present invention are not limitedly interpreted by the following specific examples. [chemical formula 62]
Figure 02_image189

作為具有骨架(2b)之化合物的較佳的一組,可以例示出下述通式(2b)所表示之化合物。 通式(2b) [化學式63]

Figure 02_image191
As a preferable group of compounds having a skeleton (2b), compounds represented by the following general formula (2b) can be exemplified. General formula (2b) [Chemical formula 63]
Figure 02_image191

在通式(2b)中,Ar 15~Ar 20分別獨立地表示經取代或未經取代的芳基、經取代或未經取代的雜芳基或者經取代或未經取代的烷基,例如可以較佳地選擇經取代或未經取代的芳基。n15、n17、n18、n20分別獨立地表示0~4的整數,n16及n19分別獨立地表示0~2的整數。A 1、A 2分別獨立地表示氫原子、氘原子或取代基。關於Ar 15~Ar 20、n15~n20、A 1、A 2的詳細內容,能夠依序參照通式(2a)的Ar 9~Ar 14、n9~n14、A 1、A 2的記載。 In the general formula (2b), Ar 15 to Ar 20 independently represent a substituted or unsubstituted aryl group, a substituted or unsubstituted heteroaryl group or a substituted or unsubstituted alkyl group, for example, A substituted or unsubstituted aryl group is preferably selected. n15, n17, n18, and n20 each independently represent an integer of 0-4, and n16 and n19 each independently represent an integer of 0-2. A 1 and A 2 each independently represent a hydrogen atom, a deuterium atom or a substituent. For details of Ar 15 to Ar 20 , n15 to n20, A 1 , and A 2 , the descriptions of Ar 9 to Ar 14 , n9 to n14, A 1 , and A 2 in the general formula (2a) can be referred to in order.

在以下中,舉出通式(2b)所表示之化合物的具體例。在本發明中能夠使用之通式(2b)的化合物不被下述具體例做限定性地解釋。 [化學式64]

Figure 02_image193
Specific examples of the compound represented by the general formula (2b) are given below. The compounds of the general formula (2b) that can be used in the present invention are not limitedly interpreted by the following specific examples. [chemical formula 64]
Figure 02_image193

在通式(G)的R 7和R 8彼此鍵結而形成單鍵時,在X 1為氮原子時,本發明的化合物例如具有下述骨架(3a),在X 2為氮原子時,本發明的化合物例如具有下述骨架(3b)。 [化學式65]

Figure 02_image195
When R 7 and R 8 of the general formula (G) are bonded to each other to form a single bond, when X 1 is a nitrogen atom, the compound of the present invention has, for example, the following skeleton (3a), when X 2 is a nitrogen atom, The compound of the present invention has, for example, the following skeleton (3b). [chemical formula 65]
Figure 02_image195

骨架(3a)及(3b)中之各氫原子可以取代為氘原子或取代基。又,可以與相鄰之氫原子一起取代為連接基而形成環狀結構。關於詳細內容,能夠參照通式(G)的對應之R 1~R 26、A 1、A 2的記載。在本發明的一態樣中,骨架(3a)及(3b)中之各氫原子可以不與相鄰之氫原子一起取代為連接基而形成環狀結構。 Each hydrogen atom in the skeleton (3a) and (3b) may be substituted with a deuterium atom or a substituent. In addition, it may be substituted together with adjacent hydrogen atoms as a linking group to form a ring structure. For details, the description of R 1 to R 26 , A 1 , and A 2 corresponding to the general formula (G) can be referred to. In one aspect of the present invention, each hydrogen atom in the skeleton (3a) and (3b) may not be substituted with adjacent hydrogen atoms as a linking group to form a ring structure.

作為具有骨架(3a)之化合物的較佳的一組,可以例示出下述通式(3a)所表示之化合物。 通式(3a) [化學式66]

Figure 02_image197
As a preferable group of compounds having a skeleton (3a), compounds represented by the following general formula (3a) can be exemplified. General formula (3a) [Chemical formula 66]
Figure 02_image197

在通式(3a)中,Ar 21~Ar 26分別獨立地表示經取代或未經取代的芳基、經取代或未經取代的雜芳基或者經取代或未經取代的烷基,例如可以較佳地選擇經取代或未經取代的芳基。n21、n23、n24、n26分別獨立地表示0~4的整數,n22及n25分別獨立地表示0~2的整數。A 1、A 2分別獨立地表示氫原子、氘原子或取代基。關於Ar 21~Ar 25、n21~n25的詳細內容,能夠參照通式(2a)的Ar 9~Ar 14、n9~n14、A 1、A 2的記載。 In the general formula (3a), Ar 21 to Ar 26 independently represent a substituted or unsubstituted aryl group, a substituted or unsubstituted heteroaryl group or a substituted or unsubstituted alkyl group, for example, A substituted or unsubstituted aryl group is preferably selected. n21, n23, n24, and n26 each independently represent an integer of 0-4, and n22 and n25 each independently represent an integer of 0-2. A 1 and A 2 each independently represent a hydrogen atom, a deuterium atom or a substituent. For details of Ar 21 to Ar 25 and n21 to n25, the descriptions of Ar 9 to Ar 14 , n9 to n14, A 1 and A 2 in the general formula (2a) can be referred to.

在以下中,舉出通式(3a)所表示之化合物的具體例。在本發明中能夠使用之通式(3a)的化合物不被下述具體例做限定性地解釋。 [化學式67]

Figure 02_image199
Specific examples of the compound represented by the general formula (3a) are given below. The compounds of the general formula (3a) that can be used in the present invention are not limitedly interpreted by the following specific examples. [chemical formula 67]
Figure 02_image199

作為具有骨架(3b)之化合物的較佳的一組,可以例示出下述通式(3b)所表示之化合物。 通式(3b) [化學式68]

Figure 02_image201
As a preferable group of compounds having a skeleton (3b), compounds represented by the following general formula (3b) can be exemplified. General formula (3b) [Chemical formula 68]
Figure 02_image201

在通式(3b)中,Ar 27~Ar 32分別獨立地表示經取代或未經取代的芳基、經取代或未經取代的雜芳基或者經取代或未經取代的烷基,例如可以較佳地選擇經取代或未經取代的芳基。n27、n29、n30、n32分別獨立地表示0~4的整數,n28及n31分別獨立地表示0~2的整數。A 1、A 2分別獨立地表示氫原子、氘原子或取代基。關於Ar 27~Ar 32、n27~n32、A 1、A 2的詳細內容,能夠依序參照通式(2b)的Ar 15~Ar 20、n15~n20、A 1、A 2的記載。 In the general formula (3b), Ar 27 to Ar 32 independently represent a substituted or unsubstituted aryl group, a substituted or unsubstituted heteroaryl group or a substituted or unsubstituted alkyl group, for example, A substituted or unsubstituted aryl group is preferably selected. n27, n29, n30, and n32 each independently represent an integer of 0-4, and n28 and n31 each independently represent an integer of 0-2. A 1 and A 2 each independently represent a hydrogen atom, a deuterium atom or a substituent. For details of Ar 27 to Ar 32 , n27 to n32, A 1 , and A 2 , the descriptions of Ar 15 to Ar 20 , n15 to n20, A 1 , and A 2 in the general formula (2b) can be referred to sequentially.

在以下中,舉出通式(3b)所表示之化合物的具體例。在本發明中能夠使用之通式(3b)的化合物不被下述具體例做限定性地解釋。 [化學式69]

Figure 02_image203
Specific examples of the compound represented by the general formula (3b) are given below. The compounds of the general formula (3b) that can be used in the present invention are not limitedly interpreted by the following specific examples. [chemical formula 69]
Figure 02_image203

在本發明的較佳的一態樣中,選擇在通式(G)中存在之構成咔唑部分結構之兩個苯環與其他環縮合之化合物。其中,可以特佳地選擇與苯并呋喃環縮合之化合物、與苯并噻吩環縮合之化合物、與苯環縮合之化合物。在以下中,舉出具體例對該等環縮合之化合物進行說明。In a preferred aspect of the present invention, a compound in which the two benzene rings constituting the partial structure of the carbazole present in the general formula (G) are condensed with other rings is selected. Among them, a compound condensed with a benzofuran ring, a compound condensed with a benzothiophene ring, and a compound condensed with a benzene ring can be particularly preferably selected. Hereinafter, such ring-condensed compounds will be described with reference to specific examples.

可以較佳地舉出在通式(G)中存在之構成咔唑部分結構之兩個苯環中硼原子未直接鍵結的苯環與苯并呋喃環或苯并噻吩環縮合之化合物。作為該種化合物的例,可以例示出具有下述骨架(4a)之化合物和具有下述骨架(4b)之化合物。 [化學式70]

Figure 02_image205
Preferable examples include compounds in which a benzene ring to which boron atoms are not directly bonded among two benzene rings constituting the carbazole partial structure present in the general formula (G) is condensed with a benzofuran ring or a benzothiophene ring. Examples of such compounds include compounds having the following skeleton (4a) and compounds having the following skeleton (4b). [chemical formula 70]
Figure 02_image205

在骨架(4a)及(4b)中,Y 1~Y 4分別獨立地表示兩個氫原子、單鍵或N(R 27)。在此所述之兩個氫原子表示與硼原子鍵結之兩個苯環不彼此連接的狀態。Y 1和Y 2相同且Y 3和Y 4相同為較佳,但是亦可以分別不同。在本發明的一態樣中,Y 1~Y 4為單鍵。在本發明的一態樣中,Y 1~Y 4為N(R 27)。R 27表示氫原子、氘原子或取代基。 Z 1~Z 4分別獨立地表示氧原子或硫原子。Z 1和Z 2相同且Z 3和Z 4相同為較佳,但是亦可以分別不同。在本發明的一態樣中,Z 1~Z 4為氧原子。此時,苯并呋喃的呋喃環與(4a)及(4b)中之構成咔唑部分結構之苯環縮合。縮合之呋喃環的朝向並無限制。在本發明的一態樣中,Z 1~Z 4為硫原子。此時,苯并噻吩的噻吩環與(4a)及(4b)中之構成咔唑部分結構之苯環縮合。縮合之噻吩環的朝向並無限制。 骨架(4a)及(4b)中之各氫原子可以取代為氘原子或取代基。又,可以與相鄰之氫原子一起取代為連接基而形成環狀結構。關於詳細內容,能夠參照通式(G)的對應之R 1~R 26、A 1、A 2的記載。在本發明的一態樣中,骨架(4a)及(4b)中之各氫原子可以不與相鄰之氫原子一起取代為連接基而形成環狀結構。 In skeletons (4a) and (4b), Y 1 to Y 4 each independently represent two hydrogen atoms, a single bond or N(R 27 ). The two hydrogen atoms mentioned here represent a state in which two benzene rings bonded to a boron atom are not connected to each other. It is preferable that Y1 and Y2 are the same and Y3 and Y4 are the same, but they may be different from each other. In one aspect of the present invention, Y 1 to Y 4 are single bonds. In one aspect of the present invention, Y 1 to Y 4 are N(R 27 ). R 27 represents a hydrogen atom, a deuterium atom or a substituent. Z 1 to Z 4 each independently represent an oxygen atom or a sulfur atom. It is preferable that Z 1 and Z 2 are the same and Z 3 and Z 4 are the same, but they may be different from each other. In one aspect of the present invention, Z 1 to Z 4 are oxygen atoms. At this time, the furan ring of benzofuran is condensed with the benzene ring constituting the partial structure of carbazole in (4a) and (4b). The orientation of the condensed furan ring is not limited. In one aspect of the present invention, Z 1 to Z 4 are sulfur atoms. At this time, the thiophene ring of benzothiophene is condensed with the benzene ring constituting the partial structure of carbazole in (4a) and (4b). The orientation of the condensed thiophene rings is not limited. Each hydrogen atom in the skeleton (4a) and (4b) may be substituted with a deuterium atom or a substituent. In addition, it may be substituted with an adjacent hydrogen atom as a linking group to form a ring structure. For details, the description of R 1 to R 26 , A 1 , and A 2 corresponding to the general formula (G) can be referred to. In one aspect of the present invention, each hydrogen atom in the skeleton (4a) and (4b) may not be substituted with adjacent hydrogen atoms as a linking group to form a ring structure.

作為具有骨架(4a)之化合物的較佳的一組,可以例示出下述通式(4a)所表示之化合物。具體例中的X為氧原子或硫原子,並且分別揭示有X為氧原子之化合物和X為硫原子之化合物。以下其他通式所表示之化合物的具體例中的X亦表示相同的含義。 通式(4a) [化學式71]

Figure 02_image207
As a preferable group of compounds having a skeleton (4a), compounds represented by the following general formula (4a) can be exemplified. X in the specific examples is an oxygen atom or a sulfur atom, and compounds in which X is an oxygen atom and compounds in which X is a sulfur atom are disclosed, respectively. X in specific examples of compounds represented by other general formulas below also has the same meaning. General formula (4a) [Chemical formula 71]
Figure 02_image207

在通式(4a)中,Ar 51及Ar 52分別獨立地表示經取代或未經取代的芳基、經取代或未經取代的雜芳基或者經取代或未經取代的烷基,例如可以較佳地選擇經取代或未經取代的芳基。R 51及R 52分別獨立地表示經取代或未經取代的烷基。m51及m52分別獨立地表示0~4的整數。n51及n52分別獨立地表示0~2的整數。Y 1~Y 4分別獨立地表示兩個氫原子、單鍵或N(R 27)。R 27表示氫原子、氘原子或取代基。Z 1~Z 4分別獨立地表示氧原子或硫原子。A 1、A 2分別獨立地表示氫原子、氘原子或取代基。 在本發明的一態樣中,n51和n52為相同數。例如,n51和n52可以為0,n51和n52可以為1。在本發明的一態樣中,m51和m52為相同數。在本發明的一態樣中,m51和m52為0~3的整數。例如,m51和m52可以為0,m51和m52可以為1,m51和m52可以為2,m51和m52可以為3。關於Ar 51、Ar 52、R 51、R 52、A 1、A 2的較佳的基團,能夠參照通式(1a)的Ar 1~Ar 4、R 41~R 42、A 1、A 2的對應之記載。 In the general formula (4a), Ar 51 and Ar 52 independently represent substituted or unsubstituted aryl, substituted or unsubstituted heteroaryl or substituted or unsubstituted alkyl, for example, A substituted or unsubstituted aryl group is preferably selected. R 51 and R 52 each independently represent a substituted or unsubstituted alkyl group. m51 and m52 each independently represent the integer of 0-4. n51 and n52 each independently represent the integer of 0-2. Y 1 to Y 4 each independently represent two hydrogen atoms, a single bond or N(R 27 ). R 27 represents a hydrogen atom, a deuterium atom or a substituent. Z 1 to Z 4 each independently represent an oxygen atom or a sulfur atom. A 1 and A 2 each independently represent a hydrogen atom, a deuterium atom or a substituent. In one aspect of the present invention, n51 and n52 are the same number. For example, n51 and n52 can be 0, and n51 and n52 can be 1. In one aspect of the present invention, m51 and m52 are the same number. In one aspect of the present invention, m51 and m52 are integers of 0-3. For example, m51 and m52 can be 0, m51 and m52 can be 1, m51 and m52 can be 2, and m51 and m52 can be 3. For preferred groups of Ar 51 , Ar 52 , R 51 , R 52 , A 1 , and A 2 , reference can be made to Ar 1 to Ar 4 , R 41 to R 42 , A 1 , and A 2 of the general formula (1a). corresponding records.

在以下中,舉出通式(4a)所表示之化合物的具體例。在本發明中能夠使用之通式(4a)的化合物不被下述一組具體例做限定性地解釋。關於包含X之具體例,分別揭示有分子內的所有X為氧原子之化合物和分子內的所有X為硫原子之化合物。亦能夠採用分子內的X的一部分為氧原子且其餘部分為硫原子之化合物。 [化學式72]

Figure 02_image209
Figure 02_image211
Figure 02_image213
Figure 02_image215
Figure 02_image217
Specific examples of the compound represented by the general formula (4a) are given below. The compounds of the general formula (4a) that can be used in the present invention are not limitedly interpreted by the following group of specific examples. Regarding specific examples containing X, a compound in which all X in the molecule are oxygen atoms and a compound in which all X in the molecule are sulfur atoms are disclosed, respectively. A compound in which a part of X in the molecule is an oxygen atom and the rest is a sulfur atom can also be used. [chemical formula 72]
Figure 02_image209
Figure 02_image211
Figure 02_image213
Figure 02_image215
Figure 02_image217

在以下中,舉出通式(4a)所表示之化合物的另一組具體例。在本發明中能夠使用之通式(4a)的化合物不被下述一組具體例做限定性地解釋。 [化學式73]

Figure 02_image219
Figure 02_image221
Another specific example of the compound represented by the general formula (4a) is given below. The compounds of the general formula (4a) that can be used in the present invention are not limitedly interpreted by the following group of specific examples. [chemical formula 73]
Figure 02_image219
Figure 02_image221

作為具有骨架(4b)之化合物的較佳的一組,可以例示出下述通式(4b)所表示之化合物。 通式(4b) [化學式74]

Figure 02_image223
As a preferable group of compounds having a skeleton (4b), compounds represented by the following general formula (4b) can be exemplified. General formula (4b) [Chemical formula 74]
Figure 02_image223

在通式(4b)中,Ar 53及Ar 54分別獨立地表示經取代或未經取代的芳基、經取代或未經取代的雜芳基或者經取代或未經取代的烷基,例如可以較佳地選擇經取代或未經取代的芳基。R 53及R 54分別獨立地表示經取代或未經取代的烷基。m53及m54分別獨立地表示0~4的整數。n53及n54分別獨立地表示0~2的整數。Y 3及Y 4分別獨立地表示兩個氫原子、單鍵或N(R 27)。R 27表示氫原子、氘原子或取代基。Z 3及Z 4分別獨立地表示氧原子或硫原子。A 1、A 2分別獨立地表示氫原子、氘原子或取代基。關於Ar 53、Ar 54、R 53、R 54、m53、m54、n53、n54、A 1、A 2的詳細內容,能夠參照通式(4a)的Ar 51、Ar 52、R 51、R 52、m51、m52、n51、n52、A 1、A 2的記載。 In the general formula (4b), Ar 53 and Ar 54 independently represent substituted or unsubstituted aryl, substituted or unsubstituted heteroaryl or substituted or unsubstituted alkyl, for example, A substituted or unsubstituted aryl group is preferably selected. R 53 and R 54 each independently represent a substituted or unsubstituted alkyl group. m53 and m54 each independently represent the integer of 0-4. n53 and n54 each independently represent the integer of 0-2. Y 3 and Y 4 each independently represent two hydrogen atoms, a single bond or N(R 27 ). R 27 represents a hydrogen atom, a deuterium atom or a substituent. Z 3 and Z 4 each independently represent an oxygen atom or a sulfur atom. A 1 and A 2 each independently represent a hydrogen atom, a deuterium atom or a substituent. For details of Ar 53 , Ar 54 , R 53 , R 54 , m53, m54, n53, n54, A 1 , and A 2 , refer to Ar 51 , Ar 52 , R 51 , R 52 , Description of m51, m52, n51, n52, A 1 , A 2 .

在以下中,舉出通式(4b)所表示之化合物的具體例。在本發明中能夠使用之通式(4b)的化合物不被下述具體例做限定性地解釋。關於包含X之具體例,分別揭示有分子內的所有X為氧原子之化合物和分子內的所有X為硫原子之化合物。亦能夠採用分子內的X的一部分為氧原子且其餘部分為硫原子之化合物。 [化學式75]

Figure 02_image225
Specific examples of the compound represented by the general formula (4b) are given below. The compounds of the general formula (4b) that can be used in the present invention are not limitedly interpreted by the following specific examples. Regarding specific examples containing X, a compound in which all X in the molecule are oxygen atoms and a compound in which all X in the molecule are sulfur atoms are disclosed, respectively. A compound in which a part of X in the molecule is an oxygen atom and the rest is a sulfur atom can also be used. [chemical formula 75]
Figure 02_image225

可以較佳地舉出在通式(G)中存在之構成咔唑部分結構之兩個苯環中硼原子直接鍵結之苯環與苯并呋喃環或苯并噻吩環縮合之化合物。作為該種化合物的例,可以例示出具有下述骨架(5a)之化合物和具有下述骨架(5b)之化合物。 [化學式76]

Figure 02_image227
Preferable examples include compounds in which the boron atoms of the two benzene rings constituting the partial carbazole structure present in the general formula (G) are condensed with a benzene ring directly bonded to a benzofuran ring or a benzothiophene ring. Examples of such compounds include compounds having the following skeleton (5a) and compounds having the following skeleton (5b). [chemical formula 76]
Figure 02_image227

在骨架(5a)及(5b)中,Y 5~Y 8分別獨立地表示兩個氫原子、單鍵或N(R 27)。Z 5~Z 8分別獨立地表示氧原子或硫原子。關於Y 5~Y 8、Z 5~Z 8的詳細內容,能夠參照骨架(4a)及(4b)的對應之記載。在本發明的一態樣中,骨架(5a)及(5b)中之各氫原子可以不與相鄰之氫原子一起取代為連接基而形成環狀結構。 In skeletons (5a) and (5b), Y 5 to Y 8 each independently represent two hydrogen atoms, a single bond or N(R 27 ). Z 5 to Z 8 each independently represent an oxygen atom or a sulfur atom. For details of Y 5 to Y 8 and Z 5 to Z 8 , reference can be made to the corresponding descriptions of skeletons (4a) and (4b). In one aspect of the present invention, each hydrogen atom in the skeleton (5a) and (5b) may not be substituted with adjacent hydrogen atoms as a linking group to form a ring structure.

作為具有骨架(5a)之化合物的較佳的一組,可以例示出下述通式(5a)所表示之化合物。 通式(5a) [化學式77]

Figure 02_image229
As a preferable group of compounds having a skeleton (5a), compounds represented by the following general formula (5a) can be exemplified. General formula (5a) [Chemical formula 77]
Figure 02_image229

在通式(5a)中,Ar 55及Ar 56分別獨立地表示經取代或未經取代的芳基、經取代或未經取代的雜芳基或者經取代或未經取代的烷基,例如可以較佳地選擇經取代或未經取代的芳基。R 55及R 56分別獨立地表示經取代或未經取代的烷基。m55及m56分別獨立地表示0~4的整數。n55及n56分別獨立地表示0~4的整數。Y 5及Y 6分別獨立地表示兩個氫原子、單鍵或N(R 27)。R 27表示氫原子、氘原子或取代基。Z 5及Z 6分別獨立地表示氧原子或硫原子。A 1、A 2分別獨立地表示氫原子、氘原子或取代基。 在本發明的一態樣中,n55和n56為0~2的整數。例如,n55和n56可以為0,n55和n56可以為1。在本發明的一態樣中,m51和m52為相同數。關於m55和m56的詳細內容,能夠參照通式(4a)的m51和m52的記載。關於Ar 55、Ar 56、R 55、R 56、A 1、A 2的較佳的基團,能夠參照通式(1a)的Ar 1、Ar 3、R 41、R 42、A 1、A 2的對應之記載。 In the general formula (5a), Ar 55 and Ar 56 independently represent substituted or unsubstituted aryl, substituted or unsubstituted heteroaryl or substituted or unsubstituted alkyl, for example, A substituted or unsubstituted aryl group is preferably selected. R 55 and R 56 each independently represent a substituted or unsubstituted alkyl group. m55 and m56 each independently represent the integer of 0-4. n55 and n56 each independently represent the integer of 0-4. Y 5 and Y 6 each independently represent two hydrogen atoms, a single bond or N(R 27 ). R 27 represents a hydrogen atom, a deuterium atom or a substituent. Z 5 and Z 6 each independently represent an oxygen atom or a sulfur atom. A 1 and A 2 each independently represent a hydrogen atom, a deuterium atom or a substituent. In one aspect of the present invention, n55 and n56 are integers of 0-2. For example, n55 and n56 can be 0, and n55 and n56 can be 1. In one aspect of the present invention, m51 and m52 are the same number. For details of m55 and m56, the descriptions of m51 and m52 in the general formula (4a) can be referred to. For preferred groups of Ar 55 , Ar 56 , R 55 , R 56 , A 1 , and A 2 , refer to Ar 1 , Ar 3 , R 41 , R 42 , A 1 , and A 2 of general formula (1a). corresponding records.

在以下中,舉出通式(5a)所表示之化合物的具體例。在本發明中能夠使用之通式(5a)的化合物不被下述一組具體例做限定性地解釋。關於包含X之具體例,分別揭示有分子內的所有X為氧原子之化合物和分子內的所有X為硫原子之化合物。亦能夠採用分子內的X的一部分為氧原子且其餘部分為硫原子之化合物。 [化學式78]

Figure 02_image231
Figure 02_image233
Figure 02_image235
Figure 02_image237
Specific examples of the compound represented by the general formula (5a) are given below. The compounds of the general formula (5a) that can be used in the present invention are not limitedly interpreted by the following set of specific examples. Regarding specific examples containing X, a compound in which all X in the molecule are oxygen atoms and a compound in which all X in the molecule are sulfur atoms are disclosed, respectively. A compound in which a part of X in the molecule is an oxygen atom and the rest is a sulfur atom can also be used. [chemical formula 78]
Figure 02_image231
Figure 02_image233
Figure 02_image235
Figure 02_image237

在以下中,舉出通式(5a)所表示之化合物的另一組具體例。在本發明中能夠使用之通式(5a)的化合物不被下述一組具體例做限定性地解釋。 [化學式79]

Figure 02_image239
Another specific example of the compound represented by the general formula (5a) is given below. The compounds of the general formula (5a) that can be used in the present invention are not limitedly interpreted by the following set of specific examples. [chemical formula 79]
Figure 02_image239

作為具有骨架(5b)之化合物的較佳的一組,可以例示出下述通式(5b)所表示之化合物。 通式(5b) [化學式80]

Figure 02_image241
As a preferable group of compounds having a skeleton (5b), compounds represented by the following general formula (5b) can be exemplified. General formula (5b) [Chemical formula 80]
Figure 02_image241

在通式(5b)中,Ar 57及Ar 58分別獨立地表示經取代或未經取代的芳基、經取代或未經取代的雜芳基或者經取代或未經取代的烷基,例如可以較佳地選擇經取代或未經取代的芳基。R 57及R 58分別獨立地表示經取代或未經取代的烷基。m57及m58分別獨立地表示0~4的整數。n57及n58分別獨立地表示0~4的整數。Y 7及Y 8分別獨立地表示兩個氫原子、單鍵或N(R 27)。R 27表示氫原子、氘原子或取代基。Z 7及Z 8分別獨立地表示氧原子或硫原子。A 1、A 2分別獨立地表示氫原子、氘原子或取代基。關於Ar 57、Ar 58、R 57、R 58、m57、m58、n57、n58、A 1、A 2的詳細內容,能夠參照通式(5a)的Ar 55、Ar 56、R 55、R 56、m55、m56、n55、n56、A 1、A 2的記載。 In the general formula (5b), Ar 57 and Ar 58 independently represent substituted or unsubstituted aryl, substituted or unsubstituted heteroaryl or substituted or unsubstituted alkyl, for example, A substituted or unsubstituted aryl group is preferably selected. R 57 and R 58 each independently represent a substituted or unsubstituted alkyl group. m57 and m58 each independently represent an integer of 0-4. n57 and n58 each independently represent an integer of 0-4. Y 7 and Y 8 each independently represent two hydrogen atoms, a single bond or N(R 27 ). R 27 represents a hydrogen atom, a deuterium atom or a substituent. Z 7 and Z 8 each independently represent an oxygen atom or a sulfur atom. A 1 and A 2 each independently represent a hydrogen atom, a deuterium atom or a substituent. For details of Ar 57 , Ar 58 , R 57 , R 58 , m57, m58, n57, n58, A 1 , and A 2 , refer to Ar 55 , Ar 56 , R 55 , R 56 , Description of m55, m56, n55, n56, A 1 , A 2 .

在以下中,舉出通式(5b)所表示之化合物的具體例。在本發明中能夠使用之通式(5b)的化合物不被下述一組具體例做限定性地解釋。關於包含X之具體例,分別揭示有分子內的所有X為氧原子之化合物和分子內的所有X為硫原子之化合物。亦能夠採用分子內的X的一部分為氧原子且其餘部分為硫原子之化合物。 [化學式81]

Figure 02_image243
Specific examples of the compound represented by the general formula (5b) are given below. The compounds of the general formula (5b) that can be used in the present invention are not limitedly interpreted by the following set of specific examples. Regarding specific examples containing X, a compound in which all X in the molecule are oxygen atoms and a compound in which all X in the molecule are sulfur atoms are disclosed, respectively. A compound in which a part of X in the molecule is an oxygen atom and the rest is a sulfur atom can also be used. [chemical formula 81]
Figure 02_image243

在以下中,舉出通式(5b)所表示之化合物的另一組具體例。在本發明中能夠使用之通式(5b)的化合物不被下述一組具體例做限定性地解釋。 [化學式82]

Figure 02_image245
Another specific example of the compound represented by the general formula (5b) is given below. The compounds of the general formula (5b) that can be used in the present invention are not limitedly interpreted by the following set of specific examples. [chemical formula 82]
Figure 02_image245

可以較佳地舉出在通式(G)中存在之構成咔唑部分結構之兩個苯環這兩者與苯并呋喃環或苯并噻吩環縮合之化合物。作為該種化合物的例,可以例示出具有下述骨架(6a)之化合物和具有下述骨架(6b)之化合物。 [化學式83]

Figure 02_image247
Preferable examples include compounds in which both of the two benzene rings constituting the carbazole partial structure present in the general formula (G) are condensed with a benzofuran ring or a benzothiophene ring. Examples of such compounds include compounds having the following skeleton (6a) and compounds having the following skeleton (6b). [chemical formula 83]
Figure 02_image247

在骨架(6a)及(6b)中,Y 9~Y 12分別獨立地表示兩個氫原子、單鍵或N(R 27)。Z 9~Z 16分別獨立地表示氧原子或硫原子。Z 9~Z 16相同為較佳,但是亦可以不同。在本發明的一態樣中,Z 9~Z 16為氧原子。在本發明的一態樣中,Z 9~Z 16為硫原子。關於Y 9~Y 12的詳細內容,能夠參照骨架(4a)及(4b)的對應之記載。在本發明的一態樣中,骨架(6a)及(6b)中之各氫原子可以不與相鄰之氫原子一起取代為連接基而形成環狀結構。 In skeletons (6a) and (6b), Y 9 to Y 12 each independently represent two hydrogen atoms, a single bond or N(R 27 ). Z 9 to Z 16 each independently represent an oxygen atom or a sulfur atom. Z 9 to Z 16 are preferably the same, but may be different. In one aspect of the present invention, Z 9 to Z 16 are oxygen atoms. In one aspect of the present invention, Z 9 to Z 16 are sulfur atoms. For details of Y 9 to Y 12 , reference can be made to the corresponding description of skeletons (4a) and (4b). In one aspect of the present invention, each hydrogen atom in the skeleton (6a) and (6b) may not be substituted with adjacent hydrogen atoms as a linking group to form a ring structure.

作為具有骨架(6a)之化合物的較佳的一組,可以例示出下述通式(6a)所表示之化合物。 通式(6a) [化學式84]

Figure 02_image249
As a preferable group of compounds having a skeleton (6a), compounds represented by the following general formula (6a) can be exemplified. General formula (6a) [Chemical formula 84]
Figure 02_image249

在通式(6a)中,R 59及R 60分別獨立地表示經取代或未經取代的烷基。m59及m60分別獨立地表示0~4的整數。Y 9及Y 10分別獨立地表示兩個氫原子、單鍵或N(R 27)。R 27表示氫原子、氘原子或取代基。Z 9~Z 12分別獨立地表示氧原子或硫原子。A 1、A 2分別獨立地表示氫原子、氘原子或取代基。關於R 59、R 60、m59、m60、Z 9~Z 12、A 1、A 2的詳細內容,能夠參照通式(5a)的R 55、R 56、m55、m56、A 1、A 2和骨架(6a)中之Z 9~Z 12的記載。 In the general formula (6a), R 59 and R 60 each independently represent a substituted or unsubstituted alkyl group. m59 and m60 each independently represent an integer of 0-4. Y 9 and Y 10 each independently represent two hydrogen atoms, a single bond or N(R 27 ). R 27 represents a hydrogen atom, a deuterium atom or a substituent. Z 9 to Z 12 each independently represent an oxygen atom or a sulfur atom. A 1 and A 2 each independently represent a hydrogen atom, a deuterium atom or a substituent. For details of R 59 , R 60 , m59, m60, Z 9 to Z 12 , A 1 , and A 2 , refer to R 55 , R 56 , m55, m56, A 1 , A 2 and Description of Z 9 to Z 12 in skeleton (6a).

在以下中,舉出通式(6a)所表示之化合物的具體例。在本發明中能夠使用之通式(6a)的化合物不被下述具體例做限定性地解釋。關於包含X之具體例,分別揭示有分子內的所有X為氧原子之化合物和分子內的所有X為硫原子之化合物。亦能夠採用分子內的X的一部分為氧原子且其餘部分為硫原子之化合物。 [化學式85]

Figure 02_image251
Figure 02_image253
Figure 02_image255
Figure 02_image257
Specific examples of the compound represented by the general formula (6a) are given below. The compounds of the general formula (6a) that can be used in the present invention are not limitedly interpreted by the following specific examples. Regarding specific examples containing X, a compound in which all X in the molecule are oxygen atoms and a compound in which all X in the molecule are sulfur atoms are disclosed, respectively. A compound in which a part of X in the molecule is an oxygen atom and the rest is a sulfur atom can also be used. [chemical formula 85]
Figure 02_image251
Figure 02_image253
Figure 02_image255
Figure 02_image257

作為具有骨架(6b)之化合物的較佳的一組,可以例示出下述通式(6b)所表示之化合物。 通式(6b) [化學式86]

Figure 02_image259
As a preferable group of compounds having a skeleton (6b), compounds represented by the following general formula (6b) can be exemplified. General formula (6b) [Chemical formula 86]
Figure 02_image259

在通式(6b)中,R 61及R 62分別獨立地表示經取代或未經取代的烷基。m61及m60分別獨立地表示0~4的整數。Y 11及Y 12分別獨立地表示兩個氫原子、單鍵或N(R 27)。R 27表示氫原子、氘原子或取代基。Z 13~Z 16分別獨立地表示氧原子或硫原子。A 1、A 2分別獨立地表示氫原子、氘原子或取代基。關於R 61、R 62、m61、m62、Z 13~Z 16、A 1、A 2的詳細內容,能夠參照通式(6a)的R 59、R 60、m59、m60、A 1、A 2和骨架(6b)中之Z 13~Z 16的記載。 In the general formula (6b), R 61 and R 62 each independently represent a substituted or unsubstituted alkyl group. m61 and m60 each independently represent an integer of 0-4. Y 11 and Y 12 each independently represent two hydrogen atoms, a single bond or N(R 27 ). R 27 represents a hydrogen atom, a deuterium atom or a substituent. Z 13 to Z 16 each independently represent an oxygen atom or a sulfur atom. A 1 and A 2 each independently represent a hydrogen atom, a deuterium atom or a substituent. For details of R 61 , R 62 , m61, m62, Z 13 to Z 16 , A 1 , and A 2 , refer to R 59 , R 60 , m59, m60, A 1 , A 2 and Description of Z 13 to Z 16 in skeleton (6b).

在以下中,舉出通式(6b)所表示之化合物的具體例。在本發明中能夠使用之通式(6b)的化合物不被下述具體例做限定性地解釋。關於包含X之具體例,分別揭示有分子內的所有X為氧原子之化合物和分子內的所有X為硫原子之化合物。亦能夠採用分子內的X的一部分為氧原子且其餘部分為硫原子之化合物。 [化學式87]

Figure 02_image261
Figure 02_image263
Figure 02_image265
Specific examples of the compound represented by the general formula (6b) are given below. The compounds of the general formula (6b) that can be used in the present invention are not limitedly interpreted by the following specific examples. Regarding specific examples containing X, a compound in which all X in the molecule are oxygen atoms and a compound in which all X in the molecule are sulfur atoms are disclosed, respectively. A compound in which a part of X in the molecule is an oxygen atom and the rest is a sulfur atom can also be used. [chemical formula 87]
Figure 02_image261
Figure 02_image263
Figure 02_image265

可以較佳地舉出在通式(G)中存在之構成咔唑部分結構之兩個苯環中硼原子未直接鍵結的苯環與苯環縮合之化合物。作為該種化合物的例,可以例示出具有下述骨架(7a)之化合物和具有下述骨架(7b)之化合物。 [化學式88]

Figure 02_image267
Preferable examples include compounds in which benzene rings in which boron atoms are not directly bonded among the two benzene rings constituting the carbazole partial structure present in the general formula (G) are condensed with benzene rings. Examples of such compounds include compounds having the following skeleton (7a) and compounds having the following skeleton (7b). [chemical formula 88]
Figure 02_image267

在骨架(7a)及(7b)中,Y 21~Y 24分別獨立地表示兩個氫原子、單鍵或N(R 27)。關於Y 21~Y 24的詳細內容,能夠參照骨架(4a)及(4b)的Y 1~Y 4的記載。在本發明的一態樣中,骨架(7a)及(7b)中之各氫原子可以不與相鄰之氫原子一起取代為連接基而形成環狀結構。 In skeletons (7a) and (7b), Y 21 to Y 24 each independently represent two hydrogen atoms, a single bond or N(R 27 ). For details of Y 21 to Y 24 , reference can be made to the description of Y 1 to Y 4 in skeletons (4a) and (4b). In one aspect of the present invention, each hydrogen atom in the skeleton (7a) and (7b) may not be substituted with adjacent hydrogen atoms as a linking group to form a ring structure.

作為具有骨架(7a)之化合物的較佳的一組,可以例示出下述通式(7a)所表示之化合物。 通式(7a) [化學式89]

Figure 02_image269
As a preferable group of compounds having a skeleton (7a), compounds represented by the following general formula (7a) can be exemplified. General formula (7a) [Chemical formula 89]
Figure 02_image269

在通式(7a)中,Ar 71~Ar 74分別獨立地表示經取代或未經取代的芳基、經取代或未經取代的雜芳基或者經取代或未經取代的烷基,例如可以較佳地選擇經取代或未經取代的芳基。n71及n73分別獨立地表示0~2的整數。n72及n74分別獨立地表示0~4的整數。Y 21及Y 22分別獨立地表示兩個氫原子、單鍵或N(R 27)。R 27表示氫原子、氘原子或取代基。A 1、A 2分別獨立地表示氫原子、氘原子或取代基。 在本發明的一態樣中,n71~n74為0~2的整數。在本發明的一態樣中,n71和n73為相同數,n72和n74為相同數。n71~n74可以為相同數。例如,n71~n74可以為0。n71~n74均可以為1。又,例如n71和n73可以為0,n72和n74可以為1。 關於Ar 71~Ar 74、A 1、A 2的較佳的基團,能夠參照通式(1a)的Ar 1~Ar 4、A 1、A 2的對應之記載。 In the general formula (7a), Ar 71 to Ar 74 independently represent a substituted or unsubstituted aryl group, a substituted or unsubstituted heteroaryl group or a substituted or unsubstituted alkyl group, for example, A substituted or unsubstituted aryl group is preferably selected. n71 and n73 each independently represent the integer of 0-2. n72 and n74 each independently represent the integer of 0-4. Y 21 and Y 22 each independently represent two hydrogen atoms, a single bond or N(R 27 ). R 27 represents a hydrogen atom, a deuterium atom or a substituent. A 1 and A 2 each independently represent a hydrogen atom, a deuterium atom or a substituent. In one aspect of the present invention, n71˜n74 are integers of 0˜2. In one aspect of the present invention, n71 and n73 are the same number, and n72 and n74 are the same number. n71 to n74 may be the same number. For example, n71 to n74 may be 0. All of n71˜n74 can be 1. Also, for example, n71 and n73 may be 0, and n72 and n74 may be 1. For preferred groups of Ar 71 to Ar 74 , A 1 , and A 2 , reference can be made to the corresponding descriptions of Ar 1 to Ar 4 , A 1 , and A 2 in the general formula (1a).

在以下中,舉出通式(7a)所表示之化合物的具體例。在本發明中能夠使用之通式(7a)的化合物不被下述具體例做限定性地解釋。 [化學式90]

Figure 02_image271
Specific examples of the compound represented by the general formula (7a) are given below. The compounds of the general formula (7a) that can be used in the present invention are not limitedly interpreted by the following specific examples. [chemical formula 90]
Figure 02_image271

作為具有骨架(7b)之化合物的較佳的一組,可以例示出下述通式(7b)所表示之化合物。 通式(7b) [化學式91]

Figure 02_image273
As a preferable group of compounds having a skeleton (7b), compounds represented by the following general formula (7b) can be exemplified. General formula (7b) [Chemical formula 91]
Figure 02_image273

在通式(7b)中,Ar 75~Ar 78分別獨立地表示經取代或未經取代的芳基、經取代或未經取代的雜芳基或者經取代或未經取代的烷基,例如可以較佳地選擇經取代或未經取代的芳基。n75及n77分別獨立地表示0~2的整數。n76及n78分別獨立地表示0~4的整數。Y 23及Y 24分別獨立地表示兩個氫原子、單鍵或N(R 27)。R 27表示氫原子、氘原子或取代基。關於n75~n78的詳細說明,能夠依序參照通式(7a)的n71~n74的記載。關於Ar 75~Ar 78的較佳的基團,能夠參照通式(1a)的Ar 1~Ar 4的對應之記載。 In the general formula (7b), Ar 75 to Ar 78 independently represent a substituted or unsubstituted aryl group, a substituted or unsubstituted heteroaryl group or a substituted or unsubstituted alkyl group, for example, A substituted or unsubstituted aryl group is preferably selected. n75 and n77 each independently represent the integer of 0-2. n76 and n78 each independently represent the integer of 0-4. Y 23 and Y 24 each independently represent two hydrogen atoms, a single bond or N(R 27 ). R 27 represents a hydrogen atom, a deuterium atom or a substituent. For detailed descriptions of n75 to n78, descriptions of n71 to n74 of the general formula (7a) can be referred to in order. For preferred groups of Ar 75 to Ar 78 , reference can be made to the corresponding descriptions of Ar 1 to Ar 4 in the general formula (1a).

在以下中,舉出通式(7b)所表示之化合物的具體例。在本發明中能夠使用之通式(7b)的化合物不被下述具體例做限定性地解釋。 [化學式92]

Figure 02_image275
Specific examples of the compound represented by the general formula (7b) are given below. The compounds of the general formula (7b) that can be used in the present invention are not limitedly interpreted by the following specific examples. [chemical formula 92]
Figure 02_image275

可以較佳地舉出在通式(G)中存在之構成咔唑部分結構之兩個苯環中硼原子直接鍵結之苯環與苯環縮合之化合物。作為該種化合物的例,可以例示出具有下述骨架(8a)之化合物和具有下述骨架(8b)之化合物。 [化學式93]

Figure 02_image277
Preferable examples include compounds in which the boron atoms of the two benzene rings constituting the carbazole partial structure present in the general formula (G) are directly bonded and the benzene rings are condensed. Examples of such compounds include compounds having the following skeleton (8a) and compounds having the following skeleton (8b). [chemical formula 93]
Figure 02_image277

在骨架(8a)及(8b)中,Y 25~Y 28分別獨立地表示兩個氫原子、單鍵或N(R 27)。關於Y 25~Y 28的詳細內容,能夠參照骨架(4a)及(4b)的對應之記載。在本發明的一態樣中,骨架(8a)及(8b)中之各氫原子可以不與相鄰之氫原子一起取代為連接基而形成環狀結構。 In skeletons (8a) and (8b), Y 25 to Y 28 each independently represent two hydrogen atoms, a single bond or N(R 27 ). For details of Y 25 to Y 28 , reference can be made to the corresponding description of skeletons (4a) and (4b). In one aspect of the present invention, each hydrogen atom in the skeleton (8a) and (8b) may not be substituted with adjacent hydrogen atoms as a linking group to form a ring structure.

作為具有骨架(8a)之化合物的較佳的一組,可以例示出下述通式(8a)所表示之化合物。 通式(8a) [化學式94]

Figure 02_image279
As a preferable group of compounds having a skeleton (8a), compounds represented by the following general formula (8a) can be exemplified. General formula (8a) [Chemical formula 94]
Figure 02_image279

在通式(8a)中,Ar 79及Ar 80分別獨立地表示經取代或未經取代的芳基、經取代或未經取代的雜芳基或者經取代或未經取代的烷基,例如可以較佳地選擇經取代或未經取代的芳基。R 71及R 72分別獨立地表示經取代或未經取代的烷基。m71及m72分別獨立地表示0~4的整數。n79及n80分別獨立地表示0~4的整數。Y 25及Y 26分別獨立地表示兩個氫原子、單鍵或N(R 27)。R 27表示氫原子、氘原子或取代基。A 1、A 2分別獨立地表示氫原子、氘原子或取代基。 在本發明的一態樣中,n79及n80為0~2的整數。在本發明的一態樣中,n79和n80為相同數,例如均可以為0或者均可以為1。在本發明的一態樣中,m71及m72為0~2的整數。在本發明的一態樣中,m71及m72為相同數,例如均可以為0或者均可以為1。關於Ar 79、Ar 80、R 71、R 72、A 1、A 2的較佳的基團,能夠參照通式(1a)的Ar 1、Ar 3、R 41、R 42、A 1、A 2的對應之記載。 In the general formula (8a), Ar 79 and Ar 80 independently represent substituted or unsubstituted aryl, substituted or unsubstituted heteroaryl or substituted or unsubstituted alkyl, for example, A substituted or unsubstituted aryl group is preferably selected. R 71 and R 72 each independently represent a substituted or unsubstituted alkyl group. m71 and m72 each independently represent the integer of 0-4. n79 and n80 each independently represent the integer of 0-4. Y 25 and Y 26 each independently represent two hydrogen atoms, a single bond or N(R 27 ). R 27 represents a hydrogen atom, a deuterium atom or a substituent. A 1 and A 2 each independently represent a hydrogen atom, a deuterium atom or a substituent. In one aspect of the present invention, n79 and n80 are integers of 0-2. In one aspect of the present invention, n79 and n80 are the same number, for example both can be 0 or both can be 1. In one aspect of the present invention, m71 and m72 are integers of 0-2. In one aspect of the present invention, m71 and m72 are the same number, for example both can be 0 or both can be 1. For preferred groups of Ar 79 , Ar 80 , R 71 , R 72 , A 1 , and A 2 , refer to Ar 1 , Ar 3 , R 41 , R 42 , A 1 , and A 2 of general formula (1a). corresponding records.

在以下中,舉出通式(8a)所表示之化合物的具體例。在本發明中能夠使用之通式(8a)的化合物不被下述具體例做限定性地解釋。 [化學式95]

Figure 02_image281
Specific examples of the compound represented by the general formula (8a) are given below. The compounds of the general formula (8a) that can be used in the present invention are not limitedly interpreted by the following specific examples. [chemical formula 95]
Figure 02_image281

作為具有骨架(8b)之化合物的較佳的一組,可以例示出下述通式(8b)所表示之化合物。 通式(8b) [化學式96]

Figure 02_image283
As a preferable group of compounds having a skeleton (8b), compounds represented by the following general formula (8b) can be exemplified. General formula (8b) [Chemical formula 96]
Figure 02_image283

在通式(8b)中,Ar 81及Ar 82分別獨立地表示經取代或未經取代的芳基、經取代或未經取代的雜芳基或者經取代或未經取代的烷基,例如可以較佳地選擇經取代或未經取代的芳基。R 73及R 74分別獨立地表示經取代或未經取代的烷基。m73及m74分別獨立地表示0~4的整數。n81及n82分別獨立地表示0~4的整數。Y 27及Y 28分別獨立地表示兩個氫原子、單鍵或N(R 27)。R 27表示氫原子、氘原子或取代基。A 1、A 2分別獨立地表示氫原子、氘原子或取代基。 關於m73、m74、n81、n82的詳細說明,能夠參照通式(8a)的m71、m72、n79、n80的記載。關於Ar 81、Ar 82、R 73、R 74、A 1、A 2的較佳的基團,能夠參照通式(1a)的Ar 1、Ar 3、R 41、R 42、A 1、A 2的對應之記載。 In the general formula (8b), Ar 81 and Ar 82 independently represent substituted or unsubstituted aryl, substituted or unsubstituted heteroaryl or substituted or unsubstituted alkyl, for example, A substituted or unsubstituted aryl group is preferably selected. R 73 and R 74 each independently represent a substituted or unsubstituted alkyl group. m73 and m74 each independently represent the integer of 0-4. n81 and n82 each independently represent the integer of 0-4. Y 27 and Y 28 each independently represent two hydrogen atoms, a single bond or N(R 27 ). R 27 represents a hydrogen atom, a deuterium atom or a substituent. A 1 and A 2 each independently represent a hydrogen atom, a deuterium atom or a substituent. For detailed descriptions of m73, m74, n81, and n82, descriptions of m71, m72, n79, and n80 of the general formula (8a) can be referred to. For preferred groups of Ar 81 , Ar 82 , R 73 , R 74 , A 1 , and A 2 , refer to Ar 1 , Ar 3 , R 41 , R 42 , A 1 , and A 2 of general formula (1a). corresponding records.

在以下中,舉出通式(8b)所表示之化合物的具體例。在本發明中能夠使用之通式(8b)的化合物不被下述具體例做限定性地解釋。 [化學式97]

Figure 02_image285
Specific examples of the compound represented by the general formula (8b) are given below. The compounds of the general formula (8b) that can be used in the present invention are not limitedly interpreted by the following specific examples. [chemical formula 97]
Figure 02_image285

可以較佳地舉出在通式(G)中存在之構成咔唑部分結構之兩個苯環這兩者與苯環縮合之化合物。作為該種化合物的例,可以例示出具有下述骨架(9a)之化合物和具有下述骨架(9b)之化合物。 [化學式98]

Figure 02_image287
Preferable examples include compounds in which both of the two benzene rings constituting the carbazole partial structure present in the general formula (G) are condensed with the benzene rings. Examples of such compounds include compounds having the following skeleton (9a) and compounds having the following skeleton (9b). [chemical formula 98]
Figure 02_image287

在骨架(9a)及(9b)中,Y 29~Y 32分別獨立地表示兩個氫原子、單鍵或N(R 27)。關於Y 29~Y 32的詳細內容,能夠參照骨架(4a)及(4b)的對應之記載。在本發明的一態樣中,骨架(9a)及(9b)中之各氫原子可以不與相鄰之氫原子一起取代為連接基而形成環狀結構。 In skeletons (9a) and (9b), Y 29 to Y 32 each independently represent two hydrogen atoms, a single bond or N(R 27 ). For details of Y 29 to Y 32 , reference can be made to the corresponding description of skeletons (4a) and (4b). In one aspect of the present invention, each hydrogen atom in the skeleton (9a) and (9b) may not be substituted with adjacent hydrogen atoms as a linking group to form a ring structure.

作為具有骨架(9a)之化合物的較佳的一組,可以例示出下述通式(9a)所表示之化合物。 通式(9a) [化學式99]

Figure 02_image289
As a preferable group of compounds having a skeleton (9a), compounds represented by the following general formula (9a) can be exemplified. general formula (9a) [chemical formula 99]
Figure 02_image289

在通式(9a)中,R 75及R 76分別獨立地表示經取代或未經取代的烷基。m75及m76分別獨立地表示0~4的整數。Y 29及Y 30分別獨立地表示兩個氫原子、單鍵或N(R 27)。R 27表示氫原子、氘原子或取代基。A 1、A 2分別獨立地表示氫原子、氘原子或取代基。關於R 75、R 76、m75、m76、A 1、A 2的詳細內容,能夠參照通式(8a)的R 71、R 72、m71、m72、A 1、A 2的記載。 In the general formula (9a), R 75 and R 76 each independently represent a substituted or unsubstituted alkyl group. m75 and m76 each independently represent the integer of 0-4. Y 29 and Y 30 each independently represent two hydrogen atoms, a single bond or N(R 27 ). R 27 represents a hydrogen atom, a deuterium atom or a substituent. A 1 and A 2 each independently represent a hydrogen atom, a deuterium atom or a substituent. For details of R 75 , R 76 , m75, m76, A 1 , and A 2 , reference can be made to the description of R 71 , R 72 , m71, m72, A 1 , and A 2 in the general formula (8a).

在以下中,舉出通式(9a)所表示之化合物的具體例。在本發明中能夠使用之通式(9a)的化合物不被下述具體例做限定性地解釋。 [化學式100]

Figure 02_image291
Specific examples of the compound represented by the general formula (9a) are given below. The compounds of the general formula (9a) that can be used in the present invention are not limitedly interpreted by the following specific examples. [chemical formula 100]
Figure 02_image291

作為具有骨架(9b)之化合物的較佳的一組,可以例示出下述通式(9b)所表示之化合物。 通式(9b) [化學式101]

Figure 02_image293
As a preferable group of compounds having a skeleton (9b), compounds represented by the following general formula (9b) can be exemplified. General formula (9b) [Chemical formula 101]
Figure 02_image293

在通式(9b)中,R 77及R 78分別獨立地表示經取代或未經取代的烷基。m77及m78分別獨立地表示0~4的整數。Y 31及Y 32分別獨立地表示兩個氫原子、單鍵或N(R 27)。R 27表示氫原子、氘原子或取代基。A 1、A 2分別獨立地表示氫原子、氘原子或取代基。關於R 77、R 78、m77、m78、A 1、A 2的詳細內容,能夠參照通式(8a)的R 71、R 72、m71、m72、A 1、A 2的記載。 In the general formula (9b), R 77 and R 78 each independently represent a substituted or unsubstituted alkyl group. m77 and m78 each independently represent the integer of 0-4. Y 31 and Y 32 each independently represent two hydrogen atoms, a single bond or N(R 27 ). R 27 represents a hydrogen atom, a deuterium atom or a substituent. A 1 and A 2 each independently represent a hydrogen atom, a deuterium atom or a substituent. For details of R 77 , R 78 , m77, m78, A 1 , and A 2 , reference can be made to the description of R 71 , R 72 , m71, m72, A 1 , and A 2 in the general formula (8a).

在以下中,舉出通式(9b)所表示之化合物的具體例。在本發明中能夠使用之通式(9b)的化合物不被下述具體例做限定性地解釋。 [化學式102]

Figure 02_image295
Specific examples of the compound represented by the general formula (9b) are given below. The compounds of the general formula (9b) that can be used in the present invention are not limitedly interpreted by the following specific examples. [chemical formula 102]
Figure 02_image295

作為通式(G)所表示之化合物,在分子內包含四個以上的咔唑部分結構之化合物亦較佳。作為該種化合物的例,可以例示出具有下述骨架(10)之化合物。 骨架(10) [化學式103]

Figure 02_image297
As the compound represented by the general formula (G), a compound containing four or more carbazole moiety structures in the molecule is also preferable. As an example of such a compound, the compound which has the following skeleton (10) can be illustrated. Skeleton (10) [Chemical Formula 103]
Figure 02_image297

骨架(10)中之各氫原子可以取代為氘原子或取代基。又,可以與相鄰之氫原子一起取代為連接基而形成環狀結構。關於詳細內容,能夠參照通式(G)的對應之R 1~R 26、A 1、A 2的記載。骨架(10)中所包含之構成咔唑部分結構之苯環中的至少一個氫原子被經取代或未經取代的芳基取代。在本發明的一態樣中,骨架(10)中之各氫原子可以不與相鄰之氫原子一起取代為連接基而形成環狀結構。 Each hydrogen atom in the skeleton (10) may be substituted with a deuterium atom or a substituent. In addition, it may be substituted together with adjacent hydrogen atoms as a linking group to form a ring structure. For details, the description of R 1 to R 26 , A 1 , and A 2 corresponding to the general formula (G) can be referred to. At least one hydrogen atom in the benzene ring constituting the partial structure of carbazole included in the skeleton (10) is substituted with a substituted or unsubstituted aryl group. In one aspect of the present invention, each hydrogen atom in the skeleton (10) may not be substituted with adjacent hydrogen atoms as a linking group to form a ring structure.

作為具有骨架(10)之化合物的較佳的一組,可以例示出下述通式(10)所表示之化合物。 通式(10) [化學式104]

Figure 02_image299
As a preferable group of compounds having a skeleton (10), compounds represented by the following general formula (10) can be exemplified. General formula (10) [Chemical formula 104]
Figure 02_image299

在通式(10)中,Ar 91~Ar 94分別獨立地表示經取代或未經取代的芳基、經取代或未經取代的雜芳基或者經取代或未經取代的烷基,例如可以較佳地選擇經取代或未經取代的芳基。n91及n93分別獨立地表示0~4的整數,n92及n94分別獨立地表示0~3的整數。α環、β環、γ環、δ環可以經取代,至少一個環被經取代或未經取代的芳基取代,或者與可以經取代的苯環縮合,或者與經取代或未經取代的苯并呋喃的呋喃環或者經取代或未經取代的噻吩的噻吩環縮合。A 1、A 2分別獨立地表示氫原子、氘原子或取代基。 在本發明的一態樣中,n91~n94為0~2的整數。在本發明的一態樣中,n91和n93為相同數,n92和n94為相同數。n91~n94均可以為相同數,例如均可以為0或者均可以為1。關於Ar 91~Ar 94的較佳的基團,能夠參照通式(1a)的Ar 1~Ar 4的對應之記載。在本發明的一態樣中,α環和γ環具有相同的取代基或者具有相同的縮合結構,β環和δ環具有相同的取代基或者具有相同的縮合結構。在本發明的一態樣中,β環和δ環均被經取代或未經取代的芳基取代,或者與可以經取代的苯環縮合,或者與經取代或未經取代的苯并呋喃的呋喃環或者經取代或未經取代的噻吩的噻吩環縮合。在本發明的一態樣中,α環和γ環均被經取代或未經取代的芳基取代,或者與可以經取代的苯環縮合,或者與經取代或未經取代的苯并呋喃的呋喃環或者經取代或未經取代的噻吩的噻吩環縮合。在本發明的一態樣中,α環、β環、γ環、δ環均被經取代或未經取代的芳基取代,或者與可以經取代的苯環縮合,或者與經取代或未經取代的苯并呋喃的呋喃環或者經取代或未經取代的噻吩的噻吩環縮合。關於A 1及A 2的說明和較佳範圍,能夠參照通式(G)的對應之記載。 In the general formula (10), Ar 91 to Ar 94 independently represent a substituted or unsubstituted aryl group, a substituted or unsubstituted heteroaryl group or a substituted or unsubstituted alkyl group, for example, A substituted or unsubstituted aryl group is preferably selected. n91 and n93 each independently represent an integer of 0 to 4, and n92 and n94 each independently represent an integer of 0 to 3. α ring, β ring, γ ring, δ ring can be substituted, at least one ring is substituted by substituted or unsubstituted aryl, or condensed with substituted benzene ring, or substituted or unsubstituted benzene The furan ring of a furan or the thiophene ring of a substituted or unsubstituted thiophene is condensed. A 1 and A 2 each independently represent a hydrogen atom, a deuterium atom or a substituent. In one aspect of the present invention, n91˜n94 are integers of 0˜2. In one aspect of the present invention, n91 and n93 are the same number, and n92 and n94 are the same number. All of n91 to n94 may be the same number, for example, all may be 0 or all may be 1. For preferred groups of Ar 91 to Ar 94 , reference can be made to the corresponding descriptions of Ar 1 to Ar 4 in the general formula (1a). In one aspect of the present invention, the α ring and the γ ring have the same substituent or the same condensed structure, and the β ring and the δ ring have the same substituent or have the same condensed structure. In one aspect of the invention, both the β and δ rings are substituted with substituted or unsubstituted aryl groups, or condensed with optionally substituted benzene rings, or substituted or unsubstituted benzofuran Furan ring or thiophene ring condensation of substituted or unsubstituted thiophene. In one aspect of the invention, both the alpha and gamma rings are substituted with substituted or unsubstituted aryl groups, or condensed with optionally substituted benzene rings, or substituted or unsubstituted benzofuran Furan ring or thiophene ring condensation of substituted or unsubstituted thiophene. In one aspect of the present invention, the α ring, β ring, γ ring, and δ ring are all substituted with substituted or unsubstituted aryl groups, or condensed with substituted benzene rings, or substituted or unsubstituted The furan rings of substituted benzofurans or the thiophene rings of substituted or unsubstituted thiophenes are condensed. For descriptions and preferred ranges of A1 and A2 , reference can be made to the corresponding description of the general formula (G).

在以下中,舉出通式(10)所表示之化合物的具體例。在本發明中能夠使用之通式(10)的化合物不被下述具體例做限定性地解釋。 [化學式105]

Figure 02_image301
Figure 02_image303
Specific examples of the compound represented by the general formula (10) are given below. The compounds of the general formula (10) that can be used in the present invention are not limitedly interpreted by the following specific examples. [chemical formula 105]
Figure 02_image301
Figure 02_image303

通式(G)所表示之化合物可以為骨架不具有對稱性者。例如,可以為具有如下述骨架(11a)或下述骨架(11b)的非對稱骨架之化合物。 [化學式106]

Figure 02_image305
The compound represented by the general formula (G) may have no symmetry in the skeleton. For example, it may be a compound having an asymmetric skeleton such as the following skeleton (11a) or the following skeleton (11b). [chemical formula 106]
Figure 02_image305

在骨架(11a)及(11b)中,Z 17及Z 18分別獨立地表示氧原子或硫原子。在本發明的一態樣中,骨架(11a)及(11b)中之各氫原子可以不與相鄰之氫原子一起取代為連接基而形成環狀結構。 In skeletons (11a) and (11b), Z 17 and Z 18 each independently represent an oxygen atom or a sulfur atom. In one aspect of the present invention, each hydrogen atom in the skeleton (11a) and (11b) may not be substituted with adjacent hydrogen atoms as a linking group to form a ring structure.

作為具有骨架(11a)之化合物的較佳的一組,可以例示出下述通式(11a)所表示之化合物。 通式(11a) [化學式107]

Figure 02_image307
As a preferable group of compounds having a skeleton (11a), compounds represented by the following general formula (11a) can be exemplified. General formula (11a) [Chemical formula 107]
Figure 02_image307

在通式(11a)中,Ar 83~Ar 85分別獨立地表示經取代或未經取代的芳基、經取代或未經取代的雜芳基或者經取代或未經取代的烷基,例如可以較佳地選擇經取代或未經取代的芳基。R 83及R 84分別獨立地表示經取代或未經取代的烷基。Z 17表示氧原子或硫原子。m83及m84分別獨立地表示0~5的整數。n83表示0~4的整數,n84及n85分別獨立地表示0~3的整數。 關於Ar 83~Ar 85、R 83、R 84、m83、m84、n83~n85的詳細說明和較佳範圍,能夠參照通式(1a)的Ar 1、Ar 2、Ar 4、R 41、R 42、m1、m2、n1、n2、n4的記載。 In the general formula (11a), Ar 83 to Ar 85 independently represent a substituted or unsubstituted aryl group, a substituted or unsubstituted heteroaryl group or a substituted or unsubstituted alkyl group, for example, A substituted or unsubstituted aryl group is preferably selected. R 83 and R 84 each independently represent a substituted or unsubstituted alkyl group. Z 17 represents an oxygen atom or a sulfur atom. m83 and m84 each independently represent the integer of 0-5. n83 represents an integer of 0 to 4, and n84 and n85 represent an integer of 0 to 3 each independently. For details and preferred ranges of Ar 83 to Ar 85 , R 83 , R 84 , m83, m84, n83 to n85, refer to Ar 1 , Ar 2 , Ar 4 , R 41 , and R 42 in general formula (1a). , m1, m2, n1, n2, n4 records.

在以下中,舉出通式(11a)所表示之化合物的具體例。在本發明中能夠使用之通式(11a)的化合物不被下述具體例做限定性地解釋。在以下具體例中,分別揭示有分子內的所有X為氧原子之化合物和分子內的所有X為硫原子之化合物。亦能夠採用分子內的X的一部分為氧原子且其餘部分為硫原子之化合物。 [化學式108]

Figure 02_image309
Specific examples of the compound represented by the general formula (11a) are given below. The compounds of the general formula (11a) that can be used in the present invention are not limitedly interpreted by the following specific examples. In the following specific examples, compounds in which all X in the molecule are oxygen atoms and compounds in which all X in the molecule are sulfur atoms are respectively disclosed. A compound in which a part of X in the molecule is an oxygen atom and the rest is a sulfur atom can also be used. [chemical formula 108]
Figure 02_image309

作為具有骨架(11b)之化合物的較佳的一組,可以例示出下述通式(11b)所表示之化合物。 通式(11b) [化學式109]

Figure 02_image311
As a preferable group of compounds having a skeleton (11b), compounds represented by the following general formula (11b) can be exemplified. general formula (11b) [chemical formula 109]
Figure 02_image311

在通式(11b)中,Ar 86~Ar 88分別獨立地表示經取代或未經取代的芳基、經取代或未經取代的雜芳基或者經取代或未經取代的烷基,例如可以較佳地選擇經取代或未經取代的芳基。R 86及R 87分別獨立地表示經取代或未經取代的烷基。Z 18表示氧原子或硫原子。m86及m87分別獨立地表示0~5的整數。n86表示0~4的整數,n87及n88分別獨立地表示0~3的整數。 關於Ar 86~Ar 88、R 86、R 87、m86、m87、n86~n88的詳細說明和較佳範圍,能夠參照通式(1a)的Ar 1、Ar 2、Ar 4、R 41、R 42、m1、m2、n1、n2、n4的記載。 In the general formula (11b), Ar 86 to Ar 88 independently represent substituted or unsubstituted aryl, substituted or unsubstituted heteroaryl or substituted or unsubstituted alkyl, for example, A substituted or unsubstituted aryl group is preferably selected. R 86 and R 87 each independently represent a substituted or unsubstituted alkyl group. Z 18 represents an oxygen atom or a sulfur atom. m86 and m87 each independently represent the integer of 0-5. n86 represents an integer of 0 to 4, and n87 and n88 represent an integer of 0 to 3 each independently. For details and preferred ranges of Ar 86 to Ar 88 , R 86 , R 87 , m86, m87, n86 to n88, refer to Ar 1 , Ar 2 , Ar 4 , R 41 , and R 42 in general formula (1a). , m1, m2, n1, n2, n4 records.

在以下中,舉出通式(11b)所表示之化合物的具體例。在本發明中能夠使用之通式(11b)的化合物不被下述具體例做限定性地解釋。在以下具體例中,分別揭示有分子內的所有X為氧原子之化合物和分子內的所有X為硫原子之化合物。亦能夠採用分子內的X的一部分為氧原子且其餘部分為硫原子之化合物。 [化學式110]

Figure 02_image313
Specific examples of the compound represented by the general formula (11b) are given below. The compounds of the general formula (11b) that can be used in the present invention are not limitedly interpreted by the following specific examples. In the following specific examples, compounds in which all X in the molecule are oxygen atoms and compounds in which all X in the molecule are sulfur atoms are respectively disclosed. A compound in which a part of X in the molecule is an oxygen atom and the rest is a sulfur atom can also be used. [chemical formula 110]
Figure 02_image313

作為通式(G)所表示之化合物,可以較佳地採用R 5為供體基團之化合物。R 5為供體基團之化合物具有莫耳消光係數高且發光效率高的傾向。例如,與R 3為供體基團之化合物相比,顯示優異之發光特性。在本發明的較佳的一態樣中,R 3不是供體基團。在本發明的較佳的一態樣中,在R 1~R 7中,僅R 5為供體基團或者均不是供體基團(尤其,σp值為-0.2以下的供體基團)。供體基團為哈米特的σp值為負的基團。R 5的供體基團的σp值為-0.2以下為較佳,例如可以為-0.4以下,例如亦可以為-0.6以下。作為較佳的供體基團,可以舉出取代胺基,較佳為經取代或未經取代的二芳胺基。芳基可以為單環,亦可以為兩個以上的環縮合而成之縮合環。在為縮合環之情況下,縮合之後的環的數量為2~6個為較佳,例如能夠從2~4個進行選擇或者設為兩個。構成二芳胺基之兩個芳基可以相同,亦可以不同。又,兩個芳基可以由單鍵或連接基連接。作為經取代或未經取代的二芳胺基,較佳為經取代或未經取代的二苯胺基。可以採用兩個苯基藉由單鍵鍵結之經取代或未經取代的咔唑-9-基,亦可以採用兩個苯基不藉由單鍵鍵結的經取代或未經取代的二苯胺基。在通式(G)的R 1~R 7中的任一個為取代胺基時,至少R 5為取代胺基為較佳,僅R 5為取代胺基為更佳。在本發明的一態樣中,R 3不是取代胺基。 在R 5為供體基團且X 1為氮原子時,R 16或R 19為供體基團為較佳,R 19為供體基團為更佳。此時,其他R 1~R 26例如可以均為氫原子或氘原子,例如可以R 3、R 6、R 15、R 20中的至少一個為取代基(較佳為經取代或未經取代的烷基或者經取代或未經取代的芳基)且其他為氫原子或氘原子。 在R 5為供體基團且X 1為硼原子時,R 20或R 23為供體基團為較佳,R 20為供體基團為更佳。此時,其他R 1~R 26例如可以均為氫原子或氘原子,例如可以R 3、R 6、R 19、R 24中的至少一個為取代基(較佳為經取代或未經取代的烷基或者經取代或未經取代的芳基)且其他為氫原子或氘原子。 作為R 5為供體基團之化合物的較佳的一組,可以例示出下述通式(12a)所表示之化合物和下述通式(12b)所表示之化合物。 通式(12a) [化學式111]

Figure 02_image315
As the compound represented by the general formula (G), a compound in which R 5 is a donor group can be preferably used. The compound in which R 5 is a donor group tends to have a high molar extinction coefficient and a high luminous efficiency. For example, compared with compounds in which R 3 is a donor group, it exhibits excellent luminescence characteristics. In a preferred aspect of the present invention, R 3 is not a donor group. In a preferred aspect of the present invention, among R 1 to R 7 , only R 5 is a donor group or neither of them is a donor group (especially, a donor group whose σp value is -0.2 or less) . The donor group is a group with a negative Hammett's σp value. The σp value of the donor group of R 5 is preferably -0.2 or less, for example, -0.4 or less, for example, -0.6 or less. As a preferable donor group, a substituted amino group can be mentioned, preferably a substituted or unsubstituted diarylamine group. The aryl group may be a single ring or a condensed ring formed by condensing two or more rings. In the case of condensed rings, the number of condensed rings is preferably 2 to 6, for example, can be selected from 2 to 4 or set to two. The two aryl groups constituting the diarylamino group may be the same or different. Also, two aryl groups may be connected by a single bond or a linking group. As the substituted or unsubstituted diarylamino group, a substituted or unsubstituted diphenylamino group is preferred. A substituted or unsubstituted carbazol-9-yl in which two phenyl groups are bonded by a single bond can be used, and a substituted or unsubstituted dicarbazol-9-yl group in which two phenyl groups are not bonded by a single bond can also be used. Anilino. When any one of R 1 to R 7 in the general formula (G) is a substituted amino group, at least R 5 is preferably a substituted amino group, and more preferably only R 5 is a substituted amino group. In one aspect of the invention, R3 is not a substituted amine. When R 5 is a donor group and X 1 is a nitrogen atom, R 16 or R 19 is preferably a donor group, and R 19 is more preferably a donor group. At this time, other R 1 to R 26 can be hydrogen atoms or deuterium atoms, for example, at least one of R 3 , R 6 , R 15 , and R 20 can be a substituent (preferably substituted or unsubstituted alkyl or substituted or unsubstituted aryl) and others are hydrogen or deuterium atoms. When R 5 is a donor group and X 1 is a boron atom, R 20 or R 23 is preferably a donor group, more preferably R 20 is a donor group. At this time, other R 1 to R 26 may be hydrogen atoms or deuterium atoms, for example, at least one of R 3 , R 6 , R 19 , and R 24 may be a substituent (preferably substituted or unsubstituted alkyl or substituted or unsubstituted aryl) and others are hydrogen or deuterium atoms. As a preferable group of compounds in which R 5 is a donor group, compounds represented by the following general formula (12a) and compounds represented by the following general formula (12b) can be exemplified. General formula (12a) [Chemical formula 111]
Figure 02_image315

在通式(12a)及通式(12b)中,Ar 1~Ar 8分別獨立地表示經取代或未經取代的芳基、經取代或未經取代的雜芳基或者經取代或未經取代的烷基,例如可以較佳地選擇經取代或未經取代的烷基或者可以較佳地選擇經取代或未經取代的芳基。R 5表示供體基團。R 41~R 44分別獨立地表示經取代或未經取代的烷基。m1~m4分別獨立地表示0~5的整數。n1、n3、n5、n7分別獨立地表示0~4的整數,n4及n8表示0~3的整數,n2’及n6’表示0~2的整數。A 1、A 2分別獨立地表示氫原子、氘原子或取代基。關於Ar 1~Ar 8、R 41~R 44、m1~m4、n1、n3~n5、n7、n8、A 1、A 2的詳細內容,能夠參照通式(1a)及通式(1b)的對應之記載。其中,與相鄰之碳原子鍵結之Ar 1彼此、與相鄰之碳原子鍵結之Ar 3彼此、與相鄰之碳原子鍵結之Ar 5彼此、與相鄰之碳原子鍵結之Ar 7彼此可以相互鍵結而形成環狀結構,較佳為可以形成苯并呋喃(與呋喃環縮合)或苯并噻吩(與噻吩環縮合)。 In general formula (12a) and general formula (12b), Ar 1 to Ar 8 independently represent substituted or unsubstituted aryl, substituted or unsubstituted heteroaryl or substituted or unsubstituted For the alkyl group, for example, a substituted or unsubstituted alkyl group may be preferably selected or a substituted or unsubstituted aryl group may be preferably selected. R 5 represents a donor group. R 41 to R 44 each independently represent a substituted or unsubstituted alkyl group. m1-m4 each independently represent the integer of 0-5. n1, n3, n5, and n7 each independently represent an integer of 0-4, n4 and n8 represent an integer of 0-3, and n2' and n6' represent an integer of 0-2. A 1 and A 2 each independently represent a hydrogen atom, a deuterium atom or a substituent. For details of Ar 1 to Ar 8 , R 41 to R 44 , m1 to m4, n1, n3 to n5, n7, n8, A 1 , and A 2 , refer to general formula (1a) and general formula (1b). Corresponding record. Among them, Ar 1 bonded to adjacent carbon atoms, Ar 3 bonded to adjacent carbon atoms, Ar 5 bonded to adjacent carbon atoms, and Ar 5 bonded to adjacent carbon atoms Ar 7 can be bonded to each other to form a ring structure, preferably can form benzofuran (condensed with furan ring) or benzothiophene (condensed with thiophene ring).

在以下中,舉出通式(12a)及通式(12b)所表示之化合物的具體例。其中,在本發明中能夠使用之通式(12a)及通式(12b)的化合物不被下述具體例做限定性地解釋。在以下具體例中,藉由在表中確定式F1~F56中的R和Ar和X來規定各化合物的結構。R從後述A~D進行選擇,Ar從後述a~d進行選擇,X從α~γ進行選擇。例如,表中的No.1的化合物為在式F1中具有R為A且Ar為a之結構之化合物。Specific examples of the compounds represented by the general formula (12a) and the general formula (12b) are given below. However, the compounds of general formula (12a) and general formula (12b) that can be used in the present invention are not limitedly interpreted by the following specific examples. In the following specific examples, the structure of each compound is specified by identifying R, Ar and X in the formulas F1 to F56 in the table. R is selected from A to D described below, Ar is selected from a to d described below, and X is selected from α to γ. For example, the compound No. 1 in the table is a compound having a structure in which R is A and Ar is a in formula F1.

[化學式112]

Figure 02_image317
[化學式113]
Figure 02_image319
[化學式114]
Figure 02_image321
[化學式115]
Figure 02_image323
[化學式116]
Figure 02_image325
[化學式117]
Figure 02_image327
[表1]
Figure 02_image329
Figure 02_image331
Figure 02_image333
Figure 02_image335
Figure 02_image337
Figure 02_image339
Figure 02_image341
Figure 02_image343
Figure 02_image345
[chemical formula 112]
Figure 02_image317
[chemical formula 113]
Figure 02_image319
[chemical formula 114]
Figure 02_image321
[chemical formula 115]
Figure 02_image323
[chemical formula 116]
Figure 02_image325
[chemical formula 117]
Figure 02_image327
[Table 1]
Figure 02_image329
Figure 02_image331
Figure 02_image333
Figure 02_image335
Figure 02_image337
Figure 02_image339
Figure 02_image341
Figure 02_image343
Figure 02_image345

[化學式118]

Figure 02_image347
[chemical formula 118]
Figure 02_image347

在本發明的一態樣中,上述骨架(1a)~(12b)為不與其他環進一步縮合的骨架。在本發明的一態樣中,上述骨架(1a)~(12b)為可以與其他環進一步縮合的骨架。關於在此所述之其他環,能夠參照上述R 1和R 2、R 2和R 3、R 3和R 4、R 4和R 5、R 5和R 6、R 6和R 7、R 8和R 9、R 9和R 10、R 10和R 11、R 11和R 12、R 13和R 14、R 14和R 15、R 15和R 16、R 16和R 17、R 18和R 19、R 19和R 20、R 20和R 21、R 22和R 23、R 23和R 24、R 24和R 25、R 25和R 26彼此鍵結而形成之環狀結構的記載。 In one aspect of the present invention, the aforementioned skeletons (1a) to (12b) are skeletons that are not further condensed with other rings. In one aspect of the present invention, the aforementioned skeletons (1a) to (12b) are skeletons that can be further condensed with other rings. Regarding the other rings described here, reference can be made to the aforementioned R 1 and R 2 , R 2 and R 3 , R 3 and R 4 , R 4 and R 5 , R 5 and R 6 , R 6 and R 7 , R 8 and R 9 , R 9 and R 10 , R 10 and R 11 , R 11 and R 12 , R 13 and R 14 , R 14 and R 15 , R 15 and R 16 , R 16 and R 17 , R 18 and R 19 , R 19 and R 20 , R 20 and R 21 , R 22 and R 23 , R 23 and R 24 , R 24 and R 25 , R 25 and R 26 are bonded to each other to form a ring structure description.

在本發明的一態樣中,通式(G)的A 1和A 2為受體基團。例如,可以舉出A 1和A 2的位置為受體基團且具有骨架(1a)~(12b)中的任一個之化合物。關於受體基團的說明和具體例,能夠參照上述通式(G)的A 1和A 2的受體基團的說明和具體例。 在以下中,舉出A 1和A 2為受體基團之化合物的具體例。在本發明中能夠使用之A 1和A 2為受體基團之化合物不被下述具體例做限定性地解釋。在以下具體例中,A 1和A 2均具有為“A”之結構,藉由單獨確定該“A”來確定各化合物的結構。 [化學式119]

Figure 02_image349
Figure 02_image351
Figure 02_image353
Figure 02_image355
Figure 02_image357
Figure 02_image359
Figure 02_image361
Figure 02_image363
Figure 02_image365
In one aspect of the present invention, A 1 and A 2 of the general formula (G) are acceptor groups. For example, a compound having an acceptor group at the positions of A1 and A2 and having any one of skeletons (1a) to (12b) can be mentioned. For the description and specific examples of the acceptor group, the description and specific examples of the acceptor groups of A1 and A2 of the general formula (G) above can be referred to. Specific examples of compounds in which A1 and A2 are acceptor groups are given below. The compounds in which A 1 and A 2 are acceptor groups that can be used in the present invention are not limitedly interpreted by the following specific examples. In the following specific examples, both A1 and A2 have the structure "A", and the structure of each compound is confirmed by determining the "A" alone. [chemical formula 119]
Figure 02_image349
Figure 02_image351
Figure 02_image353
Figure 02_image355
Figure 02_image357
Figure 02_image359
Figure 02_image361
Figure 02_image363
Figure 02_image365

在本發明的一態樣中,選擇具有旋轉對稱結構之化合物作為通式(G)所表示之化合物。在本發明的一態樣中,選擇具有線對稱結構之化合物作為通式(G)所表示之化合物。在本發明的一態樣中,選擇具有非對稱結構之化合物作為通式(G)所表示之化合物。 在以下中,舉出具有非對稱骨架之化合物的具體例。在本發明中能夠使用之具有非對稱骨架之化合物或具有非對稱結構之化合物不被下述具體例做限定性地解釋。關於包含X之具體例,分別揭示有分子內的所有X為氧原子之化合物和分子內的所有X為硫原子之化合物。亦能夠採用分子內的X的一部分為氧原子且其餘部分為硫原子之化合物。 [化學式120]

Figure 02_image367
Figure 02_image369
Figure 02_image371
In one aspect of the present invention, a compound having a rotationally symmetrical structure is selected as the compound represented by the general formula (G). In one aspect of the present invention, a compound having a line-symmetric structure is selected as the compound represented by the general formula (G). In one aspect of the present invention, a compound having an asymmetric structure is selected as the compound represented by the general formula (G). Specific examples of compounds having an asymmetric skeleton are given below. A compound having an asymmetric skeleton or a compound having an asymmetric structure that can be used in the present invention is not limitedly interpreted by the following specific examples. Regarding specific examples containing X, a compound in which all X in the molecule are oxygen atoms and a compound in which all X in the molecule are sulfur atoms are disclosed, respectively. A compound in which a part of X in the molecule is an oxygen atom and the rest is a sulfur atom can also be used. [chemical formula 120]
Figure 02_image367
Figure 02_image369
Figure 02_image371

在以下,舉出具有對稱骨架,但是由於取代基非對稱鍵結而具有非對稱結構之化合物的具體例。在本發明中能夠使用之具有非對稱結構之化合物不被下述具體例做限定性地解釋。 [化學式121]

Figure 02_image373
Specific examples of compounds having a symmetrical skeleton but having an asymmetric structure due to asymmetric bonding of substituents are given below. Compounds having an asymmetric structure that can be used in the present invention are not limitedly interpreted by the following specific examples. [chemical formula 121]
Figure 02_image373

在本發明的一態樣中,通式(G)的R 3不是二芳胺基(構成二芳胺基之兩個芳基可以彼此鍵結)。在本發明的較佳的一態樣中,通式(G)的R 3為氫原子、氘原子或受體基團(不是供體基團)。 在本發明的一態樣中,通式(1a)的n1~n4中的至少一個為1以上。在本發明的較佳的一態樣中,通式(1a)的m1及m2中的至少一個為1以上。在本發明的進一步較佳的一態樣中,通式(1a)的n1~n4中的至少一個為1以上,進而通式(1a)的m1及m2中的至少一個為1以上。 在本發明的一態樣中,通式(1b)的n5~n8中的至少一個為1以上。在本發明的較佳的一態樣中,通式(1b)的m3及m4中的至少一個為1以上。在本發明的進一步較佳的一態樣中,通式(1b)的n5~n8中的至少一個為1以上,進而通式(1a)的m3及m4中的至少一個為1以上。 在上述m1及m2中的至少一個為1以上,m3及m4中的至少一個為1以上時,R 41和R 42中的至少一個和R 43和R 44中的至少一個為可以經氘原子取代的烷基為較佳,例如R 41~R 44均為可以經氘原子取代的烷基。在上述n1~n4中的至少一個為1以上,n5~n8中的至少一個為1以上時,Ar 1~Ar 4中的至少一個和Ar 5~Ar 8中的至少一個為可以經氘原子或烷基取代的芳基為較佳,例如Ar 1~Ar 8均為可以經氘原子或烷基取代的芳基。 在本發明的一態樣中,在通式(G)的X 1為硼原子且R 8、R 10、R 12、R 13、R 15、R 17為烷基(或甲基)時,R 1~R 7、R 18~R 20、R 23~R 26中的至少一個為取代基,較佳為取代基組E的基團,例如為可以經氘原子或烷基取代的芳基。在本發明的一態樣中,在通式(G)的X 2為硼原子且R 8、R 10、R 12、R 22、R 24、R 26為烷基(或甲基)時,R 1~R 7、R 13~R 16、R 19~R 21中的至少一個為取代基,較佳為取代基組E的基團,例如為可以經氘原子或烷基取代的芳基。 在本發明的一態樣中,在通式(G)的X 1為硼原子且R 8和R 9、R 9和R 10中的任一組與R 15和R 16、R 16和R 17中的任一組彼此鍵結而形成芳香環(或苯環)時,R 1~R 7、R 18~R 20、R 23~R 26中的至少一個為取代基,較佳為取代基組E的基團,例如為可以經氘原子或烷基取代的芳基。在本發明的一態樣中,在通式(G)的X 2為硼原子且R 8和R 9、R 9和R 10中的任一組與R 22和R 23、R 23和R 24中的任一組彼此鍵結而形成芳香環(或苯環)時,R 1~R 7、R 13~R 16、R 19~R 21中的至少一個為取代基,較佳為取代基組E的基團,例如為可以經氘原子或烷基取代的芳基。 在本發明的一態樣中,通式(G)的R 9及R 11不是氰基,亦不是烷基。亦即,R 9和R 11為氫原子、氘原子或除了氰基和烷基以外的取代基。在本發明的一態樣中,通式(G)的R 9及R 11不是氰基,亦不是三級丁基。 在本發明的較佳的一態樣中,通式(G)的R 8~R 12中的至少一個為取代基。 在本發明的一態樣中,通式(G)的R 3不是取代胺基或芳基。在本發明的一態樣中,通式(G)的R 3不是取代胺基或苯基。在本發明的一態樣中,通式(G)的R 3不是二甲胺基、二苯胺基、苯基。 在本發明的較佳的一態樣中,通式(G)的R 1~R 26中的至少一個為取代基,更佳為R 1~R 26中的至少一個為烷基,例如為碳數1~4的烷基。 In one aspect of the present invention, R 3 of the general formula (G) is not a diarylamine group (two aryl groups constituting the diarylamine group may be bonded to each other). In a preferred aspect of the present invention, R 3 in the general formula (G) is a hydrogen atom, a deuterium atom or an acceptor group (not a donor group). In one aspect of the present invention, at least one of n1 to n4 in the general formula (1a) is 1 or more. In a preferred aspect of the present invention, at least one of m1 and m2 in the general formula (1a) is 1 or more. In a further preferred aspect of the present invention, at least one of n1 to n4 in the general formula (1a) is 1 or more, and at least one of m1 and m2 in the general formula (1a) is 1 or more. In one aspect of the present invention, at least one of n5 to n8 of the general formula (1b) is 1 or more. In a preferred aspect of the present invention, at least one of m3 and m4 in the general formula (1b) is 1 or more. In a further preferred aspect of the present invention, at least one of n5 to n8 in the general formula (1b) is 1 or more, and at least one of m3 and m4 in the general formula (1a) is 1 or more. When at least one of m1 and m2 is 1 or more, and at least one of m3 and m4 is 1 or more, at least one of R 41 and R 42 and at least one of R 43 and R 44 may be substituted by a deuterium atom The alkyl group is preferably, for example, R 41 to R 44 are all alkyl groups that may be substituted with deuterium atoms. When at least one of n1 to n4 is 1 or more, and at least one of n5 to n8 is 1 or more, at least one of Ar 1 to Ar 4 and at least one of Ar 5 to Ar 8 can be deuterium atom or An aryl group substituted with an alkyl group is preferred, for example, Ar 1 to Ar 8 are all aryl groups that may be substituted by a deuterium atom or an alkyl group. In one aspect of the present invention, when X 1 of the general formula (G) is a boron atom and R 8 , R 10 , R 12 , R 13 , R 15 , and R 17 are alkyl (or methyl), R At least one of 1 to R 7 , R 18 to R 20 , and R 23 to R 26 is a substituent, preferably a group of substituent group E, such as an aryl group that may be substituted with a deuterium atom or an alkyl group. In one aspect of the present invention, when X 2 in the general formula (G) is a boron atom and R 8 , R 10 , R 12 , R 22 , R 24 , and R 26 are alkyl (or methyl), R At least one of 1 to R 7 , R 13 to R 16 , and R 19 to R 21 is a substituent, preferably a group of substituent group E, such as an aryl group that may be substituted with a deuterium atom or an alkyl group. In one aspect of the present invention, X 1 in the general formula (G) is a boron atom and any combination of R 8 and R 9 , R 9 and R 10 and R 15 and R 16 , R 16 and R 17 When any of the groups are bonded to each other to form an aromatic ring (or benzene ring), at least one of R 1 to R 7 , R 18 to R 20 , and R 23 to R 26 is a substituent, preferably a group of substituents The group of E is, for example, an aryl group which may be substituted with a deuterium atom or an alkyl group. In one aspect of the present invention, X 2 in the general formula (G) is a boron atom and any combination of R 8 and R 9 , R 9 and R 10 and R 22 and R 23 , R 23 and R 24 When any of the groups are bonded to each other to form an aromatic ring (or benzene ring), at least one of R 1 to R 7 , R 13 to R 16 , and R 19 to R 21 is a substituent, preferably a group of substituents The group of E is, for example, an aryl group which may be substituted with a deuterium atom or an alkyl group. In one aspect of the present invention, R 9 and R 11 of the general formula (G) are neither cyano nor alkyl. That is, R 9 and R 11 are a hydrogen atom, a deuterium atom, or a substituent other than a cyano group and an alkyl group. In one aspect of the present invention, R 9 and R 11 of the general formula (G) are neither cyano nor tertiary butyl. In a preferred aspect of the present invention, at least one of R 8 to R 12 in the general formula (G) is a substituent. In one aspect of the present invention, R 3 of the general formula (G) is not a substituted amino group or an aryl group. In one aspect of the present invention, R 3 of the general formula (G) is not a substituted amino group or a phenyl group. In one aspect of the present invention, R 3 in the general formula (G) is not dimethylamino, diphenylamino, or phenyl. In a preferred aspect of the present invention, at least one of R 1 to R 26 in the general formula (G) is a substituent, more preferably at least one of R 1 to R 26 is an alkyl group, such as carbon Alkyl groups with numbers 1 to 4.

(基材) 在一些實施形態中,本發明的有機電致發光元件被基材保持,該基材並無特別限定,只要使用通常在有機電致發光元件中通常使用之、例如由玻璃、透明塑膠、石英及矽形成之任一材料即可。 (substrate) In some embodiments, the organic electroluminescent element of the present invention is held by a substrate, and the substrate is not particularly limited, as long as it is generally used in organic electroluminescent elements, such as glass, transparent plastic, quartz and Any material formed from silicon will suffice.

(陽極) 在一些實施形態中,有機電致發光裝置的陽極由金屬、合金、導電性化合物或它們的組合製造。在一些實施形態中,前述金屬、合金或導電性化合物具有高的功函數(4eV以上)。在一些實施形態中,前述金屬為Au。在一些實施形態中,導電性的透明材料可以從CuI、氧化銦錫(ITO)、SnO 2及ZnO進行選擇。在一些實施形態中,使用IDIXO(In 2O 3-ZnO)等能夠形成透明的導電膜之非晶材料。在一些實施形態中,前述陽極為薄膜。在一些實施形態中,前述薄膜藉由蒸鍍或濺鍍來製作。在一些實施形態中,藉由光微影方法對前述薄膜進行圖案化。在一些實施形態中,在圖案不需要高精度(例如,約100μm以上)的情況下,該圖案可以使用較佳形狀的遮罩對電極材料進行蒸鍍或濺鍍而形成。在一些實施形態中,在能夠塗佈有機導電性化合物等塗佈材料時,可以使用印刷法或塗佈法等濕膜形成方法。在一些實施形態中,在輻射光穿過陽極時,陽極具有超過10%的透射率,該陽極每單位面積具有幾百歐姆以下的片電阻。在一些實施形態中,陽極的厚度為10~1,000nm。在一些實施形態中,陽極的厚度為10~200nm。在一些實施形態中,陽極的厚度依據所使用之材料而發生變動。 (Anode) In some embodiments, the anode of the organic electroluminescent device is made of metal, alloy, conductive compound, or a combination thereof. In some embodiments, the aforementioned metal, alloy, or conductive compound has a high work function (4 eV or more). In some embodiments, the aforementioned metal is Au. In some embodiments, the conductive transparent material can be selected from CuI, indium tin oxide (ITO), SnO 2 and ZnO. In some embodiments, an amorphous material capable of forming a transparent conductive film such as IDIXO (In 2 O 3 —ZnO) is used. In some embodiments, the aforementioned anode is a thin film. In some embodiments, the aforementioned thin film is fabricated by evaporation or sputtering. In some embodiments, the aforementioned film is patterned by photolithography. In some embodiments, if the pattern does not require high precision (for example, above about 100 μm), the pattern can be formed by evaporating or sputtering the electrode material using a mask with a better shape. In some embodiments, when a coating material such as an organic conductive compound can be coated, a wet film forming method such as a printing method or a coating method can be used. In some embodiments, the anode has a transmittance greater than 10% when radiated light passes through the anode, and the anode has a sheet resistance per unit area of several hundred ohms or less. In some embodiments, the thickness of the anode is 10-1,000 nm. In some embodiments, the thickness of the anode is 10-200 nm. In some embodiments, the thickness of the anode varies depending on the material used.

(陰極) 在一些實施形態中,前述陰極由具有低的功函數之金屬(4eV以下)(稱為電子注入金屬)、合金、導電性化合物或其組合等電極材料製作。在一些實施形態中,前述電極材料可以從鈉、鈉-鉀合金、鎂、鋰、鎂-銅混合物、鎂-銀混合物、鎂-鋁混合物、鎂-銦混合物、鋁-氧化鋁(Al 2O 3)混合物、銦、鋰-鋁混合物及稀土元素進行選擇。在一些實施形態中,可以使用電子注入金屬與具有高於電子注入金屬的功函數之穩定的金屬亦即第2金屬的混合物。在一些實施形態中,前述混合物可以從鎂-銀混合物、鎂-鋁混合物、鎂-銦混合物、鋁-氧化鋁(Al 2O 3)混合物、鋰-鋁混合物及鋁進行選擇。在一些實施形態中,前述混合物提高電子注入特性及對氧化之耐性。在一些實施形態中,陰極藉由蒸鍍或濺鍍將電極材料形成為薄膜來製造。在一些實施形態中,前述陰極每單位面積具有幾百歐姆以下的片電阻。在一些實施形態中,前述陰極的厚度為10nm~5μm。在一些實施形態中,前述陰極的厚度為50~200nm。在一些實施形態中,有機電致發光元件的陽極及陰極中的任一個為透明或半透明,以使輻射光透射。在一些實施形態中,透明或半透明的電致發光元件提高光輻射亮度。 在一些實施形態中,藉由由針對前述陽極所述之導電性的透明的材料形成前述陰極來形成透明或半透明的陰極。在一些實施形態中,元件包含陽極和陰極,但是均為透明或半透明。 (Cathode) In some embodiments, the cathode is made of an electrode material such as a metal having a low work function (4 eV or less) (called an electron injection metal), an alloy, a conductive compound, or a combination thereof. In some embodiments, the aforementioned electrode material can be selected from sodium, sodium-potassium alloy, magnesium, lithium, magnesium-copper mixture, magnesium-silver mixture, magnesium-aluminum mixture, magnesium-indium mixture, aluminum-alumina (Al 2 O 3 ) Mixture, indium, lithium-aluminum mixture and rare earth elements for selection. In some embodiments, a mixture of an electron-injecting metal and a stable metal having a higher work function than the electron-injecting metal, that is, a second metal, may be used. In some embodiments, the aforementioned mixture can be selected from magnesium-silver mixture, magnesium-aluminum mixture, magnesium-indium mixture, aluminum-alumina (Al 2 O 3 ) mixture, lithium-aluminum mixture, and aluminum. In some embodiments, the aforementioned mixture improves electron injection properties and resistance to oxidation. In some embodiments, the cathode is fabricated by forming the electrode material into a thin film by evaporation or sputtering. In some embodiments, the cathode has a sheet resistance of several hundred ohms or less per unit area. In some embodiments, the cathode has a thickness of 10 nm˜5 μm. In some embodiments, the aforementioned cathode has a thickness of 50-200 nm. In some embodiments, any one of the anode and the cathode of the organic electroluminescent device is transparent or translucent to transmit radiated light. In some embodiments, a transparent or translucent electroluminescent element enhances the brightness of light radiation. In some embodiments, the transparent or translucent cathode is formed by forming the cathode from the conductive, transparent material described for the anode. In some embodiments, the element contains an anode and a cathode, but both are transparent or translucent.

(注入層) 注入層為電極與有機層之間的層。在一些實施形態中,前述注入層減少驅動電壓,並且增強光輻射亮度。在一些實施形態中,前述注入層包括空穴注入層和電子注入層。前述注入層能夠配置於陽極與發光層或空穴傳輸層之間以及陰極與發光層或電子傳輸層之間。在一些實施形態中,存在注入層。在一些實施形態中,不存在注入層。 在以下,舉出能夠用作空穴注入材料之較佳化合物例。 (injection layer) The injection layer is a layer between the electrode and the organic layer. In some embodiments, the aforementioned injection layer reduces the driving voltage and enhances the brightness of light radiation. In some embodiments, the aforementioned injection layer includes a hole injection layer and an electron injection layer. The aforementioned injection layer can be disposed between the anode and the light emitting layer or the hole transport layer, and between the cathode and the light emitting layer or the electron transport layer. In some embodiments, an injection layer is present. In some embodiments, no injection layer is present. Examples of preferable compounds that can be used as hole injection materials are given below.

[化學式122]

Figure 02_image375
[chemical formula 122]
Figure 02_image375

接著,舉出能夠用作電子注入材料之較佳化合物例。 [化學式123]

Figure 02_image377
Next, examples of preferable compounds that can be used as electron injection materials are given. [chemical formula 123]
Figure 02_image377

(障壁層) 障壁層為能夠阻止存在於發光層中之電荷(電子或空穴)和/或激子向發光層的外側擴散之層。在一些實施形態中,電子障壁層存在於發光層與空穴傳輸層之間以阻止電子穿過發光層而到達空穴傳輸層。在一些實施形態中,空穴障壁層存在於發光層與電子傳輸層之間以阻止空穴穿過發光層而到達電子傳輸層。在一些實施形態中,障壁層阻止激子向發光層的外側擴散。在一些實施形態中,電子障壁層及空穴障壁層構成激子障壁層。本說明書中所使用之術語“電子障壁層”或“激子障壁層”包括具有電子障壁層的功能及激子障壁層的功能這兩者之層。 (barrier layer) The barrier layer is a layer capable of preventing charges (electrons or holes) and/or excitons existing in the light emitting layer from diffusing to the outside of the light emitting layer. In some embodiments, an electron barrier layer exists between the light-emitting layer and the hole-transport layer to prevent electrons from passing through the light-emitting layer to the hole-transport layer. In some embodiments, a hole barrier layer exists between the light-emitting layer and the electron-transport layer to prevent holes from passing through the light-emitting layer to the electron-transport layer. In some embodiments, the barrier layer prevents excitons from diffusing to the outside of the light emitting layer. In some embodiments, the electron barrier layer and the hole barrier layer constitute an exciton barrier layer. The term "electron barrier layer" or "exciton barrier layer" used in this specification includes the layer which has both the function of an electron barrier layer and the function of an exciton barrier layer.

(空穴障壁層) 空穴障壁層作為電子傳輸層而發揮作用。在一些實施形態中,在電子的傳輸期間,空穴障壁層阻止空穴到達電子傳輸層。在一些實施形態中,空穴障壁層提高發光層中之電子與空穴的再鍵結的機率。用於空穴障壁層中之材料可以為與針對電子傳輸層所述者相同的材料。 在以下,舉出能夠用於空穴障壁層中之較佳化合物例。 (hole barrier layer) The hole barrier layer functions as an electron transport layer. In some embodiments, the hole barrier layer prevents holes from reaching the electron transport layer during transport of electrons. In some embodiments, the hole barrier layer increases the probability of rebonding of electrons and holes in the light-emitting layer. Materials used in the hole barrier layer may be the same materials as described for the electron transport layer. Examples of preferable compounds that can be used in the hole barrier layer are given below.

[化學式124]

Figure 02_image379
[chemical formula 124]
Figure 02_image379

(激子障壁層) 激子障壁層阻止藉由發光層中之空穴與電子的再鍵結而產生之激子擴散至電子傳輸層。在一些實施形態中,激子障壁層能夠有效地限制(confinement)發光層中之激子。在一些實施形態中,提高裝置的光輻射效率。在一些實施形態中,激子障壁層在陽極側和陰極側中的任一側與發光層相鄰及與其兩側的發光層相鄰。在一些實施形態中,在激子障壁層存在於陽極側時,該層可以存在於空穴傳輸層與發光層之間並與該發光層相鄰。在一些實施形態中,在激子障壁層存在於陰極側時,該層可以存在於發光層與陰極之間並與該發光層相鄰。在一些實施形態中,空穴注入層、電子障壁層或相同的層存在於陽極與和陽極側的發光層相鄰之激子障壁層之間。在一些實施形態中,空穴注入層、電子障壁層、空穴障壁層或相同的層存在於陰極與和陰極側的發光層相鄰之激子障壁層之間。在一些實施形態中,激子障壁層包含激發單重態能量和激發三重態能量,其至少一個分別高於發光材料的激發單重態能量和激發三重態能量。 (exciton barrier layer) The exciton barrier layer prevents excitons generated by rebonding of holes and electrons in the light emitting layer from diffusing to the electron transport layer. In some embodiments, the exciton barrier layer can effectively confine excitons in the light emitting layer. In some embodiments, the light radiation efficiency of the device is increased. In some embodiments, the exciton barrier layer is adjacent to the light emitting layer on either of the anode side and the cathode side and adjacent to the light emitting layers on both sides thereof. In some embodiments, when the exciton barrier layer is present on the anode side, the layer may be present between the hole transport layer and the light emitting layer adjacent to the light emitting layer. In some embodiments, when the exciton barrier layer is present on the cathode side, the layer may be present between the light emitting layer and the cathode and adjacent to the light emitting layer. In some embodiments, a hole injection layer, an electron barrier layer, or the same layer is present between the anode and the exciton barrier layer adjacent to the light emitting layer on the anode side. In some embodiments, a hole injection layer, an electron barrier layer, a hole barrier layer, or the same layer is present between the cathode and the exciton barrier layer adjacent to the light emitting layer on the cathode side. In some embodiments, the exciton barrier layer comprises an excited singlet energy and an excited triplet energy, at least one of which is higher than the excited singlet energy and the excited triplet energy, respectively, of the light-emitting material.

(空穴傳輸層) 空穴傳輸層包含空穴傳輸材料。在一些實施形態中,空穴傳輸層為單層。在一些實施形態中,空穴傳輸層具有複數個層。 在一些實施形態中,空穴傳輸材料具有空穴的注入或傳輸特性及電子的障壁特性中的一個特性。在一些實施形態中,空穴傳輸材料為有機材料。在一些實施形態中,空穴傳輸材料為無機材料。作為本發明中能夠使用之公知的空穴傳輸材料的例,並無限定,但是可以舉出三唑衍生物、㗁二唑誘導劑、咪唑衍生物、咔唑衍生物、吲哚并咔唑衍生物、聚芳基烷烴誘導劑、吡唑啉衍生物、吡唑啉酮衍生物、苯二胺衍生物、烯丙胺衍生物、胺基取代查耳酮衍生物、㗁唑衍生物、苯乙烯基蒽誘導劑、茀酮衍生物、腙衍生物、茋衍生物、矽氮烷衍生物、苯胺共聚物及導電性高分子寡聚物(尤其噻吩寡聚物)或其組合。在一些實施形態中,空穴傳輸材料可以從卟啉化合物、芳香族三級胺化合物及苯乙烯胺化合物進行選擇。在一些實施形態中,空穴傳輸材料為芳香族三級胺化合物。在以下,舉出能夠用作空穴傳輸材料之較佳化合物的具體例。 (hole transport layer) The hole transport layer contains a hole transport material. In some embodiments, the hole transport layer is a single layer. In some embodiments, the hole transport layer has a plurality of layers. In some embodiments, the hole transport material has one of a hole injection or transport property and an electron barrier property. In some embodiments, the hole transport material is an organic material. In some embodiments, the hole transport material is an inorganic material. Examples of known hole transport materials that can be used in the present invention are not limited, but include triazole derivatives, oxadiazole inducers, imidazole derivatives, carbazole derivatives, indolocarbazole derivatives substances, polyaryl alkanes inducers, pyrazoline derivatives, pyrazolone derivatives, phenylenediamine derivatives, allylamine derivatives, amino-substituted chalcone derivatives, oxazole derivatives, styryl Anthracene inducers, stilone derivatives, hydrazone derivatives, stilbene derivatives, silazane derivatives, aniline copolymers, conductive polymer oligomers (especially thiophene oligomers) or combinations thereof. In some embodiments, the hole transport material can be selected from porphyrin compounds, aromatic tertiary amine compounds, and styrylamine compounds. In some embodiments, the hole transport material is an aromatic tertiary amine compound. Specific examples of preferable compounds that can be used as a hole transport material are given below.

[化學式125]

Figure 02_image381
[chemical formula 125]
Figure 02_image381

(電子傳輸層) 電子傳輸層包含電子傳輸材料。在一些實施形態中,電子傳輸層為單層。在一些實施形態中,電子傳輸層具有複數個層。 在一些實施形態中,電子傳輸材料只要具有將從陰極注入之電子傳輸至發光層之功能即可。在一些實施形態中,電子傳輸材料還作為空穴障壁材料而發揮作用。作為本發明中能夠使用之電子傳輸層的例,並無限定,但是可以舉出硝基取代茀衍生物、二苯醌衍生物、二氧化噻喃衍生物、碳二亞胺、亞茀基甲烷(fluorenylidene methane)衍生物、蒽醌基二甲烷、蒽酮衍生物、㗁二唑衍生物、唑衍生物、𠯤衍生物或者其組合或其聚合物。在一些實施形態中,電子傳輸材料為噻二唑誘導劑或喹㗁啉衍生物。在一些實施形態中,電子傳輸材料為聚合物材料。在以下,舉出能夠用作電子傳輸材料之較佳化合物的具體例。 (electron transport layer) The electron transport layer contains an electron transport material. In some embodiments, the electron transport layer is a single layer. In some embodiments, the electron transport layer has a plurality of layers. In some embodiments, the electron transport material only needs to have a function of transporting electrons injected from the cathode to the light emitting layer. In some embodiments, the electron transport material also functions as a hole barrier material. Examples of the electron transport layer that can be used in the present invention are not limited, but include nitro-substituted stilbene derivatives, dibenzoquinone derivatives, thiopyran derivatives, carbodiimides, and tertiaryl methane (fluorenylidene methane) derivatives, anthraquinone dimethane, anthrone derivatives, oxadiazole derivatives, oxazole derivatives, 𠯤 derivatives, or combinations thereof or polymers thereof. In some embodiments, the electron transport material is a thiadiazole inducer or a quinoline derivative. In some embodiments, the electron transport material is a polymeric material. Specific examples of preferable compounds that can be used as electron transport materials are given below.

[化學式126]

Figure 02_image383
[chemical formula 126]
Figure 02_image383

進而,舉出作為能夠添加到各有機層中的材料的較佳化合物例。例如,可以考慮作為穩定化材料進行添加等。Furthermore, examples of preferable compounds as materials that can be added to each organic layer are given. For example, it is conceivable to add it as a stabilizing material.

[化學式127]

Figure 02_image385
[chemical formula 127]
Figure 02_image385

具體地例示出能夠用於有機電致發光元件中之較佳材料,但是能夠用於本發明中之材料不被示例性化合物做限定性地解釋。又,即使為作為具有特定功能之材料例示出之化合物,亦能夠轉用為具有其他功能之材料。 有機電致發光元件的各有機層能夠藉由濕式步驟形成。在濕式步驟中,將包含構成有機層之化合物之組成物溶解而獲得之溶液塗佈於表面上,在去除溶劑之後形成層。作為濕式步驟,可以舉出旋塗法、狹縫塗佈法、噴墨法(噴塗法)、凹版印刷法、膠版印刷法、柔版印刷法,但是並不限定於該等。在濕式步驟中,選擇使用適當的有機溶劑,該有機溶劑能夠溶解構成有機層之化合物。在某一實施形態中,能夠向構成有機層之化合物中導入提高在有機溶劑中之溶解性之取代基(例如,烷基)。 在某一實施形態中,能夠藉由乾式步驟形成有機層。在某一實施形態中,作為乾式步驟,能夠採用真空蒸鍍法,但是並不限定於此。在採用真空蒸鍍法之情況下,可以使構成有機層之化合物從單獨的蒸鍍源進行共蒸鍍,亦可以從混合了化合物之單一的蒸鍍源進行共蒸鍍。在使用單一的蒸鍍源之情況下,可以使用混合了化合物的粉末之混合粉,亦可以使用壓縮了該混合粉之壓縮成形體,亦可以使用將各化合物進行加熱熔融並冷卻之混合物。在某一實施形態中,藉由在單一的蒸鍍源中所包含之複數個化合物的蒸鍍速度(重量減少速度)一致或幾乎一致之條件下進行共蒸鍍,能夠形成與蒸鍍源中所包含之複數個化合物的組成比對應之組成比的有機層。只要以與所形成之有機層的組成比相同的組成比混合複數個化合物以設為蒸鍍源,則能夠容易形成具有所期望的組成比之有機層。在某一實施形態中,能夠確定要共蒸鍍之各化合物成為相同的重量減少率之溫度,並將該溫度用作共蒸鍍時的溫度。 Preferred materials that can be used in the organic electroluminescent element are specifically exemplified, but materials that can be used in the present invention are not limitedly interpreted by the exemplified compounds. Moreover, even if it is a compound illustrated as the material which has a specific function, it can also be converted into the material which has other functions. Each organic layer of the organic electroluminescence element can be formed by a wet process. In the wet process, a solution obtained by dissolving a composition including compounds constituting an organic layer is applied on a surface, and a layer is formed after the solvent is removed. Examples of the wet process include spin coating, slit coating, inkjet (spray coating), gravure printing, offset printing, and flexographic printing, but are not limited thereto. In the wet step, an appropriate organic solvent capable of dissolving the compounds constituting the organic layer is selected and used. In a certain embodiment, a substituent (for example, an alkyl group) that improves solubility in an organic solvent can be introduced into the compound constituting the organic layer. In a certain embodiment, the organic layer can be formed by a dry process. In a certain embodiment, a vacuum vapor deposition method can be used as a dry step, but it is not limited thereto. In the case of using the vacuum deposition method, the compound constituting the organic layer may be co-deposited from a single deposition source, or may be co-deposited from a single deposition source in which a compound is mixed. In the case of using a single vapor deposition source, a mixed powder mixed with powder of a compound may be used, a compression molded body obtained by compressing the mixed powder may be used, or a mixture obtained by heating, melting and cooling each compound may be used. In a certain embodiment, by performing co-evaporation under the condition that the vapor deposition rates (weight loss rates) of the plurality of compounds contained in a single vapor deposition source are the same or almost the same, it is possible to form a The composition ratio of the plurality of compounds contained corresponds to the composition ratio of the organic layer. An organic layer having a desired composition ratio can be easily formed by mixing a plurality of compounds in the same composition ratio as that of the organic layer to be formed as a vapor deposition source. In a certain embodiment, it is possible to determine the temperature at which the respective compounds to be co-deposited have the same weight loss rate, and use this temperature as the temperature at the time of co-deposition.

[裝置] 在一些實施形態中,發光層併入裝置中。例如,裝置包括OLED閥、OLED燈、電視用顯示器、電腦用監視器、移動電話及平板,但是並不限定於該等。 在一些實施形態中,電子裝置包括OLED,該OLED具有包括陽極、陰極及該陽極與該陰極之間的發光層之至少一個有機層。 在一些實施形態中,本說明書中所記載的結構物能夠併入OLED或光電子裝置等各種感光性或光活化裝置中。在一些實施形態中,前述結構物能夠用於促進裝置內的電荷轉移或能量轉移和/或用作空穴傳輸材料。作為前述裝置,例如可以舉出有機發光二極體(OLED)、有機積體電路(OIC)、有機場效電晶體(O-FET)、有機薄膜電晶體(O-TFT)、有機發光電晶體(O-LET)、有機太陽能電池(O-SC)、有機光學檢測裝置、有機感光器、有機場淬滅(field-quench)裝置(O-FQD)、發光電化學電池(LEC)或有機雷射二極體(O-laser)。 [device] In some embodiments, a light emitting layer is incorporated into a device. For example, devices include OLED valves, OLED lamps, monitors for televisions, monitors for computers, mobile phones, and tablets, but are not limited thereto. In some embodiments, an electronic device includes an OLED having at least one organic layer including an anode, a cathode, and a light emitting layer between the anode and the cathode. In some embodiments, the structures described in this specification can be incorporated into various photosensitive or photoactive devices such as OLEDs or optoelectronic devices. In some embodiments, the aforementioned structures can be used to facilitate charge transfer or energy transfer within the device and/or serve as a hole transport material. Examples of the aforementioned devices include organic light-emitting diodes (OLEDs), organic integrated circuits (OICs), organic field-effect transistors (O-FETs), organic thin-film transistors (O-TFTs), and organic light-emitting transistors. (O-LET), organic solar cell (O-SC), organic optical detection device, organic photoreceptor, organic field-quencher (O-FQD), light-emitting electrochemical cell (LEC) or organic mine Diode (O-laser).

[閥或燈] 在一些實施形態中,電子裝置包括OLED,該OLED具有包括陽極、陰極、該陽極與該陰極之間的發光層之至少一個有機層。 在一些實施形態中,裝置包括不同顏色之OLED。在一些實施形態中,裝置包括包含OLED的組合之陣列。在一些實施形態中,OLED的前述組合為三種顏色的組合(例如,RGB)。在一些實施形態中,OLED的前述組合為既不是紅色亦不是綠色亦不是藍色的顏色(例如,橙色及黃綠色)的組合。在一些實施形態中,OLED的前述組合為兩種顏色、四種顏色或其以上的顏色的組合。 在一些實施形態中,裝置為OLED燈,該OLED燈具備: 電路板,具備具有安裝面之第1面和與第1面相對的第2面,並且劃分至少一個開口部; 至少一個OLED,其為前述安裝面上的至少一個OLED,該至少一個OLED包括包含陽極、陰極及該陽極與該陰極之間的發光層之至少一個有機層且具有發光結構; 電路板用殼體;及 至少一個連接器,配置於前述殼體的端部,並且前述殼體及前述連接器劃分適合安裝於照明設備上之封裝。 在一些實施形態中,前述OLED燈具有複數個OLED,該複數個OLED安裝於電路板上以使光向複數個方向輻射。在一些實施形態中,向第1方向發射之一部分的光偏振而向第2方向輻射。在一些實施形態中,使用反射器將向第1方向發射之光偏振。 [valve or lamp] In some embodiments, an electronic device includes an OLED having at least one organic layer including an anode, a cathode, and a light emitting layer between the anode and the cathode. In some embodiments, the device includes OLEDs of different colors. In some embodiments, a device includes an array comprising a combination of OLEDs. In some embodiments, the aforementioned combination of OLEDs is a combination of three colors (eg, RGB). In some embodiments, the aforementioned combination of OLEDs is a combination of colors that are neither red nor green nor blue (eg, orange and yellow-green). In some embodiments, the aforementioned combination of OLEDs is a combination of two colors, four colors or more. In some embodiments, the device is an OLED lamp having: A circuit board having a first surface having a mounting surface and a second surface opposite to the first surface, and defining at least one opening; At least one OLED, which is at least one OLED on the aforementioned installation surface, the at least one OLED includes at least one organic layer including an anode, a cathode, and a light-emitting layer between the anode and the cathode, and has a light-emitting structure; Housings for circuit boards; and At least one connector is arranged at the end of the aforementioned casing, and the aforementioned casing and the aforementioned connector are divided into packages suitable for being installed on lighting equipment. In some embodiments, the aforementioned OLED lamp has a plurality of OLEDs, and the plurality of OLEDs are mounted on a circuit board to radiate light in a plurality of directions. In some embodiments, a portion of the light emitted in the first direction is polarized to radiate in the second direction. In some embodiments, a reflector is used to polarize the light emitted in the first direction.

[顯示器或屏幕] 在一些實施形態中,本發明的發光層能夠用於屏幕或顯示器中。在一些實施形態中,本發明之化合物並無限定,但是使用真空蒸發、沉積、蒸鍍或化學蒸鍍(CVD)等步驟沉積於基材上。在一些實施形態中,前述基材為用於提供具有獨特縱橫比的像素之兩面蝕刻中的照相板結構。前述屏幕(並且,亦稱為遮罩)可以用於OLED顯示器的製造步驟中。藉由設計相對應之原圖圖案,能夠在垂直方向上配置像素之間的非常陡峭的窄連接桿以及在水平方向上配置大範圍的傾斜開口部。藉此,能夠在優化TFT背板上的化學蒸鍍的同時,構成高解析度顯示器所需之像素的精細的圖案。 藉由像素的內部圖案化,能夠在水平方向及垂直方向上構成各種縱橫比的三維像素開口部。進而,像素區域中的被圖像化之“條紋”或半色調圓的使用保護特定區域中之蝕刻,直至將該等特定圖案底切並從基材移除。此時,所有像素區域以相同的蝕刻速度進行處理,但是其深度依據半色調圖案而發生變化。藉由變更半色調圖案的尺寸及間隔,能夠進行像素內的保護率各種不同之蝕刻,能夠進行形成陡峭的垂直傾斜時所需的局部深度蝕刻。 蒸鍍遮罩用較佳材料為因鋼。因鋼為在鋼廠冷軋成長的薄型片狀之金屬合金。因鋼無法作為鎳遮罩電沉積到旋轉心軸上。用於在蒸鍍用遮罩內形成開口區域的適當且低成本的方法為基於濕式化學蝕刻之方法。 在一些實施形態中,屏幕或顯示圖案為基材上的像素矩陣。在一些實施形態中,屏幕或顯示圖案使用微影(例如,光微影及電子束微影)進行加工。在一些實施形態中,屏幕或顯示圖案使用濕式化學蝕刻進行加工。在又一實施形態中,屏幕或顯示圖案使用電漿蝕刻進行加工。 [monitor or screen] In some embodiments, the emissive layers of the present invention can be used in screens or displays. In some embodiments, the compound of the present invention is not limited, but is deposited on the substrate using steps such as vacuum evaporation, deposition, vapor deposition or chemical vapor deposition (CVD). In some embodiments, the aforementioned substrate is a photographic plate structure in double-sided etching to provide pixels with unique aspect ratios. The aforementioned screen (and, also called mask) can be used in the manufacturing steps of OLED displays. By designing corresponding artwork patterns, it is possible to arrange very steep narrow connecting rods between pixels in the vertical direction and arrange large-scale inclined openings in the horizontal direction. Thereby, while optimizing the chemical vapor deposition on the TFT backplane, it is possible to form a fine pattern of pixels required for a high-resolution display. By patterning the inside of the pixel, it is possible to form three-dimensional pixel openings with various aspect ratios in the horizontal direction and the vertical direction. Furthermore, the use of imaged "stripes" or halftone circles in the pixel area protects etching in specific areas until those specific patterns are undercut and removed from the substrate. At this time, all pixel regions are processed at the same etching rate, but their depths vary according to the halftone pattern. By changing the size and interval of the halftone pattern, it is possible to perform etching with various protection ratios in the pixel, and to perform partial deep etching required for forming steep vertical inclinations. The preferred material for the evaporation mask is Invar. Because steel is a thin sheet metal alloy grown by cold rolling in steel mills. Insteel cannot be electrodeposited onto the rotating mandrel as a nickel mask. A suitable and low-cost method for forming an open area in a mask for evaporation is a method based on wet chemical etching. In some embodiments, the screen or display pattern is a matrix of pixels on a substrate. In some embodiments, the screen or display pattern is fabricated using lithography (eg, photolithography and electron beam lithography). In some embodiments, the screen or display pattern is processed using wet chemical etching. In yet another embodiment, the screen or display pattern is processed using plasma etching.

[裝置之製造方法] 關於OLED顯示器,通常形成大型母板,接著以單元面板單位切割該母板來製造。通常,母板上的各單元面板藉由如下形成:在基底基材上形成具有活性層和源極/汲極電極之薄膜電晶體(TFT),在前述TFT上塗佈平坦化膜以依序經時形成像素電極、發光層、對電極及封裝層,並從前述母板進行切割。 關於OLED顯示器,通常形成大型母板,接著以單元面板單位切割該母板來製造。通常,母板上的各單元面板藉由如下形成:在基底基材上形成具有活性層和源極/汲極電極之薄膜電晶體(TFT),在前述TFT上塗佈平坦化膜以依序經時形成像素電極、發光層、對電極及封裝層,並從前述母板進行切割。 [Manufacturing method of the device] With regard to OLED displays, a large-scale motherboard is usually formed, and then the motherboard is diced in unit panel units to manufacture. Generally, each unit panel on a motherboard is formed by forming a thin film transistor (TFT) having an active layer and source/drain electrodes on a base substrate, and coating a planarization film on the aforementioned TFT to sequentially A pixel electrode, a light-emitting layer, a counter electrode, and an encapsulation layer are formed over time, and cut from the aforementioned motherboard. With regard to OLED displays, a large-scale motherboard is usually formed, and then the motherboard is diced in unit panel units to manufacture. Generally, each unit panel on a motherboard is formed by forming a thin film transistor (TFT) having an active layer and source/drain electrodes on a base substrate, and coating a planarization film on the aforementioned TFT to sequentially A pixel electrode, a light-emitting layer, a counter electrode, and an encapsulation layer are formed over time, and cut from the aforementioned motherboard.

在本發明的其他態樣中,提供一種有機發光二極體(OLED)顯示器之製造方法,該方法包括: 在母板的基底基材上形成障壁層之步驟; 在前述障壁層上以單元面板單位形成複數個顯示單元之步驟; 在前述單元面板的顯示單元的各自上形成封裝層之步驟;及 在前述單元面板之間的界面部上塗佈有機薄膜之步驟。 在一些實施形態中,障壁層例如為由SiNx形成之無機薄膜,障壁層的端部被由聚醯亞胺或丙烯酸形成之有機薄膜被覆。在一些實施形態中,有機薄膜輔助母板以單元面板單位被軟切。 在一些實施形態中,薄膜電晶體(TFT)層具有發光層、閘電極及源極/汲極電極。複數個顯示單元的各自可以具有薄膜電晶體(TFT)層、形成於TFT層上之平坦化膜及形成於平坦化膜上之發光單元,塗佈於前述界面部上之有機薄膜由與前述平坦化膜的材料相同的材料形成,並且與前述平坦化膜的形成同時形成。在一些實施形態中,前述發光單元藉由鈍化層、它們之間的平坦化膜及被覆並保護發光單元之封裝層與TFT層連接。在前述製造方法的一些實施形態中,前述有機薄膜不與顯示單元連接,亦不與封裝層連接。 In other aspects of the present invention, a method of manufacturing an organic light emitting diode (OLED) display is provided, the method comprising: A step of forming a barrier layer on the base substrate of the motherboard; A step of forming a plurality of display units in units of unit panels on the aforementioned barrier layer; A step of forming an encapsulation layer on each of the display units of the aforementioned unit panel; and A step of coating an organic thin film on the interface between the aforementioned unit panels. In some embodiments, the barrier layer is, for example, an inorganic thin film formed of SiNx, and the end of the barrier layer is covered by an organic thin film formed of polyimide or acrylic. In some embodiments, the organic film-assisted master is soft cut in unit panel units. In some embodiments, the thin film transistor (TFT) layer has a light emitting layer, a gate electrode, and source/drain electrodes. Each of the plurality of display units may have a thin-film transistor (TFT) layer, a planarization film formed on the TFT layer, and a light-emitting unit formed on the planarization film. The planarization film is formed of the same material and formed simultaneously with the formation of the aforementioned planarization film. In some embodiments, the aforementioned light-emitting unit is connected to the TFT layer through a passivation layer, a planarization film between them, and an encapsulation layer covering and protecting the light-emitting unit. In some embodiments of the aforementioned manufacturing method, the aforementioned organic thin film is not connected with the display unit, nor is it connected with the encapsulation layer.

前述有機薄膜和平坦化膜的各自可以包含聚醯亞胺及丙烯酸中的任一個。在一些實施形態中,前述障壁層可以為無機薄膜。在一些實施形態中,前述基底基材可以由聚醯亞胺形成。前述方法還可以包括在由聚醯亞胺形成之基底基材的一個表面上形成障壁層之前,在該基底基材的另一個表面上安裝由玻璃材料形成之載子基材之步驟和在沿界面部切割之前,從基底基材分離前述載子基材之步驟。在一些實施形態中,前述OLED顯示器為柔性顯示器。 在一些實施形態中,前述鈍化層為配置於TFT層上以被覆TFT層之有機薄膜。在一些實施形態中,前述平坦化膜為形成於鈍化層上之有機薄膜。在一些實施形態中,與形成於障壁層的端部之有機薄膜相同地,前述平坦化膜由聚醯亞胺或丙烯酸形成。在一些實施形態中,在製造OLED顯示器時,前述平坦化膜及有機薄膜同時形成。在一些實施形態中,前述有機薄膜可以形成於障壁層的端部,藉此,該有機薄膜的一部分直接與基底基材接觸,而該有機薄膜的其餘部分在包圍障壁層的端部的同時,與障壁層接觸。 Each of the aforementioned organic thin film and planarization film may contain any one of polyimide and acrylic. In some embodiments, the aforementioned barrier layer may be an inorganic thin film. In some embodiments, the aforementioned base substrate may be formed of polyimide. The aforementioned method may further include the step of mounting a carrier substrate formed of a glass material on the other surface of the base substrate before forming the barrier layer on one surface of the base substrate formed of polyimide and A step of separating the aforementioned carrier substrate from the base substrate before cutting the interface portion. In some embodiments, the aforementioned OLED display is a flexible display. In some embodiments, the aforementioned passivation layer is an organic thin film disposed on the TFT layer to cover the TFT layer. In some embodiments, the aforementioned planarization film is an organic thin film formed on the passivation layer. In some embodiments, the planarization film is formed of polyimide or acrylic, similarly to the organic thin film formed at the end of the barrier layer. In some embodiments, the planarization film and the organic thin film are formed at the same time when the OLED display is manufactured. In some embodiments, the aforementioned organic thin film may be formed at the end of the barrier layer, whereby a part of the organic thin film is in direct contact with the base substrate, while the remaining part of the organic thin film surrounds the end of the barrier layer, contact with the barrier layer.

在一些實施形態中,前述發光層具有像素電極、對電極及配置於該像素電極與該對電極之間的有機發光層。在一些實施形態中,前述像素電極與TFT層的源極/汲極電極連接。 在一些實施形態中,在通過TFT層而向像素電極施加電壓時,在像素電極與對電極之間形成適當的電壓,藉此有機發光層輻射光,從而形成圖像。以下,將具有TFT層和發光單元之圖像形成單元稱為顯示單元。 在一些實施形態中,被覆顯示單元並防止外部的水分的滲透之封裝層可以形成為有機薄膜和無機薄膜交替積層而成之薄膜狀封裝結構。在一些實施形態中,前述封裝層具有複數個薄膜積層而成之薄膜狀封裝結構。在一些實施形態中,塗佈於界面部上之有機薄膜與複數個顯示單元的各自隔開間隔而配置。在一些實施形態中,前述有機薄膜以如下態樣形成:一部分的有機薄膜直接與基底基材接觸,而有機薄膜的其餘部分在包圍障壁層的端部的同時,與障壁層接觸。 In some embodiments, the aforementioned light emitting layer has a pixel electrode, a counter electrode, and an organic light emitting layer disposed between the pixel electrode and the counter electrode. In some embodiments, the aforementioned pixel electrodes are connected to the source/drain electrodes of the TFT layer. In some embodiments, when a voltage is applied to the pixel electrode through the TFT layer, an appropriate voltage is formed between the pixel electrode and the counter electrode, whereby the organic light emitting layer radiates light to form an image. Hereinafter, an image forming unit having a TFT layer and a light emitting unit is referred to as a display unit. In some embodiments, the encapsulation layer that covers the display unit and prevents the penetration of external moisture can be formed as a thin-film encapsulation structure in which organic thin films and inorganic thin films are alternately laminated. In some embodiments, the aforementioned encapsulation layer has a film-like encapsulation structure in which a plurality of thin films are laminated. In some embodiments, the organic thin film coated on the interface portion is arranged at a distance from each of the plurality of display units. In some embodiments, the organic thin film is formed in such a manner that a part of the organic thin film is in direct contact with the base substrate, and the rest of the organic thin film is in contact with the barrier layer while surrounding the end of the barrier layer.

在一實施形態中,OLED顯示器為柔性,並且使用由聚醯亞胺形成之柔軟的基底基材。在一些實施形態中,前述基底基材形成於由玻璃材料形成之載子基材上,接著分離該載子基材。 在一些實施形態中,障壁層形成於載子基材的相反的一側的基底基材的表面上。在一實施形態中,依據各單元面板的尺寸對前述障壁層進行圖案化。例如,在母板的所有表面上形成基底基材的同時,依據各單元面板的尺寸形成障壁層,藉此在單元面板的障壁層之間的界面部上形成凹槽。各單元面板能夠沿前述凹槽切割。 In one aspect, the OLED display is flexible and uses a flexible base substrate formed of polyimide. In some embodiments, the aforementioned base substrate is formed on a carrier substrate formed of a glass material, and then the carrier substrate is separated. In some embodiments, the barrier layer is formed on the surface of the base substrate opposite to the carrier substrate. In one embodiment, the aforementioned barrier layer is patterned according to the size of each unit panel. For example, while the base substrate is formed on all surfaces of the mother board, the barrier layer is formed according to the size of each unit panel, whereby grooves are formed on the interface portion between the barrier layers of the unit panels. Each unit panel can be cut along the aforementioned groove.

在一些實施形態中,前述製造方法還包括沿界面部切割之步驟,其中,凹槽形成於障壁層上,至少一部分的有機薄膜形成於凹槽中,該凹槽不會穿透到基底基材中。在一些實施形態中,形成各單元面板的TFT層,作為無機薄膜之鈍化層和作為有機薄膜之平坦化膜配置於TFT層上以被覆TFT層。例如,在形成聚醯亞胺或丙烯酸製的平坦化膜的同時,界面部的凹槽例如被聚醯亞胺或丙烯酸製的有機薄膜被覆。這防止如下:在各單元面板在界面部上沿凹槽切割時,由於將所產生之衝擊吸收到有機薄膜而產生龜裂。亦即,在所有障壁層由於沒有有機薄膜而完全暴露之情況下,在各單元面板在界面部上沿凹槽切割時,所產生之衝擊被傳遞到障壁層,藉此產生龜裂之風險增加。然而,在一實施形態中,障壁層之間的界面部的凹槽被有機薄膜被覆以吸收在沒有有機薄膜的情況下能夠傳遞到障壁層之衝擊,因此可以軟切各單元面板以防止在障壁層中產生龜裂。在一實施形態中,被覆界面部的凹槽之有機薄膜及平坦化膜彼此隔開間隔而配置。例如,在有機薄膜及平坦化膜彼此連接為一個層之情況下,外部的水分有可能通過平坦化膜和有機薄膜的殘留部分而浸入到顯示單元中,因此有機薄膜及平坦化膜彼此隔開間隔而配置,以使有機薄膜與顯示單元隔開間隔而配置。In some embodiments, the aforementioned manufacturing method further includes a step of cutting along the interface, wherein a groove is formed on the barrier layer, at least a part of the organic thin film is formed in the groove, and the groove does not penetrate into the base substrate middle. In some embodiments, the TFT layer of each unit panel is formed, and a passivation layer as an inorganic thin film and a planarization film as an organic thin film are disposed on the TFT layer to cover the TFT layer. For example, at the same time as the planarization film made of polyimide or acrylic is formed, the grooves in the interface portion are covered with, for example, an organic thin film made of polyimide or acrylic. This prevents cracks from being generated by absorbing the impact generated to the organic thin film when each unit panel is cut along the groove on the interface portion. That is, in the case where all the barrier layers are fully exposed due to no organic thin film, when each unit panel is cut along the groove on the interface portion, the impact generated is transmitted to the barrier layer, whereby the risk of cracking increases . However, in one embodiment, the grooves at the interface between the barrier layers are covered with an organic thin film to absorb the impact that can be transmitted to the barrier layer without the organic thin film, so that each unit panel can be soft-cut to prevent damage to the barrier ribs. cracks in the layer. In one embodiment, the organic thin film and the planarizing film covering the groove in the interface portion are arranged at intervals from each other. For example, in the case where the organic thin film and the planarizing film are connected to each other as a single layer, external moisture may infiltrate into the display unit through the remaining part of the planarizing film and the organic thin film, so the organic thin film and the planarizing film are separated from each other. They are arranged at intervals so that the organic thin film and the display unit are arranged at intervals.

在一些實施形態中,顯示單元藉由發光單元的形成而形成,封裝層配置於顯示單元上以被覆顯示單元。藉此,在完全製造母板之後,從基底基材分離承載基底基材之載子基材。在一些實施形態中,若向載子基材輻射雷射光束,則載子基材由於載子基材與基底基材之間的熱膨脹係數的不同而從基底基材分離。 在一些實施形態中,母板以單元面板單位切割。在一些實施形態中,母板使用切割器沿單元面板之間的界面部切割。在一些實施形態中,母板所沿著切割之界面部的凹槽被有機薄膜被覆,因此在切割期間,該有機薄膜吸收衝擊。在一些實施形態中,在切割期間,能夠防止在障壁層中產生龜裂。 在一些實施形態中,前述方法減少產品的不良率並穩定其品質。 其他態樣為OLED顯示器,該OLED顯示器具有形成於基底基材上之障壁層、形成於障壁層上之顯示單元、形成於顯示單元上之封裝層及塗佈於障壁層的端部之有機薄膜。 [實施例] In some embodiments, the display unit is formed by forming a light emitting unit, and the encapsulation layer is disposed on the display unit to cover the display unit. Thereby, after the master is completely manufactured, the carrier base material carrying the base base material is separated from the base base material. In some embodiments, when the carrier substrate is irradiated with a laser beam, the carrier substrate is separated from the base substrate due to the difference in thermal expansion coefficient between the carrier substrate and the base substrate. In some embodiments, the motherboard is cut in unit panel units. In some embodiments, the mother board is cut along the interface between the unit panels using a cutter. In some embodiments, the grooves of the motherboard along the dicing interface are covered with an organic film so that the organic film absorbs shock during dicing. In some embodiments, cracks can be prevented from being generated in the barrier layer during dicing. In some embodiments, the foregoing method reduces the defective rate of the product and stabilizes its quality. Another aspect is an OLED display having a barrier layer formed on a base substrate, a display unit formed on the barrier layer, an encapsulation layer formed on the display unit, and an organic thin film coated on the end of the barrier layer . [Example]

在以下,舉出合成例和實施例對本發明的特徵進一步進行具體說明。關於以下所示之材料、處理內容、處理步驟等,只要不脫離本發明的主旨,則能夠適當變更。因此,本發明的範圍不應被以下所示之具體例做限定性地解釋。再者,關於發光特性的評價,使用源表(TEKTRONIX, INC.製:2400系列)、半導體參數·分析器(Agilent Technologies Japan,Ltd.製:E5273A)、光功率計測定裝置(Newport Corporation製:1930C)、光學光譜儀(Ocean Photonics.製:USB2000)、分光輻射計(TOPCON CORPORATION,製:SR-3)及條紋照相(Hamamatsu Photonics K.K.製C4334型)進行。Hereinafter, the characteristics of the present invention will be described in more detail with reference to synthesis examples and examples. Materials, processing contents, processing procedures, and the like shown below can be appropriately changed without departing from the gist of the present invention. Therefore, the scope of the present invention should not be limitedly interpreted by the specific examples shown below. In addition, regarding the evaluation of the emission characteristics, a source meter (manufactured by TEKTRONIX, INC.: 2400 series), a semiconductor parameter analyzer (manufactured by Agilent Technologies Japan, Ltd.: E5273A), and an optical power meter measuring device (manufactured by Newport Corporation: E5273A) were used. 1930C), an optical spectrometer (Ocean Photonics.: USB2000), a spectroradiometer (TOPCON CORPORATION: SR-3), and a streak camera (C4334, Hamamatsu Photonics K.K.).

(合成例1)化合物1b的合成 [化學式128]

Figure 02_image387
(Synthesis Example 1) Synthesis of Compound 1b [Chemical Formula 128]
Figure 02_image387

在氮氣環境下,將2-(3-溴苯基)二苯并呋喃(2g,6.19mmol)、3-苯基-12H-苯并氟[2,3-a]咔唑(2.06g,6.19mmol)、三(二亞苄基丙酮)二鈀(0)(0.57g,0.62mmol)、三-三級丁基磷四氟硼酸鹽(0.36g,1.24mmol)及三級丁醇鈉(1.19g,12.4mmol)加入45ml的甲苯中,並回流了24小時。將反應溶液冷卻至室溫,並加入了氯仿。將所獲得之有機層用水清洗2次,並用硫酸鎂進行乾燥,從而去除了溶劑。藉由矽膠管柱層析法(展開溶劑:氯仿/正己烷=5:5)將所獲得之固體純化。進一步進行再結晶(甲苯/甲醇),從而獲得了白色固體的化合物1b(1.74g,49)。 1H NMR(400MHz,CDCl 3,δ):8.43(s,1H),8.32(s,1H),8.11(d, J=8Hz,1H),8.07(m, 2H),7.94-7.82(m,4H),7.77-7.68(m,6H),7.65(d, J=8Hz,1H),7.58(d, J=8Hz,1H),7.55-7.31(m,8H). MS(ASAP):576.12(M+H +).Calcd for C 42H 25NO 2:575.91. Under nitrogen atmosphere, 2-(3-bromophenyl)dibenzofuran (2g, 6.19mmol), 3-phenyl-12H-benzofluoro[2,3-a]carbazole (2.06g, 6.19 mmol), tris(dibenzylideneacetone) dipalladium (0) (0.57g, 0.62mmol), tri-tertiary butylphosphonium tetrafluoroborate (0.36g, 1.24mmol) and tertiary sodium butoxide (1.19 g, 12.4mmol) was added into 45ml of toluene, and refluxed for 24 hours. The reaction solution was cooled to room temperature, and chloroform was added. The obtained organic layer was washed with water twice, and dried over magnesium sulfate to remove the solvent. The obtained solid was purified by silica gel column chromatography (developing solvent: chloroform/n-hexane=5:5). Further recrystallization (toluene/methanol) was performed to obtain Compound 1b (1.74 g, 49) as a white solid. 1 H NMR (400MHz, CDCl 3 , δ): 8.43 (s, 1H), 8.32 (s, 1H), 8.11 (d, J = 8Hz, 1H), 8.07 (m, 2 H), 7.94-7.82 (m , 4H), 7.77-7.68 (m, 6H), 7.65 (d, J =8Hz, 1H), 7.58 (d, J =8Hz, 1H), 7.55-7.31 (m, 8H). MS (ASAP): 576.12 (M+H + ).Calcd for C 42 H 25 NO 2 :575.91.

(合成例2)化合物2b的合成 [化學式129]

Figure 02_image389
(Synthesis Example 2) Synthesis of Compound 2b [Chemical Formula 129]
Figure 02_image389

在氮氣環境下,在冰浴下,在12 H-苯并氟[2,3-a]咔唑(20.0g,77.7mmol)的氯仿溶液(900mL)中加入N-溴琥珀醯亞胺(13.8g,77.7mmol),返回至室溫,並攪拌了14小時。去除溶劑之後,用甲醇進行了清洗。將所獲得之固體溶解於加熱之甲苯中,並用覆蓋有矽藻土/矽膠/矽藻土之布氏漏斗進行了過濾。去除濾液的溶劑之後,用甲苯、氯苯分別進行再結晶,從而獲得了白色固體的中間體M1(15.9g,61%)。 1H-NMR(400MHz,CDCl 3, δ):8.63(d,J=6.8Hz,1H),8.52(br,1H),8.19(s,1H),8.11(d, J=7.6Hz,1H),7.67(d, J=7.6Hz,1H),7.57-7.43(m,4H),7.31(t, J=7.2Hz,1H) MS(ASAP):335.96(M+H +).Calcd for C 18H 10BrNO:334.99 Under nitrogen atmosphere, N-bromosuccinimide (13.8 g, 77.7mmol), returned to room temperature, and stirred for 14 hours. After removing the solvent, it was washed with methanol. The obtained solid was dissolved in heated toluene and filtered through a Buchner funnel covered with celite/silica gel/celite. After the solvent of the filtrate was removed, recrystallization was performed with toluene and chlorobenzene, respectively, to obtain white solid intermediate M1 (15.9 g, 61%). 1 H-NMR (400MHz, CDCl 3 , δ ): 8.63 (d, J=6.8Hz, 1H), 8.52 (br, 1H), 8.19 (s, 1H), 8.11 (d, J = 7.6Hz, 1H) , 7.67 (d, J =7.6Hz, 1H), 7.57-7.43 (m, 4H), 7.31 (t, J = 7.2Hz, 1H) MS (ASAP): 335.96 (M+H + ).Calcd for C 18 H 10 BrNO:334.99

[化學式130]

Figure 02_image391
[chemical formula 130]
Figure 02_image391

在氮氣環境下,將中間體M1(15.8g,46.9mmol)、苯基硼酸(6.8g,56.3mmol)、磷酸三鉀(19.9g,93.9mmol)、四(三苯基膦)鈀(0)(2.7g,2.3mmol)的1,4-二㗁烷(470mL)/超純水(150mL)溶液在100℃下攪拌了15小時。去除二㗁烷之後,過濾了在水中析出之固體。將所獲得之固體溶解於加熱之甲苯中,並用覆蓋有矽藻土/矽膠/矽藻土之布氏漏斗進行了過濾。去除濾液的溶劑,並用甲苯、氯苯分別進行再結晶,從而獲得了中間體M2(10.8g,69%)。 1H-NMR(400MHz,CDCl 3, δ):8.54(s,1H),8.13(d, J=6.8Hz,1H),7.93(s,1H),7.72(dt, J=6.8Hz,2Hz2H),7.65(d, J=8.4Hz,1H),7.59-7.46(m,6H),7.41(td, J=7.8Hz,1.2Hz,1H),7.30(td, J=7.6Hz,1.2Hz,1H),7.16(td, J=7.6Hz,1.2Hz,1H) MS(ASAP):334.44(M+H +).Calcd for C 24H 15NO:333.12 Under nitrogen atmosphere, intermediate M1 (15.8g, 46.9mmol), phenylboronic acid (6.8g, 56.3mmol), tripotassium phosphate (19.9g, 93.9mmol), tetrakis(triphenylphosphine)palladium(0) (2.7 g, 2.3 mmol) in 1,4-dioxane (470 mL)/ultrapure water (150 mL) was stirred at 100° C. for 15 hours. After removing the dioxane, the solid precipitated in water was filtered. The obtained solid was dissolved in heated toluene and filtered through a Buchner funnel covered with celite/silica gel/celite. The solvent of the filtrate was removed, and the intermediate M2 (10.8 g, 69%) was obtained by recrystallization with toluene and chlorobenzene respectively. 1 H-NMR (400MHz, CDCl 3 , δ ): 8.54 (s, 1H), 8.13 (d, J =6.8Hz, 1H), 7.93 (s, 1H), 7.72 (dt, J = 6.8Hz, 2Hz2H) , 7.65 (d, J =8.4Hz, 1H), 7.59-7.46 (m, 6H), 7.41 (td, J = 7.8Hz, 1.2Hz, 1H), 7.30 (td, J = 7.6Hz, 1.2Hz, 1H ), 7.16 (td, J =7.6Hz, 1.2Hz, 1H) MS (ASAP): 334.44 (M+H + ). Calcd for C 24 H 15 NO: 333.12

[化學式131]

Figure 02_image393
[chemical formula 131]
Figure 02_image393

在氮氣環境下,將2-(3-溴苯基)二苯并呋喃(10.6g,32.7mmol)、中間體M2(10.9g,32.7mmol)、三(二亞苄基丙酮)二鈀(0)(3.0g,3.2mmol)、三-三級丁基磷四氟硼酸鹽(1.9g,6.5mmol)、三級丁醇鈉(6.3g,65.6mmol)的甲苯溶液(240mL)在130℃下攪拌了14小時。在反應溶液中加入甲苯,並用覆蓋有矽藻土/矽膠/矽藻土之布氏漏斗進行了過濾。去除溶劑之後,用乙酸乙酯進行清洗,並進行過濾,從而獲得了褐色的固體。將所獲得之固體用氯苯、甲苯分別進行再結晶,從而獲得了化合物2b(12.4g,65%)。 1H NMR(400MHz,CDCl 3,δ):8.32(d, J=2.0Hz,1H),8.22(d, J=8.0Hz,1H),8.07(d, J=1.7Hz,1H),8.04(s,1H),7.89-7.83(m,3H),7.78-7.73(m,4H),7.66(d, J=8.4Hz,2H),7.61-7.57(m,3H),7.54-7.44(m,5H),7.38-7.30(m,3H),7.17-7.13(td, J=7.4Hz,1.2Hz,1H) MS(ASAP):576.37(M+H +).Calcd for C 42H 25NO 2:575.19. Under nitrogen atmosphere, 2-(3-bromophenyl)dibenzofuran (10.6g, 32.7mmol), intermediate M2 (10.9g, 32.7mmol), tris(dibenzylideneacetone)dipalladium (0 ) (3.0g, 3.2mmol), three-tertiary butylphosphonium tetrafluoroborate (1.9g, 6.5mmol), three-level sodium butoxide (6.3g, 65.6mmol) in toluene solution (240mL) at 130 ° C Stirred for 14 hours. Toluene was added to the reaction solution, and filtered with a Buchner funnel covered with diatomaceous earth/silica gel/diatomaceous earth. After removing the solvent, it was washed with ethyl acetate and filtered to obtain a brown solid. The obtained solid was recrystallized from chlorobenzene and toluene, respectively, to obtain Compound 2b (12.4 g, 65%). 1 H NMR (400MHz, CDCl 3 , δ): 8.32 (d, J = 2.0Hz, 1H), 8.22 (d, J = 8.0Hz, 1H), 8.07 (d, J = 1.7Hz, 1H), 8.04 ( s, 1H), 7.89-7.83 (m, 3H), 7.78-7.73 (m, 4H), 7.66 (d, J = 8.4Hz, 2H), 7.61-7.57 (m, 3H), 7.54-7.44 (m, 5H), 7.38-7.30 (m, 3H), 7.17-7.13 (td, J =7.4Hz, 1.2Hz, 1H) MS (ASAP): 576.37 (M+H + ). Calcd for C 42 H 25 NO 2 : 575.19.

(合成例3)化合物6b的合成 [化學式132]

Figure 02_image395
(Synthesis Example 3) Synthesis of Compound 6b [Chemical Formula 132]
Figure 02_image395

在氮氣環境下,將2-(3-溴苯基)二苯并呋喃(1.78g,5.5mmol)、2-苯基-12H-苯并氟[2,3-a]咔唑(2.2g,6.6mmol)、三(二亞苄基丙酮)二鈀(0)(5.03g,0.55mmol)、三-三級丁基磷四氟硼酸鹽(0.319g,1.1mmol)及三級丁醇鈉(1.59g,16.5mmol)加入50ml的甲苯中,並回流了24小時。將反應溶液冷卻至室溫,並加入了氯仿。將所獲得之有機層用水清洗2次,並用硫酸鎂進行乾燥,從而去除了溶劑。藉由矽膠管柱層析法(展開溶劑:氯仿/正己烷=3:7)將所獲得之固體純化。進一步進行再結晶(甲苯/甲醇),從而獲得了白色固體的化合物6b(2.24g,77)。 1H NMR(400MHz,CDCl 3,δ):8.32(d, J=2Hz,1H),8.28(d, J=8Hz,1H),8.18(d, J=8Hz,1H),8.09-8.06(m,2H),7.93(d, J=8Hz,1H),7.88-7.82(m,3H),7.79-7.75(m,2H),7.71-7.58(m,5H),7.54-7.31(m,10H). MS(ASAP):576.33(M+H +).Calcd for C 42H 25NO 2:575.91. Under nitrogen atmosphere, 2-(3-bromophenyl)dibenzofuran (1.78g, 5.5mmol), 2-phenyl-12H-benzofluoro[2,3-a]carbazole (2.2g, 6.6mmol), three (dibenzylideneacetone) dipalladium (0) (5.03g, 0.55mmol), three-three-level butyl phosphorus tetrafluoroborate (0.319g, 1.1mmol) and three-level sodium butoxide ( 1.59g, 16.5mmol) was added to 50ml of toluene, and refluxed for 24 hours. The reaction solution was cooled to room temperature, and chloroform was added. The obtained organic layer was washed with water twice, and dried over magnesium sulfate to remove the solvent. The obtained solid was purified by silica gel column chromatography (developing solvent: chloroform/n-hexane=3:7). Further recrystallization (toluene/methanol) was performed to obtain compound 6b (2.24 g, 77) as a white solid. 1 H NMR (400MHz, CDCl 3 , δ): 8.32 (d, J = 2Hz, 1H), 8.28 (d, J = 8Hz, 1H), 8.18 (d, J = 8Hz, 1H), 8.09-8.06 (m , 2H), 7.93 (d, J = 8Hz, 1H), 7.88-7.82 (m, 3H), 7.79-7.75 (m, 2H), 7.71-7.58 (m, 5H), 7.54-7.31 (m, 10H) . MS (ASAP): 576.33 (M+H + ). Calcd for C 42 H 25 NO 2 : 575.91.

(合成例4)化合物19b的合成 [化學式133]

Figure 02_image397
(Synthesis Example 4) Synthesis of Compound 19b [Chemical Formula 133]
Figure 02_image397

在氮氣環境下,將2-(3-溴苯基)二苯并呋喃(0.97g,3mmol)、2-苯基-5H-苯并氟[3,2-c]咔唑(1g,3mmol)、三(二亞苄基丙酮)二鈀(0)(0.27g,0.3mmol)、三-三級丁基磷四氟硼酸鹽(0.17g,0.6mmol)及三級丁醇鈉(0.58g,6mmol)加入15ml的甲苯中,並回流了24小時。將反應溶液冷卻至室溫,並加入了氯仿。將所獲得之有機層用水清洗2次,並用硫酸鎂進行乾燥,從而去除了溶劑。藉由矽膠管柱層析法(展開溶劑:氯仿/正己烷=2:8)將所獲得之固體純化。進一步進行再結晶(甲苯/甲醇),從而獲得了白色固體的化合物19b(1.09g,63)。 1H NMR(400MHz,CDCl 3,δ):8.81(s,1H),8.24(s,1H),8.02-7.97(m,4H),7.88-7.72(m,7H),7.69-7.33(m,12H). MS(ASAP):575.21(M+H +).Calcd for C 42H 25NO 2:575.91. Under nitrogen atmosphere, 2-(3-bromophenyl)dibenzofuran (0.97g, 3mmol), 2-phenyl-5H-benzofluoro[3,2-c]carbazole (1g, 3mmol) , tris(dibenzylideneacetone) dipalladium (0) (0.27g, 0.3mmol), tri-tertiary butylphosphonium tetrafluoroborate (0.17g, 0.6mmol) and tertiary sodium butoxide (0.58g, 6mmol) was added to 15ml of toluene, and refluxed for 24 hours. The reaction solution was cooled to room temperature, and chloroform was added. The obtained organic layer was washed with water twice, and dried over magnesium sulfate to remove the solvent. The obtained solid was purified by silica gel column chromatography (developing solvent: chloroform/n-hexane=2:8). Further recrystallization (toluene/methanol) was performed to obtain Compound 19b (1.09 g, 63) as a white solid. 1 H NMR (400MHz, CDCl 3 , δ): 8.81 (s, 1H), 8.24 (s, 1H), 8.02-7.97 (m, 4H), 7.88-7.72 (m, 7H), 7.69-7.33 (m, 12H). MS (ASAP): 575.21 (M+H + ). Calcd for C 42 H 25 NO 2 : 575.91.

(實施例1) 藉由真空蒸鍍法,在形成有由膜厚50nm的氧化銦錫(ITO)組成之陽極之玻璃基板上,以真空度5.0×10 -5Pa積層以下各薄膜,從而製作了有機電致發光元件。 首先,在ITO上形成10nm厚度的HATCN,在其上形成30nm厚度的NPD,進而在其上形成10nm厚度的化合物1b。接著,將主體材料(H1)和延遲螢光材料(T132)從不同之蒸鍍源進行共蒸鍍,從而形成40nm厚度的層,並將其設為發光層。此時,主體材料的含量設為65質量%,延遲螢光材料的含量設為35質量%。接著,將SF3-TRZ形成為10nm厚度之後,將Liq和SF3-TRZ從不同之蒸鍍源進行共蒸鍍,從而形成30nm厚度的層。該層中之Liq和SF3-TRZ的含量分別設為30質量%和70質量%。進而,將Liq形成為2nm厚度,接著將鋁(Al)蒸鍍為100nm厚度以形成陰極,從而製作了有機電致發光元件。將該元件設為EL元件1。 又,僅變更使用化合物6b、19b、22來代替化合物1b之點,除此以外,藉由相同的步驟製作有機電致發光元件,並將其分別設為EL元件2~4。 進而,僅變更使用比較化合物A、比較化合物B來代替化合物1b之點,除此以外,藉由相同的步驟製作有機電致發光元件,並將其分別設為比較EL元件1、比較EL元件2。 對所製作之各有機電致發光元件進行通電,其結果,觀測到來自於延遲螢光材料(T132)之延遲螢光。以電流密度12.6mA/cm 2驅動各有機電致發光元件,並測定了發光強度成為驅動開始時的95%為止的時間(LT95)。將測定結果示於表2中。表2的LT95作為將比較EL元件2的LT95設為1時的相對值而示出。測定結果表明,與以往用作電子障壁材料之比較化合物A或比較化合物B相比,將通式(1)所表示之化合物用作電子障壁材料時的元件壽命顯著變長。 (Example 1) The following thin films were laminated at a vacuum degree of 5.0×10 -5 Pa on a glass substrate on which an anode composed of indium tin oxide (ITO) with a film thickness of 50 nm was formed by the vacuum evaporation method to produce organic electroluminescent elements. First, HATCN with a thickness of 10 nm was formed on ITO, NPD with a thickness of 30 nm was formed thereon, and compound 1b was formed with a thickness of 10 nm thereon. Next, the host material (H1) and the delayed fluorescent material (T132) were co-deposited from different deposition sources to form a layer with a thickness of 40 nm, which was used as a light emitting layer. At this time, the content of the host material was set to 65% by mass, and the content of the delayed fluorescent material was set to 35% by mass. Next, after forming SF3-TRZ to a thickness of 10 nm, Liq and SF3-TRZ were co-deposited from different deposition sources to form a layer with a thickness of 30 nm. The contents of Liq and SF3-TRZ in this layer were set to 30% by mass and 70% by mass, respectively. Furthermore, Liq was formed to a thickness of 2 nm, and then aluminum (Al) was vapor-deposited to a thickness of 100 nm to form a cathode, thereby producing an organic electroluminescent element. This element is referred to as an EL element 1 . In addition, organic electroluminescent elements were produced by the same procedure except that compounds 6b, 19b, and 22 were used instead of compound 1b, and these were respectively referred to as EL elements 2 to 4. Furthermore, only the point of using Comparative Compound A and Comparative Compound B instead of Compound 1b was changed, and organic electroluminescent devices were produced by the same procedure, and these were respectively referred to as Comparative EL Device 1 and Comparative EL Device 2 . Electricity was applied to each of the produced organic electroluminescence elements, and as a result, delayed fluorescence derived from the delayed fluorescent material (T132) was observed. Each organic electroluminescence element was driven at a current density of 12.6 mA/cm 2 , and the time until the emission intensity became 95% of that at the start of driving (LT95) was measured. The measurement results are shown in Table 2. LT95 in Table 2 is shown as a relative value when LT95 of Comparative EL element 2 is set to 1. As a result of the measurement, it was found that when the compound represented by the general formula (1) was used as an electron barrier material, the device life was remarkably longer than that of Comparative Compound A or Comparative Compound B, which was conventionally used as an electron barrier material.

[表2] 元件號碼 電子障壁材料 LT95 EL元件1 化合物1b 2.01倍 EL元件2 化合物6b 1.77倍 EL元件3 化合物19b 1.40倍 EL元件4 化合物22 1.32倍 比較EL元件1 比較化合物A 1.23倍 比較EL元件2 比較化合物B 1 [Table 2] Part number Electron barrier material LT95 EL element 1 Compound 1b 2.01 times EL element 2 Compound 6b 1.77 times EL element 3 Compound 19b 1.40 times EL element 4 Compound 22 1.32 times Compare EL Elements 1 Comp A 1.23 times Compare EL Elements 2 Comp B 1

(實施例2) 變更將實施例1的發光層替換成將主體材料(H1)、延遲螢光材料(T132)及螢光材料(E1)從不同之蒸鍍源進行共蒸鍍且其含量依序為64.2質量%、35.0質量%、0.8質量%之厚度40nm的發光層這一點,除此以外,藉由與實施例1相同的步驟製作了有機電致發光元件。將該元件設為EL元件5。 又,僅變更使用化合物2b、19b來代替化合物1b之點,除此以外,藉由相同的步驟製作有機電致發光元件,並將其分別設為EL元件6、7。 對所製作之各有機電致發光元件進行通電,其結果,觀測到來自於螢光材料(E1)之延遲螢光。以6.3mA/cm 2驅動所製作之有機電致發光元件,並測定了外部量子效率(EQE)和初始驅動電壓,並且以電流密度12.6mA/cm 2驅動各有機電致發光元件,並測定了發光強度成為驅動開始時的95%為止的時間(LT95)。將測定結果示於表3中。表3的EQE和LT95作為將EL元件7的LT95設為1時的相對值而示出,驅動電壓以將EL元件7為基準(0)之相對值示出。測定結果表明,即使在發光層中使用了主體材料、延遲螢光材料及螢光材料之情況下,將通式(1)所表示之化合物用作電子障壁材料之元件的發光效率均高,驅動電壓均低,元件壽命均長。 (Example 2) The light-emitting layer in Example 1 was changed to co-evaporate the host material (H1), delayed fluorescent material (T132) and fluorescent material (E1) from different evaporation sources and their contents depend on An organic electroluminescent device was fabricated by the same procedure as in Example 1 except that the light-emitting layer with a thickness of 40 nm was 64.2 mass %, 35.0 mass %, and 0.8 mass %. This element is referred to as the EL element 5 . Also, except for changing the point of using compounds 2b and 19b instead of compound 1b, organic electroluminescence elements were fabricated by the same procedure, and these were used as EL elements 6 and 7, respectively. As a result of energizing each produced organic electroluminescence element, delayed fluorescence from the fluorescent material (E1) was observed. The organic electroluminescent element was driven at 6.3mA/ cm2 , and the external quantum efficiency (EQE) and initial driving voltage were measured, and each organic electroluminescent element was driven at a current density of 12.6mA/ cm2 , and the The time until the luminous intensity becomes 95% of that at the start of driving (LT95). The measurement results are shown in Table 3. EQE and LT95 in Table 3 are shown as relative values when LT95 of the EL element 7 is set to 1, and the driving voltage is shown as a relative value with the EL element 7 as a reference (0). The measurement results show that even when the host material, delayed fluorescent material and fluorescent material are used in the light-emitting layer, the luminous efficiency of the device using the compound represented by the general formula (1) as the electron barrier material is high, and the drive The voltage is low and the component life is long.

[表3] 元件號碼 電子障壁材料 EQE(%) 驅動電壓(V) LT95 EL元件5 化合物1b 0.93倍 0.06 1.2倍 EL元件6 化合物2b 0.93倍 -0.09 1.2倍 EL元件7 化合物19b 1 0 1 [table 3] Part number Electron barrier material EQE (%) Driving voltage (V) LT95 EL element 5 Compound 1b 0.93 times 0.06 1.2 times EL element 6 Compound 2b 0.93 times -0.09 1.2 times EL element 7 Compound 19b 1 0 1

(實施例3) 變更將實施例1的發光層替換成將主體材料(H1)和延遲螢光材料(T136)從不同之蒸鍍源進行共蒸鍍且其含量依序為65質量%、35質量%之厚度40nm的發光層這一點,除此以外,藉由與實施例1相同的步驟製作了有機電致發光元件。將該元件設為EL元件8。 又,僅變更使用化合物2b來代替化合物1b之點,除此以外,藉由相同的步驟製作有機電致發光元件,並將其分別設為EL元件9。 對所製作之各有機電致發光元件進行通電,其結果,觀測到來自於延遲螢光材料(T136)之延遲螢光。以6.3mA/cm 2驅動所製作之有機電致發光元件,並測定了外部量子效率(EQE)和初始驅動電壓。又,以電流密度12.6mA/cm 2驅動各有機電致發光元件,並測定了發光強度成為驅動開始時的95%為止的時間(LT95)。將測定結果示於表4中。表4的EQE和LT95作為將EL元件9的LT95設為1時的相對值而示出,驅動電壓以將EL元件9為基準(0)之相對值示出。測定結果表明,即使在使用了與實施例1不同之延遲螢光材料之情況下,將通式(1)所表示之化合物用作電子障壁材料之元件的發光效率均高,驅動電壓均低,元件壽命均長。 (Example 3) The light-emitting layer in Example 1 was changed to co-evaporate the host material (H1) and delayed fluorescent material (T136) from different evaporation sources, and the contents were 65% by mass, 35% by mass, An organic electroluminescent device was produced by the same procedure as in Example 1 except that the light emitting layer had a thickness of 40 nm in mass %. This element is referred to as the EL element 8 . Also, except for changing the point of using compound 2b instead of compound 1b, organic electroluminescent elements were produced by the same procedure, and these were respectively used as EL elements 9 . Electricity was applied to each of the produced organic electroluminescence elements, and as a result, delayed fluorescence derived from the delayed fluorescent material (T136) was observed. The fabricated organic electroluminescent element was driven at 6.3mA/cm 2 , and the external quantum efficiency (EQE) and initial driving voltage were measured. Also, each organic electroluminescence element was driven at a current density of 12.6 mA/cm 2 , and the time until the emission intensity became 95% of that at the start of driving was measured (LT95). The measurement results are shown in Table 4. EQE and LT95 in Table 4 are shown as relative values when LT95 of the EL element 9 is set to 1, and the driving voltage is shown as a relative value with the EL element 9 as a reference (0). The measurement results show that even when a delayed fluorescent material different from that of Example 1 is used, the luminous efficiency of the device using the compound represented by the general formula (1) as the electron barrier material is high, and the driving voltage is low. Component life is long.

[表4] 元件號碼 電子障壁材料 EQE(%) 驅動電壓(V) LT95 EL元件8 化合物1b 0.96倍 -0.06 1.4倍 EL元件9 化合物2b 1 0 1 [Table 4] Part number Electron barrier material EQE (%) Driving voltage (V) LT95 EL element 8 Compound 1b 0.96 times -0.06 1.4 times EL element 9 Compound 2b 1 0 1

(實施例4) 藉由真空蒸鍍法,在形成有由膜厚50nm的氧化銦錫(ITO)組成之陽極之玻璃基板上,以真空度5.0×10 -5Pa積層以下各薄膜,從而製作了有機電致發光元件。 首先,在ITO上形成60nm厚度的HAT-CN,在其上形成30nm厚度的TrsPCz,進而在其上形成5nm厚度的PYD2Cz。接著,將主體材料(參考化合物a)和延遲螢光材料(T3)從不同之蒸鍍源進行共蒸鍍,從而形成30nm厚度的層,並將其設為發光層。此時,主體材料的含量設為70質量%,延遲螢光材料的含量設為30質量%。接著,將SF3-TRZ形成為10nm厚度之後,將Liq和SF3-TRZ從不同之蒸鍍源進行共蒸鍍,從而形成30nm厚度的層。該層中之Liq和SF3-TRZ的含量分別設為30質量%和70質量%。進而,將Liq形成為2nm厚度,接著將鋁(Al)蒸鍍為100nm厚度以形成陰極,從而製作了有機電致發光元件。將該元件設為參考EL元件1。 以2mA/cm 2驅動所製作之有機電致發光元件,並測定了外部量子效率(EQE),其結果,顯示出21.9%的高值。藉此,可知參考化合物a為作為主體材料優異之材料。 另一方面,僅變更使用化合物1a來代替PYD2Cz之點,除此以外,藉由相同的步驟製作有機電致發光元件,並將其設為參考EL元件2。以2mA/cm 2驅動所製作之有機電致發光元件,並測定了外部量子效率(EQE),其結果,降低至17.1%。因此,可知參考化合物a不適合作為電子障壁材料。 以上結果表明,即使為有用的主體材料,作為電子障壁材料亦無用,不容易發現有用的電子障壁材料。 [化學式134]

Figure 02_image399
[產業上之可利用性] (Example 4) The following thin films were laminated at a vacuum degree of 5.0×10 -5 Pa on a glass substrate on which an anode composed of indium tin oxide (ITO) with a film thickness of 50 nm was formed by vacuum evaporation to produce organic electroluminescent elements. First, HAT-CN with a thickness of 60nm was formed on ITO, TrsPCz with a thickness of 30nm was formed on it, and PYD2Cz with a thickness of 5nm was formed thereon. Next, the host material (reference compound a) and the retarded fluorescent material (T3) were co-evaporated from different deposition sources to form a layer with a thickness of 30 nm, which was used as a light-emitting layer. At this time, the content of the host material was set to 70% by mass, and the content of the delayed fluorescent material was set to 30% by mass. Next, after forming SF3-TRZ to a thickness of 10 nm, Liq and SF3-TRZ were co-deposited from different deposition sources to form a layer with a thickness of 30 nm. The contents of Liq and SF3-TRZ in this layer were set to 30% by mass and 70% by mass, respectively. Furthermore, Liq was formed to a thickness of 2 nm, and then aluminum (Al) was vapor-deposited to a thickness of 100 nm to form a cathode, thereby producing an organic electroluminescent element. This element was set as a reference EL element 1 . The produced organic electroluminescent element was driven at 2mA/cm 2 , and the external quantum efficiency (EQE) was measured. As a result, it showed a high value of 21.9%. From this, it can be seen that the reference compound a is an excellent material as a host material. On the other hand, an organic electroluminescent element was produced by the same procedure except that the compound 1a was used instead of PYD2Cz, and this was used as a reference EL element 2 . The produced organic electroluminescent device was driven at 2mA/cm 2 , and the external quantum efficiency (EQE) was measured. As a result, it decreased to 17.1%. Therefore, it can be seen that the reference compound a is not suitable as an electron barrier material. The above results show that even if it is a useful host material, it is useless as an electron barrier material, and it is not easy to find a useful electron barrier material. [chemical formula 134]
Figure 02_image399
[Industrial availability]

通式(1)所表示之化合物作為電子障壁材料有用,並且能夠用於有機半導體元件中。只要將本發明的化合物用於有機電致發光元件的電子障壁層中,則能夠延長元件壽命。因此,本發明的產業上之可利用性高。The compound represented by the general formula (1) is useful as an electron barrier material and can be used in an organic semiconductor device. When the compound of the present invention is used in the electron barrier layer of an organic electroluminescence element, the lifetime of the element can be extended. Therefore, the industrial applicability of this invention is high.

Figure 111123192-A0101-11-0001-2
Figure 111123192-A0101-11-0001-2

Claims (16)

一種由下述通式(1)所表示之化合物作為電子障壁材料的用途, [化學式1]
Figure 03_image401
式中,R 1~R 5分別獨立地表示氘原子或不包含氰基的取代基,R 1~R 5不與其他R 1~R 5或Ar鍵結而形成環狀結構,但是相鄰之R 3彼此可以相互鍵結而形成苯并氟骨架或苯并噻吩并骨架,n1、n3、n5分別獨立地表示0~4中的任一個整數,n2表示0~3中的任一個整數,n4表示0~2中的任一個整數,X表示氧原子或硫原子,Ar表示單環伸芳基或單環雜伸芳基,前述單環伸芳基及前述單環雜伸芳基可以經氘原子或不包含氰基的取代基取代。
A use of a compound represented by the following general formula (1) as an electron barrier material, [Chemical Formula 1]
Figure 03_image401
In the formula, R 1 to R 5 independently represent a deuterium atom or a substituent that does not contain a cyano group, and R 1 to R 5 do not bond with other R 1 to R 5 or Ar to form a ring structure, but adjacent R3 can be bonded to each other to form a benzofluorine skeleton or a benzothieno skeleton, n1, n3, and n5 independently represent any integer from 0 to 4, n2 represents any integer from 0 to 3, and n4 Represents any integer from 0 to 2, X represents an oxygen atom or a sulfur atom, Ar represents a monocyclic aryl or a monocyclic heteroaryl, the aforementioned monocyclic aryl and the aforementioned monocyclic heteroaryl can be deuterated Atoms or substituents that do not contain cyano groups.
如請求項1所述之作為電子障壁材料的用途,其中 前述化合物具有下述通式(2A)所表示之結構, [化學式2]
Figure 03_image403
式中,R 1~R 6分別獨立地表示氘原子或不包含氰基的取代基,R 1~R 6不與其他R 1~R 6鍵結而形成環狀結構,但是相鄰之R 3彼此可以相互鍵結而形成苯并氟骨架或苯并噻吩并骨架,n1、n3、n5分別獨立地表示0~4中的任一個整數,n2、n6分別獨立地表示0~3中的任一個整數,n4表示0~2中的任一個整數,X表示氧原子或硫原子。
The use as an electron barrier material as described in claim 1, wherein the aforementioned compound has a structure represented by the following general formula (2A), [chemical formula 2]
Figure 03_image403
In the formula, R 1 to R 6 independently represent a deuterium atom or a substituent that does not contain a cyano group, and R 1 to R 6 do not bond with other R 1 to R 6 to form a ring structure, but the adjacent R 3 They can be bonded to each other to form a benzofluorine skeleton or a benzothieno skeleton, n1, n3, and n5 independently represent any integer from 0 to 4, and n2 and n6 independently represent any one of 0 to 3 Integer, n4 represents any integer from 0 to 2, and X represents an oxygen atom or a sulfur atom.
如請求項1所述之作為電子障壁材料的用途,其中 前述化合物具有下述通式(2B)所表示之結構, [化學式3]
Figure 03_image405
式中,R 1~R 6分別獨立地表示氘原子或不包含氰基的取代基,R 1~R 6不與其他R 1~R 6鍵結而形成環狀結構,但是相鄰之R 3彼此可以相互鍵結而形成苯并氟骨架或苯并噻吩并骨架,n1、n3、n5分別獨立地表示0~4中的任一個整數,n2、n6分別獨立地表示0~3中的任一個整數,n4表示0~2中的任一個整數,X表示氧原子或硫原子。
The use as an electron barrier material as described in claim 1, wherein the aforementioned compound has a structure represented by the following general formula (2B), [chemical formula 3]
Figure 03_image405
In the formula, R 1 to R 6 independently represent a deuterium atom or a substituent that does not contain a cyano group, and R 1 to R 6 do not bond with other R 1 to R 6 to form a ring structure, but the adjacent R 3 They can be bonded to each other to form a benzofluorine skeleton or a benzothieno skeleton, n1, n3, and n5 independently represent any integer from 0 to 4, and n2 and n6 independently represent any one of 0 to 3 Integer, n4 represents any integer from 0 to 2, and X represents an oxygen atom or a sulfur atom.
如請求項1所述之作為電子障壁材料的用途,其中 前述化合物具有下述通式(3)所表示之結構, [化學式4]
Figure 03_image407
式中,R 1~R 6分別獨立地表示氘原子或不包含氰基的取代基,R 1~R 6不與其他R 1~R 6鍵結而形成環狀結構,但是相鄰之R 3彼此可以相互鍵結而形成苯并氟骨架或苯并噻吩并骨架,n1、n3、n5分別獨立地表示0~4中的任一個整數,n2、n6分別獨立地表示0~3中的任一個整數,n4表示0~2中的任一個整數,其中,n1+n3+n4+n5為1以上,R 1及R 3~R 5中的一個或兩個表示可以被氘化的烷基或可以經氘原子取代的苯基,X表示氧原子或硫原子。
The use as an electron barrier material as described in claim 1, wherein the aforementioned compound has a structure represented by the following general formula (3), [chemical formula 4]
Figure 03_image407
In the formula, R 1 to R 6 independently represent a deuterium atom or a substituent that does not contain a cyano group, and R 1 to R 6 do not bond with other R 1 to R 6 to form a ring structure, but the adjacent R 3 They can be bonded to each other to form a benzofluorine skeleton or a benzothieno skeleton, n1, n3, and n5 independently represent any integer from 0 to 4, and n2 and n6 independently represent any one of 0 to 3 Integer, n4 represents any integer from 0 to 2, wherein, n1+n3+n4+n5 is more than 1, and one or two of R 1 and R 3 to R 5 represent an alkyl group that can be deuterated or can be deuterated A phenyl group substituted with a deuterium atom, X represents an oxygen atom or a sulfur atom.
如請求項2所述之作為電子障壁材料的用途,其中 n1、n2、n6為0。 Use as an electron barrier material as described in Claim 2, wherein n1, n2, and n6 are 0. 如請求項1所述之作為電子障壁材料的用途,其中 n3~n5分別獨立地為0或1。 Use as an electron barrier material as described in Claim 1, wherein n3 to n5 are each independently 0 or 1. 如請求項1所述之作為電子障壁材料的用途,其係具有下述中的任一個結構, [化學式5]
Figure 03_image409
The use as an electron barrier material as described in claim 1, which has any one of the following structures, [chemical formula 5]
Figure 03_image409
.
如請求項1至請求項7之任一項所述之作為電子障壁材料的用途,其係用於與下述通式(G)所表示之化合物組合使用, 通式(G) [化學式6]
Figure 03_image016
在通式(G)中,X 1及X 2中的一者為氮原子,另一者為硼原子,R 1~R 26、A 1、A 2分別獨立地表示氫原子、氘原子或取代基,R 1和R 2、R 2和R 3、R 3和R 4、R 4和R 5、R 5和R 6、R 6和R 7、R 7和R 8、R 8和R 9、R 9和R 10、R 10和R 11、R 11和R 12、R 13和R 14、R 14和R 15、R 15和R 16、R 16和R 17、R 17和R 18、R 18和R 19、R 19和R 20、R 20和R 21、R 21和R 22、R 22和R 23、R 23和R 24、R 24和R 25、R 25和R 26可以彼此鍵結而形成環狀結構,其中,在X 1為氮原子時,R 17和R 18彼此鍵結而形成單鍵以形成吡咯環,在X 2為氮原子時,R 21和R 22彼此鍵結而形成單鍵以形成吡咯環。
The use as an electron barrier material as described in any one of claim 1 to claim 7, which is used in combination with a compound represented by the following general formula (G), general formula (G) [chemical formula 6]
Figure 03_image016
In the general formula (G), one of X 1 and X 2 is a nitrogen atom, the other is a boron atom, and R 1 to R 26 , A 1 , and A 2 independently represent a hydrogen atom, a deuterium atom or a substituted R 1 and R 2 , R 2 and R 3 , R 3 and R 4 , R 4 and R 5 , R 5 and R 6 , R 6 and R 7 , R 7 and R 8 , R 8 and R 9 , R 9 and R 10 , R 10 and R 11 , R 11 and R 12 , R 13 and R 14 , R 14 and R 15 , R 15 and R 16 , R 16 and R 17 , R 17 and R 18 , R 18 and R 19 , R 19 and R 20 , R 20 and R 21 , R 21 and R 22 , R 22 and R 23 , R 23 and R 24 , R 24 and R 25 , R 25 and R 26 may be bonded to each other and A ring structure is formed in which, when X1 is a nitrogen atom, R17 and R18 are bonded to each other to form a single bond to form a pyrrole ring, and when X2 is a nitrogen atom, R21 and R22 are bonded to each other to form single bond to form the pyrrole ring.
一種有機半導體元件,其係包含請求項1至請求項7之任一項所述之化合物。An organic semiconductor device comprising the compound described in any one of claim 1 to claim 7. 如請求項9所述之有機半導體元件,其中 前述有機半導體元件為有機電致發光元件,該有機電致發光元件具有陽極、陰極及在前述陽極與前述陰極之間包括包含前述電子障壁材料之電子障壁層和發光層之至少兩層有機層。 The organic semiconductor device according to claim 9, wherein The aforementioned organic semiconductor element is an organic electroluminescent element, which has an anode, a cathode, and at least two organic layers comprising an electron barrier layer and a light-emitting layer comprising the aforementioned electron barrier material between the aforementioned anode and the aforementioned cathode. 如請求項10所述之有機半導體元件,其中 前述發光層包含主體材料和延遲螢光材料。 The organic semiconductor device according to claim 10, wherein The aforementioned light-emitting layer includes a host material and a delayed fluorescent material. 如請求項10所述之有機半導體元件,其中 前述發光層包含主體材料、延遲螢光材料及螢光發光材料,來自元件的發光中來自前述螢光發光材料的發光量最大。 The organic semiconductor device according to claim 10, wherein The light-emitting layer includes a host material, a delayed fluorescent material, and a fluorescent light-emitting material, and the amount of light emitted from the fluorescent light-emitting material is the largest among the light emitted from the device. 如請求項10所述之有機半導體元件,其中 前述發光層與前述電子障壁層相鄰。 The organic semiconductor device according to claim 10, wherein The aforementioned light emitting layer is adjacent to the aforementioned electron barrier layer. 如請求項10至請求項13之任一項所述之有機半導體元件,其中 前述發光層包含下述通式(G)所表示之化合物, 通式(G) [化學式7]
Figure 03_image016
在通式(G)中,X 1及X 2中的一者為氮原子,另一者為硼原子,R 1~R 26、A 1、A 2分別獨立地表示氫原子、氘原子或取代基,R 1和R 2、R 2和R 3、R 3和R 4、R 4和R 5、R 5和R 6、R 6和R 7、R 7和R 8、R 8和R 9、R 9和R 10、R 10和R 11、R 11和R 12、R 13和R 14、R 14和R 15、R 15和R 16、R 16和R 17、R 17和R 18、R 18和R 19、R 19和R 20、R 20和R 21、R 21和R 22、R 22和R 23、R 23和R 24、R 24和R 25、R 25和R 26可以彼此鍵結而形成環狀結構,其中,在X 1為氮原子時,R 17和R 18彼此鍵結而形成單鍵以形成吡咯環,在X 2為氮原子時,R 21和R 22彼此鍵結而形成單鍵以形成吡咯環。
The organic semiconductor device according to any one of claim 10 to claim 13, wherein the light-emitting layer comprises a compound represented by the following general formula (G), general formula (G) [chemical formula 7]
Figure 03_image016
In the general formula (G), one of X 1 and X 2 is a nitrogen atom, the other is a boron atom, and R 1 to R 26 , A 1 , and A 2 independently represent a hydrogen atom, a deuterium atom or a substituted R 1 and R 2 , R 2 and R 3 , R 3 and R 4 , R 4 and R 5 , R 5 and R 6 , R 6 and R 7 , R 7 and R 8 , R 8 and R 9 , R 9 and R 10 , R 10 and R 11 , R 11 and R 12 , R 13 and R 14 , R 14 and R 15 , R 15 and R 16 , R 16 and R 17 , R 17 and R 18 , R 18 and R 19 , R 19 and R 20 , R 20 and R 21 , R 21 and R 22 , R 22 and R 23 , R 23 and R 24 , R 24 and R 25 , R 25 and R 26 may be bonded to each other and A ring structure is formed in which, when X1 is a nitrogen atom, R17 and R18 are bonded to each other to form a single bond to form a pyrrole ring, and when X2 is a nitrogen atom, R21 and R22 are bonded to each other to form single bond to form the pyrrole ring.
如請求項10至請求項13之任一項所述之有機半導體元件,其中 前述發光層包含下述通式(4)所表示之化合物, [化學式8]
Figure 03_image413
在通式(4)中,R 21~R 23中的一個表示氰基或下述通式(5)所表示之基團,R 21~R 23的其餘兩個和R 24及R 25中的至少一個表示下述通式(6)所表示之基團,R 21~R 25的其餘部分表示氫原子或取代基,其中,在此所述之取代基不是氰基、下述通式(5)所表示之基團、下述通式(6)所表示之基團, [化學式9]
Figure 03_image415
在通式(5)中,L 1表示單鍵或2價的連接基,R 31及R 32分別獨立地表示氫原子或取代基,*表示鍵結位置, [化學式10]
Figure 03_image417
在通式(6)中,L 2表示單鍵或2價的連接基,R 33及R 34分別獨立地表示氫原子或取代基,*表示鍵結位置。
The organic semiconductor device according to any one of claim 10 to claim 13, wherein the light-emitting layer comprises a compound represented by the following general formula (4), [Chemical formula 8]
Figure 03_image413
In general formula (4), one of R 21 to R 23 represents a cyano group or a group represented by the following general formula (5), the other two of R 21 to R 23 and R 24 and R 25 At least one represents a group represented by the following general formula (6), and the rest of R 21 to R 25 represent hydrogen atoms or substituents, wherein the substituents mentioned here are not cyano groups, the following general formula (5 ), the group represented by the following general formula (6), [chemical formula 9]
Figure 03_image415
In the general formula (5), L 1 represents a single bond or a divalent linking group, R 31 and R 32 independently represent a hydrogen atom or a substituent, * represents a bonding position, [Chemical Formula 10]
Figure 03_image417
In the general formula (6), L 2 represents a single bond or a divalent linking group, R 33 and R 34 each independently represent a hydrogen atom or a substituent, and * represents a bonding position.
一種化合物,其係由下述通式(3)表示, [化學式11]
Figure 03_image419
式中,R 1~R 6分別獨立地表示氘原子或不包含氰基的取代基,R 1~R 5不與其他R 1~R 6鍵結而形成環狀結構,但是相鄰之R 3彼此可以相互鍵結而形成苯并氟骨架或苯并噻吩并骨架,n1、n3、n5分別獨立地表示0~4中的任一個整數,n2、n6分別獨立地表示0~3中的任一個整數,n4表示0~2中的任一個整數,其中,n1+n3+n4+n5為1以上,R 1及R 3~R 5中的一個或兩個表示可以被氘化的烷基或可以經氘原子取代的苯基,X表示氧原子或硫原子,其中,在n3+n4+n5為0時,R 1不是未經取代的苯基。
A compound represented by the following general formula (3), [Chemical Formula 11]
Figure 03_image419
In the formula, R 1 to R 6 independently represent a deuterium atom or a substituent that does not contain a cyano group, and R 1 to R 5 do not bond with other R 1 to R 6 to form a ring structure, but the adjacent R 3 They can be bonded to each other to form a benzofluorine skeleton or a benzothieno skeleton, n1, n3, and n5 independently represent any integer from 0 to 4, and n2 and n6 independently represent any one of 0 to 3 Integer, n4 represents any integer from 0 to 2, wherein, n1+n3+n4+n5 is more than 1, and one or two of R 1 and R 3 to R 5 represent an alkyl group that can be deuterated or can be deuterated A phenyl group substituted by a deuterium atom, X represents an oxygen atom or a sulfur atom, wherein, when n3+n4+n5 is 0, R1 is not an unsubstituted phenyl group.
TW111123192A 2021-06-23 2022-06-22 Electron barrier material, organic semiconductor element and compound TW202313931A (en)

Applications Claiming Priority (20)

Application Number Priority Date Filing Date Title
JP2021-103702 2021-06-23
JP2021103702 2021-06-23
JP2021151805 2021-09-17
JP2021-151805 2021-09-17
JP2021-157765 2021-09-28
JP2021157765 2021-09-28
JP2021-188860 2021-11-19
JP2021188860 2021-11-19
JP2021209760 2021-12-23
JP2021-209760 2021-12-23
JP2022-068629 2022-04-19
JP2022068629 2022-04-19
JP2022-068628 2022-04-19
JP2022068628 2022-04-19
JP2022073953 2022-04-28
JP2022-073953 2022-04-28
JP2022-087873 2022-05-30
JP2022087873 2022-05-30
PCT/JP2022/023781 WO2022270354A1 (en) 2021-06-23 2022-06-14 Compound, light-emitting material, and organic light-emitting element
WOPCT/JP2022/023781 2022-06-14

Publications (1)

Publication Number Publication Date
TW202313931A true TW202313931A (en) 2023-04-01

Family

ID=84544405

Family Applications (1)

Application Number Title Priority Date Filing Date
TW111123192A TW202313931A (en) 2021-06-23 2022-06-22 Electron barrier material, organic semiconductor element and compound

Country Status (3)

Country Link
JP (1) JPWO2022270592A1 (en)
TW (1) TW202313931A (en)
WO (1) WO2022270592A1 (en)

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20130084093A (en) * 2012-01-16 2013-07-24 롬엔드하스전자재료코리아유한회사 Novel organic electroluminescence compounds and organic electroluminescence device using the same
WO2013179645A1 (en) * 2012-05-30 2013-12-05 出光興産株式会社 Organic-electroluminescent-element material, and organic electroluminescent element using same
KR101985588B1 (en) * 2017-06-21 2019-06-03 성균관대학교산학협력단 Delayed fluorescence material and organic light emitting device having the delayed fluorescence material as a host material or a dopant material in light emitting layer of the organic light emitting device
CN110272427B (en) * 2018-03-14 2022-03-29 江苏三月科技股份有限公司 Compound with fluorene as core, preparation method thereof and application thereof in organic electroluminescent device
CN111560031A (en) * 2019-02-13 2020-08-21 学校法人关西学院 Polycyclic aromatic compound, reactive compound, polymer compound, crosslinked polymer, and use thereof
CN110872316B (en) * 2019-11-29 2021-09-17 清华大学 Novel compound, application thereof and organic electroluminescent device using compound
CN112940023A (en) * 2019-12-11 2021-06-11 北京鼎材科技有限公司 Organic compound, application thereof and organic electroluminescent device adopting organic compound
CN115280534A (en) * 2020-02-04 2022-11-01 九州有机光材股份有限公司 Composition, film, organic light-emitting element, method for providing light-emitting composition, and program

Also Published As

Publication number Publication date
WO2022270592A1 (en) 2022-12-29
JPWO2022270592A1 (en) 2022-12-29

Similar Documents

Publication Publication Date Title
WO2023282224A1 (en) Organic light-emitting element and design method therefor
WO2023140130A1 (en) Compound, light-emitting material and organic light-emitting device
JP7152805B1 (en) Compounds, compositions, host materials, electron barrier materials and organic light-emitting devices
TW202334159A (en) Compound, light-emitting material, and light-emitting element
WO2022168825A1 (en) Organic electroluminescence element, method for designing luminous composition, and program
WO2022270113A1 (en) Organic electroluminescent element
JP2023097788A (en) Compound, light-emitting material and light-emitting device
TW202313931A (en) Electron barrier material, organic semiconductor element and compound
WO2023276918A1 (en) Compound, electronic barrier material, and organic semiconductor element and compound
JP7461095B1 (en) Organic light-emitting device, design method thereof and program
WO2022270591A1 (en) Compound, composition, host material, electron barrier material and organic light emitting element
JP7222159B2 (en) Compounds, luminescent materials and organic light-emitting devices
WO2023053835A1 (en) Compound, composition, host material, electron barrier material and organic light emitting element
WO2022168956A1 (en) Compound, light-emitting material, and organic light-emitting element
CN117546634A (en) Electron blocking material, organic semiconductor element, and compound
JP2023089875A (en) Compound, composition, host material, and organic light-emitting element
TW202317592A (en) Organic light-emitting element and film
TW202317591A (en) Organic light emitting element and film
WO2023166883A1 (en) Compound, light-emitting material and light-emitting element
WO2023112808A1 (en) Compound, host material, electron barrier material, composition and organic light emitting element
CN117546630A (en) Organic light-emitting element and film
WO2023079993A1 (en) Compound, composition, host material, and organic electroluminescent element
JP2023159034A (en) Compound, host material, composition, and organic light-emitting element
WO2023120062A1 (en) Electronic barrier material and organic semiconductor element
JP2024123555A (en) Compound, light-emitting material and light-emitting device